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Abstract
 Prostate apoptosis response factor-4 (Par-4) is a ubiquitously expressed pro-apoptotic and 
tumour suppressive protein. Par-4 contains a highly  conserved coiled coil (CC) region at the C-
terminus, particularly the distal 40 residues fulfil the criteria for a leucine zipper (LZ). This C-
terminal domain serves as the primary recognition domain for a large number of binding 
partners. Par-4 is tightly regulated by the aforementioned binding partners and also by post-
translational modifications. Biophysical data presented here describe Par-4 as primarily  an 
intrinsically disordered protein (IDP). Bioinformatic analysis of the highly conserved Par-4 
reveals low sequence complexity and enrichment in polar and charged amino acids. High 
proteolytic susceptibility  and increased hydrodynamic radii are consistent with largely extended 
structures in solution. Spectroscopic measurements using circular dichroism (CD) and nuclear 
magnetic resonance (NMR) also reveal characteristic features of intrinsic disorder. Under 
physiological conditions, data show that Par-4 self-associates via the C-terminal domain possibly 
through coiled coil formation. Analysis of various constructs comprising the Par-4 LZ domain by 
NMR, CD, light scattering and other techniques reveals an environment-dependent con-
formational equilibrium between primarily disordered monomers and predominantly coiled coil 
dimers. Whereas the disordered monomers are easily observed by NMR, the coiled coil fraction 
is not  amenable to NMR studies possibly  due to intermediate exchange processes. Mutational 
approaches that stabilise the coiled coil fraction result in NMR spectra of lower quality 
compared to the wild-type form. The high degree of sequence conservation suggest  that coiled 
coil formation and intrinsic disorder are essential for Par-4 to function as an effective regulator 
of apoptosis.
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Glossary of Abbreviations
AXXX Absorption at XXX nm
AATF Apoptosis-antagonising transcription factor
Apaf-1 Apoptotic protease activating factor-1
Amp Ampicillin
Aβ Amyloid β-peptide
aPKC atypical protein kinase C
APP Amyloid precursor protein
AR Androgen receptor
AU Analytical Ultracentrifugation
BACE-1 β-site APP cleaving enzyme-1
BCA Bicinchoninacid
CAD Caspase activated DNase
Cam Chloramphenicol
CARD Caspase activation and recruitment domain
CC Coiled coil
CD Circular dichroism
cFLIP cellular FLICE-like inhibitory protein
CHT1 Choline transporter 1
CM Carboxymethyl
D2DR Dopamine D2 receptor
DAP Death-activated protein kinase
DD Death domain
DED Death effector domains
DIABLO Direct IAP-binding protein with low pI
DISC Death-inducing signalling complex
Dlk DAP like kinase
DLS Dynamic light scattering
DOM Disordered monomer
DTT  Dithiothreitol
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
EDTA Ethylenediaminetetraacetic acid
ER Endoplasmatic reticulum
ERK Extracellular signal regulated kinase
FADD Fas associated death domain
FLICE FADD-like interleukin 1β converting enzyme (= caspase 8)
GRP78 Glucose-regulated protein-78
GST Glutathione S-Transferase
i
HCA Hydrophobic cluster analysis
HMBP-3Cpro Hexa-histidine-MBP-tagged 3C protease
HMQC Heteronuclear multiple-quantum coherence
HSQC Heteronuclear single-quantum coherence
IAP Inhibitors of apoptosis
ICAD Inhibitor of caspase activated DNase
ID Intrinsic disorder
IDP Intrinsically disordered protein
IEC Ion-exchange chromatography
IκB Inhibitor of κB family
IKK IκB kinase
IMAC Immobilised metal ion affinity chromatography
IPTG Isopropyl-β-D-thiogalactopyranoside
Kan Kanamycin
LB Luria Bertani medium
LZ Leucine Zipper
MALLS Multi-Angle Laser Light Scattering
MAPK Mitogen-activated protein kinases
MBP Maltose binding protein
Mes 2-Morpholinoethanesulfonic acid
MOPS 3-(N-Morpholino)propanesulfonic acid
MS Mass spectrometry
MW Molecular weight
MWCO Molecular weight cut off
NFκB Nuclear factor κB
NLS Nuclear localisation sequence
NMR Nuclear magnetic resonance
NOESY Nuclear Overhauser Effect Spectroscopy
NRMSD Normalised root mean square deviation
NTA Nitrilotriacetic acid
ODXXX Optical density at XXX nm
Par-4 Prostate apoptosis response factor-4
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PCD Programmed cell death
PCR Polymerase chain reaction
PI3K Phosphoinositide 3-kinase
PKA, PKB or PKC Protein kinase A, B or C
PML Promyelocytic leukemia
POD Predominantly ordered dimer
ii
PTEN Phosphatase and tensin homolog deleted on chromosome 10
RP-HPLC Reversed phase - high performance liquid chromatography
rpm Revolutions per minute
rrPar-4 recombinant rat Prostate apoptosis response factor-4
RS Stokes radius
rTEV recombinant tobacco etch virus protease
SAC Selective apoptosis induction in cancer cells
SAXS Small-angle X-ray scattering
SEC Size exclusion chromatography
SDS Sodium dodecyl sulphate
SMAC Second mitochondria-derived activator of caspase
SOC Super optimal broth with catabolite repression
SP Sulfopropyl
SSB1, 2, 4 SPRY-domain containing SOCS box proteins 1, 2, 4
TCEP Tris(2-carboxyethyl)phosphine
TFA Trifluoroacetic acid
TFE Trifluoroethanol
Tm Melting temperature
TNFα Tumour necrosis factor α
TNFR1 Tumour necrosis factor receptor 1
TOP1 Topoisomerase 1
TRAIL TNF-related apoptosis inducing ligand
WT Wild type
WT1 Wilm’s tumour protein 1
XIAP X-linked inhibitor of apoptosis
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1. Introduction
1
1.1. The pro-apoptotic protein Par-4 - a tumour-suppressor with biological 
significance
1.1.1. Apoptosis and human disease
 Cell proliferation and cell death are two cellular processes essential for the survival of 
multicellular organisms. Tight control of both these processes is necessary for the evolution of 
differentiated cell types, ensuring the proper balance between various cell lineages. Intricate 
regulation of both processes is required for organogenesis and formation of complex multi-
cellular tissues during embryonic development. Strict regulation is also essential for tissue 
homeostasis throughout the life-span of adult organisms [1,2]. Dying cells are eliminated 
preferentially  without causing an inflammatory response and damaging neighbouring cells. This 
type of regulated cell death is an active cellular suicide process termed programmed cell death 
(PCD) [3]. The most  common form of PCD is a process called apoptosis. A detailed description 
of apoptosis and the involvement of Par-4 will be discussed in Chapter 1.3.
 Disregulation of the intricate balance between cell proliferation and PCD contributes to the 
pathogenesis of a variety of human diseases. Defects in the suppression of PCD can result in an 
uncontrolled loss of essential cells as demonstrated for neurodegenerative disorders, immuno-
deficiency, ischemia [1] and infertility  [2]. In contrast, insufficient PCD may manifest in 
autoimmune diseases or cancer [1]. Tumour development is a multi-step process and results from 
the constitutive stimulation of cell proliferation, by  active growth signalling factors called 
oncogenes [4-6]. In response to constitutively active oncogenes normal cells usually undergo 
apoptosis. However, cancer cells often evade apoptosis because of defects in the PCD machinery. 
A key step  is the inactivation of the so called tumour-suppressor genes. Other important steps in 
carcinogenesis include angiogenesis and the problem of overcoming cell senescence [4]. 
Interestingly, some cancer cells still retain some molecular components of the apoptotic pathway 
[7]. Identification and characterisation of these components would allow the development of 
anti-cancer strategies that reinitiate the apoptotic response without killing normal cells [5]. One 
appealing candidate for this approach is the prostate apoptosis response factor-4 (Par-4) [8].
1.1.2. Discovery of Par-4
 As the name implies, the par-4 gene was initially identified as a gene specifically upregulated 
during apoptosis in rat prostate cancer cells. Metastatic prostate cancer is usually treated by 
androgen ablation as androgens are essential cell survival factors for the majority  of prostate 
cancer cells. However, androgen ablation therapy is rarely  curative as tumours are 
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heterogeneous, containing both androgen-dependent and -independent cancer cells. Whereas 
androgen-dependent cancer cells undergo apoptosis after androgen ablation, androgen-
independent cancer cells are resistant to the therapy and can cause a relapse of prostate cancer 
[9]. Apoptosis in androgen-dependent cancer cells, after androgen ablation, is accompanied by 
intracellular calcium elevation [9], a common event in diverse apoptotic processes [10,11]. 
However, androgen-independent  cancer cells lack elevated intracellular calcium levels after 
androgen ablation, probably due to dysfunctions in upstream pathways. Artificial intracellular 
calcium elevation by the calcium ionophore, ionomycin, was shown to cause apoptosis in 
androgen-independent rat prostate cancer cells (AT-3 cell line) [12]. This prompted the isolation 
of genes that are differentially  induced after ionomycin treatment. The par-4 gene was identified 
as one of five immediate-early response genes associated with ionomycin-induced apoptosis in 
AT-3 cells. Induction of par-4 preceded later steps of apoptosis such as caspase activation, 
chromatin condensation and mitochondrial dysfunction. Upregulation of par-4 was apoptosis 
specific and not induced by growth stimulation, growth arrest or, oxidative stress and necrosis
[13]. Interestingly, induction of par-4 was also detected in androgen-dependent rat prostate 
cancer cells after androgen ablation, indicating that Par-4 may be a common factor in the 
apoptosis program [13].
 A common role for Par-4 in apoptosis is further indicated as it is evolutionary  conserved in 
vertebrates (Chapter 1.2.1.) and ubiquitously expressed in almost all mammalian tissues
[8,14-16]. Par-4 is expressed in healthy  non-apoptotic cells of ecto-, endo- and mesodermal 
origin indicating that the pro-apoptotic function of Par-4 is inhibited in normal cells. 
Downregulation of Par-4 in normal cells has been proposed to be correlated with differentiation. 
Typical examples for cell types with low Par-4 expression levels are neurons, the medulla of the 
adrenal gland, lymphocytes, dense connective tissue and some smooth muscle cells [15].
1.1.3. Par-4 as tumour-suppressor
 Tumour-suppressors play a critical in the development of tumours. Tumour-suppressors are 
defined as genes that (i) if inactivation in vivo leads to enhanced tumour initiation, growth or 
progression and (ii) if a loss of function is accompanied by carcinogenesis [17]. Consistent with 
this definition, Par-4 knock-out mice develop spontaneous tumours in various tissues such as the 
endometrium, liver and lung. Interestingly, heterozygous loss of Par-4 yields the same frequency 
of tumours as does homozygous loss [8].
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 Consistent with this tumour-suppressor definition, downregulation of Par-4 is detected in a 
variety of cancers such as renal-cell carcinomas [18], neuroblastomas [19], leukaemia [20], lung 
carcinomas [21] or endometrial cancers [22]. An involvement of Par-4 in Wilm’s tumourigenesis 
is likely, as this tumour is marked by chromosome reorganisations in the 12q21 region and par-4 
locates to chromosome 12q21.2 [23]. Furthermore, the 12q21 region is unstable and often 
deleted in human male germ cell tumours [24], pancreatic [25] and gastric cancers [8,26]. For 
endometrial cancer it was shown that Par-4 is downregulated by promoter hypermethylation. The 
same study  also identified a single base mutation in exon 3 (Arg 189 to Stop) that caused a 
premature termination of Par-4 and thus resulted in its inactivation [22]. Downregulation of 
Par-4 in other cancers is less well understood, but may be related to the Ras signalling pathway 
[27]. Ras genes are common oncogenes in a number of human cancers [28] and Ras (and also 
Raf or Src) mediated downregulation of Par-4 via the MEK-ERK pathway has been described 
previously  [29]. As will be discussed in the following section, ectopic overexpression of Par-4 
can be sufficient to induce apoptosis in most cancer cell types [8] highlighting Par-4 as a 
potential target for the development of anti-cancer therapies.
1.1.4. Par-4 in neurodegenerative disease
 Apoptosis is an essential cellular process during organ development, in particular for neuronal 
development in the central and peripheral nervous system where it is crucial for controlling 
neuron and glial cell numbers [30]. Par-4 was proposed to prevent hyper-proliferation of neurons 
during embryonic development through asymmetric distribution of Par-4 during mitosis of 
neuronal progenitor cells. Daughter cells with high levels of Par-4 undergo apoptosis, while 
those cells lacking Par-4 differentiate into neurons [31]. However, excessive death of neuron 
populations in the adult brain has been correlated with neurodegenerative disorders such as 
Alzheimer’s disease [32], Parkinson’s disease [33], Huntington’s disease [34], amyotrophic 
lateral sclerosis [35] or HIV encephalitis [36]. Apoptosis and other forms of PCD are relatively 
late events in neurodegenerative processes and are preceded by functional alterations and 
microanatomical deficits (e.g. synapse loss) [37]. Thus, the high levels of Par-4 detected in the 
aforementioned diseases, may not be the primary cause for the diseases, but may  contribute 
significantly to the severity  of the diseases. Similarly, high levels of Par-4 are detected in 
neurons of more acute neurodegenerative conditions such as stroke [38] or epileptic seizures 
[39]. Furthermore, an increase in Par-4 is detected in cultured neurons undergoing apoptosis after 
trophic factor withdrawal, oxidative stress or exposure to metabolic insults [38]. The increase in 
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Par-4 levels in almost  all cases, preceded both caspase activation and mitochondrial dysfunction, 
implying an early function of Par-4 in apoptosis. It  is interesting to note that inhibition of Par-4 
by antisense oligodesoxynucleotides could rescue neuronal cells from apoptosis in most of the 
aforementioned disorder paradigms [40]. Inhibition of Par-4 may  therefore open up new 
therapeutic approaches for acute and chronic neurodegenerative disorders.
1.1.5. Other cellular roles of Par-4
 Despite the potential of Par-4 for the treatment of cancer or neurodegenerative disorders, 
Par-4 is also involved in a variety of other non-apoptotic cellular processes. Facilitation of 
vascular contraction in smooth muscle was demonstrated to be dependent on Par-4 [41]. Par-4 
was also shown to regulate the secretion of immunomodulatory  cytokines such as IL-2. This 
indicates that Par-4 is involved in the stimulation, proliferation and differentiation of B- and T-
cells, and hence plays an important  role in the modulation of the immune response [42]. 
Furthermore, Par-4 appears to be an essential part of synapses. It was shown that Par-4 is 
involved in the uptake of choline into cholinergic neurons and thus in cholinergic signal 
transmission [43]. Additionally, Par-4 has been detected in the postsynaptic density of 
synaptosomes, which form synaptic contacts among neurons. The postsynaptic density is rich in 
cytoskeletal proteins and signalling proteins, and is therefore believed to be a major site for 
modulation of neuronal signal transduction. Thus Par-4 may be involved in synaptic plasticity 
and remodelling regulating the outgrowth of neurites [27,44]. The non-apoptotic role of Par-4 in 
neurons is further supported by  the observation that Par-4 is involved in the development of 
depressive symptoms in mice models [45]. Altering the activity of Par-4, be it activation or 
inhibition, may therefore negatively interfere with the above-mentioned non-apoptotic processes. 
Hence, a precise understanding of the function of Par-4 is therefore necessary for the 
development of new therapies against cancer or neurodegenerative diseases.
1.2. Structure and function of Par-4
1.2.1. Structure of Par-4
 Par-4 is an evolutionary conserved protein in vertebrates. The protein sequences of five Par-4 
orthologues deposited in the UniProt database (www.uniprot.org) are shown in Figure 1.1. The 
sequence identity  of the rat orthologue relative to mouse and human is 92% and 76%, 
respectively, whereas African clawed frog and zebra fish share 52% and 47% sequence identity 
with rat, respectively [46]. As can be seen from Figure 1.1 the degree of sequence similarity is 
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even higher. This high degree of conservation suggests functional significance for Par-4 and thus 
resistance to evolutionary pressure. It further implies that Par-4 is conserved in other vertebrates 
as well. Not surprisingly the anti-rat Par-4 antibody was shown to recognise Par-4 from other 
species [27]. Sequence conservation on the DNA level is less well studied, but a high degree of 
conservation is expected as human and mouse par-4 genes share a similar gene structure 
containing the same number of exons and introns [23,47]. The best described par-4 gene is that 
of the human orthologue. As mentioned above, the human par-4 gene locates to chromosome 
12q21.2 [23]. The gene encompasses 99.1 kb of DNA and consists of seven exons and six 
introns, with the initiation codon being localised to exon 2. Three Par-4 mRNAs of different 
lengths have been detected in human cells but their importance is currently unknown [14,16]. 
Interestingly, co-expression of two Par-4 splice variants was detected in mouse embryonic body 
cells [47]. One variant comprises the full-length Par-4 protein, whereas the second variant lacks 
exon 3. The latter splice variant will be discussed in detail in Chapter 3.6.
 All sequence numbering in this document is made with reference to the rat Par-4 isoform, to 
reflect the recombinant rat (rrPar-4) constructs used here. Rat Par-4 is a 35.9 kDa protein and 
contains 332 amino acids. Sequence analysis predicts two nuclear localisation sequences (NLS) 
in the N-terminal region and a coiled coil (CC) domain at the C-terminus (Fig. 1.1). Both NLS 
(NLS1: residues 20-25; NLS2: residues 137-153) are absolutely conserved in all known Par-4 
sequences. A high degree of conservation is also observed for the CC domain (residue 254-332). 
Especially the leucine zipper (LZ) domain (residues 292-330), which is a subset of the CC 
domain, is highly conserved in all known Par-4 sequences. Interestingly, the CC domain shows 
significant homology to the death domains of other apoptotic proteins such as Fas, RIP, FADD 
and TRADD [48,49]. The biological significance of this observation is unknown and will be 
discussed in Chapter 1.2.3. A nuclear export sequence within the LZ domain has been predicted 
[8], but no functional evidence has yet been shown. A further domain (residues 137-195) shows 
strict sequence conservation in mammals (Fig. 1.1) and due to its properties has been named 
selective apoptosis induction in cancer cells (SAC) [50]. Additionally, several more or less 
conserved phosphorylation sites for the protein kinases A (PKA), B (PKB) and C (PKC), and 
casein kinase II have been predicted [27]. Two functionally important  phosphorylation sites are 
shown in Figure 1.1 for PKA (rat: Thr 155, human: Thr 163, mouse: Thr 156) and PKB (rat: 
Ser 249, human: Ser 231, mouse: Ser 231). Whereas the PKA phosphorylation site is highly 
conserved in mammals the PKB site is not  conserved (Fig. 1.1). As will be discussed later on, the 
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presence of these motifs suggests that the function of Par-4 may be tightly  regulated by 
localisation, post-translational modification and interaction with various binding partners [8].
 Figure 1.1 − Sequence conservation in Par-4. A BLASTP/CLUSTALW [51,52] alignment of sequences 
of Par-4 from various species: rat (Rattus norvegicus), mouse (Mus musculus), human (Homo sapiens), 
African clawed frog (Xenopus laevis), and zebra fish (Danio rero). The amino acids are coloured as 
follows: red (non-polar side chains: Ala, Gly, Ile, Leu, Met, Phe, Pro, Trp and Val), blue (polar side 
chains: Asn, Cys, Gln, Ser, Thr and Tyr), green (polar, charged side chains: Arg, Asp, Glu, His and Lys). 
Symbols mean that (*) residues in that column are identical in all sequences, (:) substitutions are 
conservative, and (.) substitutions are semi-conservative. Referring to numbering of rat Par-4, several 
segments are of notable interest: two nuclear localisation sequences (NLS1 (20-25) and 2 (137-153)) 
which are completely conserved among all known Par-4s, the SAC domain (137-195) which includes 
NLS2 and is defined by being the absolute minimum fragment required for apoptosis induction [50]. The 
C-terminal domain (254-332) is a coiled coil (CC) motif that encompasses a leucine zipper (LZ, 292-330) 
as a subset. Two important phosphorylation sites Thr 155 and Ser 249 are denoted by red arrows. Figure 
and legend taken and adapted from Libich, Schwalbe et. al. [46].
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1.2.2. The pro-apoptotic function of Par-4
 The apoptosis-inducing and -sensitising effects described for Par-4 in the literature are 
complex as they depend on various factors. The most critical factor is the cell type as different 
results are obtained with different cell types. Furthermore, it is important if endogenous Par-4 is 
analysed or if Par-4 is ectopically overexpressed. To summarise most of the results, ectopic 
overexpression of Par-4 selectively  induces apoptosis in hormone-independent cancer cells. No 
apoptosis is induced in hormone-responsive, immortalised or normal cells, however, these cell 
types are sensitised to various pro-apoptotic stimuli such as chemotherapeutic agents, ionising 
radiation, serum deprivation or tumour necrosis factor to name a few. Similarly, endogenous 
Par-4 is not sufficient to induce apoptosis on its own, but  sensitises cancer cells to the action of 
pro-apoptotic agents [8]. It is further important to note that the apoptosis-inducing function 
requires a different mechanism than the apoptosis-sensitising function. The first mechanism 
requires the SAC domain whereas the latter one relies on the presence of a functional LZ 
domain.
 To identify  the domains necessary  for the pro-apoptotic function of Par-4, various N- and C-
terminal Par-4 deletion mutants were created. As coiled coils and leucine zippers are common 
protein oligomerisation motifs, it was assumed that Par-4 exerts its pro-apoptotic function 
through protein-protein interactions via the CC and/or LZ domain. The Par-4 C-terminus was 
shown to be necessary for self-association of Par-4 [48,53,54] and as will be discussed in the 
following section, the majority of Par-4 binding partners interact with the CC region. However, it 
was shown that the CC domain is dispensable for the direct apoptosis-inducing function of Par-4 
[50]. The CC domain is nonetheless essential for the apoptosis-sensitising function of Par-4. 
Cells that are resistant to apoptosis mediated by ectopically overexpressed Par-4 become 
sensitised to a variety of pro-apoptotic stimuli. In contrast, cells overexpressing a LZ deletion 
mutant (comprising residues 1-265) did not enhance apoptosis after exposure to pro-apoptotic 
stimuli [55]. It was further shown in the same study that co-expression of full-length Par-4 with a 
Par-4 CC construct (residues 240-332) rescued cancer cells from Par-4 mediated apoptosis. 
Likewise, neuronal cell lines overexpressing a construct comprising the LZ domain were 
resistant to apoptosis induced by  various pro-apoptotic insults [40]. This indicates that the 
isolated CC domain can act in a dominant-negative manner abrogating the pro-apoptotic function 
of Par-4. It was proposed that the CC construct blocked the interaction of Par-4 with its 
interaction partners either by binding to the CC domain of full-length Par-4 or by direct binding 
to the interaction partners thereby inhibiting full-length Par-4 activity  [55]. Experiments to 
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differentiate between both possibilities, such as immunoprecipitations or fluorescence tech-
niques, have not been conducted yet.
 In contrast to the apoptosis-sensitising function of Par-4 that mainly  depends on a functional 
LZ domain, the apoptosis-inducing function is dependent on two distinct events (i) 
phosphorylation at Thr 155 by PKA and (ii) nuclear entry (Fig. 1.2) [26,50]. In normal and 
immortalised cells PKA activity  is low and not sufficient for Par-4 to induce apoptosis and thus 
cells are resistant to Par-4 mediated apoptosis (Fig. 1.2A). Furthermore, in these cell types Par-4 
is primarily  located to the cytoplasm [14,26]. The mechanisms to retain Par-4 in the cytoplasm or 
for Par-4 inactivation will be discussed in Chapters 1.3.4. and 3.6. Conversely, in most  cancer 
cells PKA isoform I is overexpressed and hence Par-4 is phosphorylated at Thr 155 [26]. 
However, in Par-4-insensitive cancer cells, Par-4 is retained in the cytoplasm and cells are 
resistant to Par-4 mediated apoptosis (Fig. 1.2B). In contrast, in Par-4-sensitive cancer cells 
overexpressed Par-4 localises both to the cytoplasm and the nucleus causing cancer cells to 
undergo apoptosis (Fig. 1.2C). Mutation of Thr 155 to alanine had no effect on the nuclear 
translocation of Par-4 in Par-4-sensitive cancer cells, however, this mutation abolished apoptosis 
induction. These results demonstrated that phospho-Thr 155 is essential for the apoptosis-
inducing function of Par-4 [26]. Not surprisingly Thr 155 is absolutely conserved in vertebrates 
(Fig. 1.1).
 Nuclear translocation of Par-4 is facilitated by  the NLS motifs and precedes induction of 
apoptosis. Par-4 deletion mutants lacking both NLS motifs are incapable of nuclear entry and do 
not promote apoptosis [50]. As mentioned above, nuclear translocation does not depend on 
Thr 155. Interestingly, NLS2 is absolutely required for nuclear translocation of Par-4 [50], 
whereas NLS1 is not. This raises the question: Why is this motif strictly conserved in all known 
Par-4 sequences? (Fig. 1.1), as conserved motifs usually imply  functional significance. It  should 
be noted that the authors [50] failed to analyse a Par-4 construct only containing NLS1 but 
lacking NLS2. Therefore, no conclusions about the nuclear localisation potential of NLS1 can be 
made. Gao and co-workers recently  proposed a role for the 36 N-terminal residues of Par-4 
(including NLS1) as they  demonstrated that this domain binds the Par-4 C-terminus in an 
intramolecular interaction. They suggested that the N-terminus may thereby function in a 
dominant-negative manner impairing homo- and hetero-oligomerisations via the C-terminus and 
thus interfering with the pro-apoptotic function [54].
 Hormone-responsive cancer cells are resistant to nuclear translocation of overexpressed Par-4 
and thus resistant to Par-4 induced apoptosis, even when Par-4 is phosphorylated at Thr 155. 
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Similarly, endogenous Par-4 is retained in the cytoplasm of hormone-independent cancer cells 
preventing apoptosis induction [26]. Cytoplasmic retention is achieved by phosphorylation of 
Par-4 at Ser 249 through PKB and subsequent binding and sequestration by the chaperone 14-3-3 
[56]. This mechanism describes the best studied case, but other mechanisms may exist.
 Figure 1.2 − Model for the cancer-selective apoptosis by Par-4. The two important events, phos-
phorylation at Thr 155 and nuclear entry, necessary for apoptosis induction by Par-4 are schematically 
shown. (A) In normal or immortalised cells Par-4 is in an inactive non-phosphorylated state owing to low 
PKA activity. Furthermore, Par-4 is retained in cytoplasm by an unknown mechanism  and cells are 
viable. (B) In Par-4-insensitive cancer cells despite phosphorylation at Thr 155 through PKA, Par-4 is 
retained in the cytoplasm. One possible sequestration mechanism  involves phosphorylation through PKB, 
but other mechanism may exist. Cytoplasmic sequestration of Par-4 results in cell survival. (C) In Par-4-
sensitive cancer cells phosphorylated Par-4 is able to translocate to the nucleus resulting in apoptosis 
induction. One of the important targets of Par-4 in the nucleus is the pro-survival factor NFκB. Figure 
adapted from Ranganathan & Rangnekar [57].
1.2.3. Two cellular targets are essential for the apoptosis-inducing function of Par-4
 An essential nuclear target of Par-4 is the transcription factor nuclear factor κB (NFκB). 
NFκB is a major pro-survival protein in the cell and regulates the expression of anti-apoptotic 
proteins such as XIAP (X-linked inhibitor of apoptosis), cFLIP (cellular FLICE-like inhibitory 
protein), Bcl-2 or Bcl-XL [8] (Fig. 1.3). NFκB transcriptional activity is induced through various 
cell signalling pathways, including the Ras-pathway [58]. Par-4 is able to inhibit the NFκB 
transcriptional activity in the nucleus, which, depending on the cancer cell type, can be sufficient 
to induce apoptosis [50,59]; particularly  oncogenic Ras expressing cells are sensitive to Par-4 
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induced apoptosis through inhibition of NFκB [60]. The mechanisms by  which Par-4 regulates 
NFκB transcriptional activity  are not well understood. Although, it is known that inhibition 
occurs without disruption of the NFκB DNA-binding capacity [60], and may be localised to the 
transactivation domain of NFκB [27]. It  was further shown that the Par-4 LZ domain is 
dispensable for this inhibition [50].
 Another essential cellular target of Par-4 is the Fas receptor. Par-4 was shown to induce the 
translocation of Fas and the Fas ligand (FasL) to the cell surface thereby activating the Fas-
pathway (Chapter 1.3.3.). As inhibition of NFκB transcriptional activity  is not sufficient to 
induce apoptosis in androgen-independent prostate cancer cells, parallel activation of the Fas-
pathway is essential for the Par-4 mediated induction of apoptosis in these cells [59]. The 
mechanism of how Par-4 induces the Fas/FasL translocation is still elusive. As mentioned above, 
the C-terminus of Par-4 shows significant homology to the death domains of Fas, RIP, FADD 
and TRADD [48], which may indicate a possible interaction between Par-4 and Fas that could be 
necessary  for trafficking Fas/FasL to the cell membrane. However, recent results demonstrate 
that Fas/FasL trafficking is independent of the Par-4 C-terminus [50]. Also, as will be shown in 
Chapter 4.6, the C-terminal Par-4 CC domain forms a coiled coil. A coiled coil is a rod-like α-
helical structure that is distinct from the six-helical bundle structure of the death domains 
[61,62]. The sequence similarity  of the Par-4 C-terminus with death domains may  therefore be 
coincidental and of no physiological relevance. Taken together, both NFκB inhibition and Fas 
trafficking are required for the apoptosis-inducing function of Par-4. The fact that, for both 
proteins, no direct physical interaction with Par-4 has been described, suggests that the 
interaction is indirect through other proteins.
1.2.4. The importance of the SAC domain
 Deletion analysis showed that the apoptosis-inducing function of Par-4 resides, as the name 
implies, in the SAC (selective apoptosis induction in cancer cells) domain (residues 137-195). 
This domain comprises all essential motifs for apoptosis induction such as Thr 155 and NLS2 
(residues 137-153). Overexpression of the SAC domain is sufficient to induce apoptosis in 
cancer cells, regardless of their sensitivity or resistance to full-length Par-4, but not  in normal or 
immortalised cells [50]. This is achieved by inhibition of NFκB transcriptional activity  and 
translocation of Fas/FasL to the cell surface. As the SAC domain lacks the LZ domain, negative 
regulation through the LZ domain as observed for full-length Par-4 (Chapter 1.3.4.) is absent. 
This lack of negative regulation and its cancer cell selectivity make SAC a promising candidate 
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for molecular therapy. The SAC domain has so far only been described for the Par-4 proteins. To 
the knowledge of the author no studies have been conducted to identify SAC domains in other 
proteins. Also a simple attempt to identify similar domains in other proteins through the BLAST 
algorithm (au.expasy.org) has revealed no promising targets.
 It has been reported that an artificial increase in tumour-suppressor activity may reduce the 
risk of carcinogenesis, but at the same time, compromise proliferation of stem cells, enhance 
apoptosis and/or increase senescence [63]. This was observed in a mouse model system 
expressing N-terminally truncated p53, which resulted in a shortened life span despite increased 
tumour resistance [64,65]. Conversely, SAC transgenic mice displayed normal development and 
life span. Additionally, SAC transgenic mice were protected from Ras or c-Myc induced 
oncogenic transformation. The authors could show that in murine embryonic fibroblasts this anti-
transformation effect of the SAC domain was through the inhibition of oncogene induced NFκB 
activity and resulted in apoptosis. It was further shown that inhibition of the NFκB pathway is 
sufficient to induce apoptosis in the transformed cells. The anti-transformation effect of SAC 
transgenic mice also increased the resistance to spontaneous tumours during ageing. 
Interestingly, results indicate a stable inheritance of the SAC domain protecting the following 
generations of transgenic mice from spontaneous tumours [66]. Taken together, SAC induces 
apoptosis selectively in cancer cells upon transformation and thereby prevents tumour formation. 
Unlike classical chemo- or radiotherapy, SAC does not induce apoptosis in normal cells as it is 
inactive in these cells. These properties make SAC (unlike full-length Par-4) an ideal agent for 
anti-tumour therapy [66].
1.3. Par-4 interaction partners and their involvement in apoptosis
1.3.1. Programmed cell death
 As mentioned above, apoptosis is the most common form of programmed cell death (PCD). 
PCD was termed in 1976 by Lockshin and Williams to describe a predetermined pattern by 
which specific cells die during insect development [3]. Two years later it  was shown that in most 
cases PCD requires protein synthesis. This indicates that PCD represents an active cellular 
suicide process [67]. In 1972 the term apoptosis was introduced by Kerr and colleagues to 
describe a relatively  uniform cell death process seen in a variety of situations from development 
to cell turnover to insult  response [68]. It is important  to note that apoptosis is not the only  form 
of PCD and other non-apoptotic forms exist (Ref. [37] and references therein). Notably, some 
neurodegenerative disorders such as Huntington’s disease, amyotrophic lateral sclerosis or 
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ischemia can show non-apoptotic cell deaths [69]. Currently, three forms of PCD are accepted in 
the scientific community: type I (nuclear or apoptotic PCD); type II (autophagic PCD); and type 
III (cytoplasmic PCD). Others forms have been described, however, due to insufficient data their 
relevance is controversial [37].
 Apoptosis (Greek for ‘falling away’) is the best studied form of PCD. It is marked by  typical 
morphological changes such as rounding up of cells, zeiosis or bleb formation, chromatin 
condensation and nuclear fragmentation, and budding off of so-called apoptotic bodies. 
Apoptotic bodies and other debris of the dying cell are removed by phagocytosis by  nearby cells. 
In contrast to necrosis, apoptosis does not result in an immune response and thus a potential 
damage of neighbouring cells [2,70]. Furthermore, apoptosis is marked by mitochondrial 
membrane depolarisation and at the molecular level by  a phospholipid asymmetry. Phosphatidyl-
serine, which is usually located on the inside of the plasma membrane in living cells, faces 
inward and outward in apoptotic cells. Outward facing phosphatidylserine functions as a signal 
for phagocytosis of apoptotic bodies [37,71]. Great importance to these morphological changes 
is attributed to a set of cysteine proteases called caspases [70]. Activation of apoptosis, in 
particular activation of the caspase cascade, occurs through two main pathways: the extrinsic and 
intrinsic pathway. Both pathways will be discussed in more detail below.
 In contrast to apoptosis, little is known about autophagic and cytoplasmic PCD. Autophagy 
(Greek for ‘self eating’) is a cellular stress response that allows cells to survive prolonged times 
of starvation. It represents a form of the lysosomal pathway and results in degradation of long-
lived proteins, protein aggregates and (damaged) organelles. The targets of degradation are 
encircled in a biomembrane leading to morphologically visible ‘autophagic vacuoles’. These 
‘vacuoles’ then fuse with lysosomes resulting in degradation and thus recycling of amino acids 
and other molecular components. Autophagic PCD is observed in cases when the apoptotic 
machinery  is dysfunctional. This is important to note, as anti-apoptotic therapies for neuro-
degenerative disorders may  carry the risk of inducing other forms of PCD [37]. Cytoplasmic 
PCD represents a necrosis-like form of cell death and is marked by swelling of mitochondria and 
the endoplasmatic reticulum (ER). It  further lacks the typical morphological changes of 
apoptosis such as apoptotic bodies or nuclear fragmentation. However, even type III PCD is an 
active process requiring transcription and translation [37].
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1.3.2. Caspases
 Caspases are highly  selective aspartyl-specific proteases that only cleave at a small subset of 
aspartic acid residues. They are synthesised in an inactive form, as zymogens, and are activated 
either by  induced proximity  or by proteolytic cleavage [72]. Caspases are classified into initiator 
and effector caspases. Initiator caspases such as caspase-8, 9 or 10, exist as inactive monomers in 
the cell. Initiator caspases are able to dimerise upon binding to other specific proteins through 
their death effector domains (DED) in caspase-8 and 10, or caspase activation and recruitment 
domains (CARD) in caspase-9. This dimerisation then results in initiator caspase activation. 
Contrary  to earlier reports, no cleavage of the initiator caspase is necessary for its activation 
[72]. Cleavage occurs secondary to activation and partially stabilises the dimer. Activation is 
probably  due to conformational changes upon dimerisation and/or binding to the adaptor protein. 
Once activated, initiator caspases activate the effector caspases (caspase-3, 6 or 7) through 
proteolytic cleavage. Note that this upstream/downstream relationship probably only exist in the 
early stages of the apoptotic cascade. Effector caspases exist as dimers in the cell, and cleavage 
produces a hetero-tetramer comprising two large and two small subunits. Effector caspases 
display  a different and wider substrate specificity than initiator caspases and thus activate the 
apoptotic process by cleaving other protein substrates in the cell. More than 400 substrates are 
known and include structural proteins, other mediators of apoptosis, DNA repair proteins and 
cell cycle related proteins. An important target of the effector caspases is the inhibitor of caspase 
activated DNase (ICAD). Activated CAD together with DNase II is responsible for DNA 
fragmentation after the release from ICAD [71,72]. It is interesting to note here that caspases 
appear to contribute to some neurodegenerative disorders. Mutation of the caspase cleavage site 
in the amyloid precursor protein (APP) or polyglutamine-expanded huntingtin suppressed 
synapse loss and prevented neurodegeneration in Alzheimer’s [73] and Huntington’s disease [74] 
models, respectively.
 Caspase activity  is regulated via caspase inhibitors or through post-translational modification. 
Especially for caspase-9, phosphorylation by PKB, ERK (extracellular signal regulated kinase) 
or PKCζ has been shown to inhibit the proteolytic activity [70]. Active caspases are kept in 
control by  the inhibitors of apoptosis (IAPs) such as XIAP and Survivin. IAPs function as 
caspase inhibitors and E3-ligases mediating caspase degradation. IAP inactivated caspases may 
be rescued by proteins such as OMI (HtrA2) or SMAC (second mitochondria-derived activator 
of caspase), which is also known as DIABLO (direct IAP-binding protein with low pI). Another 
caspase inhibitor, especially of caspase-8, is cFLIP, the expression of which is under control of 
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NFκB. Depending on the cytosolic adaptor proteins, NFκB can be activated by TNFR1 (tumour 
necrosis factor receptor 1) indicating a pro- and anti-apoptotic role for this death receptor 
(Fig. 1.3) [2,37,71].
1.3.3. The extrinsic and intrinsic pathways of apoptosis
 The extrinsic or death receptor pathway  originates from the activation of death receptors at 
the cell surface and results in activation of caspase-8 or 10. The extrinsic pathway will be 
explained here on the basis of the best characterised example the Fas receptor (Fig. 1.3, left  hand 
side). The Fas ligand binds to Fas resulting in trimerisation of the receptor and thus the 
recruitment of FADD (Fas associated death domain) to the cytoplasmic site of the receptor. 
FADD is recruited through the so-called death domain (DD) of Fas. It is interesting to note here 
that DED, DD and CARD domains all adopt a similar fold indicating an evolutionary conserved 
structure in the assemblage of pro-apoptotic cascades. FADD is an adaptor protein that in turn 
binds caspase-8 via the DED domain. The resulting complex is called DISC (death-inducing 
signalling complex). DISC formation is also observed for the death receptor-ligand complexes 
TNFR1-TNFα (tumour necrosis factor α) and DR4/5-TRAIL (TNF-related apoptosis inducing 
ligand). Activated by  induced proximity, the initiator caspase-8 cleaves and activates the effector 
caspases (e.g. caspase-3, 6 and 7). The effector caspases then initiate the apoptotic process 
[2,37,71].
 The intrinsic or mitochondrial pathway is activated by diverse apoptotic stimuli such as DNA 
damage, oxidative stress or growth factor deprivation, and converges on the mitochondria. 
Depending on the relative balance between pro- and anti-apoptotic proteins of the Bcl-2 family, 
cytochrome c is released from mitochondria into the cytoplasm, which results in activation of 
caspase-9 (Fig. 1.3, right hand side) [2]. The anti-apoptotic proteins Bcl-2 and Bcl-XL protect 
mitochondria from permeabilisation and cytochrome c release by the pro-apoptotic Bcl-2 family 
members. The pro-apoptotic Bcl-2 are classified into 3 groups based on structural properties. The 
first group contains the multidomain proteins BAX and BAK that can permeabilise the outer 
mitochondrial membrane. One model suggests that BAX and BAK polymerise on the outer 
mitochondrial membrane forming a pore. The second group includes the BH-3-only  proteins 
such as BIM and tBID that activate BAX and BAK and may assist in membrane permeabi-
lisation. The last group  comprises the BH3-only derepressors such as PUMA, NOXA or BAD. 
These proteins sequester the anti-apoptotic Bcl-2 and Bcl-XL proteins thereby  freeing the BAX 
and BAK proteins [71]. Other proteins unrelated to the Bcl-2 family  can influence the actions of 
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the Bcl-2 family  members. Especially  the BH3-only  family members were shown to be 
controlled at a transcriptional level or via post-translational modification. For example, PUMA 
and NOXA are under transcriptional control of p53, whereas the activity of BAD is controlled by 
phosphorylation. Permeabilisation of the mitochondrial membrane releases various other pro-
apoptotic proteins in the cytosol such as SMAC, OMI, AIF, endoG and cytochrome c. AIF and 
endoG translocate to the nucleus resulting in chromatin condensation and nuclear fragmentation. 
Once in the cytosol, cytochrome c induces heptamerisation of Apaf-1 (apoptotic protease 
activating factor), which then binds caspase-9 via the CARD domain leading to its activation. 
The complex of Apaf-1, cytochrome c, dATP/ATP and caspase-9 is called apoptosome. 
Following caspase-9 activation, the effector caspases-3, 6 and 7 are activated initiating the 
apoptotic process. Crosstalk between the extrinsic and intrinsic pathway is facilitated by BID. 
BID is cleaved by caspase-8 to produce tBID that then activates the intrinsic pathway and 
amplifies the apoptotic signal (Fig. 1.3) [2,37,71].
 Figure 1.3 − The extrinsic and intrinsic pathways of apoptosis. For details see text.
 A subset of the intrinsic pathway is sometimes discussed as a third pathway in the literature. It  
originates from the ER in response to stress such as accumulation of misfolded protein and 
results in the activation of caspase-9. This pathway is of particular interest as accumulation of 
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misfolded protein and protein aggregation are a common in some neurodegenerative disorders 
such as Alzheimer’s or Huntington’s disease [37]. It  is interesting to note that Par-4 has been 
shown to be upregulated in response to ER stress [75], which may be related to the high levels of 
Par-4 detected in various neurodegenerative disorders. Also important for initiation of this 
second intrinsic pathway  are the Bcl-2 family members. The best characterised example 
describes the binding of BAP31 (an ER-membrane protein) to Bcl-2 and a caspase-8 containing 
complex resulting in cleavage of BAP31. The cleavage product enhances among other effects 
cytochrome c release from the mitochondria. Other mechanisms for apoptosis induction in 
response to ER stress have been described, but are beyond the scope of this chapter [37].
 It has long been hypothesised that acidification of the cytosol is necessary for apoptosis. 
Especially for neurons under ischaemic conditions it was shown that acidification of the cytosol 
induces neuronal injury and precedes nuclear fragmentation [76]. It is now commonly  accepted 
that acidosis is not essential for apoptosis, however, it does contribute to some apoptotic 
processes. In particular, the translocation of BAX to mitochondria [77], apoptosome assembly 
and caspase activation were shown to be pH dependent and more efficient at acidic pH [78]. 
Acidosis can occur through the extrinsic pathway after activation by Fas in a caspase-dependent 
process. Alternatively, acidosis can be induced through the intrinsic pathway in a mitochondria-
dependent, but  caspase-independent manner. This process relies on BAX and can be inhibited by 
Bcl-2. As an important, but not the only factor, in this mitochondria-dependent acidosis the F0F1-
ATPase was identified. The drop in pH that is commonly observed during apoptosis does not 
exceed 0.3-0.4 pH-units [11,76].
1.3.4. Interaction partners of Par-4
 The pro-apoptotic function of Par-4 is achieved either by activation of molecular components 
of the apoptosis machinery or by inhibition of pro-survival factors. Par-4 was shown to interact 
with proteins involved both in the extrinsic and the intrinsic pathway. The most important Par-4 
interaction partners and their implication in apoptosis will be discussed below. The interactions 
are schematically shown in Figure 1.4. Interactions with other proteins occur mainly  through the 
LZ or the SAC domain, with the majority of proteins binding to the CC/LZ domain (Table 1.1). 
As will be described later on, the Par-4 LZ domain is a subset of the longer CC domain 
(Fig. 1.1). However, due to its homology the CC domain is often described as a DD in the 
literature and not as an extension of the LZ domain. Thus C-terminal Par-4 deletion mutants 
were often termed LZ deletion mutants even though they protruded N-terminally into the CC 
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domain. According to the nomenclature used in this document, these mutants would represent 
CC deletion mutants. For consistency, the term LZ deletion mutants will be kept for these 
mutants; however, the rat residue numbers will be given in brackets for clarity.
Inhibition of pro-
survival function
Activation of pro-apoptotic 
function Inactivation of Par-4 Other
protein kinase B (LZ) DAP like kinase (LZ) p62 (LZ) CHT1 (?)
atypical protein kinase C 
λ/ι and ζ (LZ)
Actin filaments 
(residues 1-40)
protein kinase B (LZ)
SSB1, 2 and 4 
(?)
WT1 (LZ) Amida (LZ) 14-3-3 (phospho-Ser 249) D2DR (LZ)
Androgen receptor (SAC)
β-site APP cleaving 
enzyme-1 (LZ)
Apoptosis-antagonising 
transcription factor (LZ)
Topoisomerase 1 (LZ) THAP (LZ)
E2F1 (LZ)
Glucose-regulated protein-78 
(SAC)
NFκB? Fas/FasL?
 Table 1.1 − Par-4 interaction partners. Par-4 binding partners are classified according to the effect of 
association with Par-4. Binding with Par-4 can inhibit pro-survival proteins, stimulate pro-apoptotic 
proteins or result in inactivation of Par-4. Molecules that have other effects or where the outcome of the 
interaction is unknown are listed in the last column. The interacting domain within Par-4 is given in 
brackets. LZ includes residues 240-332 and SAC includes residues 137-195. Question marks signify that 
the exact domain is not known. For NFκB and Fas/FasL a direct interaction with Par-4 has not been 
determined (Chapter 1.2.3.).
a) Atypical protein kinase Cζ and λ/ι (aPKCζ and λ/ι)
 The atypical PKC family  consists of two isoforms: aPKCζ and λ/ι. aPKCλ is the mouse 
homolog of human aPKCι. All atypical PKCs (aPKC) share a high degree of homology across 
the catalytic and regulatory domains. In contrast to other PKC subgroups, the aPKCs are not 
regulated by calcium or diacylglycerol, but by other phospholipids such as ceramide and 
phosphatidylinositol-(3,4,5)trisphosphate. The latter, being a product of the phosphoinositide 3-
kinase (PI3K), indicates an important role for aPKCs in cell proliferation and cell survival. 
Consistent with this role, aPKCs have been described as activators of NFκB and the mitogen-
activated protein kinases (MAPK) such as ERK1 and 2 (Ref. [48] and references therein).
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 Both aPKC isoforms specifically  interact with Par-4 through their regulatory domain, in 
particular the zinc-finger domain, resulting in an inhibition of their enzymatic activity. The LZ 
domain within Par-4 is necessary for binding to the zinc-finger domain. Thus, Par-4 LZ deletion 
mutants (residues 1-261) failed to bind the aPKC regulatory domain and therefore had no effect 
on the aPKC catalytic activity [48]. Inhibition of aPKC enzymatic activity  results in a decrease 
in AP1-dependent promoter activity, which is likely to be related to aPKC-dependent activation 
of MAPK [48]. AP1 is an important transcription factor complex involved in cell proliferation, 
apoptosis and tumour development [79]. FADD is another substrate of aPKCζ and phos-
phorylation of FADD by aPKCζ in myeloid leukemic cells prevents DISC formation and 
subsequent activation of caspase-8 [80]. As mentioned above, caspase-9 is also inhibited by 
phosphorylation through aPKCζ (Fig. 1.3).
 Furthermore, aPKCs are involved in the activation of NFκB. The classical form of NFκB is a 
heterodimer of p50 and p65 (RelA), but 5 other family members are known [81]. NFκB is 
sequestered in the cytoplasm by members of the inhibitor of κB family  (IκB) [58,81]. 
Phosphorylation of IκB by  IKKα (IκB kinase α) or IKKβ (IκB kinase β) results in IκB 
ubiquitination and proteasomal degradation. The free NFκB then translocates to the nucleus and 
exerts its anti-apoptotic activity (Ref. [82] and references therein). The anti-apoptotic activity of 
free NFκB is potentiated as it  was also shown to act in a paracrine fashion thereby accelerating 
tumour growth [83]. NFκB activation by aPKCs is achieved at two different levels. First, aPKCs 
specifically phosphorylate and thus activate IKKβ, thereby promoting release of NFκB from IκB 
and allowing its translocation to the nucleus. Second, phosphorylation of NFκB in the p65 
subunit by IKKβ [84] or aPKCζ [58] enhances the transcriptional activity of NFκB. Phos-
phorylation of p65 by aPKCζ is dependent on its release from IκB [85]. Hence, Par-4 prevents 
NFκB activation and nuclear translocation through inhibition of the aPKCs. Note that 
inactivation of NFκB, through inhibition of the aPKCs, is dependent on the Par-4 LZ domain, 
but it does not depend on nuclear translocation of Par-4 [82]. This indicates that regulation of 
aPKC activity  is part of the apoptosis-sensitising function of Par-4. Consequently, inhibition of 
aPKC activity  through ectopically overexpressed Par-4 was shown to promote apoptosis in 
immortalised mouse fibroblasts. Conversely, aPKC overexpression could rescue these cells from 
Par-4 mediated apoptosis [82]. The effects of Par-4/aPKC association are summarised in 
Figure 1.4.
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b) p62
 The p62 protein (also known as sequestosome 1) is an important adaptor protein and functions 
as hub protein in cell signalling [86]. It  was originally identified as an adaptor protein for the 
aPKCs [87]. It was proposed that p62 recruits aPKCs to signalling complexes (e.g. complex-1 of 
TNFR1 in Fig. 1.3) in response to TNFα or interleukin-1 signalling mediating NFκB activation. 
Both p62 and Par-4 were shown to bind to the regulatory domain of aPKCs. However, the 
interaction was not competitive and all three proteins interact with each other and are involved in 
a ternary complex. Necessary for the interaction between p62 and Par-4 are the N-terminal 
residues 50-80 within p62 and the LZ domain (residues 296-332) of Par-4. Binding of p62 to a 
complex of aPKC and Par-4 restores the catalytic activity of the aPKC indicating an additional 
regulatory function for p62. Not surprisingly, co-expression of p62 and Par-4 in U2OS cells 
restored NFκB activity and rescued cells from Par-4 mediated apoptosis [88]. Consistent with 
these findings, it was recently shown that p62 is an important factor in Ras induced 
tumourigenesis [86]. The effects of Par-4/p62 association are summarised in Figure 1.4.
c) Protein kinase B (PKB)
 PKB (or Akt kinase) is another downstream member of the PI3K pathway and is therefore 
involved in cell survival and transformation due to inhibition of apoptosis. As a serine/threonine 
kinase PKB phosphorylates and regulates a wide range of substrates including pro-apoptotic 
proteins. Elevated PKB activity  has been detected in various cancers due to inactivation of 
PTEN (phosphatase and tensin homolog deleted on chromosome 10) and/or constitutive activity 
of PI3K. Phosphorylation of PKB by PDK1 (3-phosphoinositide dependent kinase 1) is essential 
for PKB activity, whereas the tumour suppressor PTEN as a phosphatase inactivates PKB. The 
importance of PTEN for PKB activity is demonstrated by the fact that the pten gene is often 
deleted in human cancers such as advanced prostate cancers (Ref. [56] and references therein).
 Par-4 is one of the pro-apoptotic substrates of PKB and both proteins were shown to associate 
in vivo in a variety of cell lines including cancer and normal cells [56]. An active kinase domain 
within PKB and the Par-4 LZ domain (residues 289-332) are necessary for this interaction. 
Furthermore, PKB only associates with the phospho-Thr 155 form of Par-4. PKB phosphorylates 
Par-4 at Ser 249 (mouse: Ser 231, human Ser 231) [8] and thus prevents nuclear translocation of 
Par-4. Consistent with this role, co-expression of PKB and Par-4 in Par-4-sensitive cancer cells 
abrogated the Par-4 apoptosis-inducing function. However, inhibition of PKB activity by co-
expression of PTEN or other PKB inhibitors resulted in apoptosis. Conversely, downregulation 
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of Par-4 through RNA interference, in cells expressing PTEN, abrogated apoptosis. This 
indicates that PTEN induces apoptosis primarily through Par-4.
 Nuclear translocation of Par-4 is achieved through cytoplasmic sequestration by the 
chaperone 14-3-3, which selectively binds to the phospho-Ser 249 residue. It is interesting to 
note here that even though sequestration of Par-4 by 14-3-3 appears to be conserved in 
mammalian cells, the respective serine residues in Par-4 necessary  for binding to 14-3-3 are not 
conserved relative to Thr 155. As can be seen in Figure 1.1, the serine residues Ser 249, Ser 231, 
and Ser 231 within rat, mouse and human, respectively, are at different positions within the Par-4 
sequence. The reason for this observation is not clear, but may be due to different recognition 
sites of PKB and/or 14-3-3 in different mammalian species.
 The mechanism described here explains why the active phospho-Thr 155 form of Par-4 does 
not induce apoptosis in Par-4-insensitive cells as the nuclear translocation is impaired (Fig. 1.2). 
Further, it becomes evident why the SAC domain is a more potent inducer of apoptosis than full-
length Par-4 as it lacks the LZ domain necessary for binding to PKB [56]. Interestingly, a recent 
report demonstrated that Par-4 itself negatively  regulates PKB. In the absence of Par-4, PKB was 
shown to be phosphorylated and thereby activated through aPKCζ in mouse lung cells. 
Conversely, expression of Par-4 abolished phosphorylation of PKB through inhibition of aPKCζ 
activity [21]. The effects of Par-4/PKB association are summarised in Figure 1.4.
d) DAP like kinase (Dlk)
 Dlk is a serine/threonine kinase that shows homology to the DAP (death-activated protein) 
kinase. Sequence analysis shows the presence of a leucine zipper domain within Dlk. It  was 
shown that this leucine zipper domain is necessary for homodimerisation and interaction with the 
transcription factor ATF-4 (a member of the ATF/CREB family). Thus Dlk is also termed zipper 
interacting protein kinase (ZIPK). In vitro substrates of Dlk are, for example, the core histones 
H2A, H3 and H4, and the myosin light chain (Ref. [16] and references therein). Interestingly, 
initial reports suggested that Dlk interacts with Par-4 through an arginine rich stretch (residues 
338-417) but not through the leucine zipper domain. However, this observation has recently  been 
challenged [89]. Association with Par-4 further depends on an active Dlk kinase domain. The 
interacting domain within Par-4 was mapped to the LZ domain (residues 262-332).
 Co-expression of Par-4 and Dlk in rat embryonic fibroblasts results in translocation of nuclear 
Dlk to the cytoplasm, in particular to actin filaments. Note that Par-4 co-localises with Dlk in the 
cytoplasm but shows no nuclear localisation. However, this does not exclude Par-4 being 
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transiently  located in the nucleus. Translocation of Dlk to actin filaments is followed by a 
reorganisation of the cytoskeleton and morphological changes indicative of apoptosis. Apoptosis 
is dependent on both Dlk and Par-4, and on the degree of cytoplasmic retention of Dlk. The exact 
way of apoptosis initiation by Dlk/Par-4 is not known. Localisation to actin filaments and 
phosphorylation of myosin light chain may  be critical events as the latter is implicated in 
membrane blebbing. However, it has been shown that this actin localisation of the Par-4/Dlk 
complex has an important non-apoptotic role in facilitating contraction in vascular smooth 
muscle [41]. Alternatively, disruption of Dlk interactions with other proteins within the nucleus 
may further be another contributing factor in apoptosis induction [16]. Recent findings show that 
Dlk phosphorylates Par-4 at Thr 155 [90] and as described above this is an essential step in the 
apoptosis-inducing function of Par-4 [26]. Thus, co-localisation of Dlk and Par-4 to the actin 
cytoskeleton may be an alternate mechanism for the activation of Par-4.
 A nuclear role for the Par-4/Dlk complex has also been determined. In response to the pro-
apoptotic stimuli arsenic trioxide or gamma interferon, Par-4 enhances the interaction of Dlk 
with the pro-apoptotic protein Daxx in the nucleus of HeLa cells. This ternary complex then 
localises to PML nuclear bodies (see below) and induces apoptosis through the activation of the 
caspase cascade. Necessary for apoptosis induction in this system is the overexpression of all 
three proteins together, and downregulation of anyone of the three binding partners abolished 
apoptosis. The authors proposed that in this system Par-4 may function as a scaffold recruiting 
Dlk and Daxx [89]. The effects of Par-4/Dlk association are summarised in Figure 1.4.
e) Actin filaments (F-actin)
 As mentioned above, the Dlk/Par-4 complex localises to actin filaments by  an unknown 
mechanism. It could be shown for rat embryonic fibroblasts, rat immortalised fibroblasts and 
mouse fetal brain cells that endogenous Par-4 is directly bound to F-actin. Essential for this 
interaction is the N-terminal part of Par-4 (residues 1-266), in particular the first 40 N-terminal 
residues, but not the C-terminus. This indicates that Par-4 functions as scaffold recruiting other 
proteins to the actin cytoskeleton. Actin is bound by the Par-4 N-terminus while the C-terminus, 
in particular the LZ domain, can be involved in other protein interactions (e.g. Dlk, Amida). In 
vitro studies showed that Par-4 binding promotes actin bundling. Consistent with this role, 
significant cytoskeleton reorganisation, such as stress fibre formation, is observed in transformed 
cells upon Par-4 overexpression. Binding to F-actin is important for the Dlk/Par-4 mediated 
apoptosis, as a deletion of the first 40 N-terminal residues of Par-4 resulted in a decrease of Dlk/
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Par-4 mediated apoptosis. Furthermore, disruption of the actin cytoskeleton by cytochalasin D 
also decreased the apoptotic rate. The localisation of the Dlk/Par-4 complex to F-actin appears to 
be necessary  for the Dlk mediated phosphorylation of myosin light chain. This phosphorylation 
may be necessary for cytoskeletal reorganisations and thus essential for the progression of 
apoptosis [91]. The effects of Par-4/F-actin association are summarised in Figure 1.4.
f) Amida
 Amida is a relatively poorly characterised protein. It was originally identified as an interaction 
partner of Arc (activity-regulated cytoskeleton-associated protein) and later found to associate 
with Par-4 in rat and mouse fibroblasts [53]. Critical for the interaction with Par-4 is the C-
terminal domain of Amida (residues 113-259) and the LZ domain within Par-4 (residues 
266-332). Interestingly, the authors could show that mutation of three leucine residues in d 
position of the Par-4 LZ domain to alanine (L295A, L316A, L330A) abrogated binding to 
Amida. This indicates that a functional LZ is required for the interaction with Amida. Primarily 
localised to the nucleus, Amida shows weak shuttling to the cytoplasm. Upon co-expression of 
Amida and Par-4, Amida translocates to the cytoplasm and associates with Par-4. As described 
for Dlk, Par-4 functions as a scaffold protein recruiting Amida to the actin cytoskeleton resulting 
in phosphorylation of the myosin light chain. Consistent with the observation for Dlk, co-
expression of Amida and Par-4 induces apoptosis in rat fibroblast depending on an intact actin 
cytoskeleton and binding of Par-4 to F-actin [53]. The effects of Par-4/Amida association are 
summarised in Figure 1.4.
g) THAP1
 Promyelocytic leukemia (PML) nuclear bodies are discrete sub-nuclear domains composed of 
various proteins. They are mainly organised by the PML protein, a pro-apoptotic protein 
involved in various apoptotic pathways. The exact mechanism by  which PML promotes 
apoptosis is poorly  understood, but it was proposed that PML might recruit other pro-apoptotic 
proteins, such as p53 and Daxx, into PML nuclear bodies. Consistent with this role, it was shown 
that PML acts as a transcriptional co-activator of p53 (Ref. [92] and references therein). Another 
pro-apoptotic factor associated with PML nuclear bodies is THAP1. THAP1 belongs to the 
THAP family that is characterised by a conserved DNA binding motif called THAP domain. 
Like Par-4, ectopic overexpression of THAP1 in mouse 3T3 fibroblasts was shown to sensitise 
cells to apoptotic stimuli such as serum deprivation or TNFα [92].
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 The N-terminal THAP domain is essential for the pro-apoptotic function of THAP1, but 
dispensable for the localisation to PML nuclear bodies or binding to Par-4. The interaction 
between THAP1 and Par-4 is mediated through the CC domain of Par-4 and hence a Par-4 
construct comprising residues 256-332 was sufficient for binding to THAP1. Co-localisation of 
endogenous Par-4 with THAP1 in PML nuclear bodies of primary  endothelial cells and 
fibroblasts suggests that Par-4 is a component of PML nuclear bodies for these cell types. 
However, this localisation of Par-4 is cell type specific and is not observed in HeLa cells. It was 
proposed that THAP1 and Par-4 are recruited to PML by an unknown adaptor protein. 
Interestingly, for endogenous Par-4 that co-localised with THAP1 no apoptotic phenotype was 
described indicating that nuclear endogenous Par-4 is in an inactive state [92].
 Figure 1.4  − The pro-apoptotic function of Par-4. Schematic model for the different association 
partners of Par-4 and their involvement in apoptosis. Pro-apoptotic functions of Par-4 localised to the 
cytoplasm  or extracellular space are shown in parts A-E. (A) Par-4 stimulates secretion of the neurotoxic 
Aβ(1-42) peptide. (B) Cytoplasmic translocation of the nuclear proteins Dlk or Amida and their Par-4 
mediated interaction with the actin cytoskeleton results in apoptosis. If a nuclear translocation of Par-4 is 
necessary for this interaction is currently unknown. (C) Par-4 stimulates the trafficking of Fas/FasL to 
the cell membrane thereby promoting apoptosis. This is one of the essential apoptosis-inducing functions 
of Par-4 and is dependent on the phospho-Thr 155 form. However, the exact mechanism  of Par-4 
mediated Fas/FasL trafficking remains elusive. (D) Association of Par-4 and aPKC results in inhibition 
of aPKC activity thus preventing inactivation of FADD and activation of NFκB. (E) Activation of the ER 
stress response results in secretion of Par-4. Binding of Par-4 to GRP78 results in activation of PERK 
and subsequent activation of the Fas-FADD apoptotic pathway. The amplification loop for the Par-4/
GRP78 interaction is indicated with numbers from 1-5. Nuclear functions of Par-4 are displayed in parts 
F-H. (F) Association of Par-4 with Dlk, THAP1 or Daxx within PML nuclear bodies was shown to 
promote apoptosis by unknown mechanisms. (G) Nuclear Par-4 also functions as a transcriptional 
cofactor regulating the transcription of pro- and anti-apoptotic genes. Especially, downregulation of 
NFκB transcriptional activity is an essential apoptosis-inducing function of Par-4. The mechanism of 
NFκB downregulation by Par-4 is unknown, but depends on the phospho-Thr 155 form of Par-4. (H) 
Par-4 inhibits the DNA relaxation function of TOP1. Three inactivation mechanisms for Par-4 have been 
demonstrated thus far and are shown in parts I-K. (I) Par-4 is inhibited by binding to AATF. (J) The 
phospho-Thr 155 form of Par-4 is phosphorylated by PKB at Ser 249 resulting in cytoplasmic 
sequestration of Par-4 through the chaperone 14-3-3. PKB can be activated by the aPKCs, which 
themselves are under control of Par-4. (K) p62 can rescue Par-4 inactivated aPKC through formation of 
a ternary complex. The aPKC kinase activity is restored in this complex. For more details see text. Arrows 
with white heads indicate a translocation, whereas black arrows indicate a stimulation.
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 The functional significance of the co-localisation of Par-4 and THAP1 to PML nuclear bodies 
is currently  not known. It is possible that THAP1 acts as transcriptional regulator and Par-4 as a 
cofactor of THAP1, regulating expression of pro- and anti-apoptotic proteins. PML nuclear 
bodies may further serve as a depot for both proteins and/or may have a regulatory  role by 
modulating post-translational modifications of both proteins. Taken together, these results 
suggest that recruitment of THAP1 and Par-4 represents another pathway by which PML exerts 
its pro-apoptotic function. As described above, another pathway might involve Dlk that was also 
shown to localise to PML nuclear bodies [92]. The effects of Par-4/THAP1 association are 
summarised in Figure 1.4.
h) Wilm’s tumour protein 1 (WT1)
 WT1 is a tumour-suppressor gene that  encodes four alternatively  spliced isoforms. The WT1 
proteins function as transcription factors that can activate or repress genes depending on the 
promoter and the physiological context. WT1 was shown to promote growth arrest by negatively 
regulating growth related genes. Sequence analysis shows the presence of four zinc-finger 
domains that  form the DNA binding domain of WT1 and are essential for the interaction with 
Par-4 (Ref. [14] and references therein). A second Par-4 interaction domain within WT1 has been 
described, however, is specific to a certain splice isoform [93]. All four WT1 isoforms were 
shown to bind Par-4 through its LZ domain (residues 268-332). In almost all cases, binding of 
Par-4 to WT1 inhibits the transcriptional activation function and augments the transcriptional 
repression function of WT1 [14,93]. This indicates that nuclear localised Par-4 can act as a 
transcription repressor, however, nuclear localisation depends on the cell type and physiological 
context [14,94].
 One of the important targets of WT1 is bcl-2, an important proto-oncogene promoting cell 
survival. As described above, binding of the Par-4/WT1 complex to the bcl-2 promoter resulted 
in transcriptional repression of the bcl-2 gene. Downregulation of Bcl-2 is an essential step in the 
Par-4 mediated apoptosis of androgen-independent prostate cancer cell line LNln3 [94]. 
Consistently, a mutually  exclusive expression pattern is observed for Par-4 and Bcl-2 in various 
prostate tumour types [95]. Additionally, for lymphatic cells it was shown that Bcl-2 
downregulation is a necessary step in the Par-4 apoptosis-sensitising function [96]. However, 
unlike Par-4, WT1 displays a limited expression pattern and the described mechanism for Bcl-2 
downregulation may not be a ubiquitous event [14]. The effects of Par-4/WT1 association are 
summarised in Figure 1.4.
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i) Androgen receptor (AR)
 The AR is another example for Par-4 acting as a transcription cofactor in the nucleus. As 
described above, androgens are important signalling molecules in maintaining prostate 
homeostasis. The androgen action is mediated by the AR that upon androgen binding 
translocates to the nucleus and regulates specific target genes. Association of Par-4 with the 
DNA binding domain of the AR resulted in an upregulation of the transcriptional activity  of AR. 
In contrast to WT1, Par-4 acted in this context as a transcriptional co-activator. Transcriptional 
enhancement was dependent on bound androgen ligands and there was no upregulation in the 
absence of the androgen ligand. The zinc-finger DNA binding domain of the AR is highly 
conserved among other steroid nuclear receptors, and Par-4 was shown to enhance transcription 
from estrogen, progesterone and glucocorticoid receptor controlled promoters. The interaction 
domain within Par-4 was mapped to residues 137-193, which overlaps with the previously 
described SAC domain. One of the important targets of the AR/Par-4 complex is the cFLIP 
promoter. In response to androgen signalling this complex initiates transcription of cFLIP 
thereby promoting cell survival. Conversely, androgen ablation in androgen-responsive prostate 
cells results in downregulation of cFLIP and upregulation of Par-4 and thus in induction of 
apoptosis. This model therefore explains some of the results observed for prostate (cancer) cells 
in response to androgen ablation (Ref. [54] and references therein). The effects of Par-4/AR 
association are summarised in Figure 1.4.
j) E2F1
 Neural cells undergo glutamate-induced apoptosis in ischaemic brain tissue. Using human-
bone mesenchymal stem cells as a model system, it could be shown that the glutamate-induced 
apoptosis is dependent on increased Par-4 expression and SMAC release from the mitochondria 
(for the function of SMAC see Fig. 1.3). The results further showed that  Par-4 associates with 
the transcription factor E2F1 through the LZ domain within Par-4 (residues 262-332). This 
complex targets the smac promoter and thereby  stimulates SMAC expression. Par-4 does not 
bind to DNA itself, but is recruited to the smac promoter through E2F1. The transcription 
cofactor activity of Par-4 is dependent on the LZ domain and a LZ deletion mutant failed to 
increase SMAC expression. Nuclear association of Par-4 and E2F1, and binding of this complex 
to the SMAC promoter were further shown to be dependent on glutamate treatment of the 
mesenchymal stem cells. As glutamate is a common messenger for neural cells, these results may 
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have important implications for stem cell therapies in ischaemic brain injuries [97]. The effects 
of Par-4/E2F1 association are summarised in Figure 1.4.
k) Topoisomerase 1 (TOP1)
 Regulation of DNA relaxation by TOP1 is critical for cellular processes such as DNA 
replication, transcription or recombination. Consistent with this cell-growth promoting function, 
TOP1 activity was shown to be elevated in various cancer cells and TOP1 inhibitors are used in 
anti-cancer therapies for small cell lung cancer or colon cancer (Ref. [98] and references 
therein). Endogenous Par-4 and TOP1 were shown to interact in the nucleus in a variety of 
normal, immortalised and cancer cells. Essential for this interaction is the LZ domain (residues 
268-332) within Par-4. Binding of Par-4 to TOP1 resulted in TOP1 sequestration and abrogated 
the binding of TOP1 to DNA. Inhibition of the TOP1 DNA-relaxation function resulted in an S-
phase arrest, however, no apoptosis was observed in the studied cell lines. It was further shown 
that TOP1 is essential for cellular transformation and that inhibition of TOP1 function by Par-4 
prevents transformation [98]. The effects of Par-4/TOP1 association are summarised in 
Figure 1.4.
l) β-site APP cleaving enzyme-1 (BACE-1)
 Amyloid plaques are characteristic lesions in Alzheimer’s disease and are mainly extracellular 
deposits of the amyloid β-peptide (Aβ) (1-42). Increased production, secretion and aggregation 
of Aβ(1-42) has been shown to be a neurotoxic event that  contributes to the pathogenesis of 
Alzheimer’s disease. Aβ(1-42) is produced by cleavage of APP through β- and γ-secretases. The 
β-secretase BACE-1 is a membrane-bound aspartyl protease and is responsible for early APP 
processing events (Ref. [99] and references therein). Par-4 overexpression was previously shown 
to stimulate Aβ(1-42) secretion in human neuroblastoma cells, whereas inactivation of Par-4 
activity by a dominant negative Par-4 LZ construct prevented Aβ(1-42) production. Aβ(1-42) 
production occurred in a caspase dependent way  and only after trophic factor withdrawal. This 
indicates that apoptosis and aberrant APP processing may be intimately  linked processes [100]. 
Furthermore, in human neuroblastoma cells and primary  hippocampal neurons, Par-4 selectively 
binds to the cytosolic site of BACE-1 increasing APP cleavage and Aβ(1-42) secretion [99]. The 
C-terminal half of Par-4 was necessary  for the interaction with BACE-1 suggesting that binding 
to BACE-1 is through the LZ domain. Conversely, silencing of Par-4 by RNA interference 
resulted in decreased APP cleavage by BACE-1. These findings indicate the importance of Par-4 
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in Alzheimer’s disease pathogenesis and its implication in the development of new therapeutic 
strategies [99]. The effects of Par-4/BACE-1 association are summarised in Figure 1.4.
m) Apoptosis-antagonising transcription factor (AATF)
 AATF was initially  identified as an interaction partner of Dlk. It was shown to contain two 
putative nuclear localisation signals and a leucine zipper domain. AATF and Par-4 selectively 
interact through their respective leucine zipper domains and co-localise both in the cytoplasm 
and the nucleus of neural cells. A Par-4 LZ deletion mutant (residues 1-265) was unable to bind 
to AATF indicating the importance of the Par-4 LZ domain for this interaction. Binding of AATF 
to Par-4 antagonised Par-4 mediated apoptosis implying a functional inhibitor role for AATF. As 
mentioned above, Par-4 is involved in APP processing and stimulation of Aβ(1-42) production 
thus increasing intracellular and secreted Aβ(1-42) levels. Increased Aβ(1-42) production is 
observed in neuronal cells undergoing apoptosis and was shown to contribute to the development 
of the Alzheimer’s disease. Consistent with this role, AATF inhibits Par-4 induced Aβ(1-42) 
production and secretion in Alzheimer’s disease models (Ref. [101] and references therein). The 
effects of Par-4/AATF association are summarised in Figure 1.4.
n) Glucose-regulated protein-78 (GRP78)
 Association of Par-4 with GRP78 represents the first example for an extracellular function of 
Par-4. Cell culture studies indicated a bystander effect of Par-4 overexpression as neighbouring 
cells not expressing Par-4 were shown to undergo apoptosis. Ectopic and endogenous Par-4 are 
spontaneously  secreted through a brefeldin A-sensitive pathway  in cultured normal and cancer 
cells. Secretion of Par-4 was independent of apoptosis, but could be stimulated in response to 
ER-stress. The cell surface receptor GRP78 is a stress protein of the HSP70 superfamily and may 
promote either apoptosis or growth stimulation. Binding of Par-4 to GRP78 was shown to induce 
apoptosis through activation of the FADD/caspase-8 pathway  in diverse cancer cell lines but not 
in non-transformed cells. Activation of FADD occurred through PERK (PKR-like ER kinase) a 
proximal component of the ER stress response pathway (Ref. [75] and references therein). 
Binding of Par-4 to GRP78 further induced an ER stress response loop  upregulating and 
trafficking GRP78 to the cell surface in an intracellular Par-4 dependent manner. Sufficient for 
the interaction of Par-4 with GRP78 were the N-terminus within GRP78 and the SAC domain 
within Par-4. The ectopically expressed SAC domain was secreted in a similar manner as full-
length Par-4. The same study also showed that the extracellular ligand TRAIL induces secretion 
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of Par-4, and that TRAIL induced apoptosis is dependent on both extra- and intracellular Par-4 
[75]. This is important as TRAIL, like Par-4, selectively  induces apoptosis in diverse cancer cells 
[71]. The effects of Par-4/GRP78 association are summarised in Figure 1.4.
o) Choline transporter CHT1
 CHT1 is a sodium and chloride dependent choline transporter that is specifically  located in 
cholinergic neurons. Cholinergic neurotransmission is important for various physiological 
functions (e.g. motor, autonomic, behavioural or cognitive functions) and defects in the 
cholinergic system have been implicated in disorders like Alzheimer’s disease. Choline uptake is 
believed to be the rate-limiting step in acetylcholine synthesis in cholinergic neurons and thus 
essential for cholinergic transmission (Ref. [43] and references therein). Par-4 was shown to 
interact with CHT1 in cholinergic neurons through its C-terminal half (residues 164-332) 
suggesting that the LZ domain may be critical for this interaction. Association of Par-4 with 
CHT1 resulted in cytoplasmic sequestration of CHT1. Reduced incorporation of CHT1 into the 
cell membrane resulted in reduced choline uptake. The affinity  of CHT1 for choline was 
unaltered when bound or unbound by Par-4. The regulation of choline uptake by  Par-4 may  have 
important implications for the pathogenesis of Alzheimer’s disease, but may also be of general 
importance for synapse physiology in non-apoptotic neuronal cells [43].
p) Dopamine D2 receptor (D2DR)
 Interaction of Par-4 with D2DR represents another modulatory function of Par-4 in neuronal 
signalling. An interaction between the D2DR and Par-4 was demonstrated by yeast two-hybrid 
assays. Additional experiments indicated an association of the endogenous proteins in mouse 
brain lysates. Using cultured striatal neurons, a co-localisation of Par-4 and D2DR could be 
shown for the periphery of the cell soma and neuronal processes. The interaction domains were 
mapped to the calmodulin binding motif in the third cytoplasmic loop  of D2DR and to the LZ 
domain (residues 235-332) within Par-4. Binding of Par-4 to D2DR is essential for the 
dopamine-mediated inhibition of cyclic adenosine monophosphate (cAMP) signalling. A 
physiological relevance of this interaction has been demonstrated in mouse models where 
inhibition of the Par-4/D2DR complex formation resulted in the development of depression-like 
behaviours [45].
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q) SPRY-domain containing SOCS box proteins 1, 2 and 4 (SSB-1, 2 and 4)
 Little is known about the SSB proteins except that they contain two conserved motifs, the 
SPRY domain and the SOCS-box domains. SOCS-box containing proteins have been described 
as E3-ligases involved in ubiquitination and proteasomal degradation of proteins. SPRY domains 
on the other hand have been described as protein-protein interaction modules. For SSB-1 a more 
detailed function has been described where it is involved in enhancing Ras/ERK signalling. All 
three proteins SSB-1, 2 and 4 were shown to bind to Par-4 through the SPRY domain. However, 
the biological significance of this interaction and the involved Par-4 domains are unknown (Ref.
[102] and references therein).
 These results indicate that Par-4 has a wide spectrum of binding partners and that different 
domains of Par-4 are involved these interactions. Even though the interaction studies between 
Par-4 and its partners were carried out carefully, there is still the possibility  that some of the 
interactions are false positive results. It was also shown that Par-4 is involved in both the 
extrinsic and the intrinsic pathway. Whereas Par-4 was shown to directly activate the extrinsic 
pathway through trafficking of Fas/FasL to the cell membrane [59], it is mainly involved in 
inhibiting anti-apoptotic proteins of the intrinsic pathway. It is interesting to note here that Par-4 
activates caspase-8, thereby promoting cleavage of BID. Processed tBID is then translocated into 
the mitochondria, promoting the release of cytochrome c and other pro-apoptotic proteins thus 
activating the intrinsic pathway in a Par-4-dependent manner [103].
 The Par-4 CC/LZ domain was shown to be the major interaction domain of Par-4. It  is 
possible that for complexes where the interaction is mediated by  the CC/LZ domain, other 
domains of Par-4 or other proteins may be involved in the interaction and thus necessary for the 
pro-apoptotic function. If contacts are solely mediated by  the CC/LZ domain, a construct 
comprising only  the Par-4 CC or LZ domain should have a similar effect. However, such a 
construct comprising the Par-4 CC domain was demonstrated to have an opposite effect than 
full-length Par-4 acting in a dominant negative manner [55]. This hypothesis remains speculative 
as the information about Par-4 protein complexes is sparse and as it is not known how the Par-4 
CC construct acts in a dominant negative manner. Taken together, as can be expected for a 
strictly regulated cellular process like apoptosis, the pro-apoptotic function of Par-4 depends on a 
variety of factors: sub-cellular localisation, phosphorylation state, availability of interaction 
partners or cell type to name a few.
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1.3.5. The oligomeric state of homo- and heteromeric Par-4 complexes
 The Par-4 CC domain has been described in the previous chapter as the binding domain for 
the majority of interaction partners. Sequence analysis of the Par-4 CC domain (Chapter 4.1.2.) 
further suggests that Par-4 is able to self-associate through formation of a dimeric coiled coil. 
Experimental evidence for in vivo self-association of Par-4 was initially  gained from yeast two-
hybrid assays [48]. Immunoprecipitation experiments further suggested that the CC domain is 
required for self-association of mouse full-length Par-4 and a 33 kDa splice variant of Par-4 [47]. 
Recently, in vitro pull-down experiments using Par-4 deletion mutants confirmed that the CC 
domain is essential for self-association [54]. However, non of the above described experiments 
could demonstrate that self-association is via coiled coil formation, nor that Par-4 dimerises as 
suggested by the amino acid sequence. Therefore, the in vivo oligomeric state of Par-4 is still 
elusive. Similarly  the exact stoichiometry of complexes of Par-4 and its binding partners are 
unknown. Association of Par-4 and its effector proteins was analysed in vivo and in vitro using 
yeast two-hybrid assays (e.g. Dlk [16] or THAP1 [92]), immunoprecipitation (e.g. p62, aPKCζ 
[88] or AATF [101]), or pull-down assays (e.g. WT1 [14] or Amida [53]). It  remains to be 
determined if Par-4 forms 1:1 complexes with its partners, or if self-association of Par-4 is a 
prerequisite to form 2:1 complexes with its partners. The often described homo- and 
heterodimeristion of Par-4 [54,57] is therefore a hypothetical assumption based on the amino 
acid sequence, which awaits experimental confirmation.
1.4. Coiled Coils and Leucine Zippers
 Sequence analysis predicts the presence of a coiled coil domain within the C-terminus of 
Par-4 (Chapter 1.2.1.). Coiled coils are common oligomerisation motifs and are predicted in 
approximately 10% of all eukaryotic proteins [104]. These amphipathic α-helical motifs are able 
to form left-handed supercoiled structures by wrapping two or more helices around each other 
[105]. The amino acid sequence of coiled coils is characterised by a seven residue repeat 
designated (abcdefg)n [106]. The a and d positions of each heptad are generally hydrophobic and 
form the centre of the oligomeric interface. Amino acids at other positions are generally polar or 
charged. Despite these simple sequence requirements, or perhaps because of it, a large variety of 
coiled coil structures is observed. Dimers [107,108], trimers [109,110], tetramers [111,112], 
pentamers [113] and heptamers [114] with varying orientation have been described in the 
literature.
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 Coiled coils are associated with various functions and can occur either as homo- or hetero-
complexes. Short coiled coils of six or seven heptad repeats often function as protein-protein 
interaction domains in signal transduction pathways [115-121]. Long coiled coils of several 
hundred residues can form fibres, meshworks or scaffolds due to their rod-like tertiary structures 
[105] and have various functions, most notably as components of the cytoskeleton [122], the 
extra cellular matrix [123] and cellular motor proteins [124].
 Leucine zippers are a special case of coiled coils and are often found in the bZIP (basic 
leucine zipper proteins) [117] and b-HLH-LZ (basic helix-loop-helix leucine zipper proteins) 
[118] transcription factor families. They are characterised predominantly  by  leucine residues at 
position d of the heptad repeat [125,126]. Together with hydrophobic residues at position a they 
form the oligomeric interface. Residues at position a are more variable and define the oligomeric 
state of the leucine zipper, whereas leucine residues at position d contribute mainly  to leucine 
zipper stability [127]. Due to its favourable properties the GCN4 leucine zipper has been used to 
study the relationship between the oligomeric state of coiled coils and the effect of amino acid 
type at  various heptad positions [109,128]. The most important factors determining the 
oligomeric state and helix orientation are (i) the packing complementarity of residues at 
positions a and d, (ii) electrostatic interactions between residues at positions e and g, and (iii) 
hydrogen bonding of buried and partially buried polar residues [128].
 The occurrence of β-branched hydrophobic residues such as isoleucine or valine at  position a 
has been correlated with a dimeric state, particularly if d positions are occupied by leucine 
residues. Conversely, trimeric and tetrameric states are observed if β-branched residues 
predominantly occupy d positions and leucine residues position a [109]. A GCN4 leucine zipper 
variant with exclusively isoleucine at  positions a and d adopts a parallel trimeric conformation 
[109]. Interestingly, a pentameric coiled coil has been described if both the a and d position are 
occupied by phenylalanine residues [113]. The occurrence of polar residues, in particular 
asparagine, within the hydrophobic interface is also common. Whereas residues such as 
threonine at position a usually  indicate heterodimeric coiled coils, asparagine residues at the 
same position result in homodimeric conformations[117]. The polar asparagine side chain 
interacts preferentially with other asparagine residues rather than with non-polar or other polar 
residues [129]. This helps to define a parallel unstaggered conformation of the dimer by forming 
an interhelical hydrogen bond between opposing asparagines in position a [107]. In contrast, 
other polar residues, such as threonine, preferentially form heterotypic interactions with 
opposing residues in position a necessitating heterodimeric coiled coils [129]. The specificity  in 
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interhelical orientation and register conferred by  asparagine (and other polar residues at position 
a) comes, however, at the expense of leucine zipper stability  [109,130]. The decrease in leucine 
zipper stability was in these cases compared to the stability contributions of hydrophobic 
residues, such as isoleucine, leucine or valine, at  position a. Interestingly, a trimeric coiled coil 
structures has been described that has almost exclusively asparagine residues at position d [131]. 
It was proposed that this trimeric structure is due to sequence peculiarities of the coiled coil 
domain of Salmonella autotransporter adhesins. Next to asparagine at d position, these coiled 
coils are marked by  having primarily  isoleucine at position a and threonine at position e. The 
high abundance of polar residues is thought to facilitate the sequestration of anions within the 
central cavity of the coiled coil, which thereby stabilises the trimeric structure.
 Further contributions to leucine zipper oligomerisation specificity and stability  stem from 
residues in the e and g positions. Charged residues at these positions are able to form interhelical 
ion-pairs [132,133]. Whereas the contribution of attractive e-g electrostatic interactions to 
leucine zipper stability  and specificity  is case-dependent [134,135], repulsive e-g electrostatic 
interactions are important destabilising factors that can affect overall leucine zipper stability  and 
specificity [117,136]. In addition to charged amino acids, uncharged amino acids are also 
important factors in determining the oligomeric state of the coiled coil. Substitution of all 
residues at position e and g of the GCN4 leucine zipper with alanine resulted in a switch from a 
dimeric to a heptameric coiled coil [114]. Residues at position e and g are further important for 
helix orientation within the coiled coil, particularly  for parallel and antiparallel tetramers[128]. 
For a special GCN4 variant, mutation of a single glutamate to cysteine was sufficient to switch 
from a parallel tetramer to an antiparallel one [137]. A further level of specificity and stability 
control arises from van der Waals interactions between the side-chain methylene groups of 
residues at positions e and g, and the sidechains of hydrophobic residues at positions a and d 
[107].
 Isolated α-helices are rarely observed in aqueous solutions [138,139] unless certain additives 
such as trifluoroethanol (TFE) are added that favour helix formation (see Ref. [140] and 
references therein). Furthermore, helix formation and interhelical association are tightly coupled 
events. It was therefore proposed that coiled coil formation occurs, in most cases, as a two-state 
process between unfolded monomers and the coiled coil oligomers (e.g. dimer) [138,139]. A 
typical experimental indication of a two-state process for coiled coil formation is observed by 
Circular Dichroism (CD) spectropolarimetry in the form of an isodichroic point near 203 nm 
[134,136]. A different CD parameter that indicates coiled coil formation is obtained from the 
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ratio of the ellipticities at 222 and 208 nm ([θ]222/[θ]208 ratio). For α-helical proteins deep 
negative transitions at 222 nm and 208 nm are observed. Supercoiling as observed in coiled coils 
results in an increase of the ellipticity at 208 nm to less negative values, however, does not affect 
the ellipticity at 222 nm. Thus ratios above 1.0 are interpreted as an indication for a stable coiled 
coil [141, whereas ratios below 0.9 indicate non-coiled helices [142]. Based on these criteria, a 
detailed analysis of the Par-4 CC and LZ domain will be given in Chapter 4.1.2.
1.5. Intrinsically disordered proteins
 The ubiquitous expression of Par-4, its post-translational modifications and a plethora of 
binding partners are characteristics common to many intrinsically disordered proteins (IDPs) 
[143] and prompted the investigation if Par-4 indeed can be classified as an IDP. A short 
introduction explaining the importance and characteristics of IDPs is given below. Under 
physiological conditions IDPs either entirely  lack a well defined secondary  and/or tertiary 
structure or contain long regions without a well defined secondary and/or tertiary structure. In 
contradiction to the structure-defines-function paradigm, stating that an ordered 3D structure is 
required for effective protein functioning, IDPs are biologically active and functional [144-146]. 
Proteins particularly  involved in cell regulation exhibit a high prevalence for ID with 
approximately 75% of these proteins predicted to contain disordered regions of 40 or more 
consecutive residues. Cell regulation involves processes such as cell division, transcription, 
translation, signal transduction, protein phosphorylation, and assembly/disassembly of multi-
protein complexes [146]. Additionally, cytoskeletal, ribosomal and cancer-associated proteins 
(e.g. Par-4) show a high abundance of disordered regions [147] implying that ID may be 
important for their function. The cancer-associated protein class may be considered as an 
extension of the cell regulatory  protein class as highly regulated processes such as cell 
proliferation or apoptosis often become dysregulated in cancer cells [4]. A prominent example 
for the relation of signalling proteins with cancerous processes is the well established IDP p53. 
Loss of its transcriptional control due to mutations has been shown to contribute to the 
development of tumours [148]. This suggests an important function for ID in human diseases 
[149,150]. Consistent with these observations, ID is more common in the eukaryotic proteome 
than in the prokaryotic. Approximately 35-51% of eukaryotic proteins contain disordered regions 
of 40 or more consecutive residues relative to 6-33% of prokaryotic proteins. It was proposed 
that this is because eukaryotes utilise a more complex protein network for signalling and 
regulation [151,152].
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 IDPs possess characteristics that are distinct from those of folded globular proteins. Relative 
to globular proteins, the sequences of IDPs display a low complexity. Furthermore, IDPs are 
depleted of hydrophobic amino acids (e.g. Ile, Phe, Trp, Tyr) and hence enriched in polar and 
charged amino acids, and proline (e.g. Glu, Gly, Lys, Pro) [153]. The depletion of hydrophobic 
residues has an important consequence, it prevents the formation of a hydrophobic core. Hence, 
IDPs adopt rather elongated structures with increased hydrodynamic radii relative to globular 
proteins of similar molecular weight. The protein backbone further displays increased structural 
flexibility resulting in rapid interconversion between multiple conformers [146]. Multiple 
conformers are thought to arise as residues in disordered segments display  a distribution of 
Ramachandran phi and psi angles. However, it was noted that IDPs tend to transiently adopt 
polyproline II helices in solution [154,155].
 While some IDPs completely  lack secondary  structure, others exhibit partial secondary 
structure that may be transient in nature. In most cases the residual secondary structure is of α-
helical nature predominating over β-strands [146]. Based on their structural properties such as 
secondary  structural content or compactness, IDPs can be classified into three non-exclusive 
groups: random coil, pre-molten globule and molten globule. The latter two groups are marked 
by varying degrees of fluctuating secondary  structure and increasing compactness [145]. The 
Protein Quartet model proposes [145] that a protein may exist in any of the four thermodynamic 
states: ordered, molten globule, pre-molten globule and random coil [144]. The function of the 
protein may  depend on any of the states or on a transition between two of the states [144,145]. 
Various examples for the Protein Quartet model have been reviewed in references [144-146] and 
some of the most prominent examples are given below. This list is not thought to be 
comprehensive, but to give an impression of the complexity  of cellular processes IDPs are 
involved in.
 Several cases have been described where the biological function of IDPs resides in the 
disordered state. Disordered segments, due to their inherent flexibility, have been described to 
serve as linkers between structured domains in multi-domain proteins such as p53 [156] or 
Calmodulin [157]. Another function of disordered segments involves the presentation of post-
translational modification, or protease digestion sites as suggested for Bcl-XL and Bcl-2 
[158-161]. Furthermore, disordered regions were demonstrated to function as entropic bristles 
necessary  for the separation of neighbouring neurofilaments, or to serve as entropic springs such 
as Titin in muscle filaments [162]. Biologic functions for pre-molten globules, molten globules 
or transitions between either of the two have been described for various proteins; such as myelin 
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binding protein [163], calsequestrin [164] or 1,25-dihydroxyvitamin D3 receptor [165]; upon 
binding to metal ions or other non-protein metabolites.
 A common feature for many  IDPs is a disorder-to-order transition upon binding to their 
biologic targets, a process termed induced folding [152,166]. Examples for induced folding 
includes the binding of p21 to Cdk2 [146,167], formation of a functional ribosome by ribosomal 
proteins [168], or binding of transcription factors such as the Lac-Repressor to DNA [169,170]. 
However, binding to a biologic target does not necessarily  induce structure and examples are 
known where ID regions retain disorder and a high degree of flexibility after binding. One such 
case has been described for p27 bound to the Cdk2-Cyclin A complex. Residual flexibility  in 
some regions of p27 allow for phosphorylation of a buried tyrosine residue thus marking p27 for 
ubiquitination and proteasomal degradation [171].
 These examples indicate that  ID is more common then previously thought. It  was therefore 
asked what functional advantages IDPs possess. (i) As disordered regions are solvent exposed 
they  are easily  accessible for post-translational modifications that help control function, locali-
sation and turnover. (ii) Consistently, disordered segments are more susceptible to proteolysis, 
which may influence the lifetime of an IDP in the cell. Proteolytic degradation was shown to 
depend on the exposition of protease cut sites or certain regulatory  sequences such as PEST sites. 
These sites may be buried upon complexation thus increasing the lifetime of a protein, whereas 
in the non-complexed state the protein is rapidly degraded. However, since protein degradation 
in vivo is a highly regulated process the generality of this concept has been challenged. (iii) 
Disordered regions confer increased structural plasticity overcoming steric restrictions that result 
in larger interaction surface areas per residue compared to folded globular proteins [166]. (iv) 
Furthermore, IDPs bind their targets with high specificity yet low affinity; (v) the latter 
increasing association/dissociation rates. The fly-casting mechanism has been proposed to 
describe how increased association rates are achieved [172]. Due to their extendedness 
disordered segments can sample a larger solution volume for interaction partners relative to 
globular proteins. Binding to the target surface is initially weak followed by folding to reel in the 
target thereby  increasing the strength of the interaction. (vi) Another important functional 
advantage of IDPs is their ability  to specifically bind to structurally different targets [144-146]. 
This promiscuous binding property sparked the idea that IDPs function as hubs in protein 
interaction networks [173]. However, recent studies have challenged the generality  and validity 
of this concept [174,175]. As the number of studied IDP complexes is increasing, more definitive 
results can be expected.
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1.6. Assessing intrinsic disorder
 The methods listed below represent only a small number of available methods to study protein 
disorder. These methods can be considered as initial experiments to assess ID. More information 
about these methods and additional experiments are found in the review articles given in Ref. 
[150,155,176] and references therein.
1.6.1. Computational methods
 Due to their unique structural characteristics computational algorithms have been developed 
to recognise ID. Two prominent examples are PONDR [177] and DisEMBL [178]. Hydrophobic 
cluster analysis (HCA) identifies the presence or absence of hydrophobic clusters and thus might 
indicate regions of order or disorder [179]. Additionally, charge-hydrophobicity plots can be 
used to identify  IDPs. In contrast  to globular folded proteins, IDPs occupy a distinct space 
marked by high mean net charge and low mean hydrophobicity [144,180].
1.6.2. Biochemical methods
 A first indication for ID can be gained from sodium dodecyl sulfate - polyacrylamide gel 
electrophoresis (SDS-PAGE). As IDPs tend to bind less SDS compared to globular folded 
proteins due to a depletion in hydrophobic amino acids, IDPs are marked by an abnormal 
electrophoretic mobility resulting in high apparent molecular weights (MWs). The SDS-PAGE 
determined MWs are often 1.2-1.8 times larger than can be expected from the amino acid 
sequence. In contrast to IDPs, globular proteins tend to aggregate upon heat or acid denaturation 
due to exposure of buried hydrophobic residues. As IDPs are depleted in hydrophobic residues, 
they  exhibit increased thermal and acid resistance that has been successfully used to purify IDPs. 
As mentioned above, IDPs are hypersensitive to protease digestion. Folded segments in contrast 
to disordered regions sequester their protease cut sites and are thus cleaved at a much lower rate. 
Limited proteolysis assays may  therefore be used to identify possible regions of ID (optimally 
combined with the analysis of possible fragments by mass spectrometry) [155].
1.6.3. Methods to assess the protein dimension and shape
 In contrast to globular proteins, IDPs are marked by varying degrees of extended 
conformations. A critical parameter that can be determined in this respect is the hydrodynamic 
radius or Stokes radius (RS). Consistent with the above mentioned IDP characteristics, the 
hydrodynamic radius (and thus the hydrodynamic volume) increases from globular, over molten 
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globule, pre-molten globule to coil-like states. Based on their hydrodynamic properties it  is 
therefore possible to discriminate between these states [181]. Size exclusion chromatography 
(SEC) for instance is a simple method to assess the hydrodynamic properties of proteins. Due to 
their increased hydrodynamic radii IDPs produce higher apparent MWs by SEC compared to 
globular proteins of similar chain length. However, similar high apparent MWs are also observed 
for well-ordered but asymmetrically (i.d. non-globular) shaped proteins. Similarly, RS values can 
be obtained from dynamic light scattering (DLS) experiments that allow distinction between 
globular proteins and IDPs. An alternative method for the determination of RS values has been 
described for pulsed-field-gradient nuclear magnetic resonance (PFG-NMR) diffusion 
experiments [176].
 Hydrodynamic properties of proteins can also be assessed by analytical ultracentrifugation, 
which determines the apparent sedimentation coefficient. This value is related to the MW and 
shape of the molecule, allowing MW estimates for proteins or protein complexes. A more 
powerful method for assessing the dimension and shape of proteins is small-angle X-ray 
scattering (SAXS). The shape of a protein may be determined by SAXS if it  is well defined. 
Otherwise, the maximum dimensions can be obtained from the distance distribution function, 
which is the histogram of all interatomic distances within the molecule. Furthermore, the 
forward scattering intensity is proportional to the MW of a protein and thus allows the 
determination of the oligomeric state. This, in conjunction with the experimentally determined 
radius of gyration (Rg), allows the discrimination between globular, pre-molten globule and coil-
like states. The Rg value is the root-mean-square distance from the centre of gravity  of the 
molecule weighted by the electron density. Typically large Rg values are obtained for IDPs [155].
1.6.4. Methods for the assessment of secondary structure
 One of the simplest methods to determine the secondary structural content is provided by far-
UV CD spectropolarimetry. The CD effect relies on the interaction of circular polarised light 
with chiral compounds. For protein spectroscopy the interaction with the peptide bond proved to 
be crucial. As the CD signal reflects the symmetry  of the peptide bond, it is dependent on the 
conformation of the two participating residues and thus gives information about the secondary 
structure [182]. CD measures the overall secondary structural content and does not allow the 
localisation of certain secondary structural elements to specific regions in the protein sequence. 
Furthermore, the obtained spectrum represents the population-weighted average of all structures 
in the conformational ensemble. CD spectra of IDPs are typically marked by a large negative 
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ellipticity at 200 nm, a negligible negative ellipticity at 222 nm, and an ellipticity  close to zero at 
185 nm. Other optical analysis methods to assess residual secondary structure are provided by 
Raman spectroscopy [150,155].
 Nuclear magnetic resonance (NMR) spectroscopy allows, unlike CD spectropolarimetry, the 
determination of secondary structure down to the atomic level. Thus, secondary structural 
elements can be located within the protein sequence. A detailed description of NMR would be 
beyond the scope of this section, therefore only  important concepts will be provided. NMR 
measures the magnetic properties of susceptible atoms such as 1H, 13C and 15N. As the latter two 
are not naturally occurring in biologic samples, proteins can be enriched in these atoms with 
specific labelling techniques (Chapter 2.5.). In strong external magnetic fields these atoms, or 
more accurate spins, can be excited through absorption of energy, a phenomenon called 
resonance. Energy is provided through irradiation of radio wave pulses. NMR follows the return 
of the excited spins to equilibrium, which yields characteristic resonance frequencies for each 
spin. These resonance frequencies depend on local magnetic fields and thus on the local 
chemical environment. As the local chemical environment is influenced by  neighbouring atoms, 
resonance frequencies are therefore reflective of the local secondary structure [183].
 Due to their flexibility  and rapid interconversion between multiple conformers, residues in 
IDPs experience similar local chemical environments. This results in similar resonance 
frequencies, especially of protons, and thus in a narrow spectral dispersion. As mentioned for CD 
spectropolarimetry, the observed resonance frequencies therefore represent a population-
weighted average over all structures in the conformational ensemble [155]. For comparison with 
residues in secondary structural elements, these resonance frequencies have been termed random 
coil chemical shifts. Secondary  structure induces a deviation from the random coil shifts termed 
the secondary chemical shift. As a result of secondary structure, an increased dispersion of the 
resonance frequencies is usually observed. Especially, 13C resonances such as the alpha and beta 
carbons (Cα and Cβ), or the carbonyl of the peptide bond (C’) are sensitive to the secondary 
structure induced shifts. Therefore, the secondary chemical shift values of these residues can be 
used for the identification of secondary structural elements. Secondary structure can further be 
identified from specific proton-proton distances. These distances are measured by  NOE (nuclear 
Overhauser enhancement) experiments.
 Measurements of amide proton exchange rates by  NMR can further provide information about 
the compactness of a protein. In folded segments the amide exchange rate is reduced due to a 
possible involvement in hydrogen bonds or due to burial in a hydrophobic core, whereas in 
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disordered regions the rate is increased as the amides are solvent exposed and unprotected. 
Finally, NMR determined dynamics of a residue can provide information about secondary 
structure, with residues in flexible segments having distinct dynamics than residues in ordered 
regions [150,155,176].
1.6.5. Methods to assess tertiary structure
 Various methods can be applied to gain information about the presence of tertiary structure 
and, under certain conditions, of residual secondary structure. Differential scanning 
microcalorimetry (DSC) produces heat absorption curves, which shape is characteristic for the 
presence or absence of tertiary structure. Alternatively, extrinsic fluorescence compounds such as 
ANS may be used to identify  residual hydrophobic core-like structures in a given protein. ANS 
binds to hydrophobic pockets that  may be present in molten globule or pre-molten globule states 
resulting in a fluorescence increase. In this way  molten globule or pre-molten globule states can 
be easily  discriminated from extended coil-like states. Various other fluorescence techniques 
have been described to assess the degree of tertiary structure in IDPs, most importantly  Förster 
resonance energy transfer (FRET) techniques. Due to the low abundance of tryptophan in IDPs 
this residue type is commonly used as donor in fluorescence experiments [150,155]. Information 
about the local environment of aromatic amino acid residues, in particular the tertiary  structure 
around them, can be gained by near-UV CD spectropolarimetry  (250-350 nm). Near-UV CD 
spectra of IDPs typically  display a low complexity and intensity  due to a lack of ordered 
structure. The aforementioned limited proteolysis assay is another method useful for the 
identification of possible regions of order.
 NMR spectroscopy can also provide useful information about the tertiary structure of a 
protein. Long range NOE contacts over distances up to ~10 Å can indicate the proximity  of 
certain regions within an IDP. However, these NOEs may be difficult to detect in IDPs as the 
contacts may  be to short lived due to the inherent flexibility of the molecule. Therefore, a 
different NMR technique has been proven more useful in the determination of tertiary contacts 
within IDPs. Paramagnetic relaxation enhancement (PRE) involves the introduction of a 
paramagnetic label, commonly  by  coupling to free cysteine groups, which drives the enhanced 
relaxation of nearby nuclei. This method is more sensitive and enables the detection of contacts 
up to ~20-25 Å apart [150,155,176].
 As IDPs are marked by fast interconversion between various structures the gathered structural 
information has to be interpreted as ensemble-average values. Despite computational approaches 
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a unique representation of the conformational ensemble has seldom been achieved. This is, 
however, of great importance for the analysis of the biological function, as only a small 
population of the ensemble might represent the biologically active state [176].
1.7. Research Aims
 Par-4 is an important regulatory protein of apoptosis and has been associated with various 
human diseases such as cancer or neurodegenerative disorders. The Par-4 CC/LZ domain has 
been described in the literature as the main protein interaction domain of Par-4 (e.g. binding to 
aPKCζ). As will be discussed in Chapter 4, this domain shows sequence peculiarities that are 
detrimental to coiled coil stability. It was previously  shown that the Par-4 LZ domain displayed a 
pH dependent coiled coil formation allowing self-association at  low pH and low temperature 
[184].
 (1) Determination of the NMR solution structure of the Par-4 LZ domain at low pH and low 
temperature was the main objective of this thesis. Furthermore, these results were to be 
compared with structural data of the Par-4 LZ domain in its disordered state at neutral pH.
 (2) Also the NMR solution structures of two basic mutants of the Par-4 LZ domain that form a 
coiled coil independent of pH [185] were main objectives.
 (3) Determination of the NMR solution structure of the Par-4 LZ domain in complex with the 
zinc-finger domain of the aPKCζ.
 (4) Determination if the LZ domain of Par-4 binds to the aPKCζ as an oligomeric coiled coil 
or as an unfolded monomer.
 However, instabilities of the LZ constructs and the insolubility of the aPKCζ zinc-finger 
domain prevented the completion of these objectives (Appendix C). Coiled coil formation of the 
Par-4 CC domain was therefore analysed using full-length Par-4 and Par-4 LZ deletion mutants 
that were considered to be more stable than the LZ constructs. Initial NMR experiments of a 
Par-4 LZ deletion mutant suggested that Par-4 may  be an IDP. This idea was further corroborated 
by the facts that the multitude of Par-4 interaction partners and stringent control by post-
translational modifications are characteristic features commonly  linked with the concept of 
intrinsic disorder. Based on this hypothesis, new research aims were formulated and the results 
are reported in Chapter 3.
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 (5) Is there evidence for intrinsic disorder in Par-4?
 (6) If Par-4 is an IDP, does it or specific sub-domains (e.g. SAC) contain residual secondary 
and/or tertiary structure?
 (7) If residual structure is detected, can it be localised to specific regions in Par-4?
 In contrast to earlier reports [184], full-length Par-4 self-associated independent of pH most 
likely via coiled coil formation. As an understanding of the molecular details of coiled coil 
formation in Par-4 may be beneficial for developing Par-4 inhibitors, analysis of the Par-4 CC/
LZ domain was resumed. Due to the experience gained with the isolation of full-length Par-4 
stable Par-4 LZ constructs could be purified that allowed further analysis by  NMR spectroscopy 
and CD spectropolarimetry. Despite clear indications for coiled coil formation of the isolated 
Par-4 LZ domain by CD spectropolarimetry, no coiled coil state was observed by NMR 
spectroscopy. These results are reported in Chapter 4.
 (8) Why is the coiled coil state of the isolated Par-4 LZ domain, or of two basic mutants, not 
observed by NMR?
 (9) What is the oligomeric state of the Par-4 LZ coiled coil?
 (10) What factors influence the coiled coil stability of the Par-4 LZ domain?
 (11) Is the Par-4 CC domain, unlike the LZ domain, sufficient to form a coiled coil inde-
pendent of pH, and is the formed coiled coil more stable than the LZ coiled coil?
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2.1. Basic microbiologic techniques
 A list of suppliers for the used materials and enzymes is given in Appendix A. Unless stated 
otherwise the buffer recommended by the manufacturer was used for enzymatic reactions. 
Standard molecular biologic procedures were performed as described in Sambrook et al. [186]. 
All buffers were prepared with MilliQ grade water and were autoclaved before use.
2.1.1. Preparation of ultra-competent cells
 Ultra-competent E. coli cells were made from TOP10 or DH5α E. coli strains for plasmid 
maintenance and from BL21(DE3) CodonPlus or Rosetta(DE3) E. coli strains for protein 
expression. Starting from a glycerol stock, cells were streaked out on a Luria-Bertani (LB) Agar 
plate and incubated overnight at 37 ºC. For BL21(DE3) CodonPlus and Rosetta(DE3) strains 
LB-Agar plates were supplemented with 34 µg/ml chloramphenicol (Cam). A single colony was 
picked and used to inoculate 50 ml of LB medium. The culture was agitated at 37 ºC until an 
OD600 = 0.3-0.4 and subsequently  incubated on ice for 15 min. Cells were harvested by 
centrifugation for 15 min at 4 ºC and 3,300 g (Heraeus Multifuge 1 S-R, Rotor TTH400, Kendro, 
Langenselbold, Germany). The cell pellet was resuspended in 18 ml RF1 buffer, containing 
100 mM  RbCl, 50 mM  MnCl2, 10 mM  CaCl2 and 30 mM  KAc, pH 5.8. The cell suspension was 
kept on ice for 30 min and then centrifuged again. The cell pellet was resuspended in 4 ml RF2 
buffer, containing 10 mM  RbCl, 75 mM CaCl2, 10 mM MOPS. The cell suspension was divided 
into 100 µl aliquots and stored at -80 ºC.
2.1.2. Transformation of E. coli cells
 Ultra-competent E. coli cells were thawed on ice for 10 min. Typically  10 ng of plasmid DNA 
(Chapters 2.3. and 2.4.) were added and the cell suspension was gently mixed. Cells were 
incubated on ice for 30 min, then put into a water bath kept at  42 ºC for 90 s and incubated again 
on ice for 120 s. After adding 400 µl of SOC medium the transformation reactions was agitated 
for one hour at 37 ºC in a shaking incubator. The transformation reaction was plated out on LB-
Agar plates, which were supplemented with the necessary  antibiotics for the plasmid and the E. 
coli strain, and left to dry for one hour on the bench close to a burning Bunsen burner. The LB-
Agar plates were incubated at 37 ºC overnight, but no longer than 18 h.
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2.1.3. Preparation of glycerol stocks
 A single colony from the LB-Agar plate was picked and used to inoculate 25 ml of LB 
medium. Depending on the plasmid and E. coli strain used, the LB medium contained 0.1 mg/ml 
ampicillin (Amp) or 0.1 mg/ml Amp and 34 µg/ml Cam, respectively. The culture was agitated at 
37 ºC up to an OD600 = 0.5-0.6. From that culture 10 ml were centrifuged for 15 min at 4 ºC and 
3,300 g (Rotor TTH400). The cell pellet was resuspended in 1 ml LB medium with 25% 
glycerol (v/v) and stored at -80 ºC.
2.2. Expression and purification of recombinant proteases
2.2.1. Expression and purification of HMBP-3Cpro
 The 3C protease from human rhinovirus 14 was expressed as a fusion protein with an N-
terminal hexa-histidine and maltose binding protein-tag (HMBP) [187] and therefore denoted 
HMBP-3Cpro. A 25 ml preculture of LB, containing 0.1 mg/ml Amp and 34 µg/ml Cam, was 
inoculated with cell material from a glycerol stock and agitated overnight at 37 ºC. The OD600 
value was measured and the preculture centrifuged for 15 min at 4 ºC and 3,300 g (Rotor 
TTH400). The cell pellet was resuspended in 3 ml fresh LB and then used to inoculate the main 
culture. The main culture had a volume of 500 ml LB containing 0.1 mg/ml Amp and 34 µg/ml 
Cam. The volume of the preculture used for inoculation was measured so that the main culture 
had a starting OD600 = 0.06. The main culture was agitated at 37 ºC up to an OD600 = 0.6. 
Expression was induced by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a 
concentration of 0.4 mM  and cells were incubated overnight at 25 ºC with agitation. Cells were 
harvested by centrifugation at  4,400 g and 4 ºC (Sorvall Evolution RC, Rotor GS3, Kendro, 
Langenselbold, Germany).
 The cell pellet  was resuspended in 20 ml 100 mM NaCl, 25 mM imidazole, 0.5 mM  TCEP 
and 50 mM  Na2HPO4/NaH2PO4, pH 8.0 and 50 µl of the protease inhibitor cocktail were added. 
The cell suspension was passed three times through a French Press (AMINCO, Silver Spring, 
USA). The cell lysate was clarified by centrifugation for 30 min at 14,000 g and 4 ºC (Heraeus 
Multifuge 1 S-R, Rotor FA12.94 Highconic, Kendro, Langenselbold, Germany). The supernatant 
was passed through a 0.8 µm syringe filter and the filtrate was rotated for 3 h with 2 ml (bed-
volume) Chelating Sepharose, which had been charged with NiCl2 and equilibrated to the lysis 
buffer. The Ni-NTA column was washed successively  with 10 ml lysis buffer and 5 ml lysis 
buffer with 50 mM imidazole. The 64 kDa fusion protein was eluted with 10 ml 100 mM NaCl, 
250 mM imidazole, 0.5 mM TCEP and 50 mM Na2HPO4/NaH2PO4, pH 8.0. HMBP-3Cpro 
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containing fractions were pooled and dialysed overnight at 4 ºC against 500 ml 200 mM  NaCl, 
1 mM  DTT and 40 mM Na2HPO4/NaH2PO4, pH 7.8. The dialysate was concentrated to a protein 
concentration of approximately  5 mg/ml using a Vivaspin 20 device (MWCO = 10 kDa) at 
3,000 g and 4 ºC (Rotor TTH400). After adding ice-cold glycerol to 25% (v/v), HMBP-3Cpro 
was divided into 1 ml aliquots and stored at  -20 ºC. Cleavage reactions were usually  performed 
for 10 h and 4 ºC at a HMBP-3Cpro to substrate ratio of 1:100.
2.2.2. Expression and purification of rTEV protease
 The rTEV protease from tobacco etch virus was expressed as a fusion protein with an N-
terminal hexa-histidine tag. The rTEV expressing E. coli strain was kindly provided by Dr. Gill 
Norris (Institute of Molecular Biosciences, Massey University, New Zealand). The rTEV 
expressing E. coli strain was streaked out on an agar plate, containing 0.1 mg/ml Amp and 
30 µg/ml kanamycin (Kan), and incubated overnight at 37 ºC. A 25 ml preculture of LB, 
containing 0.1 mg/ml Amp and 30 µg/ml Kan was inoculated with a single colony from the agar 
plate and agitated overnight at 37 ºC. The OD600 value was measured and the preculture 
centrifuged for 15 min at 4 ºC and 3,300 g (Rotor TTH400). The cell pellet was resuspended in 
3 ml fresh LB and then used to inoculate the main culture. The main culture had a volume of 
500 ml LB, containing 0.1 mg/ml Amp and 30 µg/ml Kan. The volume of the preculture used for 
inoculation was measured so that the main culture had a starting OD600 = 0.06. The main culture 
was agitated at  37 ºC up to an OD600 = 0.6. Expression was induced by the addition of IPTG to a 
concentration of 0.1 mM  and cells were incubated overnight at 25 ºC with agitation. Cells were 
harvested by centrifugation at 4,400 g and 4 ºC (Rotor GS3).
 The cell pellet was resuspended in 20 ml 100 mM NaCl, 25 mM imidazole, 10% glycerol (v/v) 
and 50 mM  Na2HPO4/NaH2PO4, pH 8.0 and 50 µl of the protease inhibitor cocktail were added. 
The cell suspension was passed three times through a French Press. The cell lysate was clarified 
by centrifugation for 30 min at 14,000 g and 4 ºC (Rotor FA12.94 Highconic). The supernatant 
was passed through a 0.8 µm syringe filter and the filtrate was rotated for 3 h with 2 ml (bed-
volume) Chelating Sepharose, which had been charged with NiCl2 and equilibrated to the lysis 
buffer. The Ni-NTA column was washed successively  with 10 ml lysis buffer and 5 ml lysis 
buffer with 50 mM Imidazole. The 27 kDa fusion protein was eluted with 10 ml 100 mM NaCl, 
500 mM imidazole, 10% glycerol (v/v) and 50 mM Na2HPO4/NaH2PO4, pH 8.0. rTEV containing 
fractions were pooled and the buffer concentration adjusted to 1 mM EDTA and 1 mM  DTT. The 
eluate was concentrated to a protein concentration of 1-2 OD280 using a Vivaspin 20 device 
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(MWCO = 10 kDa) at 3,000 g and 4 ºC (Rotor TTH400). The concentrate was dropped with a 
1 ml pipette into liquid nitrogen. The formed balls were collected and stored in 1.5 ml reaction 
tubes (7-8 balls per tube) at -80 ºC. One ball with 2 OD280 usually cleaves 5 mg protein in 2 h at 
room temperature.
2.2.3. Summary
 With the methods described above highly  active HMBP-3Cpro and rTEV protease were 
purified. The proteases were stable and remained active for at  least 9 months; for HMBP-3Cpro 
even 18 month old preparations showed very good cleavage activity. The use of proteases with 
an N-terminal hexa-histidine tag allowed the removal of the proteases by immobilised metal ion 
affinity chromatography (IMAC). In the case of HMBP-3Cpro separation by affinity 
chromatography  with Amylose resin is possible as well. High purity of the proteases is not 
necessary  and hence the purification time is very short. Since most of the impurities elute at 
imidazole concentrations of 250 mM, they are likely  to be removed together with the protease by 
the second IMAC step used for the removal of the expression tag after cleavage of the Par-4 
fusion proteins (see below). In case of the Par-4 constructs with a GST tag (Chapters 2.10. and 
2.11.), these impurities are removed by the RP-HPLC (reversed phase-high performance liquid 
chromatography) step. Furthermore, the proteases are used at  lower concentrations than the Par-4 
fusion proteins and the impurities are therefore considerably diluted. This dilution effect also 
makes a buffer exchange step to reduce the imidazole concentration for rTEV obsolete.
2.3. Preparation of cell free expression vectors
2.3.1. Materials and Methods
 Primer sequences, annealing temperatures and the templates used for the PCR reactions are 
listed in Table 2.1. PCR with KOD Polymerase was performed according to the manufacturers 
instructions with the following cycle:
1.) 2 min at 95 ºC
2.) 60 s at 95 ºC
3.) 45 s at X ºC (see Table 2.1)
4.) 60 s at 72 ºC
5.) 5 min at 72 ºC
steps 2.) to 4.) are repeated 30 times
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 The PCR products and the pET23a vector were cut with Nde I and BamH I according to the 
manufacturers instructions. The double digested PCR products and vectors were ligated with T4-
DNA Ligase at 16 ºC according to the manufacturers instructions. The ligation reaction was used 
to transform TOP10 E. coli cells (Chapter 2.1.1.). Vectors with the correct sequence were 
identified by sequencing of the plasmid (Allan Wilson Centre for Molecular Ecology and 
Evolution, Massey University, New Zealand).
Construct Name Forward Primer (5’-3’) Reverse Primer (5’-3’) Template Annealing Temperature
pCFE-GST-3C
pCFE-GST-TEV
pCFE-GST-TEV2
pCFE-HMal-TEV
pCFE-HTEV
pCFE-TrxH-TEV
CTGGCATATGTCCCCTATA
CTAGGTTAT
CCGGGGATCCCAGGGGCCCC
TGGAACAG pGex-4T-3 55 ºC
CTGGCATATGTCCCCTATA
CTAGGTTAT
CCGGGGATCCCTGAAAATAC
AGGTTTTCATCCGATTTTGG
AGGATG
pGex-4T-3 55 ºC
CTGGCATATGTCCCCTATA
CTAGGTTAT
CCGGGGATCCCTGAAAATAC
AGGTTTTCGGTCGTTGGGAT
ATCGTAATCATCCGATTTTG
GAGGATG
pGex-4T-3 45 ºC
GGGAATTCCATATGCATCA
CCATCACCATCACATGAAA
ACTGAAGAAGGTAAACTGG
CCGGGGATCCCTGAAAATAC
AGGTTTTCCCCGAGGTTGTT
GTTATTGTT
HpMal-c2P 50 ºC
GAGCGGCCATATGTCGTAC
TACCATCACCATCACC
TGCCAAGCTTTCTAGAGGAT
CCGGATTGAAAATACAGGTT
TTCGGTC
pET32TEV 55 ºC
CTGGCATATGAGCGATAAA
ATTATTCAC
CCGGGGATCCCTGAAAATAC
AGGTTTTCGGTCGTTGGGAT
ATCGTAATCGTGATGGTGAT
GGTGATGCATATG
pET32a 55 ºC
 Table 2.1  − Preparation of cell free expression vectors. Primer sequences, DNA templates and 
annealing temperatures used for PCR amplification to prepare the cell free expression vectors.
2.3.2. Results and Discussion
 Cell free expression [188] is a method combining in vitro transcription and translation for 
rapid protein expression. Therefore, the time consuming fermentation of E. coli cell cultures is 
not necessary. This also allows the expression of proteins that would be toxic to the expression 
host. Additives such as ligands, detergents or chaperones can be added to increase the yield in 
folded protein [188]. Another advantage that this system allows is selective isotopic labelling. 
Using defined combinations of isotopically labelled and unlabelled amino acids, various 
labelling schemes can be achieved. As cell free expression is based on in vitro transcription with 
T7-RNA-Polymerase from plasmid DNA, co-expression of various proteins from different 
plasmids containing the T7-promoter is possible. Co-expression of Par-4 proteins with potential 
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binding partners, in particular with the zinc finger domain of aPKCζ, was considered as a 
potential expression method for Par-4, as complex formation might increase the solubility of 
full-length Par-4. The aPKCζ constructs and particularly full-length Par-4 (Chapter 2.6.) are 
mostly insoluble in native lysis buffer and different purification strategies had to be considered.
 The requirements for a cell free expression vector are (i) a T7-promoter and T7-terminator for 
transcription initiation and termination, (ii) a ribosome binding site and an initiation codon for 
translation initiation and (iii) a multi cloning site for insertion of the protein sequence. These 
requirements are based on the cell free expression system used by our collaborator Dr. Andrew 
Kralicek (HortResearch, Auckland, New Zealand). It was further necessary to exclude a lac 
operator from the operon. Since in vitro translation systems use cell lysates [188], in particular 
from E. coli, endogenous lac repressor may prevent transcription from vectors containing a lac 
operator. Hence, the lac repressor coding lacI gene must be removed. Therefore, the pET23a 
vector was chosen as the backbone for all cell free expression vectors (pCFE-vectors) listed in 
Table 2.1. pET23a contains no lac operator and lacI gene, but instead it has a T7 promoter and a 
T7 terminator. Also the ribosome binding site and initiation codon are correctly spaced relative 
to each other. The multi cloning site offered the use of the same restriction enzymes as were 
already used by our group. This allows a simple transfer of Par-4 inserts from existing vectors to 
the new pCFE-vectors. Expression tags such as glutathione S-transferase (GST), maltose binding 
protein (MBP), thioredoxin or a hexa-histidine tag can easily  be inserted into the Nde I and 
BamH I site without affecting the spacing between ribosome binding site and initiation codon.
 The strong T7 promoter allows high level protein expression in E. coli cells containing the 
λDE3 lysogen. However, under certain circumstances, high level expression may be detrimental 
and lead to insoluble or improperly folded protein. In addition, due to the missing lac operator, 
transcription control is less stringent compared to other vectors, which may  be problematic for 
cytotoxic proteins. More stringent control can be achieved using hosts carrying pLysS or pLysE 
genes (pET System Tutorial, Merck Biosciences, Darmstadt, Germany).
 Various cell free expression vectors were created during the PhD offering the choice between 
different purification tags such as (i) GST (pCFE-GST-3C, pCFE-GST-TEV or pCFE-GST-
TEV2), (ii) MBP (pCFE-HMal-TEV), (iii) thioredoxin (pCFE-TrxH-TEV) or (iv) a hexa-
histidine  tag (pCFE-HTEV). Plasmid maps of each vector are given in Appendix B. The pCFE-
vectors with GST as purification tag further offer the choice between two different proteases 
(HMBP-3Cpro and rTEV) for the removal of the purification tag. pCFE-GST-TEV and pCFE-
GST-TEV2 differ in the length of the spacer between GST and the rTEV cleavage site. The 
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longer spacer of pCFE-GST-TEV2 might be favourable if bulky proteins are fused to GST. MBP, 
thioredoxin and the hexa-histidine tag allow purification through standard IMAC purification 
protocols. In addition, the well established solubilising properties of MBP allow the expression 
of target proteins with limited solubility. rTEV is the protease of choice as it only leaves a two 
amino acid (pCFE-GST-TEV, pCFE-GST-TEV2 and pCFE-HMal-TEV) or three amino acid 
artefact (pCFE-HTEV and pCFE-TrxH-TEV) at the N-terminus of the target protein (see plasmid 
maps, Appendix B). rTEV has further advantages over HMBP-3Cpro as will be discussed in 
Chapter 2.12.1.
 Sequencing showed that all cell free expression vectors listed in Table 2.1 had the correct 
sequence. The vectors pCFE-GST-TEV (Chapter 2.11.4.), pCFE-HMal-TEV (data not shown), 
and pCFE-TrxH-TEV (Chapter 2.8.2.) were used for protein expression in E. coli cells and 
showed good expression results. The expression levels are comparable to other vectors (pET32a, 
HpMal-c2P). In the case of pCFE-HMal-TEV with a human rhinovirus 14 3C protease insert, the 
over-expressed fusion protein accounted for approximately 30% of the total cell proteins as 
judged by SDS-PAGE (personal communication with Dr. J. Claridge). In vitro expression was 
tested by Dr. Andrew Kralicek with pCFE-GST-3C, pCFE-HMal-TEV and pCFE-TrxH-TEV. 
Protein expression is observed only for pCFE-TrxH-TEV and only with aPKCζ inserts. pCFE-
TrxH-TEV constructs with inserts from Par-4 show no expression indicating a dependence of 
protein expression from the insert. The expressed aPKCζ proteins were, however, mostly 
insoluble (personal communication with H. Venugopal). It is not clear why other pCFE-vectors 
(pCFE-GST-3C and pCFE-HMal-TEV) or pCFE-TrxH-TEV vectors with Par-4 inserts, e.g. 
Par-4(1-290)G40G in pCFE-TrxH-TEV (Chapter 2.8.2.), show no expression. These vectors 
show good expression in E. coli cells indicating a functional operon.
 Taken together, a new set of expression vectors was created allowing stable over-expression 
of heterologous recombinant proteins. Various expression tags are combined with cleavage sites 
for highly specific proteases allowing the removal of the expression tag. Due to the same multi 
cloning site in all vectors transfer of inserts between different vectors is simplified. Hence, 
different purification strategies can be selected depending on the kind of expression vector 
allowing an adaptation of the purification process to the properties of the target protein.
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2.4. Preparation of Par-4 expression vectors
2.4.1. Materials and Methods
 Table 2.2 contains a list of all prepared Par-4 expression vectors. It lists the PCR primer 
sequences and the templates used for the PCR reactions. The expression vector and restriction 
enzymes used for cloning are also given. PCR with Pwo or KOD Polymerase was performed 
according to the manufacturers instructions. The PCR cycles for the two used polymerases were:
Pwo Polymerase KOD Polymerase
1.) 5 min at 94 ºC 1.) 2 min at 95 ºC
2.) 60 s at 94 ºC 2.) 20 s at 95 ºC
3.) 45 s at 60 ºC 3.) 15 s at 60 ºC
4.) 75 s at 72 ºC 4.) 45 s at 72 ºC
5.) 5 min at 72 ºC 5.) 5 min at 72 ºC
steps 2.) to 4.) are repeated 30 times steps 2.) to 4.) are repeated 30 times
 The expression vectors and PCR products were digested with the corresponding restriction 
enzymes (Table 2.2) according to the manufacturers instruction. Cut vectors and inserts were 
ligated with T4-DNA Ligase according to the manufacturers instruction. The ligation reaction 
was used to transform TOP10 or DH5α E. coli cells (Chapter 2.1.1.). Correct insertion of the 
PCR product was assessed by sequencing of the plasmid (Allan Wilson Centre for Molecular 
Ecology and Evolution, Massey  University, New Zealand). Plasmids with the correct sequence 
were used to transform the expression hosts E. coli BL21(DE3) CodonPlus or Rosetta(DE3).
 pET32TEV is an in-house expression vector created by Dr. Rose Brown (Institute of 
Molecular Biosciences, Massey University, New Zealand) and is derived from pET32a. The 
hexa-histidine tag and TEV cleavage site from pProEX-HTb was PCR amplified using the 
Primers 5’-GGTTCTGGCCATATGTCGTACTACCATCACCATCA-3’ (Fw) and 5’-TGCCAAG 
CTTTCTAGAGGATCCGGATTGAAAATACAGGTTTTCGGTC-3’ (Rv). The PCR product 
was cut with Msc I and BamH I and then used to replace the original sequence, with a Thrombin 
and Enterokinase cleavage site, in pET32a. The vector name HpMal-c2P is used instead of 
HMBP-3C [187] to avoid any confusion with the hexa-histidine and MBP-tagged 3C protease 
(HMBP-3Cpro).
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Construct Name Forward Primer (5’-3’)
Reverse Primer 
(5’-3’) Template
Restriction 
Enzymes
Expression 
Vector
Par-4(1-332)WT
Par-4(1-332)WT
Par-4(1-332)G40G
Par-4(1-332)G40G
Par-4(1-290)G40G
Par-4(286-332)WT
Par-4(286-332)WT
Par-4(286-332)WT
Par-4(286-332)N313I
CAGGAATTCCATGGC
GACCGGCGGCTATCG
GAGC
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA EcoR I / Sal I pGex-4T-3
CAGGAATTCAAATGG
CGACCGGCGGCTATC
GGAG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA EcoR I / Sal I pProEX-HTb
CAGGGATCCATGGCG
ACCGGCGGCTATCGG
AG
CTTGGCGGCTGGAT
CTCCGCCGCTCGAA
C
rat Par-4 cDNA BamH I pET32a
GTTCGAGCGGCGGAG
ATCCAGCCGCCAAG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA Sal I
CAGGGATCCATGGCG
ACCGGCGGCTATCGG
AG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
Par-4(1-332)G40G 
in pET32a BamH I / Sal I pET32TEV
CAGGGATCCATGGCG
ACCGGCGGCTATCGG
AG
CCGGAAGCTTTTAT
TCTTCTTTATCTTG
CATCAG
Par-4(1-332)G40G 
in pET32a BamH I / Hind III pCFE-TrxH-TEV
GCACTAGGATCCCAA
GATAAAGAAGAAATG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA BamH I / Sal I pCFE-GST-3C
GCACTAGGATCCCAA
GATAAAGAAGAAATG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA BamH I / Sal I pCFE-GST-TEV
GCACTAGGATCCCAA
GATAAAGAAGAAATG
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
rat Par-4 cDNA BamH I / Sal I pGex-6P-3
GCACTAGGATCCCAA
GATAAAGAAGAAATG
CCTGCTTTAGTTGC
TCGATTTCGTC
Par-4(286-332)
WT in pGex-6P-3 BamH I pGex-6P-3
GACGAAATCGAGCAA
CTAAAGCAGGA
CAGGTCGACTTACC
TTGTCAGCTGCCCA
ACAAC
Par-4(286-332)
WT in pGex-6P-3 Sal I
 Table 2.2 − Preparation of Par-4 expression vectors. Primer sequences and DNA templates for PCR 
amplification are given. Restriction enzymes and host vectors are also listed.
2.4.2. Results and Discussion
 The Par-4 constructs made for this study were designed so that they  produce proteins, which 
are of biological significance (Chapter 1.2.). All sequence numberings refer to the rat isoform of 
Par-4. Note that the cDNA of rat Par-4 was used as a template for PCR reactions during the 
preparation of Par-4 expression vectors. Full-length constructs of Par-4 (Par-4(1-332)) were 
made as reference constructs to all other constructs comprising deletion mutants and single 
domains of Par-4. To take advantage of an N-terminal BamH I site, an internal BamH I site 
present in the rat  Par-4 cDNA was removed by PCR (Table 2.2). Constructs with this silent point 
mutation are denoted G40G instead of WT (wild-type). Using a BamH I site at the N-terminus 
reduces the N-terminal cloning artefact for most expression vectors, especially  for vectors of the 
pET series. Also transfer between different expression vectors is simplified as most BamH I sites 
2. Expression and Purification of Par-4
54
are in the same translation frame in various vectors. As mentioned in the Introduction, ectopic 
over-expression of Par-4 in PC3 or melanoma cells showed that the LZ domain is essential for 
the sensitivity to apoptotic stimuli [55]. Deletion mutants that lack the LZ domain, however, did 
not confer enhanced sensitivity [55]. Two such LZ deletion mutants were made (Par-4(1-265) 
and Par-4(1-290)). The Par-4(1-290) constructs contain 15 additional residues of the C-terminal 
CC region (residues 254-332) [46]. The rationale was to determine if coiled coil formation is 
possible without the LZ domain. The SAC domain is sufficient for apoptosis induction in cancer 
cells [50]. Therefore, a similar construct as used in this previous study  comprising only  the SAC 
domain was made (Par-4(137-195)). A construct  comprising the CC domain (Par-4(240-332)) 
was made as it was shown that this domain is able to act in a dominant negative manner 
abrogating the pro-apoptotic function of Par-4 [55]. Various constructs of the LZ domain (Par-4
(286-332)) were made as these constructs show an interesting pH dependent folding behaviour
[184]. However, a physiological function has not been described for this construct. The Par-4
(286-332)W285 mutant was created to determine the protein concentration by A280 
measurements as the wild-type LZ domain does not contain aromatic residues. The rationale for 
the creation of the Par-4(286-332)D305K and E310K point mutants is described in Dutta et. al. 
[185]. In short, these two mutants adopt a coiled coil conformation independent of pH.
 Sequencing confirmed correct insertion of the PCR products into the vectors and verified the 
right nucleotide sequence for almost  all constructs. Only  one Par-4 expression vectors listed in 
Table 2.2 could not be created during the PhD (see below). Some of the vectors used in this 
study were created by other researchers in a similar way and their acknowledgements are given 
below. The HpMal-c2P expression vectors of Par-4(286-332)WT, Par-4(286-332)W285, Par-4
(286-332)D305K and Par-4(286-332)E310K [184,185], and the pGex-6P-3 expression vector of 
Par-4(240-332)WT were kindly provided by Dr. Kaushik Dutta (New York Structural Biology 
Center, New York, USA). The HpMal-c2P expression vectors of Par-4(1-332)WT, Par-4(1-265)
WT and Par-4(1-290)WT were prepared by Dr. Komala Ponniah (Institute of Molecular 
Biosciences, Massey University, Palmerston North, New Zealand). Par-4(137-195)WT in 
pET32TEV was created by Sachin Kate (Institute of Fundamental Sciences, Massey University, 
Palmerston North, New Zealand).
 The only  Par-4 expression vector that  could not be created during the PhD was Par-4(1-332)
WT in pGex-4T-3. Even though a similar vector is described in the literature [53], all attempts to 
create this vector resulted in recombination. Sequencing of several clones after transformation 
showed that both the pGex-4T-3 vector and the PCR product were cut properly  at the 5’ and 3’ 
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end and that  the PCR product and the vector ligated properly. However, in all sequenced 
constructs the central part  of Par-4, approximately residues Ser 8 to Asp 308, was lost by 
recombination. Restriction digest, ligation and transformation were repeated, however, gave 
similar results. Additionally, different E. coli strains such as DH5α, TOP10 or BL21(DE3) 
CodonPlus were tested, but all gave similar results. As expression results of Par-4(1-332)G40G 
from pET32a were promising, preparation of the pGex-4T-3 vector was abandoned. Re-cloning 
of this construct was not tried as Par-4(1-332) can be purified in high purity from a different 
construct.
 Due to improper cleavage of the 5’-end of the PCR insert for pCFE-GST-3C four additional 
nucleotides were included between the ribosome binding site and the initiation codon. In case of 
Par-4(286-332)WT in pCFE-GST-3C (Chapter 2.11.2.) this increased spacing between the 
ribosome binding site and the initiation codon still allowed expression. However, the protein 
expression levels were comparable to the pGex-6P-3 (Chapter 2.11.3.) vector suggesting that the 
increased spacing decreased the expression efficiency. pCFE-GST-3C has been re-cloned to 
remove these four additional residues, but it has not been tested for expression with new inserts.
2.5. Protein expression and labelling techniques
2.5.1. Expression of unlabelled Par-4
 Par-4 was expressed either from BL21(DE3) CodonPlus or Rosetta(DE3) E. coli cells. A 
preculture, 20 to 50 ml LB containing 0.1 mg/ml Amp and 34 µg/ml Cam, was inoculated with 
cell material from a glycerol stock and agitated overnight at  37 ºC. The OD600 value was 
measured and the preculture centrifuged for 15 min at 4 ºC and 3,300 g (Rotor TTH400). The 
cell pellet was resuspended in 1-3 ml fresh LB and then used to inoculate the main culture. The 
main culture had a volume of 300-1000 ml LB, containing 0.1 mg/ml Amp and 34 µg/ml Cam. 
The volume of the preculture used for inoculation was measured so that the main culture had a 
starting OD600 = 0.06. The main culture was agitated at 37 ºC up  to an OD600 = 0.6. Expression 
was induced by the addition of IPTG to a concentration of 0.4 mM  and cells were agitated at 
25 ºC for 8 h or overnight, respectively. Cells were harvested by centrifugation at 4,400 g and 
4 ºC (Rotor GS3).
2.5.2. Expression of 13C/15N-labelled Par-4
 For isotopic labelling of proteins with 13C and (or) 15N, the initial steps are identical to the 
expression of unlabelled proteins (see above). When the main culture had reached an 
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OD600 = 0.6, cells were harvested by centrifugation for 15 min at 4,400 g and 4 ºC (Rotor GS3). 
The cell pellet was resuspended in half the starting volume of M9 minimal medium, i.d. 250 ml 
of M9-medium if the main culture had a volume of 500 ml. The culture was agitated for 30 min 
at 30 ºC with agitation. 15N-ammonium chloride and uniformly 13C-labelled D-glucose were 
dissolved in 10 ml M9 medium and added to the culture by sterile filtration through a 0.2 µm 
syringe filter to a final concentration of 1 g/l and 6 g/l, respectively. For proteins with only 15N 
labelling, 13C-labelled D-glucose was substituted by  12C-D-glucose. After one hour incubation at 
30 ºC, expression was induced by the addition of IPTG to a concentration of 0.4 mM  and cells 
were agitated at 25 ºC for 8 h or overnight, respectively. Cells were harvested by centrifugation 
at 4,400 g and 4 ºC (Rotor GS3).
2.5.3. Deuteration of Par-4
 Deuterated proteins were produced with M9 minimal medium utilising D2O as solvent and 
with d8-glycerol (final concentration 6 g/l) as sole carbon and 15N-ammonium chloride (final 
concentration 1 g/l) as sole nitrogen source. A preculture; 20 to 50 ml LB containing 0.1 mg/ml 
Amp and 34 µg/ml Cam; was inoculated with cell material from a glycerol stock and agitated 
overnight at 37 ºC. The OD600 value was measured and the preculture centrifuged for 15 min at 
4 ºC and 3,300 g (Rotor TTH400). The cell pellet was resuspended in 1 ml fresh M9 medium and 
then used to inoculate 25 ml of M9 medium to an OD600 = 0.06. The culture was agitated at 37 ºC 
up to an OD600 = 0.6 or higher. The culture was harvested by centrifugation for 15 min at 4 ºC 
and 3,300 g (Rotor TTH400), the cell pellet resuspended in 1 ml fresh M9 medium and the main 
culture of 250 ml M9 medium was then inoculated to an OD600 = 0.06. The main culture was 
agitated at 37 ºC up to an OD600 = 0.6. Expression was induced by the addition of IPTG to a 
concentration of 0.4 mM and cells were agitated at 25 ºC for 38 h. Cells were harvested by 
centrifugation at 4,400 g and 4 ºC (Rotor GS3).
2.5.4. REDPRO expression of Par-4
 REDPRO (reduced protonation) [189] samples of Par-4 were produced with M9 minimal 
medium utilising D2O as solvent and with uniformly 13C-labelled D-glucose (final concentration 
6 g/l) as sole carbon and 15N-ammonium chloride (final concentration 1 g/l) as sole nitrogen 
source. Competent BL21(DE3) CodonPlus cells(Chapter 2.1.1.) were freshly transformed with 
plasmid DNA. A preculture; 20 to 50 ml LB containing 0.1 mg/ml Amp and 34 µg/ml Cam; was 
inoculated with a single colony and agitated overnight at  37 ºC. The OD600 value was measured 
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and the preculture centrifuged for 15 min at 4 ºC and 3,300 g (Rotor TTH400). The cell pellet 
was resuspended in 1 ml fresh LB medium and then used to inoculate the main culture; 500 ml to 
2 l LB containing 0.1 mg/ml Amp and 34 µg/ml Cam; to an OD600 = 0.06. The culture was 
agitated at  37 ºC up to an OD600 = 2.0. The culture was harvested by centrifugation for 15 min at 
4,400 g and 4 ºC (Rotor GS3), and the cell pellet resuspended in a quarter of the starting volume 
of M9 medium containing D2O, e.g. 125 ml M9 medium if the main culture had a volume of 
500 ml. The culture was incubated for one hour at 25 ºC with agitation, and expression was 
induced by the addition of IPTG to a concentration of 0.4 mM. After 5-8 h incubation at 25 ºC 
with agitation, cells were harvested by centrifugation at 4,400 g and 4 ºC (Rotor GS3). An 
adapted version of this protocol has been used in the later stages of the PhD for the production of 
15N-labelled samples.
2.6. Purification of Par-4(1-332)
2.6.1. Purification of Par-4(1-332)WT from HpMal-c2P
a) Materials and Methods
 For conciseness, purification steps are described once in detail as a general protocol. For later 
protocols only  differences to this general protocol will be described. Unless stated otherwise all 
Par-4 purifications were performed on ice or at 4 ºC. All purification methods are described for a 
culture volume of one litre.
 The cell pellet was resuspended in 20 ml PBS and 100 µl of the protease inhibitor cocktail 
were added. The cell suspension was passed three times through a French Press. The cell lysate 
was clarified by centrifugation for 30 min at 14,000 g (Rotor FA12.94 Highconic). The 
supernatant was passed through a 0.8 µm syringe filter and the filtrate rotated for 3 h with 2 ml 
(bed-volume) Chelating Sepharose, which had been charged with NiCl2 and equilibrated to PBS. 
The Ni-NTA column was washed successively  with 10 ml PBS, 15 ml PBS with 1 M  NaCl and 
10 ml PBS. For cleavage of the Par-4 fusion protein, the TCEP concentration was adjusted to 
0.3 mM, HMBP-3Cpro was added and the Ni-NTA column was rotated overnight at 4 ºC. In case 
of incomplete cleavage of the Par-4 fusion protein more HMBP-3Cpro was added and the 
cleavage reaction continued till more than 90% of the fusion protein was cleaved. Cleaved Par-4
(1-332)WT was eluted from the column with 10 ml PBS. Par-4(1-332)WT containing fractions 
were pooled and concentrated to 2 ml using a Vivaspin 20 device (MWCO = 10 kDa) at 3,000 g 
(Rotor TTH400). To remove traces of residual MBP, the concentrate was applied to 2 ml 
Amylose resin and the flow-through collected.
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b) Results
 Par-4(1-332)WT in HpMal-c2P was expressed in an unlabelled form with a final OD600 = 4 
after overnight expression. The Par-4 fusion protein was mostly soluble, but 40-50% remained in 
the insoluble fraction after clarification of the cell lysate. The IMAC purified Par-4 fusion 
protein was 70-80% pure and was cleaved on the column with HMBP-3Cpro. Adding TCEP to a 
concentration of 0.3 mM improved the cleavage performance of HMBP-3Cpro and nearly  90% 
of the Par-4 fusion protein was cleaved. Due to the same electrophoretic mobility of MBP and 
Par-4(1-332)WT, only  one band corresponding to a 45 kDa protein is visible by SDS-PAGE. 
Amylose resin purification showed that all eluted protein bound to the Amylose resin, indicating 
that only MBP eluted from the Ni2+-Sepharose column. Cleaving the Par-4 fusion protein in 
solution, resulted in protein precipitation, suggesting that Par-4(1-332)WT without the MBP tag 
is mostly insoluble in solution. Hence no Par-4(1-332)WT could be purified with this method.
2.6.2. Purification of Par-4(1-332)WT from pProEX-HTb
a) Materials and Methods
 The cell pellet was resuspended in 20 ml 100 mM NaCl, 25 mM imidazole and 50 mM  
Na2HPO4/NaH2PO4, pH 8.0 and 100 µl of the protease inhibitor cocktail were added. Cell lysis 
and incubation with Chelating Sepharose are described in Chapter 2.6.1. The Ni-NTA column 
was washed successively  with 10 ml lysis buffer and 5 ml lysis buffer with 50 mM imidazole. 
The Par-4 fusion protein was eluted with 10 ml 100 mM NaCl, 250 mM imidazole and 50 mM 
Na2HPO4/NaH2PO4, pH 8.0. Par-4 fusion protein containing fractions were pooled and dialysed 
overnight against 500 ml 100 mM NaCl, 25 mM imidazole, 0.3 mM TCEP and 20 mM Tris, 
pH 8.0. The Par-4 fusion protein was cleaved for 4 h at room temperature with rTEV 
(Chapter 2.2.2.).
b) Results
 Par-4(1-332)WT in pProEX-HTb was expressed in an unlabelled form with a final OD600 = 5 
after overnight expression. A protein of the correct size (~45 kDa), as estimated by  SDS-PAGE, 
was purified by IMAC. Dialysis of this protein against rTEV cleavage buffer (100 mM NaCl, 
25 mM Imidazole, 0.3 mM TCEP and 20 mM Tris, pH 8.0) resulted in protein precipitation. 
Cleavage of the remaining soluble protein with rTEV showed no cleavage activity, suggesting 
that the isolated protein is a bacterial protein without rTEV cleavage site. Optimising induction 
of protein expression with various IPTG concentrations (final concentrations 0-0.5 mM) showed 
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no upregulated protein relative to the non-induced cell culture, indicating that Par-4(1-332)WT is 
not expressed from pProEX-HTb.
2.6.3. Purification of Par-4(1-332)G40G from pET32a
a) Materials and Methods
 Cell lysis and IMAC purification are described in Chapter 2.6.2. Par-4 fusion protein 
containing fractions were pooled and dialysed overnight against 500 ml 150 mM  NaCl, 0.5 mM 
EDTA, 0.3 mM TCEP and 50 mM  Tris, pH 7.5. The Par-4 fusion protein was cleaved overnight 
with 1 mg Thrombin.
b) Results
 Par-4(1-332)G40G in pET32a was expressed in an unlabelled form with a final OD600 = 4 
after overnight expression. A 60 kDa protein, as estimated by SDS-PAGE, was isolated by IMAC 
and was more than 90% pure after elution. As described in Chapter 2.6.1, over 50% of the Par-4 
fusion protein remained in the insoluble fraction after clarification of the cell lysate. Cleavage of 
the Par-4 fusion protein with Thrombin resulted in the degradation of the Par-4 fusion protein as 
was indicated by SDS-PAGE with protein bands below 20 kDa.
2.6.4. Native purification of Par-4(1-332)G40G from pET32TEV
a) Materials and Methods
 Cell lysis and IMAC purification are described in Chapter 2.6.2. Par-4 fusion protein 
containing fractions were pooled and dialysed overnight against 500 ml 100 mM NaCl, 25 mM 
imidazole, 0.3 mM TCEP and 20 mM Tris, pH 8.0.
b) Results
 Par-4(1-332)G40G in pET32TEV was expressed in an unlabelled form with a final OD600 = 4 
after overnight expression. Using a standard lysis buffer with 100 mM  NaCl, approximately 90% 
of the Par-4 fusion protein remained in the insoluble fraction after clarification of the cell lysate. 
Lysis conditions were optimised with six different buffers, testing two NaCl concentrations (250 
and 500 mM) at three different pH values (pH 6.0, 7.0 and 8.0). The imidazole and Na2HPO4/
NaH2PO4 concentration were the same in all six lysis buffers. Using a lysis buffer containing 
500 mM NaCl at pH 8.0, almost 90% of the Par-4 fusion protein remained in the soluble fraction 
after clarification of the cell lysate. Note that at pH 6.0 the Par-4 fusion protein was virtually 
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insoluble, with intermediate solubility  at pH 7.0. The IMAC purified Par-4 fusion protein was 
~80% pure after elution and had an apparent MW of 60 kDa as judged by SDS-PAGE (Fig. 2.1, 
lane 7). Dialysis against rTEV cleavage buffer resulted in an almost  complete precipitation of the 
Par-4 fusion protein. Hence, no Par-4(1-332)G40G could be purified by this method.
2.6.5. Denaturing purification of Par-4(1-332)G40G from pET32TEV −
Purification of rrPar-4FL
a) Materials and Methods
 Unless stated otherwise, all steps of the denaturing purification were carried out at room 
temperature. The cell pellet was resuspended in 20 ml 8 M urea, 1 M  NaCl, 25 mM  imidazole, 
100 mM NaH2PO4 and 10 mM Tris, pH 8.0 and 100 µl of the protease inhibitor cocktail were 
added. The cell suspension was passed three times through a French Press. The cell lysate was 
clarified by centrifugation for 30 min at 14,000 g and 4 ºC (Rotor FA12.94 Highconic). The 
supernatant was passed through a 0.8 µm syringe filter and the filtrate rotated for 3 h with 2 ml 
(bed-volume) of Chelating Sepharose, which had been charged with NiCl2 and equilibrated to 
the lysis buffer. The Ni-NTA column was washed successively with 10 ml lysis buffer and 5 ml 
lysis buffer with 50 mM imidazole. The Par-4 fusion protein was eluted with 10 ml 8 M urea, 
500 mM  NaCl, 250 mM imidazole, 100 mM NaH2PO4 and 10 mM Tris, pH 8.0. Par-4 fusion 
protein containing fractions were pooled and dialysed for 6 h against 500 ml 4 M  urea, 250 mM 
NaCl, and 50 mM Tris, pH 8.0, followed by an overnight dialysis against 500 ml cleavage buffer, 
containing 1 M urea, 100 mM NaCl, 25 mM  imidazole, 0.3 mM TCEP and 50 mM Tris, pH 8.0. 
The Par-4 fusion protein was cleaved for 6 h with rTEV. After more than 90% of the Par-4 fusion 
protein was cleaved, the cleavage reaction was applied again to the Ni-NTA column, which had 
been equilibrated to the cleavage buffer. The flow through was collected and the Ni-NTA column 
washed with 5 ml cleavage buffer. Par-4(1-332)G40G containing fractions were pooled and 
concentrated to 2 ml using a Vivaspin 20 device (MWCO = 10 kDa) at 3,000 g and 25 ºC (Rotor 
TTH400).
 Par-4(1-332)G40G was further purified either by ion-exchange chromatography (IEC) or RP-
HPLC. Ion-exchange chromatography was performed using a HiTrap Q FF column connected to 
the BioLogic DuoFlow System (BioRad, Hercules, USA). Par-4(1-332)G40G was purified on a 
linear gradient of 0-60% high salt buffer over 20 min. The low salt buffer contained 1 M urea, 
50 mM NaCl and 20 mM  Tris, pH 7.5; the high salt  buffer contained 1 M urea, 1 M NaCl and 
20 mM Tris, pH 7.5. Par-4 was purified at 4 ºC with a flow rate of 0.8 ml/min. Par-4(1-332)
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G40G containing fractions that were free of impurities, were pooled and concentrated using a 
Vivaspin 20 device (MWCO = 10 kDa) at 3,000 g and 4 ºC (Rotor TTH400). Buffer exchange 
was achieved by successive 1:1 dilution with 20 mM NaCl, 10 mM  Tris, pH 7.0 and subsequent 
re-concentration. After 8 steps the buffer exchange was to 99.6% complete.
 RP-HPLC was performed with a Delta Pak C18-300Å column connected to an Ultimate 3000 
HPLC (Dionex Corporation, Sunnyvale, USA). Par-4(1-332)G40G was purified at 25 ºC with a 
flow rate of 1.5 ml/min using a linear water-acetonitrile gradient of 20-45% over 20 min in the 
presence of 0.1% TFA (v/v). Par-4(1-332)G40G containing fractions that  were free of impurities 
were lyophilised and then resolubilised in 20 mM NaCl, 10 mM Tris, pH 7.0. The protein 
concentration was determined by  A280 and A205 absorbance measurements using the extinction 
coefficient 13,075 M-1cm-1 and the relationship described by Scopes [190].
 Figure 2.1 − Denaturing purification of rrPar-4FL. A typical purification of Par-4 by IMAC is shown 
for rrPar-4FL using a denaturing purification protocol. Similar results are obtained for other Par-4 
constructs using native protocols. All fractions were analysed by 11% SDS-PAGE. Expression of the 
thioredoxin-Par-4(1-332)G40G fusion protein is evident from the comparison of (1) non-induced and (2) 
induced E. coli cells. Note that the size of the Par-4 proteins as judged by SDS-PAGE is greater than what 
is expected from the amino acid sequence (66 kDa relative to 51 kDa for the fusion protein and 46 kDa 
relative to 36 kDa for rrPar-4FL). The cell lysate was clarified by centrifugation (3) and applied to a Ni-
NTA column. After 3 h incubation the flow-through (4) was collected and the column washed successively 
with buffers containing 25 mM (5) and 50 mM (6) imidazole. The fusion protein was eluted from  the 
column with 250 mM imidazole (7,8) and the Ni-NTA column assessed for remaining fusion protein (9). 
The fusion protein was dialysed against cleavage buffer containing 1 M urea (10) and incubated for 6 h 
with rTEV protease at room  temperature (11). The cleavage reaction was applied again to a Ni-NTA 
column to remove the thioredoxin tag. After 3 h incubation the flow-through (12) was collected and the 
column washed with cleavage buffers (13,14). The Ni-NTA column was assessed for remaining 
rrPar-4FL (15). rrPar-4FL was then further purified by RP-HPLC (data not shown). Lanes with 
molecular weight (MW) markers are labelled with (M). Approximate molecular weights are shown on the 
left edge.
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b) Results
 Using a denaturing purification protocol almost all Par-4 fusion protein remained in the 
soluble fraction after clarification of the cell lysate. The IMAC purified Par-4 fusion protein was 
70-80% pure after elution. Reducing the urea concentration for the cleavage reaction resulted in 
precipitation of ~10% of the Par-4 fusion protein. The cleaved Par-4(1-332)G40G after the 
second IMAC purification was ~90% pure (Fig. 2.1, lane 12). Buffer exchange of the IEC-
purified Par-4(1-332)G40G with a Vivaspin 20 device resulted in a complete loss of Par-4
(1-332) due to precipitation. Alternatively, dialysing the IEC-purified Par-4(1-332)G40G and 
then concentrating it, also lead to a complete loss due to precipitation.
 Using RP-HPLC for final purification, improved the purity of Par-4(1-332)G40G (rrPar-4FL) 
to > 98% as judged by  mass spectrometry (MS, Centre for Protein Research, University of 
Otago, Dunedin, New Zealand). Resolubilising the lyophilised rrPar-4FL in 20 mM NaCl, 
10 mM Tris, pH 7.0 gave a concentrated (0.43 mM) soluble protein. Storage of this solution at 
4 ºC resulted in protein precipitation after a few days. The protein yield using the denaturing 
purification protocol and RP-HPLC was ~20 mg rrPar-4FL per litre cell culture. Par-4(1-332)
G40G purified by this protocol (denaturing purification, RP-HPLC) will be denoted as 
rrPar-4FL throughout the remainder of this text.
2.7. Purification of Par-4(1-265)
2.7.1. Purification of Par-4(1-265)WT from HpMal-c2P
a) Materials and Methods
 Cell lysis and IMAC purification are described in Chapter 2.6.2. Par-4 fusion protein 
containing fractions were pooled and dialysed overnight against 500 ml 150 mM NaCl, 25 mM 
imidazole, 0.3 mM TCEP and 20 mM Tris, pH 7.5. The Par-4 fusion protein was cleaved 
overnight with HMBP-3Cpro. After more than 90% of the Par-4 fusion protein was cleaved, the 
cleavage reaction was applied again to the Ni-NTA column, which had been equilibrated with the 
cleavage buffer. The flow through was collected and the Ni-NTA column washed with 5 ml 1 M 
NaCl. Traces of residual MBP were removed by applying the Par-4(1-265)WT containing 
fractions to 2 ml Amylose resin and collecting the flow-through.
b) Results
 Par-4(1-265)WT in HpMal-c2P was expressed in an unlabelled form with a final OD600 = 4.5 
after overnight expression. More than 95% of the Par-4 fusion protein remained in the soluble 
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fraction after clarification of the cell lysate. The IMAC purified Par-4 fusion protein was 70-80% 
pure after elution and appeared as a 80 kDa protein as judged by SDS-PAGE. After 
HMBP-3Cpro cleavage two bands of 45 kDa (MBP) and 40 kDa (Par-4(1-265)WT) were visible 
by SDS-PAGE. Separation of MBP and Par-4(1-265)WT by a second IMAC step resulted in 
retention of Par-4(1-265)WT on the Ni-NTA column together with the majority  of MBP. The 
flow through only  contained MBP. Applying the cleavage reaction to Amylose resin also failed 
to separate MBP from Par-4(1-265)WT. The purification was stopped after most of Par-4(1-265)
WT had degraded.
2.8. Purification of Par-4(1-290)
2.8.1. Purification of Par-4(1-290)WT from HpMal-c2P
a) Materials and Methods
 The purification of Par-4(1-290)WT from HpMal-c2P is identical to the protocol described in 
Chapter 2.7.1. for Par-4(1-265)WT from HpMal-c2P.
b) Results
 Par-4(1-290)WT in HpMal-c2P was expressed in an unlabelled form with a final OD600 = 5 
after overnight expression. The results for the purification are virtually  identical to the results 
described above for the purification of Par-4(1-265)WT from HpMal-c2P and no Par-4(1-290)
WT could be purified due to degradation.
2.8.2. Purification of Par-4(1-290)G40G from pCFE-TrxH-TEV − Purification of rrPar-4ΔLZ
a) Materials and Methods
 Cell lysis and IMAC purification are described in Chapter 2.6.2. Par-4 fusion protein 
containing fractions were pooled and dialysed overnight against 500 ml 100 mM NaCl, 25 mM 
imidazole, 0.3 mM TCEP and 20 mM  Tris, pH 8.0. The Par-4 fusion protein was cleaved for 4 h 
at room temperature with rTEV. After more than 90% of the Par-4 fusion protein was cleaved, 
the cleavage reaction was applied again to the Ni-NTA column, which had been equilibrated with 
the cleavage buffer. The flow through was collected and the Ni-NTA column washed with 5 ml 
cleavage buffer. Par-4(1-290)G40G containing fractions were pooled and concentrated using a 
Vivaspin 20 device (MWCO = 10 kDa) at 3,000 g (Rotor TTH400).
 The concentrate was further purified by IEC on a HiTrap Q FF column connected to the 
BioLogic DuoFlow System. Par-4(1-290)G40G was purified at 4 ºC with a flow rate of 0.8 ml/
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min using a linear gradient of 0-60% high salt  buffer over 20 min. The low salt  buffer contained 
50 mM NaCl and 20 mM Na2HPO4/NaH2PO4, pH 7.5; the high salt buffer contained 1 M  NaCl 
and 20 mM  Na2HPO4/NaH2PO4, pH 7.5. Par-4(1-290)G40G containing fractions that were free 
of impurities, were pooled and concentrated using a Vivaspin 20 device (MWCO = 10 kDa) at 
3,000 g and 4 ºC (Rotor TTH400). Buffer exchange was achieved by  successive 1:1 dilution with 
20 mM NaCl, 10 mM Tris, pH 7.0 and subsequent re-concentration. After 8 steps the buffer 
exchange was to 99.6% complete. The protein concentration was determined as described in 
Chapter 2.6.5.a.
b) Results
 Par-4(1-290)G40G in pCFE-TrxH-TEV was expressed in unlabelled and 15N-labelled form 
with final OD600 = 4.0 and OD600 = 6.0, respectively, after overnight expression. More than 95% 
of the Par-4 fusion protein remained in the soluble fraction after clarification of the cell lysate. 
The IMAC purified Par-4 fusion protein was 70-80% pure after elution and appeared as a 55 kDa 
protein as judged by SDS-PAGE. The purity of the cleaved Par-4(1-290)G40G after the second 
IMAC step was ~90% and improved to > 95% after the IEC step as judged by MS. The protein 
yield was ~22 mg Par-4(1-290)G40G per litre cell culture. Par-4(1-290)G40G purified by  this 
protocol will be denoted as rrPar-4ΔLZ throughout the remainder of this text.
2.9. Purification of Par-4(137-195)
2.9.1. Purification of Par-4(137-195)WT from pET32TEV − Purification of rrPar-4SAC
a) Materials and Methods
 Purification of Par-4(137-195)WT from pET32TEV is virtually identical to the protocol 
described above for Par-4(1-290)G40G from pCFE-TrxH-TEV except for the IEC step 
(Chapter 2.8.2.a). IEC was performed at 4 ºC with a flow rate of 0.8 ml/min using a 
HiTrap SP FF column and a linear gradient  of 0-60% high salt buffer over 25 min. The low salt 
buffer contained 50 mM NaCl, 20 mM Na2HPO4/NaH2PO4, pH 6; the high salt buffer contained 
1 M  NaCl, 20 mM  Tris, pH 7.5. Par-4(137-195)WT containing fractions that were free of 
impurities, were pooled and concentrated using a Vivaspin 20 device (MWCO = 3 kDa) at 
3,000 g and 4 ºC (Rotor TTH400). Buffer exchange was achieved by  successive 1:1 dilution with 
20 mM NaCl, 10 mM Tris, pH 7.0 and subsequent re-concentration. After 8 steps the buffer 
exchange was to 99.6% complete. The protein concentration was determined by A280 and A205 
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absorbance measurements as described in Chapter 2.6.5.a with an extinction coefficient of 
1,490 M-1cm-1.
b) Results
 Par-4(137-195)WT in pET32TEV was expressed in 15N-labelled form with a final 
OD600 = 4.0 after overnight expression. More than 95% of the Par-4 fusion protein remained in 
the soluble fraction after clarification of the cell lysate. The IMAC purified Par-4 fusion protein 
was 80-90% pure after elution and appeared as a 25 kDa protein as judged by SDS-PAGE. The 
purity  of the cleaved Par-4(137-195)WT after the second IMAC step  was ~95% and improved to 
> 98% after the IEC step as judged by MS. Concentration of Par-4(137-195)WT in 20 mM NaCl, 
10 mM  Tris, pH 7.0 resulted in minor precipitation. The protein yield was ~8 mg Par-4(137-195)
WT per litre cell culture. Par-4(137-195)WT purified by  this protocol will be denoted as 
rrPar-4SAC throughout the remainder of this text.
2.10. Purification of Par-4(240-332)
2.10.1. Denaturing purification of Par-4(240-332)WT from pGex-6P-3 −
Purification of rrPar-4CC
a) Materials and Methods
 The cell pellet was resuspended in 20 ml PBS and 100 µl of the protease inhibitor cocktail 
were added. The cell suspension was passed two times through a French Press. The cell lysate 
was clarified by centrifugation for 30 min at 16,000 g and 4 ºC (Sorvall Evolution RC, Rotor 
SS34, Kendro, Langenselbold, Germany). The supernatant was stored overnight at 4 ºC. To 
increase protein yields the centrifugation pellet was resuspended in 15 ml 6 M  urea, 250 mM 
NaCl, 5 mM DTT and 50 mM Tris, pH 8.0. The suspension was passed again through a French 
Press and clarified as described above. The supernatant was dialysed for 3 h at room temperature 
against 500 ml 2 M urea, 250 mM NaCl, 1 mM  DTT and 50 mM Tris, pH 8.0, followed by  3 h at 
room temperature against 500 ml 0.5 M urea, 250 mM  NaCl, 1 mM  DTT and 50 mM Tris, 
pH 8.0, and finally  overnight at 4 ºC against 500 ml 250 mM NaCl, 1 mM DTT and 50 mM Tris, 
pH 8.0. Any precipitate occurring during dialysis was removed by centrifugation at 14,000 g 
(Rotor FA12.94 Highconic). The dialysate was then united with the clear supernatant from the 
first lysis (see above), passed through a 0.8 µm syringe filter, and the filtrate was rotated for 3 h 
with Glutathione Sepharose, which had been equilibrated with PBS. The Glutathione Sepharose 
was washed with 10 ml 1 M NaCl, 20 mM Na2HPO4/NaH2PO4, pH 7.0 followed by 5 ml PBS. 
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The Par-4 fusion protein was eluted with 6 ml 10 mM  reduced glutathione, 50 mM Tris, pH 8.0. 
Par-4 fusion protein containing fractions were pooled and dialysed for 1 h at 4 ºC against 500 ml 
150 mM  NaCl, 1 mM  DTT and 20 mM Tris, pH 7.5. The Par-4 fusion protein was cleaved at 
4 ºC with HMBP-3Cpro and dialysis was continued overnight. The resulting precipitate was spun 
down for 15 min at 14,000 g (Rotor FA12.94 Highconic) and the pellet was resolubilised in a 
minimal volume of 7 M urea.
 The urea resolubilised Par-4(240-332)WT was further purified by  RP-HPLC using a Delta 
Pak C18-300Å column connected to the Ultimate 3000 HPLC system. The protein was purified 
at 25 ºC with a flow rate of 1.0 ml/min using a linear water-acetonitrile gradient of 30-50% over 
25 min in the presence of 0.1% TFA (v/v). Par-4(240-332)WT containing fractions that were free 
of impurities, were lyophilised and then resolubilised in H2O. The protein concentration was 
determined by A205 absorbance measurements as described by Scopes [190].
b) Results
 Par-4(240-332)WT in pGex-6P-3 was expressed in unlabelled form with a final OD600 = 4.3 
after overnight expression. Using a denaturing protocol, more than 95% of the Par-4 fusion 
protein remained in the soluble fraction after clarification of the cell lysate. Reducing the urea 
concentration of the cell lysate by dialysis, resulted in protein precipitation of approximately 
20% of the Par-4 fusion protein. The purified Par-4 fusion protein was more than 90% pure after 
elution and appeared as 37 kDa protein as judged by  SDS-PAGE. During the cleavage reaction 
the majority  (> 95%) of Par-4(240-332)WT precipitated. Resolubilisation in 7 M  urea allowed 
purification by RP-HPLC. The purity of Par-4(240-332)WT after the RP-HPLC step was more 
than 98% as judged by  SDS-PAGE. The H2O-resolubilised lyophilisate was stable and showed 
no signs of precipitation. The protein yield was ~8 mg Par-4(240-332)WT per litre cell culture. 
Par-4(240-332)WT purified by this protocol will be denoted as rrPar-4CC throughout the 
remainder of this text.
2.11. Purification of Par-4(286-332)
2.11.1. Purification of Par-4(286-332)WT from HpMal-c2P
a) Materials and Methods
 This purification protocol is described in Alexandrov et. al. [187]. Cells were lysed and the 
resulting lysate clarified as described in Chapter 2.6.1.a The supernatant was passed through a 
0.8 µm syringe filter and the filtrate rotated for 3 h with 5 ml (bed-volume) of TALON cobalt 
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affinity resin, which had been equilibrated to PBS. The TALON resin was washed successively 
with 10 ml PBS, 15 ml PBS with 1 M NaCl and 10 ml PBS. The Par-4 fusion protein was 
cleaved with HMBP-3Cpro on the column and the TALON resin was rotated overnight at 4 ºC. 
In case of incomplete cleavage of the fusion protein, more HMBP-3Cpro was added and the 
cleavage reaction continued till more than 90% of the fusion protein was cleaved. Cleaved Par-4
(286-332)WT was eluted from the column with 15 ml PBS. Par-4 containing fractions were 
pooled and concentrated using a Vivaspin 20 device (MWCO = 3 kDa) at 3,000 g (Rotor 
TTH400).
 For the removal of residual MBP that co-eluted with Par-4(286-332)WT, five different 
strategies were tested:
i) The Par-4(286-332)WT concentrate was passed over two columns that were used in series. 
Each column contained 1.5 ml bed-volume of Maltoheptaose Agarose or Amylose resin, 
respectively, that  had been equilibrated to PBS. The columns were washed with further 
10 ml of PBS. Aliquots of 1 ml were collected and Par-4(286-332)WT containing fractions 
were identified by SDS-PAGE analysis.
ii) The Par-4(286-332)WT concentrate was rotated for one hour with 1 ml bed-volume of 
Chelating Sepharose, that had been charged with NiCl2 and equilibrated to PBS. The 
column was washed successively  with 5 ml PBS and 5 ml PBS with 1 M NaCl. Aliquots of 
1 ml were collected and Par-4(286-332)WT containing fractions were identified by SDS-
PAGE analysis.
iii) The Par-4(286-332)WT concentrate was passed over a column with 3 ml bed-volume of 
CM-sephadex that had been equilibrated to PBS. The column was washed successively 
with 5 ml PBS and 5 ml PBS with 1 M  NaCl. Aliquots of 1 ml were collected and Par-4
(286-332)WT containing fractions were identified by SDS-PAGE analysis.
iv) The Par-4(286-332)WT concentrate was passed over a column with 3 ml bed-volume of 
QAE-sephadex that had been equilibrated to PBS. The column was washed successively 
with 5 ml PBS, 5 ml 200 mM NaCl and 5 ml 500 mM  NaCl. Aliquots of 1 ml were 
collected and Par-4(286-332)WT containing fractions were identified by  SDS-PAGE 
analysis.
v) Par-4(286-332)WT and MBP were separated by size exclusion chromatography  (SEC). 
The concentrate was applied to a Superdex 75 column. Separation was achieved by  an 
isocratic flow of 0.4 ml/min using the BioLogic DuoFlow System. The buffer contained 
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50 mM KCl, 20 mM Na2HPO4/NaH2PO4, pH 7.5. Aliquots of 1 ml were collected and 
Par-4(286-332)WT containing fractions were identified by SDS-PAGE analysis.
 Par-4(286-332)WT fractions that  were free of impurities, were pooled and concentrated using 
a Vivaspin 20 device (MWCO = 3 kDa) at 3,000 g and 4 ºC (Rotor TTH400). Buffer exchange to 
NMR buffer was achieved as described in Chapter 2.8.2.a The protein concentration was 
determined by BCA-assays [191]. As a reference, Par-4(286-332)WT was buffer exchanged to 
H2O and subsequently lyophilised. The lyophilisate was weighed and then used to establish a 
BCA-assay calibration curve.
b) Results
 Par-4(286-332)WT in HpMal-c2P was expressed in unlabelled (final OD600 = 6 after 8 h 
expression), 15N-labelled (final OD600 = 6 after 8 h expression), 13C,15N-labelled (final 
OD600 = 4.5 after overnight expression) and 2H,15N-labelled form (final OD600 = 3 after 38 h 
expression). Approximately  50% of the Par-4 fusion protein remained in the insoluble fraction 
after clarification of the cell lysate. The Par-4 fusion protein bound to the TALON resin was 
~90% pure and appeared as a 50 kDa protein as judged SDS-PAGE (Fig. 2.2A, lane 12). 
Cleavage of the Par-4 fusion protein on the column took on average three to six days. The 
cleavage performance of HMP-3Cpro was improved by  adding TCEP to a concentration of 
0.3 mM. Elution of cleaved Par-4(286-332)WT resulted in co-elution of MBP (Fig. 2.2B, lane 
13). The majority of the impurities were removed using an IEC step with QAE sephadex 
(Fig. 2.2C, lanes 22-24). Repeating the IEC improved the purity  of Par-4(286-332)WT to > 98%, 
however, high molecular weight impurities (> 45 kDa) were still visible on the corresponding 
acrylamide gels (Fig. 2.2D). Concentration and buffer exchange using a Vivaspin 20 device 
resulted in protein precipitation of 10-20% of Par-4(286-332)WT. The protein yield for 
unlabelled, 15N-labelled and 13C,15N-labelled Par-4(286-332)WT was ~6-7 mg per litre cell 
culture and ~8 mg per litre cell culture for 2H,15N-labelled Par-4(286-332)WT, respectively.
 Separation of Par-4(286-332)WT from HMBP using Amylose resin was inefficient. Some 
HMBP could be removed, but the majority co-eluted with Par-4(286-332)WT. Using SEC 
80-90% of the HMBP could be removed, but due to the close retention times (~29 and 
~32.5 min) the Par-4(286-332)WT fraction still contained MBP. Samples with traces of HMBP 
had shorter life times than samples purified as above with QAE sephadex. No separation of 
HMBP and Par-4(286-332)WT was achieved with CM-sephadex or Chelating sepharose.
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 Figure 2.2 − Purification of Par-4(286-332)WT as MBP fusion protein. The purification of {2H,15N}-
Par-4(286-332)WT is shown as a typical example for the purification method described in Chapter 
2.11.1. (A) Over-expression of the HMBP-Par-4(286-332)WT fusion protein is evident by 12% SDS-PAGE 
comparing non-induced (1-3) and induced (4,5) E. coli cells. The cell lysate (6) was clarified by 
centrifugation (7) and applied to TALON resin. After 3 h incubation at 4 ºC the flow-through (8) was 
collected and the column washed successively with PBS (9), PBS + 1M NaCl (10) and PBS (11). The 
purity of the fusion protein on the column is shown in lane 12. (B) The 16.5% Tricine-PAGE [192] 
displays co-elution of MBP with Par-4(286-332)WT from the TALON resin after cleavage with 
HMBP-3Cpro. The eluate was collected in 1.5 ml fractions (13-20) and the TALON resin (21) was 
assessed for complete elution of Par-4(286-332)WT. (C) Typical result of an IEC purification with QAE-
sephadex analysed by 16.5% Tricine-PAGE. Pooled Par-4(286-332)WT containing fractions were applied 
to a QAE-sephadex column and the flow-through (22) was collected. The column was washed with PBS 
(23) and Par-4(286-332)WT was eluted from the column with increasing concentrations of NaCl (24-34). 
The QAE-sephadex was assessed for remaining Par-4(286-332)WT (35). (D) After repeating the IEC step, 
Par-4(286-332)WT containing fractions were concentrated (36) and the purity was analysed by 16.5% 
Tricine-PAGE. Lanes with molecular weight markers are labelled with (M). Approximate MWs are shown 
on the left edge of each gel. Note that the gel shown in panel A is stained with Coomassie Blue, whereas 
all other gels were silver stained. The apparent increase in impurities in lanes 13-15 relative to lane 12 is 
a result of the silver staining process. Visualisation of the 6 kDa peptide Par-4(286-332)WT by silver 
staining resulted in an overstaining of the larger proteins such as MBP (~45 kDa).
2.11.2. Purification of Par-4(286-332)WT from pCFE-GST-3C
a) Materials and Methods
 The cell pellet was resuspended in 20 ml 100 mM NaCl, 1 mM DTT and 50 mM  Na2HPO4/
NaH2PO4, pH 8.0 and 100 µl of the protease inhibitor cocktail were added. The cells were lysed 
and the cell lysate clarified as described in Chapter 2.6.1.a. The supernatant was passed through 
a 0.8 µm syringe filter and the filtrate was rotated for 3 h with 2 ml (bed-volume) of Glutathione 
Sepharose, which had been equilibrated to PBS. The Glutathione Sepharose was washed with 
10 ml 1 M NaCl, 20 mM Na2HPO4/NaH2PO4, pH 7.0 followed by 5 ml PBS. The Par-4 fusion 
protein was eluted with 6 ml 10 mM  reduced glutathione, 50 mM  Tris, pH 8.0. Par-4 fusion 
protein containing fractions were pooled and dialysed overnight against 500 ml 150 mM  NaCl, 
1 mM DTT and 20 mM  Tris, pH 7.5. The Par-4 fusion protein was cleaved at 4 ºC with 
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HMBP-3Cpro. After more than 90% of the Par-4 fusion protein was cleaved, the cleavage 
reaction was rotated for 3 h with 2 ml Glutathione Sepharose. The flow through was collected 
and the Glutathione Sepharose washed with 5 ml PBS. Par-4(286-332)WT containing fractions 
were pooled and concentrated using a Vivaspin 20 device (MWCO = 3 kDa) at  3,000 g (Rotor 
TTH400).
 Par-4(286-332)WT was further purified by RP-HPLC as described in Chapter 2.10.1.a using a 
linear water-acetonitrile gradient of 30-50% over 25 min. Par-4(286-332)WT containing 
fractions that were free of impurities, were lyophilised and then resolubilised in 50 mM KCl, 
100 mM Na2HPO4/NaH2PO4, pH 7.5. The protein concentration was determined as described in 
Chapter 2.10.1.a.
b) Results
 Par-4(286-332)WT in pCFE-GST-3C was expressed in unlabelled and 15N-labelled form with 
final OD600 = 3.5 and OD600 = 5.0 after 6 h expression. After clarification of the cell lysate, 
40-50% of the Par-4 fusion protein remained in the insoluble fraction. The purified Par-4 fusion 
protein was more than 95% pure after elution and appeared as 30 kDa protein as judged by SDS-
PAGE (Fig. 2.3A, lane 8). Separation of cleaved Par-4(286-332)WT from GST by applying the 
cleavage reaction again to Glutathione Sepharose failed and resulted in co-elution of GST and 
Par-4(286-332)WT. Separation was only achieved using a RP-HPLC step. The purity of Par-4
(286-332)WT was > 98% after RP-HPLC purification as judged by MS. Resuspending the 
lyophilisate in buffers at pH 6.0 or dialysing resolubilised Par-4(286-332)WT to buffers at 
pH 6.0 resulted in precipitation of approximately  50% of Par-4(286-332)WT. At pH values 
above 6.0 Par-4(286-332)WT was mostly soluble. The protein yield was ~8.5 mg Par-4(286-332)
WT per litre cell culture.
2.11.3. Denaturing purification of Par-4(286-332)WT from pGex-6P-3 −
Purification of rrPar-4LZ
a) Materials and Methods
 Par-4(286-332)WT from pGex-6P-3 was purified as described in Chapter 2.10.1.a. The 
cleavage reaction containing soluble Par-4(286-332)WT was concentrated, then RP-HPLC 
purified and the protein concentration determined as described in Chapter 2.11.2.a.
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 Figure 2.3 − Purification of Par-4(286-332)WT as GST fusion protein. The purification of {15N}-
Par-4(286-332)WT is shown as a typical example for the purification method described in Chapter 
2.11.2. (A) Over-expression of the GST-Par-4(286-332)WT fusion protein is evident from the comparison 
of non-induced (1) and induced (2) E. coli cells. Under native conditions 70% of the fusion protein 
remains in the insoluble fraction after clarification of the cell lysate (3). The soluble fraction of the cell 
lysate (4) was applied to a Glutathione Sepharose column. After 3 h incubation at 4 ºC the flow-through 
(5) was collected and the column washed successively with PBS + 1M NaCl (6) and PBS (7). The fusion 
protein was eluted (8) and the column (9) assessed for remaining fusion protein. (B) The eluted fusion 
protein was cleaved with HMBP-3Cpro (not shown) and GST was removed by re-purification with 
Glutathione Sepharose. After 3 h incubation at 4 ºC, the flow-through (10) was collected and the column 
washed with PBS (11,12). However, only a minority of GST was bound to the column (13), the majority of 
GST co-eluted with rrPar-4LZ. Uncleaved GST-Par-4 fusion protein is indicated by a 31 kDa band. (C) 
rrPar-4LZ containing fractions were concentrated and purified by RP-HPLC (I-XII). The corresponding 
RP-HPLC chromatogram  is shown in panel (D). The collected fractions (I-XII) are indicated by vertical 
dotted lines. For analysis, 10% Tricine-PAGE was used in (A), (B) and (C). Lanes with molecular weight 
markers are labelled with (M). Approximate MWs are shown on the left edge of each gel.
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b) Results
 Par-4(286-332)WT in pGex-6P-3 was expressed in 15N-labelled form with a final OD600 = 5.0 
after overnight expression. Using a native protocol 60-70% of the Par-4 fusion protein remained 
in the insoluble fraction after clarification of the cell lysate (Fig. 2.3A, lane 3). In contrast, with a 
denaturing protocol an almost complete solubilisation was achieved. Reducing the urea 
concentration of the cell lysate by dialysis, resulted in protein precipitation of 10-20% of the 
Par-4 fusion protein. The subsequent steps of the purification gave similar results as described 
above for Par-4(286-332)WT in pCFE-GST-3C (Chapter 2.11.2.b). The protein yield was 
~10 mg Par-4(286-332)WT per litre cell culture. Par-4(286-332)WT purified by this protocol 
will be denoted as rrPar-4LZ throughout the remainder of this text.
2.11.4. Purification of Par-4(286-332)WT from pCFE-GST-TEV
a) Materials and Methods
 Purification of Par-4(286-332)WT from pCFE-GST-TEV is identical to the protocol described 
above for Par-4(286-332)WT from pCFE-GST-3C (Chapter 2.11.2.a). However, the Par-4 fusion 
protein after elution was not cleaved with rTEV, but dialysed against  50 mM  NaCl, 1 mM  DTT 
and 20 mM Na2HPO4/NaH2PO4, pH 7.0. The protein concentration was determined by A280 
absorbance measurements using an extinction coefficient of 44,600 M-1cm-1.
b) Results
 Par-4(286-332)WT in pCFE-GST-TEV was expressed in 15N-labelled form with a final 
OD600 = 3.0 after overnight expression. After clarification of the cell lysate 60-70% of the Par-4 
fusion protein remained in the insoluble fraction. The purified Par-4 fusion protein was more 
than 95% pure after elution The protein yield was ~4 mg GST-Par-4(286-332)WT fusion protein 
per litre cell culture.
2.11.5. Purification of Par-4(286-332)W285 from HpMal-c2P
a) Materials and Methods
 Purification of Par-4(286-332)W285 from HpMal-c2P is identical to the protocol described in 
Chapter 2.11.1.a for Par-4(286-332)WT from HpMal-c2P. Residual MBP was removed with two 
Amylose resin columns.
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b) Results
 Par-4(286-332)W285 in HpMal-c2P was expressed in 15N-labelled form with a final 
OD600 = 6 after 8 h expression. The purification results were similar as described above for Par-4
(286-332)WT from HpMal-c2P (Chapter 2.11.1.b). Traces of MBP after IMAC purification were 
almost completely removed by affinity chromatography using Amylose resin columns.
2.11.6. Purification of Par-4(286-332)D305K from HpMal-c2P −
Purification of rrPar-4LZD305K
a) Materials and Methods
 Par-4(286-332)D305K in HpMal-c2P was purified as described above in Chapter 2.6.2.a. 
Par-4 fusion protein containing fractions were pooled and dialysed for 4 h against 500 ml 
150 mM NaCl, 25 mM imidazole, 0.3 mM  TCEP and 20 mM Tris, pH 7.5. The Par-4 fusion 
protein was cleaved overnight with HMBP-3Cpro, while dialysis was continued against 500 ml 
fresh cleavage buffer. After more than 90% of the Par-4 fusion protein was cleaved, the cleavage 
reaction was applied again to the Ni-NTA column, which had been equilibrated to the cleavage 
buffer. The flow through was collected and the Ni-NTA column washed successively with 5 ml 
lysis buffer and 5 ml 1 M NaCl, 20 mM  Tris, pH 7.0. Par-4(286-332)D305K containing fractions 
were pooled, concentrated, RP-HPLC purified and the protein concentration determined as 
described in Chapter 2.11.2.a.
b) Results
 Par-4(286-332)D305K in HpMal-c2P was expressed in 15N-labelled form with a final 
OD600 = 2 after overnight expression. Approximately 50% of the Par-4 fusion protein remained 
in the soluble fraction after clarification of the cell lysate. The IMAC purified Par-4 fusion 
protein was 70-80% pure after elution and appeared as a 50 kDa protein as judged by  SDS-
PAGE. Elution of cleaved Par-4(286-332)D305K resulted in co-elution of MBP after the second 
IMAC step. The purity  of Par-4(286-332)D305K after RP-HPLC purification was > 98%. The 
protein yield was ~2.5 mg Par-4(286-332)D305K per litre cell culture. Par-4(286-332)D305K 
purified by this protocol with RP-HPLC will be denoted as rrPar-4LZD305K throughout the 
remainder of this text.
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2.11.7. Purification of Par-4(286-332)E310K from HpMal-c2P −
Purification of rrPar-4LZE310K
a) Materials and Methods
 Par-4(286-332)E310K in HpMal-c2P was purified as described in Chapter 2.11.6.
b) Results
 Par-4(286-332)E310K in HpMal-c2P was expressed in 15N-labelled form with a final 
OD600 = 2 after overnight expression. Purification results are similar to the results described in 
Chapter 2.11.6.b. The protein yield was ~3 mg Par-4(286-332)E310K per litre cell culture. Par-4
(286-332)E310K purified by this protocol will be denoted as rrPar-4LZE310K throughout the 
remainder of this text.
2.11.8. Denaturing purification of Par-4(286-332)E310K from HpMal-c2P
a) Materials and Methods
 To further improve the yields of Par-4(286-332)E310K, especially  of insoluble Par-4
(286-332)E310K that remains in the pellet after cell lysis, a denaturing protocol was applied. 
Initial cell lysis steps are as described in Chapter 2.6.2.a. The supernatant was stored at 4 ºC until 
further use. The cell lysis pellet was resuspended in 20 ml 6 M urea, 250 mM NaCl, 25 mM 
imidazole and 50 mM Tris, pH 8.0. The suspension was passed again through a French Press and 
clarified by centrifugation for 30 min at  16,000 g and 4 ºC (Rotor SS34). This supernatant was 
united with the first supernatant and passed through a 0.8 µm syringe filter. The filtrate was 
rotated for 3 h with 2 ml (bed-volume) of Chelating Sepharose, which had been charged with 
NiCl2 and equilibrated to 6 M  urea, 250 mM  NaCl, 25 mM imidazole and 50 mM Tris, pH 8.0. 
The Ni-NTA column was washed successively  with 10 ml 6 M urea, 250 mM NaCl, 25 mM 
imidazole and 50 mM  Tris, pH 8.0 and 5 ml 6 M urea, 250 mM  NaCl, 50 mM  imidazole and 
50 mM Tris, pH 8.0. The Par-4 fusion protein was eluted with 10 ml 6 M  urea, 250 mM  NaCl, 
250 mM  imidazole and 50 mM Tris, pH 8.0. Par-4 fusion protein containing fractions were 
pooled and dialysed for 6 h at room temperature against 500 ml 1 M urea, 250 mM NaCl, 
25 mM imidazole 0.3 mM TCEP and 50 mM Tris, pH 7.5. Dialysis was continued overnight at 
4 ºC against 500 ml fresh buffer. Any precipitate occurring during dialysis was removed by 
centrifugation at 14,000 g (Rotor FA12.94 Highconic). The Par-4 fusion protein was cleaved for 
4 h at room temperature with HMBP-3Cpro. After more than 90% of the Par-4 fusion protein 
was cleaved, the cleavage reaction was applied again to the Ni-NTA column, which had been 
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equilibrated with cleavage buffer. The flow through was collected and the Ni-NTA column 
washed with 10 ml cleavage buffer. Par-4(286-332)D305K containing fractions were pooled and 
concentrated as described in Chapter 2.11.2.a.
 RP-HPLC purification of Par-4(286-332)E310K was achieved using a Jupiter 5u C18 300Å 
column connected to a Ultimate 3000 HPLC system. The protein was purified at 25 ºC with a 
flow rate of 5.0 ml/min using a linear water-acetonitrile gradient of 30-40% over 25 min in the 
presence of 0.1% TFA (v/v). Par-4(286-332)E310K containing fractions that were free of 
impurities, were lyophilised and then resolubilised in H2O. The protein concentration was 
determined as described in Chapter 2.10.1.a.
b) Results
 A REDPRO sample of Par-4(286-332)E310K in HpMal-c2P was expressed as described in 
Chapter 2.5.4. with a final OD600 = 6.3 after 6 h expression. Using a denaturing protocol, almost 
no Par-4 fusion protein was detected in the pellet after cell lysis. Furthermore, retention of 
cleaved Par-4(2686-332)E310K on the Ni-NTA column was reduced in the presence of 1 M urea. 
Other purification results were similar as described in Chapter 2.11.7.b. Using a preparative C18-
column for RP-HPLC greatly reduced the purification time and also reduced the amount of Par-4 
peptide that was not retained on the column. The protein yield was ~2 mg Par-4(286-332)E310K 
per litre cell culture. Par-4(286-332)E310K purified by this protocol will be denoted as 
REDPRO rrPar-4LZE310K throughout the remainder of this text.
2.11.9. Denaturing purification of Par-4(286-332)N313I from pGex-6P-3 −
Purification of rrPar-4LZN313I
a) Materials and Methods
 Par-4(286-332)N313I in pGex-6P-3 was purified as described in Chapter 2.10.1.a. The 
cleavage reaction containing soluble Par-4(286-332)N313I was concentrated as described in 
Chapter 2.11.2.a. RP-HPLC purification of Par-4(286-332)N313I was achieved as described in 
Chapter 2.11.8.a using a linear water-acetonitrile gradient of 40-47% over 25 min. The protein 
concentration was determined as described in Chapter 2.10.1.a.
b) Results
 Par-4(286-332)N313I in pGex-6P-3 was expressed in 15N-labelled form with a final 
OD600 = 8.2 after 5 h expression. Including a second lysis step  under denaturing conditions gave 
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an almost complete solubilisation of the Par-4 fusion protein. Note that 60% of the total Par-4 
fusion protein was in the denaturing lysate. Reducing the urea concentration of the cell lysate by 
dialysis, resulted in protein precipitation of 20-30% of the total Par-4 fusion protein. The purified 
Par-4 fusion protein was more than 95% pure after elution and appeared as a 30 kDa protein as 
judged by SDS-PAGE. Separation of cleaved Par-4(286-332)WT from GST was achieved using 
a RP-HPLC step. The protein yield was ~11 mg Par-4(286-332)N313I per litre cell culture. Par-4
(286-332)N313I purified by this protocol will be denoted as rrPar-4LZN313I throughout the 
remainder of this text.
2.12. Summary
2.12.1. General purification problems of Par-4
 Of the various purification protocols described above (Chapters 2.6. to 2.11.) only a few result 
in pure soluble Par-4 protein. The Par-4 proteins that were successfully isolated are the full-
length construct rrPar-4FL (Chapter 2.6.5.), the leucine zipper-less construct rrPar-4ΔLZ 
(Chapter 2.8.2.), the SAC domain comprising rrPar-4SAC (Chapter 2.9.1.), the coiled coil 
domain comprising rrPar-4CC (Chapter 2.10.1.), the LZ domain comprising rrPar-4LZ 
(Chapter 2.11.3.) and the three LZ domain point mutants rrPar-4LZD305K (Chapter 2.11.6.), 
rrPar-4LZE310K (Chapters 2.11.7. and 2.11.8.) and rrPar-4LZN313I (Chapter 2.11.9.). Par-4
(1-265)WT and Par-4(286-332)W285 could not be purified due to degradation of the proteins. 
Since Par-4(1-265)WT is almost identical to rrPar-4ΔLZ no further purifications were attempted. 
For almost all Par-4 constructs the ID nature and/or self-association complicate the purification 
process and make it more difficult. General problems observed during the purification are 
discussed below.
 Par-4 constructs containing the LZ domain (Par-4(1-332) and Par-4(286-332) constructs) are 
less soluble than Par-4 constructs without the LZ domain (Par-4(1-265), Par-4(1-290) and Par-4
(137-195) constructs). The later group shows very  little Par-4 fusion protein in the insoluble 
fraction after clarification of the cell lysate. The decreased solubility of the LZ containing 
constructs is probably  due to self-association linked to the presence of the LZ domain. MBP, as 
is established in general, shows a greater solubilising effect as purification tag (~50% soluble 
Par-4(1-332) and Par-4(286-332) constructs) than GST (~40% soluble Par-4(286-332)WT) or 
thioredoxin (~10% soluble Par-4(1-332)G40G) (Chapters 2.6.1, 2.11.1, 2.11.2. and 2.6.5, 
respectively). The solubility of the Par-4 fusion proteins could be improved in most cases if cells 
were fermented at 25 ºC after induction with IPTG. Even though MBP has a favourable 
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solubilising effect, effective separation of cleaved Par-4 proteins such as Par-4(1-265)WT 
(Chapter 2.7.1.) or Par-4(286-332)WT (Chapter 2.11.1.) from the MBP tag could seldom be 
achieved. This is probably due to non-specific interactions between Par-4 and MBP. Residual 
MBP further affects the stability  of the Par-4 proteins (see below). MBP was therefore replaced 
by other purification tags that allowed a more effective purification of the Par-4 proteins. 
Solubility problems are greatly overcome using denaturing purification protocols resulting in the 
solubilisation of most of the Par-4 fusion proteins (e.g. Chapter 2.6.5.). This allows the use of 
GST and thioredoxin as fusion tags, which are easier to separate from the Par-4 proteins. This 
further benefits the stability of the Par-4 proteins (see below). Importantly, urea as a denaturant is 
essential for the purification of rrPar-4FL. If not kept in urea containing buffers until it  has been 
purified by RP-HPLC, rrPar-4FL is almost completely lost due to precipitation (Chapter 2.6.5.).
 Due to their extended coil-like conformations (Chapter 3.2.2.) Par-4 proteins contain 
hydrophobic residues that are not buried and are accessible for non-specific interactions. Such 
interactions could occur with other hydrophobic residues and may result in aggregation. 
Alternatively, such interactions could lead to non-specific binding to surfaces of consumables 
(e.g. storage tubes). Freely accessible residues other than hydrophobic residues may be involved 
as well. In particular for rrPar-4FL and rrPar-4ΔLZ, significant protein losses were observed 
using Vivaspin devices or dialysis tubings, probably due to non-specific binding to the 
membrane. Protein losses of rrPar-4FL were greatly reduced in the presence of urea (see above). 
The use of Vivaspin devices and dialysis tubing should therefore be kept to a minimum and only 
when absolutely necessary to prevent greater protein losses. Furthermore, storage of Par-4 
proteins in non-siliconised reaction tubes resulted in the loss of Par-4 protein. In case of 
rrPar-4ΔLZ no protein was detectable after three days if the sample was left on the bench at 
room temperature in a standard 1.5 ml reaction tube (Fig. 2.4A). Storage of the same protein 
under identical conditions in a siliconised 1.5 ml reaction tube showed virtually no decrease in 
protein concentration after three (Fig. 2.4B) or more days (data not shown). Non-specific binding 
of Par-4 was also observed by other research groups [91].
 Time and concentration dependent aggregation is another critical factor especially  at higher 
protein concentration. For nearly  all Par-4 proteins, except rrPar-4SAC, precipitates were 
observed after a few days in concentrated storage solutions kept at 4 ºC. In particular LZ domain 
containing constructs were prone to aggregation and precipitation at 4 ºC. This is not surprising 
as concentration dependent aggregation is not unusual for amphipathic helices [142]. An 
example for the aggregation of the Par-4 LZ mutant Par-4(286-332)E310K is shown in 
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Figures 2.4C and D. Native PAGE analysis of freshly purified Par-4(286-332)E310K produces 
one major band (Fig. 2.4C). Similarly, only a single band is observed For Par-4(286-332)WT 
under the conditions of the native PAGE (pH 8 and 20 ºC). These results indicate predominantly 
single oligomeric species for both proteins. The difference in the electrophoretic mobility of 
Par-4(286-332)E310K relative to Par-4(286-332)WT is probably related to different oligomeric 
states for both proteins (Chapter 4.2.2.) and to the charge difference between both proteins. Par-4
(286-332)E310K has one glutamate residue mutated to a lysine residue resulting in a charge 
difference of two relative to Par-4(286-332)WT. A control experiment a week later under similar 
conditions, but after the Par-4(286-332)E310K stock solution showed precipitation, produced 
completely different result. Multiple bands of low electrophoretic mobility are visible for Par-4
(286-332)E310K indicating the existence of aggregates (Fig. 2.4D). Similarly, Gao et. al. 
reported that full-length Par-4, heterologously  expressed in bacteria, was prone to polymerise, 
and was thus not suitable for some of their in vitro assays [54]. Precipitation and non-specific 
binding are therefore likely factors contributing to the relatively low Par-4 protein yields.
 Figure 2.4 − Non-specific binding and aggregation of Par-4 constructs. Analysis of the stability of 
rrPar-4ΔLZ by 10% Tricine-PAGE. (A) An aliquot of rrPar-4ΔLZ is transferred to a standard non-
siliconised 1.5 ml reaction tube and left on the bench at room temperature. Aliquots are taken after five 
minutes (0 d), one day (1 d), two days (2 d), three days (3 d) and five days (5 d). (B) For comparison, an 
aliquot of rrPar-4ΔLZ is transferred into a siliconised 1.5 ml reaction tube and left on the bench at room 
temperature. Aliquots are taken after five minutes (0 d), one day (1 d), two days (2 d), three days (3 d) 
and three and a half days (3.5 d). No protein loss is observed with siliconised tubes, even after five days 
(data not shown). Lanes with molecular weight markers are labelled with (M). Approximate MWs are 
shown on the left edge of each gel. (C,D) Native PAGE analysis of Par-4(286-332)E310K. The 12% 
native PAGE is run as a standard Laemmli SDS-PAGE but without SDS [186]. (C) Freshly purified Par-4
(286-332)E310K (10.11.2006) is analysed together with Par-4(286-332)WT. (D) A week later, after the 
Par-4(286-332)E310K stock solution showed precipitation, the clarified supernatant is analysed again 
displaying various bands with low electrophoretic mobility.
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 Increased proteolytic susceptibility due to extended conformations is another typical property 
of IDPs (Chapters 1.5. and 1.6.2.). The degradation of Par-4(1-332)G40G in pET32a by 
Thrombin (Chapter 2.6.3.) is therefore interesting, as it  can be considered as another indication 
for the extended conformation of Par-4(1-332)G40G. In addition to the Thrombin cleavage site 
between thioredoxin and Par-4(1-332)G40G, a second internal Thrombin cleavage site is 
predicted for Par-4(1-332)G40G. Cleavage at this site would result  in Par-4(1-332)G40G 
fragments of 9 and 27 kDa. However, only fragments below 21 kDa are observed suggesting 
non-specific cleavage at other sites. This non-specific cleavage is probably  enhanced by the 
extended structure that  exposes other cleavage sites, which are then more accessible for the 
protease. Degradation is a great problem during the purification of Par-4 and was observed 
several times for various Par-4 constructs, especially rrPar-4FL and rrPar-4ΔLZ. This was 
probably  due to proteolysis resulting from protein impurities. Therefore, fast work, careful 
preparation of buffers and non-contaminated consumables are required to prevent degradation of 
Par-4 during the purification process. Degradation was the major reason that prevented 
purification of Par-4(1-265)WT (Chapter 2.7.1.). The separation of MBP from Par-4(1-265)WT 
was inefficient and time consuming therefore allowing enough time for proteolytic degradation. 
A protease inhibitor could have been included in the buffers making the purification more 
expensive. However, fast working and efficient removal of any impurities made this step 
unnecessary  for most other Par-4 constructs. Especially RP-HPLC purified Par-4 proteins show 
increased stability relative to other purification methods. For example, Par-4(286-332) constructs 
containing traces of MBP and other impurities (Fig. 2.2D) at the end of the purification process 
had decreased life times relative to RP-HPLC purified Par-4(286-332) proteins. Therefore, to 
prevent protein losses due to precipitation and proteolytic degradation, purified Par-4 solutions 
are kept at -20 ºC. Even though it is not the best  way  to store proteins in general, it greatly 
contributed to the stability of the Par-4 samples.
 The cell densities after overnight expression are fairly low with OD600 of approximately  4. To 
increase the protein yield future cultures may be induced at higher cell densities as described in 
Chapter 2.5.4. for the REDPRO growth. However, this may result in more insoluble Par-4 fusion 
protein and should be tested before trying isotopically labelled growths. In the case of 
rrPar-4LZN313I (Chapter 2.11.9.) this expression protocol did contribute to an increased cell 
density  and in the end to an increased protein yield. For three Par-4 constructs, Par-4(286-332)
WT in pCFE-GST-TEV (Chapter 2.11.4.), rrPar-4LZD305K (Chapter 2.11.6.) and 
rrPar-4LZE310K (Chapter 2.11.7.) significantly lower cell densities were obtained (OD600 ≈ 2). 
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These were due to problems with the M9 medium. After discarding the old M9 medium and 
using a freshly made M9 medium, higher cell densities (~4 OD600) were obtained. The low cell 
densities are therefore responsible for the reduced yields of these three proteins.
 The use of rTEV protease is favoured over HMBP-3Cpro. A virtually complete removal of the 
thioredoxin tag after cleavage with rTEV is easily achieved by an additional IMAC purification 
step. In contrast, cleavage with HMBP-3Cpro reduced the efficiency of the removal of the 
purification tag. This resulted in co-elution of HMBP (Fig. 2.2B, lane 13) or GST 
(Chapter 2.11.2.b) with the Par-4 protein. Removal of GST was so inefficient that  the cleavage 
reaction was directly purified by  RP-HPLC (Chapter 2.11.3.). A second Glutathione Sepharose 
affinity purification step was not necessary.
 Taken together, recombinant expression of Par-4 proteins was achieved in E. coli systems. 
However, the ID nature of Par-4 and self-association due to the LZ domain, made this 
purification process non trivial. These difficulties are further worsened by the inherent 
“instability” of the Par-4 proteins. Effective separation of impurities is therefore necessary to 
prevent proteolytic degradation. The non-specific binding of Par-4 to surfaces is an additional 
factor contributing to the “instability” of the Par-4 proteins and great care should be taken when 
handling Par-4 proteins to minimise protein losses. The time dependent aggregation, especially  at 
higher protein concentration, requires further optimisation to determine suitable long term 
storage conditions. Considering these factors, it is not surprising that development of effective 
purification protocols for Par-4 and finding conditions increasing the stability of the proteins was 
(and still is) a time consuming process.
2.12.2. Purification problems of Par-4(286-332)
 The Par-4(286-332) constructs were the first Par-4 proteins to be purified during the PhD. 
Hence the greatest modifications to an existing protocol [184,187] were made (Chapter 2.11.). 
These modifications and the reasons for them will be given below. The term Par-4(286-332) 
includes the WT construct as well as the mutants W285, D305K, E310K and N313I.
 The specificity of the TALON resin is higher relative to a Ni-NTA matrix (Talon manual) and 
Par-4 fusion proteins of greater purity were therefore obtained (compare Figures 2.1, lane 7 and 
2.2A, lane 12). However, due to the above mentioned problems with HMBP-3Cpro this 
advantage was nullified by  co-elution of MBP. Using a Ni-NTA based system increased the 
protein yields due the higher affinity of the Ni-NTA matrix and therefore minimised Par-4 fusion 
protein losses. Cleaving Par-4 constructs on the column was abandoned as this method was 
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inefficient and time consuming. Even though initially  less HMP-3Cpro was used, adding more 
protease did not resulted in complete cleavage of the fusion protein. The cleavage efficiency  was 
increased by adding TCEP. Cleavage reactions performed in this way took on average three to 
six days. In contrast, almost complete cleavage was achieved by  eluting the fusion protein off the 
column and cleaving it overnight in solution (e.g. Chapter 2.11.6.a).
 IEC with QAE-sephadex reduced the amount of protein impurities, but was not very efficient. 
IEC with QAE-sephadex was nonetheless superior in removing MBP to all other methods 
described in Chapter 2.11.1. It was generally  necessary  to perform the IEC step  twice. Note that 
separation of Par-4(286-332) constructs form MBP using a Vivaspin 20 device 
(MWCO = 30 kDa) as described in Ref. [187] was not possible. Par-4(286-332) constructs were 
efficiently retained in the Vivaspin 20 device. Taken together, even with the changes introduced, 
purification by this method was time consuming and took 15 to 30 days, depending on the 
efficiency of the cleavage reaction and IEC purification. The long purification times, that may 
favour proteolytic degradation, and repeated purification by IEC were detrimental to protein 
yields. Also impurities were not completely removed (Fig. 2.2D) and most Par-4(286-332) 
samples only  remained stable for a short time. This is based on stability analysis by  Tricine-
PAGE [192] that showed decreasing band intensities for the Par-4(286-332) constructs. This 
decrease may have been caused by degradation or non-specific binding to the storage tube.
 As is well established, GST binds with high affinity and high specificity to glutathione. 
Indeed, very  pure GST-Par-4(286-332)WT fusion protein was obtained (Fig. 2.3A, lane 8). It 
was therefore thought that this method would allow complete removal of GST after cleavage 
with HMBP-3Cpro. However, less than 30% of GST was removed after cleavage in this way 
(Fig. 2.3B, lanes 10-13). The reason for the decreased binding of GST to the glutathione 
sepharose matrix after cleavage with HMBP-3Cpro is not clear. Efficient removal of GST was 
achieved by  RP-HPLC (see below). As mentioned above, more GST-Par-4(286-332)WT fusion 
protein (~60-70%) (Chapter 2.11.2.b) was found in the insoluble fraction after clarification of the 
cell lysate relative to a similar HMBP-Par-4(286-332)WT fusion protein (40-50%) (Chapter 
2.11.1.b). Most of the GST-Par-4(286-332)WT fusion protein was resolubilised with a 
denaturing purification protocol and only 10-20% of the fusion protein remained insoluble in 
native buffer (Chapter 2.11.3.b). Reducing the urea concentration by dialysis appears to increase 
the total purification time, however, this method is still faster than the Ni-NTA-based purification 
of HMBP-tagged Par-4(286-332) constructs (Chapter 2.11.6.). Elution of cleaved Par-4(286-332) 
constructs from a Ni-NTA column required two to three times the volume needed for the elution 
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of cleaved rrPar-4LZ from a Glutathione column (compare Chapters 2.11.6.a and 2.11.3.a). 
Hence, for the RP-HPLC purification more eluate coming from the IMAC column needed to be 
concentrated. This was then the most time consuming step and took one to two days. 
Additionally, concentration allowed for degradation and non-specific binding to the Vivaspin 20 
device (see above), thus reducing the protein yields. As mentioned earlier, separation of 
rrPar-4LZ from GST by a second affinity chromatography step was not worthwhile and thus less 
volume needed to be concentrated reducing the protein losses. Elution of Par-4(286-332) from 
the Ni-NTA column was increased using high salt  buffers (Chapter 2.11.6.a) as Par-4(286-332) 
was most likely retained because of ionic interactions between the negatively charged Par-4
(286-332) (pI ~ 4.4-4.5) and the positively charged Ni-NTA-matrix.
 RP-HPLC greatly  improved the purity of Par-4(286-332) constructs and contributed to an 
increased stability. The Delta Pak C18-300Å column was used due to budget restrictions as it 
was available and saved the need of buying a new column. Approximately 30% of rrPar-4LZ did 
not bind to the C18-300Å column, due to overloading, and eluted in the flow through together 
with excess GST (Fig. 2.3C, lane I). Due to the low binding capacity of the column, the RP-
HPLC purification took in most cases several days. As these results showed that RP-HPLC 
purification is the better way to purify  Par-4(286-332), a preparative scale C18-column was 
bought. The increased binding capacity reduced the purification time down to one day  in the case 
of rrPar-4LZN313I (Chapter 2.11.9.). Furthermore, no protein was observed in the flow through 
indicating that all applied protein was retained by the column. Decreasing the pore size of the 
column matrix further contributed to a better resolution.
 Lyophilisation removed the need to concentrate the RP-HPLC eluates and hence protein 
losses due to precipitation and non-specific binding were minimised. Lyophilised rrPar-4LZ 
constructs were easily dissolved in H2O allowing concentration measurements by the A205 
method without interference from buffer components. These measurements allowed an easier 
determination of the protein concentration than the initially used BCA-assay (Chapter 2.11.1.a). 
The H2O-dissolved Par-4 protein solutions were strongly acidic (pH ~ 3-4) after lyophilisation. 
To some extent, this was probably  due to residual TFA that could not be removed by 
lyophilisation. Also the low pI of the rrPar-4LZ proteins may have contributed to the low pH. 
Residual TFA is likely to have interfered with the A205 absorbance measurements and may have 
skewed the results to a higher apparent concentration. A more accurate concentration 
determination would be achieved by  amino acid analysis, which should be used for comparison 
with the results from the A205 measurements. However, appropriate institutions that  offer amino 
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analysis are not easily  accessible in New Zealand. The Par-4(286-332)W285 construct 
(extinction coefficient 5,500 M-1cm-1) was created to allow easy concentration determination 
from A280 measurements. With this information a calibration curve for the BCA-assay was 
attempted. However, rapid degradation of Par-4(286-332)W285 prevented any concentration 
determination. Dissolving lyophilised rrPar-4LZ in H2O allowed higher protein concentrations 
(> 1 mM) relative to centrifugal concentration devices. The H2O-dissolved Par-4(286-332) was 
easily diluted with appropriate buffers for CD or NMR spectroscopy at the desired ionic strength 
and pH. Because the RP-HPLC purified Par-4(286-32) were acidic when dissolved in H2O, 
neutralisation was required before use. Especially  the low salt buffers used for CD 
spectropolarimetry were not able to compensate for this low pH.
 The switch from HMBP-tagged fusion proteins to GST-tagged fusion proteins, and 
particularly using RP-HPLC for Par-4(286-332) purification, became necessary  as the initial 
NMR results of the Par-4(286-332) peptides (Chapter 2.11.1.) were not consistent. Additionally, 
using GST-tagged Par-4(286-332) fusion proteins and RP-HPLC resulted in higher purity, an 
increased stability  and higher yields in a shorter amount of time. This instability of the Par-4
(286-332) peptides was probably due to problems associated with the original purification 
protocol of HMBP-fusion proteins (Chapter 2.11.1.). NMR spectra of the Par-4(286-332) 
peptides displayed more peaks than were expected from the amino acid sequence (Appendix C). 
The peak number increased as the pH was decreased and it was therefore thought that this 
increase in peak number is correlated with an increase in secondary  structure (Chapter 4.). A 
significant amount of time was spent on analysing these spectra and also with trying to improve 
the spectral quality. For conciseness, only representative NMR spectra of Par-4(286-332)WT 
under various pH conditions are shown in Appendix C. As a CD spectrometer was not available 
at this time, an increase in secondary structure could not be confirmed. However, mounting 
evidence from SEC, 15N-relaxation measurements and backbone assignments suggested that the 
increase in peak number is not correlated with an increase in secondary structure, but an 
indication of peptide degradation (data not shown). This was consistent with results from 16.5% 
Tricine-PAGE showing a decrease in the intensity of the band representing the intact Par-4
(286-332) constructs (data not shown). However, no low molecular weight bands (indicating 
degradation products) could be detected. With the availability of a CD spectrometer it was 
proven that the increase in peak numbers is associated with protein disorder (data not  shown). It 
is likely that degradation is related to the insufficient purity and the presence of contaminants in 
the Par-4 protein samples. Attempts to increase the stability of the Par-4 LZ domain are shown in 
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Appendix D. In short  the Par-4 LZ domain was analysed as a GST fusion protein 
(Chapter 2.11.4.), which increased the stability, but did not allow structural characterisation. 
Apart from the need of highly pure Par-4(286-332) peptides, great care should also be taken 
when preparing the NMR samples as this was identified as another source contributing to Par-4
(286-332) instability. However, with the use of highly pure protein stock solutions obtained by 
RP-HPLC and extensively cleaned NMR tubes an increased protein stability  was achieved. The 
risk of contamination was further reduced by avoiding dialysis and instead diluting H2O-
dissolved Par-4(286-332) peptides in buffer with the desired ionic strength and pH. Using pH 
paper instead of a pH probe for pH adjustment and minimising transfers in and out of the NMR 
tube also minimised the possibility  for contamination. With these measures higher quality 
spectra were obtained and the life times of the NMR samples could be prolonged. 
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3. Intrinsic Disorder
 in Par-4
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 Most parts of this section have been published recently by Libich, Schwalbe et. al. [46] and is 
given here in an adapted form to fit the style of this thesis. This publication is a joint  first 
authorship  between Dr. David Libich (Institute of Fundamental Sciences, Massey University, 
Palmerston North, New Zealand) and Martin Schwalbe. Computational analysis of Par-4 
(DisEMBL, GOR4 etc. and RS calculation) was performed by Dr. Libich and all figures were 
created by  Dr. Libich as well. All experimental results such as protein expression, limited 
proteolysis, CD, DLS and NMR spectroscopy were carried out by  Martin Schwalbe. SEC results 
for the Par-4 proteins and TFE studies of rrPar-4SAC have not been published, but are given 
here to further illustrate the extent of ID in Par-4.
3.1. Bioinformatic analysis
 Many proteins lack a well defined secondary or tertiary structure in their biologically  active 
state questioning the ‘classical’ structure-defines-function paradigm [193-195]. A short 
introduction to this phenomenon called intrinsic disorder was given in Chapter 1.5. As 
mentioned in this section, Par-4 exhibits several characteristics of intrinsically disordered 
proteins (IDP) that prompted the investigation if Par-4 can be classified as an IDP. For structural 
characterisation several constructs were created that comprise different domains of Par-4, most 
notably the domains with a high degree of sequence conservation. Sequence conservation in the 
SAC (selective apoptosis induction in cancer cells), CC (coiled coil) and in particular the LZ 
(leucine zipper) domain (Fig. 1.1) has been discussed in Chapter 1.2.1. Due to their distinct 
structural properties the CC and LZ domain containing constructs (except rrPar-4FL) will be 
discussed in Chapter 4. The extent of ID in Par-4 was therefore mainly  analysed with three 
constructs shown in Figure 3.1A. Note that all sequence numbering will be in reference to rat 
Par-4, to reflect the recombinant rat (rrPar-4) constructs used in these studies. As mentioned in 
Chapter 2.4, rrPar-4FL comprises the full-length Par-4 (residues 1-332), rrPar-4∆LZ (residues 
1-290) lacks the LZ domain, but still contains N-terminal parts of the CC domain, and 
rrPar-4SAC comprises the SAC domain including NLS2 (residues 137-195) (Fig. 3.1A).
 The results of the analysis of full-length Par-4 by  various bioinformatic methods are shown in 
Figure 3.1. DisEMBL analysis [178] predicts more than 70% of Par-4 to be disordered 
(Fig. 3.1B). The putative ordered regions (indicated by  grey bars in Figure 3.1B) align with 
highly  conserved and functionally  important regions of Par-4 such as NLS1 and 2, the SAC 
domain and the CC domain (Fig. 3.1A). These putative ordered regions further align with 
regions showing the highest helical propensity as indicated by the GOR4 plot [196] (Fig. 3.1C) 
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and with the most hydrophobic regions as indicated by  the hydrophobic cluster analysis (HCA 
[179]) (Fig. 3.1D).
 Figure 3.1 − Computational analysis of Par-4. (A) A block diagram of the three constructs of rrPar-4 
mainly used in this chapter. Marked on each construct are the primary regions of functional importance 
including the nuclear localisation sequences 1 (NLS1, 20-25) and 2 (137-153), coloured green, the region 
necessary for selective apoptosis induction in cancer cells (SAC, 137-195), the coiled coil C-terminal 
domain (CC, 254-332, coloured red) and the leucine zipper (LZ, 292-330, shown with hatching). The 
rrPar-4∆LZ construct lacks residues 291-332 which is approximately half of the coiled-coil and the entire 
leucine zipper. The rrPar-4SAC construct represents residues 137-195 of Par-4 including NLS2. All three 
constructs used in this study have an N-terminal GGS tag, a remnant from the cleavage of the purification 
tag, which is omitted here for simplicity. (B) DisEMBL predicts regions of order/disorder in proteins using 
neural networks trained on multiple definitions of disorder [178]. The dashed line in panel B represents a 
threshold value separating order and disorder. (C) Secondary structure prediction (only α-helix shown) 
using GOR4 [196], and (D) hydrophobic cluster analysis (HCA) [179], a visually enhanced 
representation of the amino acid sequence that highlights clustering of hydrophobic residues using 
symbols for Thr (open squares), Ser (open squares with black dot), Gly (filled diamonds) and Pro (red 
stars); and colours (red – Pro, Asn, Asp, Gln, Glu; blue – basic residues Arg, His, Lys; green – 
hydrophobic residues Ile, Leu, Met, Phe, Trp, Tyr, Val; and black for all other residues – Ala, Cys, Gly, 
Ser, Thr). The grey bars indicate the predicted regions of order in panel B and for comparison are 
extended over panels C and D. Figure and legend taken and adapted from Libich, Schwalbe et. al. [46].
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 A plot of mean net charge (R̅) against  mean hydrophobicity (H ̅) determined from a protein’s 
primary structure allows differentiation between folded and intrinsically disordered proteins as 
folded proteins occupy different spaces than intrinsically disordered proteins. Intrinsically 
disordered proteins typically fall into spaces marked by low mean hydrophobicity and high net 
charge [144]. Based on an analysis by Uversky et. al [180] an empirically determined line 
(R̅ = 2.785H ̅ – 1.151) divides the plot space into regions typical for folded and intrinsically 
disordered proteins (Fig. 3.2A). The three rrPar-4 constructs used in this study  are plotted in 
Figure 3.2A. For comparison several well established folded (‘classically folded’) proteins are 
plotted too. Clearly rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC fall into disordered space. Not 
surprisingly, the rrPar-4SAC construct with 14 positively charged and 13 negatively  charged 
residues, but few hydrophobic residues, lies further in the disordered region.
 The percent difference between the amino acid usage of a set folded (globular) proteins versus 
a set of known IDPs is shown in Figure 3.2B (black bars). Relative to folded proteins positive 
values indicate a depletion in the corresponding amino acid while negative bars indicate an 
enrichment. The sequence complexity of rrPar-4FL can be described by comparison to this 
reference set. The amino acid usage of a set folded proteins versus rrPar-4FL is shown in 
Figure 3.2B (grey bars). The observed pattern is similar to what is observed for IDPs [144,193] 
namely a depletion of order-promoting amino acids (Asn, Cys, Ile, Leu, Phe, Trp, Tyr) and 
enrichment of disorder-promoting residues (Gln, Glu, Lys, Pro, Ser) [153]. A similar amino acid 
usage pattern is observed for rrPar-4∆LZ and rrPar-4SAC (data not shown).
 The HCA plot shows a low abundance of hydrophobic residues and only few regions with 
hydrophobic clusters (Fig. 3.1D). A depletion in hydrophobic residues is further indicated by 
charge/hydrophobicity plots and sequence complexity analysis (Fig. 3.2). These results speak 
against the formation of a hydrophobic core and thus provides a strong argument against the 
formation of stable global tertiary structure [193]. Interestingly, the highly conserved and 
functionally important regions of Par-4 correlate well with the predicted regions of order 
(Fig. 3.1B), with the predicted regions of secondary structure (Fig. 3.1C), and with the predicted 
regions of greatest hydrophobic clustering (Fig. 3.1D). As disorder prediction in Par-4 does not 
exclude formation of short regions of structure, or of larger but  transient secondary  structure 
elements, highly conserved regions of rrPar-4FL (and possibly  other regions) may be capable of 
forming α-helices either independently  or upon association with binding partners. This would 
suggest that Par-4’s function may be associated with structure stabilisation in the functionally 
important regions. Induced folding upon binding to interaction partners has been described for 
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various proteins. In the absence of binding partners the interaction domain of ACTR (activator 
for thyroid hormone and retinoid receptors) is unfolded in solution [197]. Similarly, the kinase-
inducible transcriptional-activation domain (KID) of CREB (cAMP-responsive element-binding 
protein) is disordered in solution and adopts an α-helical fold upon association with CBP 
[198,199]. Interestingly, the ID nature and the CBP-induced helical residues could be predicted 
from the primary structure [194].
Figure 3.2  – Charge/hydrophobicity plot 
and sequence complexity of Par-4. (A) 
Charge/hydrophobicity plot of rrPar-4 
proteins. The dividing line (R ̅ = 2.785H ̅ – 
1.151) represents an empirically deter-
mined divisor between intrinsically dis-
ordered (high charge, low hydrophobicity) 
and structured (low charge, high hydro-
phobicity) space. Proteins such as 
aprotinin [200], actin [201], ubiquitin 
[202] and 3C protease [203] are plotted 
as examples of ‘classically folded’ 
proteins. (B) Sequence complexity of 
rrPar-4FL (grey bars) compared with the 
average amino acid distribution of IDPs 
(black bars) relative to the average amino 
acid distribution of globular proteins. The 
relative distributions were sampled from 
proteins (both IDPs and folded) deposited 
in the Protein Data Bank. Positive and 
negative values indicate an enrichment or 
depletion, respectively, of a particular 
residue relative to globular proteins. 
Residues marked with an asterisk occur two times more or less frequently on average in IDPs than in 
globular proteins [193]. Figure and legend taken from Libich, Schwalbe et. al. [46].
 In summary, bioinformatic analysis of Par-4 displays characteristic features of IDPs including 
high net charge, low mean hydrophobicity and low sequence complexity. Further a depletion in 
order-promoting amino acids and an enrichment in disorder-promoting residues could be shown. 
The lack of hydrophobic residues suggests that the formation of a hydrophobic core is unlikely 
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and thus the formation of stable tertiary  structure. However, next to the primarily ID nature of 
Par-4 potential α-helical regions are predicted that may be stabilised upon binding to interaction 
partners.
3.2. Electrophoretic mobility, hydrodynamic and proteolytic analysis
3.2.1. Materials and Methods
a) Dynamic Light Scattering (DLS)
 The rrPar-4 proteins rrPar-4FL, rrPar-4ΔLZ and rrPar-4SAC were expressed and purified as 
described in Chapters 2.6.5, 2.8.2. and 2.9.1. The apparent Stokes radii (RS) of the rrPar-4 
constructs were analysed using a Zetasizer Nano ZS (Malvern Instruments, Malvern, United 
Kingdom). Sample concentrations were 0.3 mg/ml (8 µM  rrPar-4FL, 10 µM  rrPar-4ΔLZ and 
43 µM rrPar-4SAC) in native buffer (20 mM NaCl, 10 mM  Tris, pH 7.0) or native buffer + 1 M 
urea. An additional sample of 8 µM  rrPar-4FL was prepared in native buffer + 6 M urea. DLS 
data was obtained at 25 ºC using a low-volume disposable 1 cm pathlength plastic cuvette. Five 
successive scans were collected and averaged for each protein sample. Samples were prepared a 
day in advance and allowed to sit overnight at 4 ºC to permit bubbles to dissipate, and then 
allowed to equilibrate to 25 ºC before measurements. The diffusion coefficients were extracted 
from the correlation curve and the hydrodynamic radius was calculated using the Stokes-Einstein 
equation. The highest peak of the resulting histogram recorded for each sample was taken as the 
mode diameter for that particular sample. RS values obtained from measurements in urea were 
corrected using the Dispersion Technology  Software 5.1 (Malvern Instruments, Malvern, United 
Kingdom) to account for the increased solvent viscosity and the increased refractive index.
b) Limited Proteolysis
 BSA and the rrPar-4 proteins were incubated with trypsin for 15 min at 37 ºC at a protein to 
protease ratio of 280:1 (w/w) in 50 mM  NaCl, 20 mM  Na2HPO4/NaH2PO4, pH 7.5. Aliquots were 
taken after 1, 2, 5, 10 and 15 min and the reaction was quenched by the addition of Laemmli 
sample buffer and boiling for 5 min. The proteolysis reaction was analysed by  10% Tricine-
PAGE and the extent of digestion was measured from the relative intensities of the 
polyacrylamide gel band representing the non-digested band by densitometry using the Gel Doc 
Imager and Quantity One software package (BioRad, Hercules, USA).
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3.2.2. Results and Discussion
 MALDI-TOF mass spectrometry (Centre for Protein Research, University of Otago, Dunedin, 
New Zealand) was used to assess the purity  and to determine the sizes of the recombinant Par-4 
constructs. As described in Chapter 2.12.1, all three proteins were isolated in high purity. After 
accounting for 15N-labelling of the samples used for MS analysis, the sizes determined for 
rrPar-4∆LZ (44.5 Da difference between expected and observed) and rrPar-4SAC (6.6 Da 
difference between expected and observed) agree within error (approx. 0.1%) with the sizes 
predicted from sequence analysis (Table 3.1). Interestingly, MS indicates that the rrPar-4FL 
construct is approximately 0.2 kDa larger than expected. The source of the size difference is 
currently unknown and matter of ongoing research. A possible source may be that rrPar-4FL is 
modified by the E. coli based expression system. However, no greater mass differences are 
observed for rrPar-4∆LZ and rrPar-4LZ. Both proteins comprise, to a certain extent, the same 
residues as rrPar-4FL.
 Aberrant electrophoretic mobility in denaturing PAGE systems can be an indication of ID in 
proteins. Due to their unique amino acid composition relative to globular proteins the amount of 
SDS that is able to bind to IDPs is reduced [155,193,204]. Therefore, the reduced mass/charge 
ratio relative to globular proteins results in a reduced migration in denaturing polyacrylamide 
gels and thus in higher apparent molecular weights (MWs). Aberrant mobility  was detected for 
rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC (Fig. 3.3, lanes 1-3) but not for rrPar-4LZ (Fig. 3.3, lane 
4). Consistently, the LZ point mutants rrPar-4LZD305K, rrPar-4LZE310K, rrPar-4LZN313I and 
the CC construct rrPar-4CC show normal electrophoretic mobility  (data not shown). The later 
four constructs have a higher content in hydrophobic residues (Fig. 3.1D) and may therefore bind 
SDS to similar amounts as globular proteins. The apparent MWs are summarised in Table 3.1.
Figure 3.3 − Electrophoretic mobility of Par-4. 
Displayed is the electrophoretic mobility of 
four Par-4 constructs using 10% Tricine-
PAGE. The approximate MWs for various 
globular proteins (M) are shown on the left 
edge. The from the amino acid sequence 
expected sizes of the Par-4 constructs 
rrPar-4FL (1), rrPar-4ΔLZ (2), rrPar-4SAC 
(3) and rrPar-4LZ (4) are shown on the right 
edge. Clearly, aberrant electrophoretic 
mobility is observed in lanes 1-3.
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 Table 3.1 compares the experimentally determined MWs from Tricine-PAGE for rrPar-4FL, 
rrPar-4∆LZ and rrPar-4SAC to other experimentally (MS and DLS) determined MWs, and from 
sequence calculated MWs. The amino acid sequence predicts MWs of 36.1, 31.1 and 7.0 kDa for 
rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC, respectively. The experimentally  determined apparent 
MWs from Tricine-PAGE of 49.1, 41.5 and 12.4 kDa for rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC, 
respectively, are 36%, 33%, and 77% larger than the MWs predicted from sequence or measured 
using MS (Table 3.1). Aberrant electrophoretic mobility of Par-4 and Par-4 constructs (i.e. 
deletion mutants) has been previously  shown by other research groups although there is little 
indication that the authors considered the effects of IDP amino acid composition on their results 
(e.g. Refs. [88,91,98]). It  is interesting to note here that  Par-4 is repeatedly reported as a 38 kDa 
protein in the literature when expressed in mammalian cells (e.g. Refs. [47,99]). It  is possible 
that this rather normal electrophoretic behaviour is due to post-translational modifications such 
as phosphorylation, which may be absent in E. coli cells.
Method of analysis
Construct Sequence MS PAGE DLS
rrPar-4FL 36.1 (26.5) 36.2 (26.5) 49.5 (29.6) 8899 (189)
rrPar-4∆LZ 31.1 (25.1) 31.2 (25.1) 41.5 (27.8) 64.1 (32.5)
rrPar-4SAC 7.0 (14.8) 7.1 (14.8) 12.5 (18.1) 18.7 (20.9)
 Table 3.1 − Hydrodynamic properties of rrPar-4 constructs using various biophysical techniques. MW 
(kDa) and hydrodynamic radius RS (Å) are shown in the format MW (RS) for three constructs using four 
techniques. RS and MW were calculated from the amino acid sequence in reference to a folded 
conformation using log(RS) = 0.357*log(MW) − 0.204. Results are taken from Libich, Schwalbe et. al. 
[46].
 For comparison with the PAGE and MS results, the DLS obtained Stokes radii (RS) for 
rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC are converted to MWs using the equation log
(RS) = 0.357*log(MW) – 0.204 [181,205]. It should be noted that this equation is strictly valid 
only for globular proteins as it assumes a spherical shape of the particle. However, it is used here 
to illustrate the degree of extended structure (‘unfoldedness’) in the rrPar-4 proteins. The RS 
values measured for rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC correspond to MWs of 8.9 x 103, 
64.1 and 18.7 kDa, respectively. Consistent  with the proposed ID nature, these experimentally 
determined values are much larger (713, 129 and 141%) than the expected values for a globular 
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protein of the same size (Table 3.1). It  further shows that the degree of ‘unfoldedness’ of the 
rrPar-4 proteins is very high. 
 ID in proteins is not synonymous with the term random coil. ID is better described as 
ensembles of rapidly interchanging conformers that sample varying regions of secondary 
structure space [193]. As mentioned in Chapter 1.5, IDPs are usually categorised into three non-
exclusive groups: random coil, pre-molten globule or molten globule [149]. For comparison with 
the DLS results under denaturing and non-denaturing conditions, the theoretical RS values for the 
rrPar-4 proteins as either monomeric globular (folded), molten globule, pre-molten globule, 
random coil or urea-denatured states are given in Table 3.2. As can be seen from these results, 
the observable RS values of a protein increase in proportion to its degree of ‘unfoldedness’ with 
random coil conformations producing larger observable RS values than folded globular proteins 
of the same MW [205,206] (for examples see Uversky et. al. [145].
Measured RS (Å) Calculated RS (Å)
Construct MW (kDa) 0 M urea 1 M urea G MG PMG RC U
rrPar-4FL 36.1 189 78.4 26.5 29.4 37.7 49.6 53.1
rrPar-4∆LZ 31.1 32.5 43.6 25.1 28.0 35.6 46.1 49.2
rrPar-4SAC 7.0 20.9 28.1 14.8 17.1 19.9 22.2 22.7
 Table 3.2  − Comparison of experimental and theoretical Stoke's radii (RS). The RS was measured in 
20 mM NaCl, 10 mM Tris, pH 7.0, in the presence or absence of 1 M urea. Calculated RS values were 
obtained using the mean values from equations given in Ref. [181] for globular (folded) (G), molten 
globule (MG), pre-molten globule (PMG), random coil (RC) and urea-denatured (U) states. Results are 
taken from Libich, Schwalbe et. al. [46].
 The experimentally  determined RS values for rrPar-4∆LZ (32.5 Å) and rrPar-4SAC (20.9 Å) 
in native buffer (20 mM NaCl, 10 mM Tris, pH 7.0) are smaller than the calculated random coil 
values (46.1 and 22.2 Å, respectively) for either protein (Table 3.2). This suggests that both 
proteins exist  in an unfolded yet monomeric form under these conditions. The high degree of 
‘unfoldedness’ for rrPar-4∆LZ and rrPar-4SAC suggests that the conformation of the ensembles 
is best described by random coil-like ensembles rather than molten globule or pre-molten 
globule ensembles [205]. IDPs such as CREB (cAMP response element binding protein) and 
p27Kip1 (cyclin- dependent kinase inhibitor) have been shown to exist as structurally 
interconverting populations. The relatively  broad distributions for rrPar4∆LZ and rrPar-4SAC 
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(Figs. 3.4B and C) are consistent with such conformational exchange. It  was further shown that 
under physiological conditions IDPs contain nascent secondary structure to varying degrees 
[146]. The subtle, but significant, increase in RS for rrPar4∆LZ and rrPar-4SAC (Table 3.2) 
suggests that upon addition of 1 M urea some folding elements get disrupted. While 
conformational exchange continues, the conformation of the ensemble is, however, shifted closer 
to a random coil.
Figure 3.4 − DLS analysis of rrPar-4FL, rrPar-4∆LZ and 
rrPar-4SAC. Volume distribution representation of DLS results 
showing the apparent hydrodynamic radius of (A) rrPar-4FL, 
(B) rrPar-4∆LZ and (C) rrPar-4SAC dissolved in either native 
buffer (20 mM NaCl, 10 mM Tris, pH 7.0) (grey bars) or in 
native buffer + 1 M urea (hatched bars). These results are 
summarised in Table 3.2. Upon the addition of 1 M urea the RS 
for rrPar-4FL is significantly decreased (A). Both rrPar-4∆LZ 
(B) and rrPar-4SAC (C) exhibit a slight increase in RS upon 
addition of 1 M urea. Figure and legend taken and adapted 
from Libich, Schwalbe et. al. [46].
 Interestingly, the measured RS value for rrPar-4FL in 
native buffer with 189 Å is much larger than what would 
expected for a monomeric random coil (49.6 Å) 
suggesting a polymeric state under these conditions 
(Table 3.2). Upon addition of 1 M  urea to rrPar-4FL the 
RS value decreases to 78.4 Å, which is still larger than the 
calculated RS value of a random coil protein. However, it 
indicates the disruption of a non-covalent complex suggesting that rrPar-4FL is able to self-
associate. Self-association of rrPar-4FL will be discussed in more detail in Chapter 3.6. and the 
DLS results in 6 M  urea will also be given there. As discussed for rrPar4∆LZ and rrPar-4SAC, 
the relatively broad volume weighted distributions for rrPar-4FL indicate ensembles of 
interconverting conformations (Fig. 3.4A), and the high degree of ‘unfoldedness’ for rrPar-4FL is 
best described by a random coil-like ensemble.
 Limited proteolysis is a useful method for distinguishing ordered and disordered proteins, and 
for the mapping of disordered regions in proteins [207]. Due to protection of protease cleavage 
sites by tertiary folding [208,209] globular proteins are less susceptible to proteolysis than IDPs 
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[144,210]. The results of a limited tryptic digest of rrPar-4FL, rrPar-4∆LZ, rrPar-4SAC and BSA 
are shown in Figure 3.5. BSA was chosen for comparison, as it contains a comparable percentage 
of predicted trypsin cut sites as the rrPar-4 constructs. After 15 minutes incubation with trypsin, 
rrPar-4∆LZ was more than 95% digested, whereas rrPar-4FL and rrPar-4SAC were over 80% 
digested. In contrast, BSA was only  10% digested. This indicates that, unlike BSA, the Par-4 
constructs lack protection by folded stable tertiary structure and are for the greater part solvent 
exposed. Furthermore, rrPar-4∆LZ is somewhat less stable than rrPar-4FL and rrPar-4SAC 
suggesting a less compact conformation.
Figure 3.5 − Limited proteolysis of rrPar-4FL, 
rrPar-4∆LZ and rrPar-4SAC. BSA (open 
triangles), rrPar-4FL (filled circles), 
rrPar-4∆LZ (open circles) and rrPar-4SAC 
(filled triangles) were incubated with trypsin at 
a ratio of 280:1 (w/w) in 50 mM NaCl, 20 mM 
Na2HPO4/NaH2PO4, pH 7.5. Figure and 
legend taken and adapted from  Libich, 
Schwalbe et. al. [46].
 Taken together, MS indicates that the isolated rrPar-4 proteins had the expected masses. This 
implies that the apparent high molecular weights for the rrPar-4 proteins are caused by aberrant 
electrophoretic mobility. Aberrant mobility is due to the unique amino acid composition of the 
rrPar-4 proteins. Additional DLS and limited proteolysis experiments for the rrPar-4 proteins 
suggest extended coil-like conformations and the lack of stable tertiary structure in solution. For 
rrPar-4∆LZ and rrPar-4SAC, DLS suggests the existence of folding elements that get  disrupted 
upon addition of 1 M  urea. DLS further shows that rrPar-4FL unlike rrPar-4∆LZ and rrPar-4SAC 
is polymeric in native buffer.
3.3. Characterisation of Par-4 by size exclusion chromatography
3.3.1. Materials and Methods
 For SEC, proteins were separated by an isocratic flow of 0.4 ml/min at 4 ºC using a Superdex 
200 column connected to the BioLogic DuoFlow System. Calibration curves to convert retention 
times to MWs were established using the commercially  available Molecular Weight Marker Kit 
(12-200 kDa) from Sigma-Aldrich and results are shown in Appendix E. The SEC buffer used 
for calibration contained 50 mM NaCl, 20 mM  Na2HPO4/NaH2PO4, pH 7.5. The buffer for the ?????? ?? ???? ????
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analysis of rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC contained 20 mM NaCl, 10 mM Tris, pH 7.0. 
Buffers distinct  from this composition will be given in the Results section. All samples were 
filtered using an Ultrafree-MC Centrifugal Filter device (pore size 0.22 µm) prior to application 
to the SEC column. Collected fractions were analysed by SDS-PAGE.
3.3.2. Results and Discussion
 As mentioned above, IDPs have different hydrodynamic properties compared to globular 
proteins [155]. The calibration curves used for conversion of retention time to MW are therefore 
only strictly valid for globular proteins like the molecular weight standards. However, for 
comparative purposes the apparent MW will be used rather than the retention time. As can be 
expected for IDPs, the SEC results are suggestive of extended confirmations for the rrPar-4 
proteins. Extended structures are indicated by  higher MW values than are expected from the 
amino acid sequence [155]. The broad and non-symmetric peaks observed for the rrPar-4 
proteins relative to the peaks observed for the molecular weight standards (data not shown) 
further suggest the existence of interconverting ensembles [211,212].
 Analysis of rrPar-4FL by SEC was not possible. Upon injection of rrPar-4FL (at  
concentrations of 55 µM  and 15 µM) into the sample loop a faint precipitate was visible. The 
resulting chromatogram showed no signs of proteins indicating that all rrPar-4FL precipitated. 
Precipitation of rrPar-4FL upon dilution was observed various times, but the reason for 
precipitation is unknown. Concentrated rrPar-4FL solutions are stable, but  below concentrations 
of ~10 µM  precipitation occurs. Unlike DLS, an accurate control of the concentration was not 
possible as the protein solution was diluted upon injection. Collection of useful SEC data for 
rrPar-4FL was therefore not possible. Recently, the SEC analysis of a full-length Par-4 construct 
has been published by Gao et. al. [54]. In this study full-length Par-4 displayed a broad peak. 
Elution of Par-4 started at retention times corresponding to MWs of approximately  500-600 kDa 
and ended at retention times corresponding to 43 kDa with a maximum around 360 kDa. Using 
the maximum value of 360 kDa, an RS value of ~60.2 Å can be approximated [181]. This value is 
not as large as the value obtained by DLS in the previous chapter (Table 3.1), but still larger than 
what can be expected for a coil-like conformation of rrPar-4FL (Table 3.2). The size difference 
between these two data sets may be attributed to the fact that Gao et. al. used full-length Par-4 
isolated from LNCaP prostate cancer cells. Possible post-translational modifications in 
mammalian cell may affect the self-association of Par-4. Consistent with the analysis of the DLS 
data of rrPar-4FL (Chapter 3.2.2.), Gao et. al. concluded that full-length Par-4 is polymerising 
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[54]. Considering the extent of ID in Par-4, an octameric state as proposed by the authors is 
unlikely. The high apparent MW is probably, to some extent, due to ID in Par-4 as shown above.
 Analysis of rrPar-4ΔLZ (31.1 kDa) at a concentration of ~0.5 mM (stock solution) was 
performed using a buffer containing 100 mM NaCl, 1 mM  DTT and 20 mM Na2HPO4/NaH2PO4, 
pH 7.0. Application of 50 µl of the stock solution to the SEC column produced a chromatogram 
displaying two peaks (Fig. 3.6A, dashed line) with retention times corresponding to MWs of 
~41 kDa and ~29 kDa. Applying seven times more sample, but otherwise identical conditions, a 
chromatogram with three peaks was obtained (Fig. 3.6A, solid line), indicating a dependence of 
the SEC results on the concentration of the Par-4 protein. The retention times correspond to MWs 
of approximately 207 kDa, 47 kDa and 30 kDa. Analysis of the collected fractions by  SDS-
PAGE showed that the peak corresponding to 207 kDa contained the majority  (70-80%) of the 
applied rrPar-4ΔLZ.
 Figure 3.6  − Size exclusion chromatography of Par-4. (A) Chromatograms of 0.5 mM rrPar-4ΔLZ 
using a Superdex 200 column at 4 ºC and 100 mM NaCl, 1 mM DTT and 20 mM Na2HPO4/NaH2PO4, 
pH 7.0 as buffer. Different results are obtained depending on the protein concentration. The 
chromatogram marked by a solid line is obtained if 350 µl of 0.5 mM rrPar-4ΔLZ are applied to the 
column; the chromatogram marked by a dashed line if 50 µl are applied. (B) Chromatogram of 0.21 mM 
rrPar-4SAC using a Superdex 200 column at 4 ºC and a low salt buffer containing 20 mM NaCl, 10 mM 
Tris, pH 7.0. Dashed vertical lines in both chromatograms indicate the expected elution times if both 
proteins were globular. Both proteins elute at earlier time points suggesting a non-globular conformation.
 An apparent MW of 207 kDa corresponds to an RS value of ~49.4 Å [181]. This value is close 
to the value that can be expected for a coil-like conformation of rrPar-4ΔLZ (Table 3.2). In 
contrast, the RS value of 29.1 Å calculated for the second peak corresponding to 47 kDa (or 
41 kDa) is close to what can be expected for a molten globule state of rrPar-4ΔLZ (Table 3.2). 
The last peak (30 and 29 kDa, respectively) would correspond well with the expected value for a 
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globular protein of 31 kDa, however, a globular conformation is not to be supported by other 
experiments (Chapter 3.4.2.). It is currently not known what causes the different peaks and the 
concentration dependent behaviour. The 207 kDa peak suggests a coil-like conformation for 
rrPar-4ΔLZ, consistent with the DLS and limited proteolysis results (Chapter 3.2.2.). Consistent 
with DLS results, the non-symmetric peak shape further suggests the existence of an ensemble of 
interconverting structures. It  is also possible that  the 207 kDa peak represents aggregated 
rrPar-4ΔLZ. Protein aggregation was not detected by  DLS experiments (Chapter 3.2.2.), 
however, for DLS the protein concentration was significantly  lower than for SEC. Applying 
seven times less protein to the SEC could have resulted in the dissolution of the rrPar-4ΔLZ 
aggregates, and therefore no high molecular weight  peak is seen in the corresponding 
chromatogram (Fig. 3.6A, dashed line). The other two peaks (47 kDa and 30 kDa) may represent 
retarded fractions that are interacting with the gel matrix thereby reducing the apparent MW. The 
reduction in the apparent MW of these two peaks is not due to protein degradation, as no 
degradation products were detected by SDS-PAGE.
 For comparison with the DLS, CD and NMR results of rrPar-4ΔLZ and rrPar-4SAC, SEC was 
repeated using 20 mM NaCl, 10 mM Tris, pH 7.0 as buffer (Fig. 3.6B, only rrPar-4SAC is 
shown). The stock solutions were at a concentration of 10 µM (rrPar-4ΔLZ) and 210 µM 
(rrPar-4SAC). For both proteins broad peaks were obtained suggesting structural interconversion 
under these conditions. Peak maxima corresponded to ~38 kDa (rrPar-4ΔLZ) and ~49 kDa 
(rrPar-4SAC). The results obtained for rrPar-4ΔLZ (data not shown) are similar to the results at 
higher salt  concentration (Fig. 3.6A). The high apparent MW (49 kDa) observed for the 7.0 kDa 
rrPar-4SAC protein (Fig. 3.6B) corresponds to an RS of ~ 29.5 Å. This is slightly  larger than the 
expected value for a coil-like conformation (Table 3.2). In contrast to the DLS results 
(Chapter 3.2.2.), this would suggest a higher oligomeric state for rrPar-4SAC or could indicate 
aggregation. DLS results show no indication for aggregation or oligomerisation, but were carried 
out at lower concentration. It should be noted that calibration of the Superdex 200 column using 
the low salt buffer was problematic and may have affected the accurate calculation of the 
apparent MW. The results for rrPar-4SAC may have therefore been skewed to higher MWs. 
According to manufacturer instructions the recommended NaCl concentration for SEC should be 
150 mM  to avoid non-specific interactions with the gel matrix. Slightly different retention times 
were observed for the molecular weight standards in buffers containing 50 mM  NaCl, 20 mM 
Na2HPO4/NaH2PO4, pH 7.5 relative to 20 mM NaCl, 10 mM Tris, pH 7.0 (data not shown). This 
suggests that non-specific interactions with the matrix occur under low salt conditions. 
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Therefore, non-specific interactions may, to some extent, affect retention time and also the peak 
width. Due to the increased surface area of Par-4 proteins, or IDPs in general [166], non-specific 
interactions with the matrix may be even more pronounced for Par-4 than for globular proteins. 
Taken together, the SEC results were consistent with proposed ID nature for the rrPar-4 proteins. 
Probably due to the incompatibility  of the SEC column matrix with the used low salt buffer 
conditions the results were inferior to DLS results. Additionally, no results could be obtained for 
rrPar-4FL.
3.4. Secondary structure assessment by CD and NMR spectroscopy
3.4.1. Materials and Methods
a) Circular Dichroism (CD)
 CD spectra were recorded on a Chirascan CD spectropolarimeter (Applied Photophysics, 
Leatherhead, United Kingdom) equipped with a recirculating water bath. CD data was obtained 
using a quartz cuvette with 1 mm pathlength. Samples were at a concentration of 0.3 mg/ml 
(8 µM  rrPar-4FL, 10 µM rrPar-4ΔLZ and 43 M  rrPar-4SAC) in native buffer (20 mM  NaCl, 
10 mM  Tris, pH 7.0). Additional samples of 8 µM  rrPar-4FL were prepared in native 
buffer + 1 M  or 6 M urea. Spectra were recorded in 0.5 nm steps from 260 to 190 nm with an 
integration time of 1 s at each wavelength. Further acquisition parameters are given in 
Appendix F. Three successive scans were recorded, the sample blank subtracted and the scans 
averaged and smoothed using a sliding window function (Chirascan Software, Applied 
Photophysics). Thermal stability was determined by  acquiring CD spectra as a function of 
temperature at 5 ºC intervals from 5 ºC to 75 ºC with 2 minutes equilibration time at each 
temperature point. Melting curves were obtained by monitoring the ellipticity at 222 nm ([θ]222) 
as a function of temperature. Melting temperatures (Tm) were estimated by evaluating the 
maximum of d[θ]222/dT. Spectral deconvolution was performed using the CONTIN-LL 
algorithm [213] through the DICHROWEB server interface [214,215].
b) NMR spectroscopy
 NMR experiments were recorded on a Bruker Avance 700 MHz spectrometer equipped with a 
cryoprobe, four rf-channels and gradient pulse capabilities. All spectra were acquired at  5 ºC on 
300 µl samples containing 5% D2O (v/v) in Shigemi NMR tubes. The rrPar-4FL sample 
concentration was 0.48 mM  in 20 mM NaCl, 10 mM Tris, pH 7.0. The rrPar-4∆LZ construct was 
uniformly 15N-labelled with a protein concentration of 0.09 mM in 100 mM NaCl, 1 mM  DTT, 
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20 mM Na2HPO4/NaH2PO4, pH 7.5. Similarly, rrPar-4SAC was uniformly 15N-labelled at a 
concentration of 0.34 mM  in 20 mM NaCl, 10 mM Tris, pH 7.0. In all cases the carrier 
frequency was set to the frequency  of the water resonance in the 1H dimension. Further 
acquisition parameters are listed in Appendix G. All data sets were linear predicted (32 
prediction coefficients), apodised using a shifted (π/6) squared sinusoidal bell function and zero-
filled once in the indirect dimension before Fourier transformation and final processing. Spectra 
were processed using TopSpin 2.1 (Bruker BioSpin GmbH, Rheinstetten, Germany). The 1H and 
15N chemical shifts were referenced to the water signal [216].
3.4.2. Results and Discussion
 The CD spectra for rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC are shown in Figure 3.7. 
Significant α-helical character is evident in the spectra of rrPar-4FL that remains stable up to 
65 ºC (Fig. 3.7A). In contrast, rrPar-4∆LZ (Fig. 3.7C) and rrPar-4SAC (Fig. 3.7E) display IDP 
characteristic CD spectra with a deep transition at  200 nm and a minor transition at 222 nm 
[155]. It was previously demonstrated that CD spectra of IDPs show minor contributions from 
secondary  structure elements such as alpha or poly-proline type II helices [217]. Spectral 
deconvolution of the 25 ºC spectra estimates an α-helical content (combined regular and 
distorted α-helix [218]) of 32%, 17% and 18% for rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC, 
respectively. The results of rrPar-4FL in 1 M  or 6 M  urea will be discussed in Chapter 3.6. The 
CD traces from 5 ºC through to 65 ºC display  similar features indicating that all three constructs 
are relatively stable throughout the heating cycle. Interestingly, an isodichroic point at 210 nm is 
observed for rrPar-4SAC (Fig. 3.7C) indicating a two-state transition [134,136]. Although the 
overall temperature-induced conformational changes are minor, this two-state transition could be 
due to secondary  and/or tertiary structure that gets thermally  disrupted. Thus in addition to the 
CC region of rrPar-4FL (Chapter 3.6.), other regions of the rrPar-4 proteins may  transiently 
populate α-helical or other secondary structures.
 As mentioned earlier, the secondary  structural content of IDPs can be assessed by NMR with 
atomic resolution [155]. However, most residues in IDPs experience a similar chemical 
environment as they are solvent exposed and inherently flexible. This results in similar NMR 
frequencies and hence significant spectral overlap  (particularly for 1H resonances) [155,219]. 
Furthermore, population-weighted average chemical shifts are observed for IDPs [220]. The 
inherent flexibility also results in sharp peaks due to increased T2 values [221].
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 Figure 3.7 − CD spectropolarimetry indicates ID in Par-4. Temperature dependence of the CD 
spectra of rrPar-4FL (A, B), rrPar-4∆LZ (C, D) and rrPar-4SAC (E, F). Data for all constructs were 
recorded in 20 mM NaCl, 10 mM Tris, pH 7.0 over a temperature range of 5-75 ºC. Panels A, C and E 
show the traces for each temperature recorded in the experiment. For clarity panels B, D and F show four 
equally spaced temperatures from the sampled range. Acquisition parameters are given in Appendix F. 
Figure and legend taken and adapted from Libich, Schwalbe et. al. [46].
 Pairwise overlays of 1H,15N-HSQC spectra for rrPar-4FL, rrPar-4∆LZ and rrPar-4SAC are 
shown in Figure 3.8. The spectra of all three proteins exhibit the aforementioned characteristic 
features of ID, such as narrow 1H chemical shift dispersion and sharp peaks. Interestingly, some 
structural similarity between rrPar-4FL and rrPar-4∆LZ is indicated by chemical shift similarities 
(Fig. 3.8A). The constructs differ by  the presence of the LZ domain (residues 292-332) in 
rrPar-4FL (Fig. 3.1A). This indicates that some residues (most likely at the N-Terminus) share a 
similar local environment and probably  a similar conformation in both constructs. Residues 
closer to the C-terminus (hence closer to the LZ domain) probably experience different  chemical 
environments due to the presence of the LZ domain resulting in chemical shift differences of the 
corresponding peaks for each construct. Fewer chemical shift similarities are observed for 
Wavelength (nm) Wavelength (nm)
rrPar-4FL rrPar-4FL
Wavelength (nm) Wavelength (nm)
rrPar-4!LZ rrPar-4!LZ
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rrPar-4FL or rrPar-4∆LZ with rrPar-4SAC (Figs. 3.8B and C). This suggests that  the majority of 
residues in rrPar-4SAC experience a different local environment and thus probably a different 
conformation than the SAC domain in the context of either rrPar-4FL or rrPar-4∆LZ.
 Figure 3.8 − NMR spectroscopy displays typical features of ID in Par-4. Pairwise overlays of 1H,15N-
HSQC spectra of (A) rrPar-4FL (black contours) and rrPar-4∆LZ (blue contours), (B) rrPar-4∆LZ (blue 
contours) and rrPar-4SAC (red contours) and (C) rrPar-4FL (black contours) and rrPar-4SAC (red 
contours). Sample conditions were: 0.34 mM rrPar-4SAC in 20 mM NaCl, 10 mM Tris, pH 7.0 and 5% 
D2O (v/v); 0.48 mM rrPar-4FL in 20 mM NaCl, 10 mM Tris, pH 7.0 and 5% D2O (v/v); and 0.09 mM 
rrPar-4∆LZ in 100 mM NaCl, 1 mM DTT, 20 mM Na2HPO4/NaH2PO4, pH 7.5 and 5% D2O (v/v). The 
rrPar-4∆LZ and rrPar-4SAC proteins were uniformly 15N-labelled. All spectra were recorded at 5 ºC. 
Acquisition parameters are given in Appendix G. Figure and legend taken and adapted from Libich, 
Schwalbe et. al. [46].
 For rrPar-4FL only approximately 160 of the 308 peaks expected (335 – N-terminal residue - 
26 prolyl residues) and for rrPar-4∆LZ only approximately  152 of the 266 expected peaks (293 – 
N-terminal residue - 26 prolyl residues) are readily identifiable in the 1H,15N-HSQC (Figs. 3.8A 
and C). Due to missing assignments it is not clear if the same residues (or residues from the same 
regions) are unobservable in both constructs. Possible explanations for the low peak count 
include significant spectral overlap  and/or intermediate exchange processes of currently 
unknown nature [183]. Further studies, including sequential assignment and 15N-relaxation 
analysis, may help to identify the unobservable peaks or regions and to elucidate the time scales 
of motion for the visible peaks of rrPar-4FL and rrPar-4∆LZ [222]. In contrast, the spectrum of 
rrPar-4SAC (Figs. 3.8B and C) is much more complete. Of the expected 60 peaks (62 – N-
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terminal residue - 1 prolyl residue) 58 peaks were readily picked and only two glycyl residues 
remained unobservable. The small size of rrPar-4SAC (7 kDa), relative to rrPar-4FL and 
rrPar-4∆LZ (> 30 kDa), is beneficial in the observance of almost all resonances as the chance of 
spectral overlap and the likelihood of slow to intermediate exchange is reduced due to fewer 
residues. Nonetheless, the sharp peak shape and poor chemical shift dispersion suggest  a similar 
degree of disorder relative to rrPar-4FL and rrPar-4∆LZ.
 In summary, both CD and NMR spectroscopy indicate that rrPar-4FL, rrPar-4∆LZ and 
rrPar-4SAC are mostly disordered. An isodichroic point in the CD data suggests the presence of 
transient secondary and/or tertiary  structure in rrPar-4SAC. CD spectropolarimetry also indicates 
residual α-helical structure in rrPar-4FL that remains stable up to 65 ºC. However, the residual α-
helical structure in rrPar-4FL is not readily identifiable in the corresponding NMR spectra. The 
NMR spectra of all three proteins display typical features of IDPs. The situation is further 
complicated as approximately 52% of the expected peaks for rrPar-4FL and rrPar-4∆LZ are not 
readily observed.
3.5. Influence of pH and TFE on the conformation of the Par-4 SAC domain
3.5.1. Materials and Methods
a) Circular Dichroism
 An aliquot containing 2 mg 15N-labelled rrPar-4SAC (Chapter 2.9.1.) was dialysed overnight 
at 4 ºC against 500 ml H2O and the protein concentration was determined. CD samples of 
rrPar-4SAC were prepared at four different pH values from 4-7 by dilution of this rrPar-4SAC 
stock solution with appropriate buffers (Table 3.3). Additionally, a CD sample containing 30% 
d3-TFE (v/v) was prepared from this stock solution (Table 3.3, sample e). In all cases, the final 
rrPar-4SAC concentration was 43 µM (0.3 mg/ml). CD spectra were recorded in 1 nm steps from 
260 to 190 nm as described in Chapter 3.4.1.a. Acquisition parameters are given in Appendix F. 
Spectral deconvolution was performed using the CONTIN-LL algorithm through the 
DICHROWEB server interface.
b) NMR spectroscopy
 An aliquot containing 4 mg 15N-labelled rrPar-4SAC (Chapter 2.9.) was dialysed overnight  at  
4 ºC against 500 ml PBS. The dialysate was concentrated to ~500 µl using a Vivaspin 20 device 
(MWCO = 3 kDa) and the concentration determined (~0.5 mM). After adding D2O to 5% (v/v), 
the sample was used for NMR. Furthermore, the 43 µM  rrPar-4SAC sample in 20 mM NaCl, 
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10 mM Tris + 30% d3-TFE (v/v), pH 5 (Table 3.3, sample e) was analysed by NMR after adding 
D2O to 5% (v/v). NMR spectra were recorded and processed as described in Chapter 3.4.1.b 
using a shifted (π/2) squared sinusoidal bell function for apodisation. Acquisition parameters are 
given in Appendix G.
rrPar-4SAC concentration Buffer composition
a) 43 µM 20 mM NaCl, 10 mM NaAc, pH 4.0
b) 43 µM 20 mM NaCl, 10 mM NaAc, pH 5.0
c) 43 µM 20 mM NaCl, 10 mM Mes, pH 6.0
d) 43 µM 20 mM NaCl, 10 mM Tris, pH 7.0
e) 43 µM 20 mM NaCl, 10 mM Tris + 30% d3-TFE (v/v), pH 5
 Table 3.3 − Sample conditions of rrPar-4SAC at various pH values.
3.5.2. Results and Discussion
 The CD series of rrPar-4SAC as a function of temperature at four different pH values are 
shown in Figure 3.9. A CD series of rrPar-4SAC at pH 7.0 under almost identical conditions is 
shown in Fig. 3.7E. It was repeated here for consistency with the CD results at pH 6.0, 5.0 and 
4.0, and to exclude the formation of artefacts during the buffer exchange to H2O. To save time, 
the thermal stability  at  pH 7.0 was assessed in 10 ºC intervals instead of 5 ºC intervals. The 
obtained CD spectrum is almost identical to the previous spectrum (Fig. 3.7E) indicating the 
reproducibility of the results. The slight difference in the [θ] values relative to the results of 
Figure 3.7E is probably due to minor uncertainties in the concentration determination by A280 
measurements and is within the error range expected. Note that rrPar-4SAC only  contains one 
tyrosine residue resulting in only minor absorption at 280 nm The spectra at pH 6.0, 5.0 and 4.0 
are virtually identical to the spectrum at pH 7.0 and indicative of ID with deep transitions at 
200 nm (Fig. 3.9). Due to buffer absorption, no reliable data was obtained below 200 nm in most 
cases. Since no greater structural changes were observed over the pH range from 4.0 to 7.0 
(Fig. 3.9), it was concluded that it is not worthwhile to acquire NMR spectra of these samples.
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 Figure 3.9 − pH and TFE dependence of the CD spectra of rrPar-4SAC. Influence of pH on the CD 
spectra of 43 µM rrPar-4SAC as a function of temperature; (A, B) at pH 7.0, (C, D) at pH 6.0, (E, F) at 
pH 5.0 and (G, H) at pH 4.0. (I, J) Temperature dependence of the CD spectra of 43 µM rrPar-4SAC in 
30% TFE (v/v). Sample conditions are given in Table 3.3. All spectra were acquired in 5 ºC intervals 
(10 ºC for panel A) over a temperature range of 5-75 ºC. Traces for each temperature are shown in panels 
A, C, E, G and I, and for clarity panels B, D, F, H and J show traces of four evenly spaced temperatures. 
The dotted line through panels A, C, E and G is used as reference to show the shift of the isodichroic point 
at 210 nm to longer wavelengths. Acquisition parameters for each spectrum are given in Appendix F.
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 A notable difference in the CD spectra at different pH values is the position of the isodichroic 
point. At pH 7.0 and 6.0 an isodichroic point at 210 nm is visible (Figs. 3.9A-D). With 
decreasing pH this isodichroic point shifts to longer wavelengths of approximately 212 nm 
(pH 5.0, Fig. 3.9E) and 214 nm (pH 4.0, Fig. 3.9G), respectively. The isodichroic point at 
210 nm has been discussed as an indication of secondary and/or tertiary  structure that gets 
disrupted upon thermal denaturation (Chapter 3.4.2.). The shift of the isodichroic point to higher 
wavelengths may indicate minor structural changes induced with decreasing pH. At pH 4.0 the 
isodichroic point is less well defined (Fig. 3.9G) and one may argue that it is lost altogether. This 
may be interpreted that less secondary and/or tertiary structure is present at pH 4.0 relative to 
pH 7.0 and hence that the transient secondary and/or tertiary structure is disrupted with 
decreasing pH.
 1H,15N-HSQC spectra of rrPar-4SAC were acquired to asses if rrPar-4SAC adopts a similar 
conformation under low salt conditions as used for CD spectropolarimetry relative to 
physiological buffer conditions. The 1H,15N-HSQC spectra of rrPar-4SAC under low salt 
conditions (20 mM NaCl, 10 mM  Tris, pH 7.0) and under physiological salt conditions (PBS, 
140 mM NaCl) are shown in Figure 3.10A. Comparison of these two spectra shows almost no 
difference, indicating that rrPar-4SAC residues are in a similar local environment and probably 
in a similar conformation under both conditions. This further suggests that no artefacts are 
introduced using a low salt buffer for CD, DLS and NMR spectroscopy. Minor differences in the 
spectra may be due to the different concentration of rrPar-4SAC in low salt buffer (0.34 mM) 
and PBS (0.5 mM).
 Secondary  structure prediction of the SAC domain shows a propensity for α-helix 
(Chapter 3.1, Fig. 3.1B). TFE is well known to stabilise α-helical conformations in proteins 
[140]. Furthermore, TFE has been used to stabilise molten globule structures to allow NMR 
spectroscopic studies [223]. The rationale was therefore to use TFE to stabilise an α-helical state 
that may be similar to the conformation of the biological active SAC domain. The TFE-induced 
helix formation levels off above concentrations of 25% TFE [224]. Therefore, a TFE 
concentration of 30% was used as the starting concentration to induce a significant 
conformational change and analyse this by CD spectropolarimetry and NMR spectroscopy. CD 
spectropolarimetry  shows significant α-helical character for rrPar-4SAC in 30% TFE, as is 
indicated by  transitions near 208 and 222 nm (Fig. 3.9I). This α-helical character is stable up to 
approximately 35 ºC and with further increasing temperature gradually converts to a spectrum 
indicative of protein disorder. Note that the addition of d3-TFE to the 20 mM  NaCl, 10 mM  Tris, 
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pH 7.0 buffer results in a pH drop to approximately  pH 5. Spectral deconvolution estimates 39% 
α-helicity for rrPar-4SAC in 30% TFE at 5 ºC and pH 5 relative to 8% for rrPar-4SAC without 
TFE at 5 ºC and pH 5.0. This indicates that 30% TFE does not  induce a complete conversion of 
rrPar-4SAC to an α-helix, and that rrPar-4SAC remains to a certain degree disordered.
 Figure 3.10 − Influence of ionic strength and TFE on the NMR spectra of rrPar-4SAC. (A) Pairwise 
comparison of the 1H,15N-HSQC spectra of rrPar-4SAC under low salt (black contours) and 
physiological salt conditions (red contours). Sample concentrations were 0.34 mM rrPar-4SAC in 20 mM 
NaCl, 10 mM Tris, pH 7.0 and 5% D2O (v/v) (black contours) and 0.5 mM rrPar-4SAC in PBS, pH 7.4 
and 5% D2O (v/v) (red contours). (B) Overlay of the 1H,15N-HSQC spectrum of 0.34 mM rrPar-4SAC in 
20 mM NaCl, 10 mM Tris, pH 7.0 and 5% D2O (v/v) (black contours) with the 1H,15N-SOFAST-HMQC 
[225] spectrum of 43 µM rrPar-4SAC in 20 mM NaCl, 10 mM Tris + 30% d3-TFE (v/v), pH 5 and 5% 
D2O (v/v) (red contours). For preparation of the 0.34 mM rrPar-4SAC sample in 20 mM NaCl, 10 mM 
Tris, pH 7.0 and 5% D2O (v/v), see Chapter 3.4.1.b. All spectra were acquired at 5 ºC. All samples were 
uniformly 15N-labelled. Acquisition parameters for each spectrum are given in Appendix G.
 The TFE-induced increase in α-helicity observed by CD spectropolarimetry is also reflected 
in the corresponding NMR spectrum (Fig. 3.10B). Compared to the spectrum acquired without 
TFE an increased 1H chemical shift  dispersion is observed for the spectrum with 30% TFE 
(Fig. 3.10B). Notably is further the decreased intensity of the peaks in the centre of the spectrum 
compared to the peaks with lower 1H ppm values. Furthermore, only 50 of the expected 60 peaks 
(62 − N-terminal residue − one prolyl residue) are visible in the presence of TFE. This may be 
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partly due to spectral overlap, but together with the decreased intensity of some of the peaks this 
is suggestive of intermediate exchange. Intermediate exchange resulting in peak broadening in 
the presence of TFE is not uncommon [140]. However, without residue specific assignments and 
assessment of the dynamics of rrPar-4SAC no more definitive statements can be made. Future 
experiments should be performed at higher concentration to reduce limitations arising from low 
signal intensity.
 Taken together, no greater conformational changes in rrPar-4SAC are induced with decreasing 
pH. A significant increase in α-helicity is induced by TFE, which is observed by CD 
spectropolarimetry  and NMR spectroscopy. However, due to the poor NMR spectroscopic 
properties of rrPar-4SAC, even in the presence of TFE, structural characterisation was suspended 
in favour of more promising experiments with other Par-4 constructs. However, rrPar-4SAC may 
adopt a stable secondary  and/or tertiary  structure upon binding to a target protein [152]. Once 
such a binding partner has been identified and expressed, structural characterisation of 
rrPar-4SAC may be resumed. It may then be worth testing other TFE concentrations for 
comparative purposes.
3.6. Evidence for self-association through coiled coil formation
 The putative CC domain (residues 254-332, Fig. 1.1) is the main interaction domain for the 
majority  of the known Par-4 binding partners (Chapter 1.3.4.). C-terminal deletion mutants 
(comprising the whole CC domain or only  the LZ domain) of Par-4 were shown to be sufficient 
to prevent binding of Par-4 to proteins such as WT1, aPCKζ, Dlk, or PKB (for more examples 
see Table 1.1). As described in Chapter 1.4, coiled coils are characterised by the heptad repeat 
(abcdefg)n with hydrophobic residues at the a and d positions [109].
 To assess the degree of α-helicity at 25 ºC in the Par-4 C-terminus, especially the LZ domain, 
a CD difference spectrum between rrPar-4FL and rrPar-4∆LZ was created and is shown in 
Figure 3.11A. Both constructs differ in the presence of the LZ domain that is deleted in 
rrPar-4∆LZ (Fig. 3.1A). The difference spectrum is characteristic of a coiled coil with a ratio of 
[θ]222/[θ]208 > 1 [141], suggesting that at least  two rrPar-4FL monomers are involved in self-
association. As was shown in Chapter 3.2.2, a large RS value of 189 Å is measured for rrPar-4FL 
in native buffer (Table 3.1 and Fig. 3.11C). Coiled coils are rod-like structures that are known to 
produce larger RS values than globular proteins of the same MW [226]. Examples of various 
coiled coils (e.g. chromogranin A [227] or SAP1 [226]) and rod-shaped proteins (e.g. winter 
flounder anti-freeze protein [228], hydrophobin SC3 [229]) with larger RS values have been 
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described in the literature. However, the apparent RS value of rrPar-4FL is much larger than the 
calculated RS value for a random coil monomer (Table 3.2) suggesting self-association of at  least 
two monomers. In contrast, the rrPar-4 proteins lacking the LZ domain (rrPar-4∆LZ and 
rrPar-4SAC) did not have appreciably large RS values relative to the estimated random coil 
values (Table 3.2). It was also shown above that addition of 1 M urea resulted in a reduction of 
the RS from 189 to 78 Å suggesting the disruption of a non-covalent interaction. However, this RS 
value is still larger than the expected value for a random coil monomer (Table 3.2). A further 
increase in the urea concentration to 6 M  urea produces an RS value (58 Å) that is close to the 
calculated value for a urea denatured protein of the same MW (Table 3.2 and Fig. 3.11C). Melt 
curves obtained by CD spectropolarimetry under similar conditions show an increase in Tm from 
25 ºC (6 M urea), 55 ºC (1 M urea) to 75 ºC (0 M  urea) with decreasing urea concentrations 
(Fig. 3.11B). Thus as the concentration of urea is increased, a polymeric state of rrPar-4FL is 
disrupted resulting in decreased thermal stability  of the complex. The stability of the coiled coil 
in rrPar-4FL in relation to other rrPar-4 constructs will be discussed in more detail in 
Chapter 4.6.
 As mentioned before, the α-helical character detected by CD spectropolarimetry for rrPar-4FL 
(Fig. 3.7A) is not readily identifiable in the corresponding 1H,15N-HSQC spectrum (Fig. 3.8A). It 
was further noticed that only  52% of the expected peaks are observed. Recently, it was 
demonstrated that the observable signals in a 1H,15N-HSQC of a GST-fusion peptide arose 
almost exclusively from the target protein and the linker region but not from the GST-tag [230]. 
As GST forms a 52 kDa dimer, Liew et. al. proposed that the signals arising from GST are 
broadened beyond observable limits and thus the observable peaks are from the flexible linker 
and target protein [230]. In an analogous way the elongated and highly self-associated CC 
domain of rrPar-4FL may form a large core that behaves as a much larger protein and thus 
resonances arising from the CC domain may  be unobservable due to line broadening. In contrast, 
signals of attached ID regions of rrPar-4FL are observable due to their inherent flexibility. 
Consistent with this proposal, comparison of the 1H,15N-HSQC spectra of rrPar-4FL and 
rrPar-4∆LZ show approximately  50 resonances that have identical or reasonably close chemical 
shifts suggesting similar local environments in both proteins (Fig. 3.8A). Non-overlap of the 
remaining peaks suggests that a significant portion of rrPar-4FL may be affected by coiled coil 
formation, through direct or relayed interactions. However, due to missing assignments it is not 
clear if the missing peaks correspond to the CC domain. Other contributions to line broadening 
may come from intermediate conformational exchange processes such as interconversion 
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between monomeric and oligomeric states. All data presented in this study are consistent with 
this hypothesis.
Figure 3.11 – Influence of increasing concentrations of urea 
on rrPar-4FL. (A) Difference between the 25 ºC traces of 
rrPar-4FL and rrPar-4∆LZ (Fig. 3.7). The difference 
spectrum is characteristic of a well defined coiled-coil 
displaying a [θ]222/[θ]208 ratio greater than one. (B) 
Temperature dependence of the molar ellipticity measured at 
222 nm for rrPar-4FL in native buffer (20 mM NaCl, 10 mM 
Tris, pH 7.0) only (filled circles), native buffer + 1 M urea 
(open diamonds) and native buffer + 6 M urea (open 
triangles). (C) Volume distribution of DLS measurements of 
rrPar-4FL showing the apparent hydrodynamic radius of the 
particles in native buffer (white bars), native buffer + 1 M 
urea (grey bars) and native buffer + 6 M urea (hatched bars). 
The reduction of the apparent RS upon increasing urea 
concentration suggests the disruption of a polymeric 
complex. Sample preparation and data acquisition are 
described in Chapters 3.2.1.a and 3.4.1.a Figure and legend 
taken and adapted from Libich, Schwalbe et. al. [46].
 The functional importance of homo-oligomeric 
coiled coil formation in Par-4 is currently unknown. 
Recently  a 33 kDa splice variant of Par-4 was described 
by Wang et. al. This variant lacks exon 3 that comprises 
C-terminal residues of the SAC domain (residues 166-209), but retains the coiled coil region 
[47]. Residues 191-195 are necessary for the nuclear translocation of Par-4 [50] and hence this 
variant is retained in the cytoplasm. It was proposed that this variant has a dominant negative 
function and inhibits the pro-apoptotic activity of Par-4 by binding to and sequestering Par-4 in 
the cytoplasm [47]. Due to the presence of the CC domain in the 33 kDa splice variant, self-
association of Par-4 may be physiologically relevant as an additional layer of regulation for its 
pro-apoptotic activity.
 A further physiological implication of the presented data is that Par-4 may be an efficient 
linker protein binding one interaction partner through the coiled coil, while the ID regions 
comprising the majority of Par-4 are available for simultaneous interactions with another partner 
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or partners. Most  interacting partners of Par-4 were shown to bind to the C-terminus, but a few 
were shown to bind N-terminally of the CC domain (e.g. F-actin [91], the androgen receptor 
[54], or GRP78 [75]). Ternary complexes of this kind have been described for Par-4 in Chapter 
1.3.4. Par-4 binds to Dlk or Amida through the LZ domain and then translocates to actin 
filaments, which are bound by the Par-4 N-terminus. This translocation of Dlk and Amida to 
actin filaments was shown to be essential for their pro-apoptotic function [53,91]. Furthermore, 
ternary complexes have been demonstrated between Par-4, aPKCζ and p62 [88], and between 
Par-4, Dlk and Daxx[89].
 Taken together, CD (Fig. 3.11A) and DLS results (Fig. 3.11C) suggest that rrPar-4FL self-
associates through the CC domain. The LZ domain is of critical importance for self-association 
as no self-association (Fig. 3.4) or strong α-helical character (Fig. 3.7C) are observed for 
rrPar-4∆LZ. This indicates that the LZ domain is necessary  for self-association and that the 
majority  of the α-helical character observed in rrPar-4FL (Fig. 3.7A) may be attributed to this 
domain. It is further proposed here that  self-association occurs through coiled coil formation, and 
that self-association may be of physiological importance for the pro-apoptotic function of Par-4 
[173].
3.7. The advantage of disorder in regulatory processes
 Apoptosis is a highly  dynamic cellular process that is dependent on the localisation, functional 
activity and stability of pro- and anti-apoptotic proteins [2,70,71]. ID may therefore impart 
several advantages for the pro-apoptotic role of Par-4. The solvent exposed disordered regions 
are easily accessible for post-translational modifications (e.g. phosphorylation, ubiquitination or 
Ubl-conjugation), which enable the precise control of localisation, function and turnover rate 
[143,231]. Notably, two phosphorylations were shown to be important for the function and 
localisation of Par-4. Phosphorylation of Thr 155 (Fig. 1.1) is required for the initiation of 
apoptosis [26], while phosphorylation of Ser 249 results in sequestration of Par-4 in the 
cytoplasm [56]. It was further proposed that ID is essential for the recognition of NLS by  their 
respective receptors. NLS comprise a basic stretch of lysines or arginines that is flanked by 
acidic residues and helix breakers such as proline or glycine. Otherwise NLS are poorly 
conserved yet bind the same receptor. ID is proposed to facilitate the exposure of the signal 
stretch and the adaptation to the receptor [144]. An additional layer of cellular control is offered 
by the extreme proteolytic sensitivity of IDPs enabling rapid and controlled turnover [232].
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 Three human and two mouse Par-4 splice variants have been described in Chapter 1.2.1. 
Alternate splicing is a regulatory process that increases the complexity  of the signalling network 
by producing different  proteins with distinct  functions from the same gene. Splicing within 
ordered domains of a protein could potentially  disrupt the tertiary structure of a protein. It was 
therefore proposed that alternate splicing occurs in intrinsically disordered regions of a protein 
thereby reducing the risk of disrupting existing structure in a protein [233]. Consistently, for the 
33 kDa splice variant of mouse Par-4, which lacks exon 3 (residues 166-209) [47], the spliced 
region localises to a sequence that was shown to be disordered in Chapter 3.4.2.
 ID in proteins also confers an increased structural plasticity  that allows IDPs to bind multiple 
targets with high specificity yet in a readily reversible manner. Promiscuous binding through 
primarily  disorder containing regions has been shown for several proteins (e.g. p53 or high 
mobility  group protein A (HMGA)) [147]. Similarly, Par-4 could contain multiple specific 
binding sites enabling the simultaneous interaction with different  binding partners as 
demonstrated for the several ternary complexes of Par-4 (see above). Beneficial for the 
promiscuous binding ability of IDPs might be their increased amount of accessible surface area 
per residue that  is available for intermolecular interactions [166]. It is interesting to note here 
that all 26 prolines present in Par-4 occur in the first 255 residues (Fig. 1.1). Proline has been 
discussed to favour open conformations and extended structures such as polyproline-type II 
helices. Polyproline-type II helices are an interesting type of secondary structure as they were 
shown to convert to other conformational states [234]. Additionally, prolyl residues are thought 
to promote inter-molecular recognition due to the absence of intra-residue hydrogen bonds [235].
 As mentioned in the Introduction (Chapter 1.5.), IDPs are often found to form hubs or nodes 
in cellular pathways as they are tightly regulated through post-translational modifications and 
due to their promiscuous binding, that serves to link the functions of several proteins and/or 
cofactors together [173]. The extensively  studied IDP HMGA, a chromosome and chromatin 
modulator, functions as a hub in cancer and other related pathological processes [236,237]. 
Considering the ubiquitous expression, tight temporal and spatial regulation, rapid turnover, the 
multitude of interaction partners and the inherent flexibility of Par-4, a similar role is likely  for 
Par-4. Therefore, it is proposed here that due to the above mentioned properties, Par-4 is 
uniquely situated as a control factor hub for apoptosis integrating the signals of various pro- and 
anti-apoptotic pathways.
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 It has been suggested in Chapter 3.6. that the full-length Par-4 protein self-associates through 
coiled coil formation. The Par-4 LZ domain was shown to be essential for this self-association. 
As was discussed in Chapter 1.3.4, the LZ domain is also important for binding to Par-4 
interaction partners. It was previously shown by CD spectropolarimetry  that a peptide 
comprising the Par-4 LZ domain displays a pH and temperature dependent coiled coil formation 
[184]. Mutation of key acidic residues abolished the pH dependency and resulted in an increased 
thermal stability  of the coiled coil [185]. In this chapter the NMR spectroscopic characterisation 
of various Par-4 LZ peptides is shown, and together with other biophysical methods an 
environment-dependent folding behaviour for these peptides is described. Furthermore, the 
contributions of internal asparagine residues to coiled coil stability will be shown. A comparison 
of the thermal stabilities of various coiled coil forming Par-4 constructs and their possible 
implications for the physiological function of Par-4 will be given at the end of this chapter.
4.1. Sequence analysis of the Par-4 C-terminus
 As mentioned in Chapter 1.4, coiled coils are amphipathic α-helical structures that are able to 
form left-handed supercoils by  winding two or more helices around each other [105]. To 
summarise the most important characteristics, the amino acid sequence of coiled coils is 
characterised by a seven residue repeat designated (abcdefg)n [106]. The a and d positions of 
each heptad are generally hydrophobic and form the centre of the oligomeric interface. Leucine 
zippers as a coiled coil subset are typified by a predominance of leucine residues at position d of 
the heptad repeat [125,126]. Leucine residues at this position contribute mainly  to leucine zipper 
stability, whereas residues at position a are more variable and define the oligomeric state of 
leucine zippers [127]. The occurrence of β-branched hydrophobic residues such as isoleucine or 
valine, and of polar asparagine residues at position a has been correlated with a dimeric state 
[109,117]. Asparagine residues further help  to define a parallel unstaggered conformation of the 
dimer by forming an interhelical hydrogen bond between opposing asparagines in position a 
[107]. The specificity in interhelical orientation and register conferred by asparagine comes, 
however, at the expense of leucine zipper stability [109,130]. Amino acids at all other positions 
are generally polar or charged. Especially  residues in the e and g positions contribute further to 
leucine zipper dimerisation specificity and stability. In particular, avoidance of repulsive e-g 
electrostatic interactions is an important factor in leucine zipper stability  [117,136]. Based on 
these criteria a detailed discussion of the Par-4 CC and LZ domains will be given below.
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4.1.1. Materials and Methods
 Potential coiled coil regions in Par-4 were predicted using the program COILS [238]. A 
homology  model of the C-terminal 41 residues of Par-4 (Met 291-Arg 332) was created with 
Swiss Model [239], using the GCN4 leucine zipper (PDB-code: 2zta) [107] as the template. 
Pymol (DeLano Scientific LLC) was used for visualisation and generation of the electrostatic 
surface.
4.1.2. Results and Discussion
 It was shown earlier (Chapter 1.2.1.) that the C-terminal residues 254-332 of Par-4 are highly 
conserved within mammals (Fig. 1.1) suggesting functional significance for these amino acids. 
The program COILS predicts a high probability of coiled coil formation for this domain 
(Fig. 4.1A) and hence this domain has been termed the coiled coil domain (CC) of Par-4. The C-
terminal 79 residues of Par-4 are shown in a helical wheel representation in Figure 4.1B. 
Residues 292-330 fulfil the criteria for a leucine zipper with 5 out of 6 d positions occupied by 
leucine residues (Fig. 4.1B). For clarity the 6 heptad repeats of the Par-4 leucine zipper (LZ) 
domain (residues Ile 292-Arg 332) are displayed in bold, whereas all other residues of the CC 
domain are shown in grey. From a didactic point of view the isolated LZ domain will be 
discussed first and the discussion will then be extended to the full CC domain. As can be seen 
from Figure 4.1B, three out of six a positions of the LZ domain are occupied by  β-branched 
hydrophobic residues (two isoleucines and one valine) and two positions are occupied by 
asparagine residues, Asn 313 and Asn 320. Each of these characteristics is consistent with the 
formation of a parallel dimer, hence the representation of the helical wheel in a parallel dimeric 
conformation (Fig.4.1B). The e and g positions of the LZ domain further show the possibility for 
a salt bridge between Glu 312 and Lys 317, and more importantly a repulsive electrostatic 
interaction between Asp 305 and Glu 310. This repulsive interaction has been proposed to 
prevent coiled coil formation of a 51-residue peptide comprising the C-terminal 47 residues of 
rat Par-4 under physiological conditions [184].
 A homology model of the C-terminal 41 residues (Met 291-Arg 332) in a parallel dimeric 
conformation is shown in Figure 4.1C. As can be seen from this model, the repulsive 
electrostatic interaction between Asp 305 and Glu 310 is located near the centre of the dimer. It is 
therefore not surprising that coiled coil formation of the isolated Par-4 LZ is prevented under 
physiological conditions [184]. This repulsive interaction appears to be further enhanced by  a 
patch of acidic residues surrounding Glu 310 (Figs. 4.1D and E). In addition to this destabilising 
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interhelical interaction, this LZ segment (Asp 308-Glu 314) exhibits only a low abundance of 
potential intrahelical salt  bridges (Fig. 4.1E). Intrahelical salt bridges have been proposed to 
stabilise the helical conformation and thereby contribute, to some extent, to leucine zipper 
stability  [240]. Figure 4.1E also shows the presence of four aspartate residues in this segment. 
Statistical analysis showed that due to its low helix-forming propensity  [241], aspartate is less 
frequently found in salt bridges than glutamate [240]. The high local concentration of aspartate 
may therefore be another factor detrimental to Par-4 LZ stability.
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 As mentioned above, asparagine residues at position a define the dimerisation specificity  of a 
coiled coil at  the expense of coiled coil stability. It could be shown that  asparagine residues 
increase the dissociation rate of the coiled coil resulting in enhanced strand exchange [138,242]. 
Interestingly, unlike most other LZ-families (except for the Oasis family), the Par-4 LZ contains 
two asparagine residues at position a within its heptad repeats [117] (Figs. 4.1B and C). The 
influence of asparagine residues on coiled coil stability was shown to be position-dependent and 
coiled coils were found to be more stable with asparagine residues at the C-terminus relative to 
more N-terminally located asparagines [243]. Both Asn 313 and Asn 320 are located in the 
centre of the dimer (Fig. 4.1C) indicating that both residues may be critical for Par-4 LZ stability.
 Figure 4.1 − Coiled coil formation and stability - sequence analysis of Par-4. (A) Full-length Par-4 
(residues 1-332) was analysed using the program  COILS [238]. The probability for coiled coil formation 
for three window sizes is displayed on the y-axis, with increasing values indicating an increased 
likelihood for coiled coil formation. (B) Helical wheel representation of the Par-4 CC domain (residues 
Phe 254-Arg 332). Positions in the heptad repeat are denoted by abcdefg. Residues that are part of the LZ 
domain are shown in black bold letters. All other letters of the CC domain are shown in grey. Polar 
residues at position a of the heptad repeats are shown in purple (Ser 257, Asn 278, Asn 313 and Asn 320), 
charged residues at position d of the heptad are shown in green (Glu 274 and Lys 288). The acidic 
residues Asp 305 and Glu 310 at position e and g are shown in bold red, with the potential repulsive 
electrostatic interactions between these two residues indicated by a red double arrow. For clarity only 
one of the two possible interactions within the dimer is shown in the lower half of the model. Possible salt 
bridges between residues in e and g position are indicated by blue double arrows (upper half). Primes (‘) 
are used to distinguish between the two molecules of the dimer. (C) Homology model of the Par-4 LZ 
domain (residues Met 291-Arg 332) as a parallel dimer based on the GCN4 structure [107]. Proposed 
residues that may affect coiled coil stability are coloured and labelled as in part (B). (D) Electrostatic 
surface of the Par-4 LZ domain homology model showing negatively and positively charged surfaces in 
red and blue, respectively. The orientation is as in (C). The potential repulsive interaction between 
Asp 305 and Glu 310’ is indicated by a black double arrow. (E) Helical net analysis of the Par-4 CC 
domain. The predicted coiled coil segment (residues Phe 254-Arg 332) was flattened into two dimensions 
by splitting the helix lengthwise. The display starts in the lower left corner with Phe 254. The first full 
helical turn is initiated by Ser 256 and completed with Thr 259. Thus the second full turn is initiated by 
Lys 260 and so on till Arg 322. The split bisects four residues (Glu 270, Lys 283, Leu 306 and Leu 324) 
such that each of these residues is displayed in duplicate. Potential complementary and repulsive 
electrostatic interactions (i to i + 3 or i to i + 4) within the helix are indicated by blue and red double 
arrows. Positively charged residues (Arg, Lys) are shown as blue circles, whereas negatively charged 
glutamate and aspartate residues are shown as red circles or squares, respectively. The dashed line 
indicates the start of the LZ domain. Figure D is adapted from Landschulz et. al. [125].
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 Expanding the sequence analysis to the full Par-4 CC domain reveals further interesting 
features. In addition to the 6 heptad repeats predicted for the LZ domain 5 more repeats are 
likely to form (Fig. 4.1B). Increasing the chain length was demonstrated to increase coiled coil 
stability  [224], and it appears that this is sufficient to overcome some of the destabilising factors 
noted in the Par-4 LZ domain (Chapter 3.6.). However, a closer analysis of residues in position d 
of the additional heptads shows the presence of three leucine residues and more importantly two 
charged residues (Glu 274 and Lys 288). As residues in d position are part of the oligomeric 
interface and determine coiled coil stability, these residues have generally  long hydrophobic 
sidechains such as leucine[127]. Charged residues in this position are rare [240] and detrimental 
for coiled coil stability [117]. However, both Glu 274 and Lys 288 are flanked N-terminally 
(Arg 273, Asp 287) and C-terminally (Arg 275, Glu 289) by oppositely  charged residues 
(Figs. 4.1B and E). It is possible that these residues mitigate some of charge introduced by 
Glu 274 and Lys 288. In position a of the heptad repeats of the CC domain three additional 
hydrophobic residues are observed. Especially the β-branched residues Ile 264 and Val 271 are a 
further indication for a parallel dimeric conformation of the Par-4 CC domain. This is further 
strengthened by another asparagine (Asn 278) residue in position a (Fig. 4.1B). The involvement 
of the a position polar residue Ser 257 in CC formation is questionable as this residue and all 
other residues N-terminal to Ser 257 are predicted with a low coiled coil forming probability 
(Fig. 4.1A). Occurrence of polar residues, such as serine or threonine, at a position has been 
proposed as a characteristic feature for heterodimerisation. Hence Ser 257 may be necessary for 
hetero-oligomerisation of Par-4 with effector proteins, which however remains to be determined.
 Analysis of potential interhelical electrostatic interactions in the Par-4 CC domain between 
residues in e and g positions exhibits two additional complementary interactions but no further 
repulsive interactions (Fig. 4.1B). The salt bridges between Arg 263 and Glu 268’ (the prime 
indicating the second molecule of the proposed dimer) and between Glu 270 and Arg 275’ may 
have a stabilising effect on the CC domain. A recent study  showed that parallel coiled coils rely 
more on intrahelical salt  bridges than interhelical for stability  [240]. The potential 
complementary  and repulsive electrostatic interactions within the Par-4 CC domain are listed in 
Table 4.1 and are displayed in Figure 4.1E. Statistical analysis showed that not all potential salt 
bridges between residues in i to i + 3 or i to i + 4 position occur (e.g. 3RD, 3RE or 4DK). Such 
interactions are therefore omitted in this analysis. 3RD for example denotes a potential 
interaction between arginine at position i and aspartate at position i + 3. In contrast, other 
interactions are found more frequently  (e.g. 3ER, 4ER or 4RE) and were thus proposed to be 
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important for coiled coil stability  [240]. Salt  bridges between neighbouring residues (i to i + 1) 
probably  do not increase coiled coil stability  [240] (and are therefore not listed in Table 4.1). As i 
to i + 1 interactions of unlike charge are more common than of like charge [240], this may 
indicate that prevention of repulsive interactions may  be critical for coiled coil stability. The 
same study proposed that formation of a salt bridge network is more stabilising than isolated 
interactions [240]. An almost uninterrupted network is evident for the N-terminus of the CC 
domain (Fig. 4.1E), which may stabilise this region. Conversely, this network is interrupted in 
the LZ domain between residues Asp 308-Glu 314 suggesting destabilisation of the coiled coil in 
this segment (see above). It is further evident from Figure 4.1E that some of the repulsive 
intrahelical electrostatic interactions may be mitigated by neighbouring residues of unlike 
charge.
Attractive i to i + 3 
interaction
Attractive i to i + 4 
interaction
Repulsive i to i + 1 
interaction
Repulsive i to i + 3 
interaction
Repulsive i to i + 4 
interaction
Lys 262 − Glu 265 Lys 262 − Glu 266 Glu 261 − Glu 265
Glu 265 − Lys 269 Glu 265 − Asp 266 Glu 265 − Glu 268 Asp 266 − Glu 270
Lys 269 − Arg 273
Glu 270 − Arg 273 Glu 270 − Glu 274
Arg 273 − Glu 277 Glu 274 − Glu 277
Glu 277 − Arg 280 Arg 280 − Arg 283
Arg 283 − Asp 287 Asp 287 − Glu 290
Glu 290 − Lys 294 Glu 289 − Glu 290
Lys 294 − Glu 297 Lys 294 − Glu 298 Glu 297 − Glu 298 Glu 297 − Asp 300
Lys 296 − Asp 300
Arg 304 − Asp 308 Asp 307 − Asp 308 Asp 305 − Asp 308
Asp 307 − Glu 310 Asp 307 − Asp 311
Glu 310 − Asp 311 Asp 308 − Asp 311 Asp 308 − Glu 312
Asp 311 − Glu 312 Asp 311 − Glu 314 Glu 310 − Glu 314
Glu 314 − Lys 317 Lys 318 − Lys 321
Lys 321 − Lys 325
 Table 4.1 − Potential electrostatic interactions within the Par-4 CC domain. Only those possible salt 
bridges (i to i + 3 and i to i + 4) are listed that were shown to occur with statistical significant frequency 
[240]. Additionally, repulsive electrostatic interactions (i to i + 1, i to i + 3 and i to i + 4) are shown. A 
graphical display of these interactions is given in Figure 4.1E. The dashed line indicates the start of the 
LZ domain.
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 Taken together, sequence analysis strongly  suggests the presence of a coiled coil at the Par-4 
C-terminus. Furthermore, a parallel dimeric conformation is suggested. In addition to various 
potentially stabilising factors, the Par-4 CC domain contains residues that may be detrimental for 
coiled coil stability. Consistent with these findings, the isolated LZ domain was shown to be 
unfolded under physiological conditions [184]. Interestingly, data suggest  that full-length Par-4 
forms a coiled coil under physiological conditions (Chapter 3.6. and Ref. [46]). Possible reasons 
for the different coiled coil-forming properties of Par-4 constructs will be discussed in the 
following chapters.
4.2. Coiled coil formation of the Par-4 LZ domain - Assessing the oligomeric 
state
 The coiled coil-forming potential of the Par-4 LZ domain (residues 292-330) is analysed 
using the Par-4(286-332) constructs. As was discussed above, this Par-4 domain contains a 
potential repulsive interhelical electrostatic interaction between residues Asp 305 and Glu 310’. 
This interaction was proposed to prevent coiled coil formation of the Par-4(286-332)WT 
construct under physiological conditions. Decreasing the pH allowed coiled coil formation at 
low temperature presumably  due to partial protonation of Asp 305 and/or Glu 310 sidechains 
[184]. Based on an isodichroic point near 203 nm [134,136] a two-sate transition between a 
largely disordered and an α-helical state was proposed [184]. Concentration dependence studies 
and [θ]222/[θ]208 ratios near 1.1 indicated the formation of an intermolecular coiled coil. 
Mutation of either Asp 305 or Glu 310 to lysine (constructs called in this document Par-4
(286-332)D305K or Par-4(286-332)E310K) abolished the pH-dependence of the constructs and 
increased the thermal stability  of the coiled coil [185]. The D305K mutant was found to be 
somewhat more thermally stable than the E310K mutant, possibly due to the introduction of an 
additional methylene group that becomes involved in van der Waals interactions with the 
hydrophobic core [185].
4.2.1. Materials and Methods
a) Combined sample preparation for CD and DLS
 rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K were expressed and purified as described 
in Chapters 2.11.3, 2.11.6. and 2.11.7. Samples of rrPar-4LZ were prepared at four different pH 
values by  diluting the H2O-dissolved rrPar-4LZ with the appropriate sample buffer (Table 4.2). 
For samples with pH values below or equal to pH 6.0 the solubility of rrPar-4LZ is reduced and 
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precipitation occurred. The precipitate was removed by centrifugation in a tabletop centrifuge 
and the protein concentration was remeasured. In contrast, the H2O-dissolved rrPar-4LZ stock 
solution was acidic but stable. No precipitation occurred when it is further diluted with H2O. The 
pH of this sample was assessed with pH paper to avoid contamination and found to be 
approximately 4. The point mutants rrPar-4LZD305K and rrPar-4LZE310K were prepared at 
pH 7.0 in the same way as rrPar-4LZ. Four additional samples of both mutants were prepared in 
the presence of increasing concentrations of urea (Table 4.2). The same samples were used for 
CD spectropolarimetry and DLS.
Par-4 LZ peptide concentration Buffer composition
a) 75 µM rrPar-4LZ 20 mM NaCl, 10 mM Tris, pH 7.0
b) 75 µM rrPar-4LZ 20 mM NaCl, 10 mM Mes, pH 6.5
c) 40 µM rrPar-4LZ 20 mM NaCl, 10 mM Mes, pH 6.0
d) 50 µM rrPar-4LZ H2O, pH 4
e) 75 µM rrPar-4LZD305K 20 mM NaCl, 10 mM Tris, pH 7.0
f) 75 µM rrPar-4LZE310K 20 mM NaCl, 10 mM Tris, pH 7.0
g) 75 µM rrPar-4LZD305K 20 mM NaCl, 10 mM Tris, pH 7.0 + 1M urea
h) 75 µM rrPar-4LZE310K 20 mM NaCl, 10 mM Tris, pH 7.0 + 1M urea
i) 75 µM rrPar-4LZD305K 20 mM NaCl, 10 mM Tris, pH 7.0 + 6M urea
j) 75 µM rrPar-4LZE310K 20 mM NaCl, 10 mM Tris, pH 7.0 + 6M urea
 Table 4.2 − Sample conditions of Par-4 LZ peptide used for CD spectropolarimetry and DLS
b) Circular Dichroism
 CD spectropolarimetry was used to assess the proportion of stable secondary structure and the 
thermal stability  of rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K. Spectra were recorded as 
described in (Chapter 3.4.1.a) in 1 nm steps from 260 to 190 nm. Acquisition parameters are 
given in Appendix F. Spectral deconvolution was performed using the Selcon3 [218] algorithm 
through the DICHROWEB server interface
c) Dynamic Light Scattering
 The apparent Stokes radii (RS) of rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K were 
measured as described in Chapter 3.2.1.a. RS values obtained from measurements in urea were 
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corrected using the Dispersion Technology  Software 5.1 (Malvern Instruments, Malvern, United 
Kingdom) to account for the increased solvent viscosity and the increased refractive index.
d) Size Exclusion Chromatography
 SEC was performed at 4 ºC using a Superdex 75 SEC column connected to the BioLogic 
DuoFlow System with a flow rate of 0.4 ml/min. Calibration curves to convert retention times to 
MWs were established using the commercially available Gel Filtration Calibration Kit 
(6.5-75 kDa) from GE-Healthcare and results are shown in Appendix E. The running buffer 
contained 50 mM NaCl, 20 mM  Na2HPO4/NaH2PO4, at pH 7.0 or pH 6.0. Sample concentrations 
were (i) 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0; (ii) 40 µM rrPar-4LZ in 20 mM 
NaCl, 10 mM Mes, pH 6.0; and (iii) 75 µM  rrPar-4LZD305K in 20 mM NaCl, 10 mM Tris, 
pH 7.0. All samples were filtered using an Ultrafree-MC Centrifugal Filter device (pore size 
0.22 µm) prior to application to the SEC column.
e) Size Exclusion Chromatography - Multi Angle Laser Light Scattering (SEC-MALLS)
 SEC-MALLS analysis was performed by  Dr. David Gell (School of Molecular and Microbial 
Biosciences, University  of Sydney, Australia). Samples were prepared by dissolving the 
lyophilised rrPar-4LZ and rrPar-4LZD305K in 20 mM NaCl, 10 mM  Tris, pH 7.0 to a final 
peptide concentration of 0.33 mM (2 mg/ml). Each sample was passed over a 0.45 µM pore filter 
prior to loading 200 µg of peptide onto a Superdex 75 gel filtration column, running at ambient 
temperature (~22 ºC) with a flow rate of 0.6 ml/min. The SEC buffer contained 50 mM NaCl, 
20 mM Na2HPO4/NaH2PO4, pH 7.0.
 The eluate from the column was subject to in-line laser-light scattering and refractive index 
measurements. Light scattering intensity was measured with a mini-DAWN (Wyatt Technology 
Corp., Santa Barbara, USA) equipped with a 690 nm laser at  three independent angles (41.5º, 
90.0º and 138.5º). Voltages for the three detectors were normalised using BSA monomer as a 
standard isotropic scatterer. Absolute scattering intensity was calibrated against a standard 
sample of HPLC grade toluene. Protein concentrations were obtained from in-line refractive 
index measurements (Optilab differential refractometer, Wyatt), calibrated against standard salt 
solutions and a refractive index increment, with respect to mass concentration (dn/dc), of 
0.19 ml g-1 for protein. A weight-average molecular weight (MW) was calculated every  5 µl 
across each eluting peak (data “slice”) according to the Rayleigh-Debye-Gans scattering model 
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for a dilute polymer solution, as implemented by the ASTRA software [244]. Molecular weights 
reported for each sample are a weight average calculated over the peak 0.2 ml fraction.
f) Crosslinking
 For crosslinking reactions, 4.5 µl Par-4 LZ peptide were incubated with 0.5 µl 400 mM EDC 
(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) for 1 h on ice. The reaction was quenched 
with 0.3 µl 3 M NaAc, pH 5.2. Control reactions were performed without EDC. The crosslinked 
Par-4 LZ peptides were analysed by 10% Tricine-PAGE. Sample conditions for rrPar-4LZ at 
pH 7.0, rrPar-4LZ at pH 6.0 and rrPar-4LZD305K at pH 7.0 were identical to the SEC study 
described above.
4.2.2. Results and Discussion
a) CD spectropolarimetry
 Expression of Par-4(286-332)WT as a GST-fusion (= rrPar-4LZ) (Chapter 2.11.3.) produced 
higher yields in a shorter time relative to HMBP-fusions (Chapter 2.11.1.). Using the pGex-6P-3 
vector for expression introduced an additional leucine residue at the N-terminus of rrPar-4LZ 
that Par-4(286-332)WT expressed as a HMBP-fusion lacks. The HMBP-fusion construct was 
used in an earlier study  demonstrating an increase in coiled coil formation of the Par-4 LZ 
domain with decreasing pH [184]. For this document, CD spectropolarimetry  was repeated for 
consistency with DLS and NMR spectroscopy results. The pH dependence of coiled coil 
formation for rrPar-4LZ was found to be virtually identical to the aforementioned results of 
Dutta et. al. [184].
 The CD spectra of rrPar-4LZ at four different pH values are shown in Figure 4.2 and indicate 
an increase in α-helicity  with decreasing pH. Consistent with the previous study, rrPar-4LZ is 
mostly  disordered between pH 7.0 and 6.5 (Figs. 4.2A and B). Contrary to previous results [184], 
using similar peptide concentrations (~40 µM) the α-helical content of rrPar-4LZ at pH 6.0 and 
5 ºC is decreased from 75% to 56%. Also in contrast with the earlier study, a [θ]222/[θ]208 ratio of 
0.89 at 5 ºC is observed (Fig. 4.2C) suggesting the absence of stable supercoiling. Consistent 
with these results, the thermal stability  is decreased relative to previous results with a reduction 
in the Tm value from 24 ºC to 18 ºC (Fig. 4.3A). These results together indicate that the 
additional leucine residue in the N-terminus of rrPar-4LZ may interfere with coiled coil 
formation at decreasing pH.
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 Figure 4.2 − CD spectropolarimetry of Par-4 LZ peptides. Temperature dependence of the CD spectra 
of (A) rrPar-4LZ at pH 7.0 (B) rrPar-4LZ at pH 6.5 (C) rrPar-4LZ at pH 6.0 (D) rrPar-4LZ at pH 4 (E) 
rrPar-4LZD305K at pH 7.0 and (F) rrPar-4LZE310K at pH 7.0. Sample conditions are given in Table 4.2 
and acquisition parameters are listed in Appendix F. The abbreviations WT, D305K and E310K denote 
rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, respectively.
 This additional leucine residue also appears to have negatively influenced the solubility  of 
rrPar-4LZ at low pH. No solubility limitations at  pH 6.0 were reported previously [184]. 
Furthermore, CD spectra could be recorded down to pH values of 5.5. For rrPar-4LZ the 
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precipitation between pH 5.0 and 6.0 is almost quantitative and no reliable spectra could be 
recorded below pH 6.0. Conversely, around and below pH 4.0 the solubility of rrPar-4LZ 
improves. The theoretical pI of rrPar-4LZ is calculated as 4.5. However, it is likely that the pI is 
actually higher possibly due to the influence of coiled coil formation on the pKa values of acidic 
residues [135]. Hence, it is not surprising then that  the solubility of rrPar-4LZ is reduced 
between pH 5.0 and 6.0. It is further possible that some of the observed differences to the 
previous study  are an artefact resulting from the freeze-drying process. It  has been reported 
previously  that lyophilisation of proteins results in conformational changes, especially  a 
reduction of the α-helical content, and promotion of aggregation [245]. However, the results for 
rrPar-4LZD305K and rrPar-4LZE310K were largely identical to previous results even though 
these peptides were freeze-dried. It should also be mentioned that despite the negative effects 
lyophilisation may have on the Par-4 LZ peptides, it proved to be a reliable method for obtaining 
stable peptides and consistent results.
 Due to solubility limitations in the previous study, no CD spectra could be recorded below 
pH 5.5 [184]. A CD series of rrPar-4LZ at pH 4 is shown in Figure 4.2D. This series of 
rrPar-4LZ at pH 4 displays strong α-helical character and is indicative of a coiled coil with a 
[θ]222/[θ]208 ratio of 1.04. Noteworthy is the high thermal stability  (Tm ≈ 50 ºC) of rrPar-4LZ at 
pH 4 (Figs. 4.3A and B), which is higher than obtained previously for other Par-4(286-332) 
peptides [184,185]. This is consistent with the possible mitigation of repulsive electrostatic 
interactions due to partial protonation of acidic residues in the Par-4LZ domain (Chapter 4.1.2.). 
The high stability of rrPar-4LZ at pH 4 may be favoured as the sample is only  dissolved in H2O. 
It was previously  shown that salt  marginally disfavours helix formation at acidic pH [184]. 
Despite this increased thermal stability, stable supercoiling is only indicated until 25 ºC with 
[θ]222/[θ]208 ratios above one. The observed isodichroic point at 203 nm further suggests a two-
state transition between coiled coil and unfolded states. The decreasing [θ]222/[θ]208 ratios may 
therefore suggest that the equilibrium between coiled coils and unfolded monomers shifts 
towards monomers with increasing temperatures.
 CD spectropolarimetry  results for the LZ point mutants rrPar-4LZD305K and 
rrPar-4LZE310K are virtually identical to previous results [185]. Consistent with their pH-
independent folding, both mutants display coiled coil conformations at 5 ºC and neutral pH with 
[θ]222/[θ]208 ratios above one (Figs. 4.2E and F). As noticed previously [185], rrPar-4LZD305K 
(Tm ≈ 45 ºC) is slightly more stable than rrPar-4LZE310K (Tm ≈ 35 ºC) (Fig. 4.3B). Consistent 
with these results, a stable coiled coil with [θ]222/[θ]208 ratios above one is indicated until 25 ºC 
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for rrPar-4LZD305K and only until 15 ºC for rrPar-4LZE310K (Figs. 4.2E and F). Coiled coil 
formation at neutral pH is probably  due to abrogation of the repulsive electrostatic interaction 
between Asp 305 and Glu 310’ [185]. However, both mutants are less stable than rrPar-4LZ at 
pH 4 (Fig. 4.3B). This suggests that other electrostatic interactions such as the aspartate patch 
(Chapter 4.1.2.) are involved in the Par-4 LZ stability  and that partial protonation of these amino 
acids results in slightly  increased LZ stability. This is consistent with previous results, which 
show an increase in thermal stability of rrPar-4LZE310K with decreasing pH [185].
 The thermal stability of both LZ point mutants was further analysed by CD spectro-
polarimetry under denaturing conditions. It was repeatedly noticed for both peptides that they 
aggregate and precipitate at higher (> 300 µM) protein concentration (Chapter 2.12.1.). Urea was 
included in this study of rrPar-4LZD305K and rrPar-4LZE310K as it was shown to disrupt a 
polymeric state of rrPar-4FL, but still allow for self-association (Chapter 3.6.). The rationale was 
therefore to include 1 M urea to dissociate possible aggregates, but still be able to analyse a 
folded conformation. Urea concentrations of 6 M were used particularly with respect  to DLS as a 
reference state for a mostly unfolded conformation of rrPar-4LZD305K and rrPar-4LZE310K.
 Due to buffer absorption, the spectral width of the CD spectra is reduced from 190-260 nm in 
native buffer (20 mM  NaCl, 10 mM Tris, pH 7.0) to 200-260 nm in native buffer + 1 M  urea, and 
to 210-260 nm in native buffer + 6 M urea. Therefore, only the thermal stability  as a change in 
[θ]222 is shown for rrPar-4LZD305K and rrPar-4LZE310K under these conditions (Figs. 4.3C 
and D). As was expected, under the strong denaturing conditions of 6 M urea both peptides are 
mostly  unfolded (Figs. 4.3C and D). In contrast, in the presence of 1 M urea, CD 
spectropolarimetry  results show that both LZ point mutants maintain an α-helical fold. However, 
the thermal stability of this helical conformation is reduced (Figs. 4.3C and D). Relative to native 
buffer without urea the Tm values decrease from 45 ºC to 35 ºC and from 35 ºC to 23 ºC for 
rrPar-4LZD305K and rrPar-4LZE310K. Note that no accurate information about the supercoiling 
status can be gained due to buffer absorption preventing collection of reliable CD data below 
210 nm at urea concentrations above 1 M. Hence, the [θ]222/[θ]208 ratio cannot be determined 
accurately and no correlation between supercoiling and thermal stability can be made.
 For rrPar-4LZD305K the destabilising effect of urea is less pronounced at low temperatures 
and thus similar [θ]222 values are obtained at 5 ºC in native buffer and native buffer + 1 M urea 
(Fig. 4.3C). The [θ]222/[θ]208 ratio above one at  5 ºC for rrPar-4LZD305K in native buffer + 1 M 
urea further suggests a supercoiled oligomeric state [141], indicating similar conformations 
under both conditions. Note that buffer absorption is decreased at lower temperature allowing the 
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collection of data down to ~207 nm, however, this value should be considered with caution. At 
25 ºC the destabilising effect of 1 M urea is greater and a [θ]222 value is obtained that is more 
similar to the value obtained for rrPar-4LZE310K at 25 ºC in native buffer (Figs. 4.3C and D).
 The rrPar-4LZE310K mutant was shown to be less stable than rrPar-4LZD305K [185]. Not 
surprisingly, the destabilising effect of 1 M  urea is more pronounced for this mutant. At 5 ºC a 
partial α-helical character is observed that is significantly  less helical than in native buffer. At 
25 ºC rrPar-4LZE310K in 1 M urea is to a great extent unfolded (Fig. 4.3D). These results 
indicate that using both LZ point mutants and increasing concentrations of urea, coiled coil and 
α-helical states of different stabilities can be probed that are similar to the results of rrPar-4LZ at 
various pH values. However, no precipitation was observed for both LZ mutants under these 
conditions allowing measurements at higher peptide concentration.
 Figure 4.3 − Thermal stability of Par-4 LZ peptides. (A) Melting curves of rrPar-4LZ at pH 6.5, 6.0 
and 4, and of (B) rrPar-4LZ at pH 4, rrPar-4LZD305K at pH 7.0 and rrPar-4LZE310K at pH 7.0. The 
%[θ]222 values are displayed as a function of temperature. The %[θ]222 values were obtained by 
normalising the [θ]222 values at each temperature to the corresponding [θ]222 value at 5 ºC. Thermal 
stability of (C) rrPar-4LZD305K at pH 7.0 and (D) rrPar-4LZE310K at pH 7.0 under native conditions 
(0 M urea) and increasing denaturing conditions of 1 M and 6 M urea. The loss in α-helicity by thermal 
denaturation from 5-75 ºC was monitored as a change in [θ]222. Sample conditions are given in Table 4.2 
and acquisition parameters are listed in Appendix F. The abbreviations WT, D305K and E310K denote 
rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, respectively.
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 It is interesting to note here that  both LZ point mutants are less stable than previously 
described leucine zippers. For comparison, two leucine zippers of similar length, GCN4p1 [109] 
and rJun [246], have Tm values of 53 ºC (pH 7.0, 10 µM peptide concentration) and 52 ºC 
(pH 3.6, 15 µM peptide concentration), respectively. In contrast, the LZ point mutants 
rrPar-4LZD305K and rrPar-4LZE310K have Tm values of 45 ºC and 35 ºC (Fig. 4.3B), which are 
still below the 53 ºC and 52 ºC observed for GCN4p1 and rJun. Unlike GCN4p1 and rJun, which 
contain only  one asparagine residue at position a, the LZ point mutants contain two asparagine 
residues at  position a. As discussed in Chapter 4.1.2, this suggest that the two asparagine 
residues within the Par-4 LZ domain are detrimental for coiled coil stability  resulting in less 
thermal stability compared to well-characterised leucine zipper model systems. To summarise 
this sub-section, using a new protein purification protocol did not significantly  affect the CD 
spectroscopic properties of the Par-4 LZ peptides and results are comparable to previous studies 
[184,185]. Consistent with these studies the isolated wild-type Par-4 LZ domain (rrPar-4LZ) 
displays a highly pH and temperature dependent coiled coil formation. This pH dependence is 
mainly caused by repulsive electrostatic interactions between Asp 305 and Glu 310 residues, but 
other charged residues appear to contribute as well.
b) SEC and MALLS
 Even though SEC was of limited use as a purification method for the Par-4 LZ peptides 
(Chapter 2.11.1.), the information gained about the hydrodynamic properties of the Par-4 
constructs is, in most cases, comparable to DLS results (see below). The greatest hydrodynamic 
size at  4 ºC is obtained for rrPar-4LZD305K at pH 7.0, an intermediate size for rrPar-4LZ at 
pH 6.0 and the smallest size for rrPar-4LZ at  pH 7.0 (Fig. 4.4A). The results obtained for 
rrPar-4LZE310K are virtually identical to rrPar-4LZD305K (data not  shown). For comparison, 
volume distributions for these three peptides obtained by DLS are shown in Figure 4.4B, and 
will be discussed in more detail further below. Conversion of the retention times to MWs yields 
28 kDa, 23 kDa and 21 kDa for rrPar-4LZD305K at pH 7.0, rrPar-4LZ at pH 6.0 and rrPar-4LZ 
at pH 7.0, respectively. MALLS results, obtained under similar conditions but higher 
temperature, suggest MWs of 11.5 and 5.8 kDa for rrPar-4LZD305K and rrPar-4LZ, both at 
pH 7.0 (Fig. 4.4C).
 A retention time corresponding to an apparent MW of ~21 kDa is very large for the 6.0 kDa 
peptide rrPar-4LZ (Fig. 4.4A). This suggests that the high apparent MW is due to non-globular 
shapes or oligomerisation. However, a MW of 5.8 kDa is determined by MALLS for rrPar-4LZ 
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at pH 7.0 and 22 ºC (Fig. 4.4C). This is consistent with a monomeric conformation and thus 
indicates that the high apparent MW is due to non-globular shapes. CD spectropolarimetry 
indicates that rrPar-4LZ at pH 7.0 is disordered between 5 and 25 ºC (Fig. 4.2A). The similar CD 
results at 5 and 25 ºC therefore allow the comparison of the SEC results obtained at 4 and 22 ºC. 
Using the theoretical RS values given in Table 4.3 for a 6 kDa protein in either a spherical 
(14.0 Å) or random coil state (20.5 Å), a three times increased hydrodynamic volume is expected 
for the random coil conformation relative to the globular conformation. Thus the SEC results are 
consistent with a monomeric, disordered coil-like conformation for rrPar-4LZ at pH 7.0 
(DOM = disordered monomer). The hydrodynamic volume is calculated by VS = 4/3πRS3 [145].
Figure 4.4 − SEC and DLS of Par-4 LZ peptides. 
(A) The Par-4 LZ peptides elute from  the SEC 
column in the order rrPar-4LZD305K at pH 7.0, 
rrPar-4LZ at pH 6.0 and rrPar-4LZ at pH 7.0. The 
estimated sizes correspond to spherical proteins with 
MWs of 28 kDa, 23 kDa and 21 kDa, respectively. 
The rrPar-4LZE310K peptide at pH 7.0 runs 
virtually identical to rrPar-4LZD305K (data not 
shown). Data have been normalised to present 
similar peak heights. (B) DLS results for the same 
three samples as in panel (A). Results are consistent 
with SEC results. (C) SEC-MALLS results of Par-4 
LZ peptides at pH 7.0 and ambient temperature. 
Solid and dashed traces are the elution profiles of 
rrPar-4LZ and rrPar-4LZD305K recorded with the 
refractive index detector (left scale). Circles show 
the MW profile (right scale). To match data from the 
two detectors the elution volumes of the refractive 
index detector were subtracted by 0.14 ml to omit the 
dead volumes. Data have been normalised to present 
similar peak heights.
 For both mutants rrPar-4LZD305K and 
rrPar-4LZE310K, the MWs estimated by SEC 
are also high with ~28 kDa (Fig. 4.4A). MALLS 
results indicate a MW of 11.5 kDa for rrPar-4LZD305K at 22 ºC (Fig. 4.4C). This suggests a 
dimeric state for rrPar-4LZD305K, which is consistent with CD results indicating a coiled coil 
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conformation under these conditions (Fig. 4.2E). As similar CD spectra are obtained for 
rrPar-4LZD305K at 5 and 25 ºC, comparison of the SEC results obtained at 4 and 22 ºC is 
allowed. The high apparent MWs obtained for both LZ point mutants are not unusual, as the 
elongated rod-like shape of coiled coils is known to produce larger apparent MWs by SEC than 
are expected from the amino acid sequence [247]. As was discussed above, the coiled coil 
conformation of both LZ point mutants is less stable relative to other well-characterised leucine 
zippers [109,246]. Together with other experiments that will be presented below, this suggests 
that both LZ point  mutants obtain an ordered dimeric conformation (with typical characteristics 
of a coiled coil), which, however, displays a certain degree of flexibility. The dimeric 
conformation of both rrPar-4LZD305K and rrPar-4LZE310K will be described from here on as a 
predominantly ordered dimer (POD).
 Interestingly, a peak with intermediate retention time relative to rrPar-4LZ and 
rrPar-4LZD305K, both peptides at pH 7.0, is obtained for rrPar-4LZ at pH to 6.0 (Fig. 4.4A). 
These results suggest that  under the SEC conditions disordered monomeric and ordered dimeric 
conformations are in fast interconversion. This is consistent with CD results at pH 6.0 and 5 ºC 
indicating 56% α-helicity (Fig. 4.2C). It was mentioned in Chapter 1.4. that the existence of 
isolated α-helices in solution is unlikely. Together with the SEC results, the moderate α-helical 
content may therefore indicate an interconversion between DOMs and PODs under these 
conditions. The isodichroic point at 203 nm further suggests a two-state transition between these 
two states with no significantly populated intermediates.
Calculated RS
Oligomeric state MW S MG PMG RC U
Monomer 6.0 14.0 16.2 18.7 20.5 20.9
Dimer 12.0 17.9 20.4 24.5 28.8 29.9
Trimer 18.0 20.7 23.3 28.7 35.2 37.0
Tetramer 24.0 22.9 25.7 32.1 40.6 43.0
 Table 4.3 − Hydrodynamic properties of various oligomers of a 6 kDa peptide. Theoretical values of 
Stoke’s radii (RS) calculated for various oligomeric and folding states of a 6 kDa peptide using the mean 
values from equations given in [181] for spherical (S), molten globule (MG), pre-molten globule (PMG), 
random coil (RC) and urea-denatured (U) states. The MW is given in kDa and the RS in Å.
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 Another interesting SEC result is the peak shape of the Par-4 LZ proteins. Whereas a fairly 
symmetric peak shape is observed for rrPar-4LZ at  pH 7.0 (Fig. 4.4A, solid trace), tails are 
evident for the peaks of rrPar-4LZ at pH 6.0, rrPar-4LZD305K at pH 7.0 and rrPar-4LZE310K at 
pH 7.0 (Fig. 4.4A, results for rrPar-4LZE310K not shown). A symmetric peak shape suggests a 
single molecular species [247] that is in the case of rrPar-4LZ at pH 7.0 a mostly disordered 
conformation. A tail may indicate structural interconversion between various molecular species 
[211,212], which is consistent with the previous interpretation for rrPar-4LZ at  pH 6.0. These 
results therefore suggest that also rrPar-4LZD305K and rrPar-4LZE310K interconvert between 
DOMs and PODs. However, the POD state represents the major population for both LZ point 
mutants. Interestingly, a shoulder is observed for rrPar-4LZD305K at 22 ºC (Fig. 4.4C), and the 
elution time of this shoulder corresponds well with the elution time of the DOM  (rrPar-4LZ at 
pH 7.0). This may indicate that exchange between DOM  and POD states is slow under the SEC 
conditions for rrPar-4LZD305K resulting in separate peaks for POD and DOM. Similarly, the 
downward curving plots of MW versus elution time observed for rrPar-4LZD305K (Fig. 4.4C) 
are characteristic of a complex dissociating in response to dilution. Conversely, for rrPar-4LZ at 
pH 6.0 POD and DOM  states appear to be equally populated resulting in an intermediate elution 
time. The elution time for rrPar-4LZ at pH 6.0 may further suggest that interconversion between 
DOM and CCD states is fast under the conditions of the SEC. Additional SEC experiments with 
varying peptide concentrations may be necessary for rrPar-4LZ at pH 6.0 and both LZ point 
mutants at  pH 7.0. The analysis of the concentration dependency of the elution time may allow a 
better understanding of the involved dynamic processes. To summarise this sub-section, SEC and 
MALLS results indicate that rrPar-4LZ at  pH 7.0 is a DOM. Conversely, results for 
rrPar-4LZD305K at pH 7.0 are consistent with a POD conformation that is in slow exchange 
with a DOM conformation. For rrPar-4LZ at pH 6.0 a dynamic interconversion between DOM 
and POD states is suggested with an approximately equal population in both states.
c) Dynamic light scattering
 DLS was used to determine the hydrodynamic properties of the Par-4 LZ peptides under the 
same buffer conditions and with the same peptide concentration as used for CD 
spectropolarimetry  and NMR (Chapter 4.3.2.). It was also assumed that DLS might allow the 
determination of the oligomeric state of coiled coil LZ peptides. However, as will be discussed 
below DLS did not have the high enough resolution and in most cases only allowed the 
exclusion of aggregated species under the studied conditions.
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 The results of DLS experiments are summarised in Table 4.4. For comparative purposes, the 
equation log(RS) = 0.357*log(MW)-0.204 [181] was used to convert the experimentally 
determined RS values to MWs. For rrPar-4LZ the obtained RS values at various pH and 
temperatures (hence disordered and coiled coil states) are all similar (15.6-20.9 Å) but not 
indicative of aggregates (Table 4.4). For example, the presence of high molecular weight species 
is estimated to be below 1% for rrPar-4LZ at pH 4 (Fig. 4.5C). Similarly, the RS values for 
rrPar-4LZD305K and rrPar-4LZE310K also show only  slight differences (24.2-28.1 Å) under 
native and denaturing conditions. Interestingly, the RS values for rrPar-4LZD305K and 
rrPar-4LZE310K are larger compared to rrPar-4LZ but also not indicative of aggregation. These 
results indicate that a differentiation between folded coiled coil states (rrPar-4LZ at pH 4, 
rrPar-4LZD305K at pH 7.0) and unfolded states (rrPar-4LZ at pH 7.0, rrPar-4LZD305K at 
pH 7.0 + 6 M urea) by DLS is not possible (Table 4.4). However, the DLS results are consistent 
with SEC results (see above), as larger RS values are obtained for the Par-4 LZ peptides than are 
expected from their amino acid sequence (Table 4.4). It was previously mentioned that this is a 
typical observation for disordered and coiled coil proteins [145,181,226,248].
 DLS determination of the oligomeric state of the Par-4 LZ peptides in coiled coil 
conformations was not possible. For comparative purposes the theoretical RS values of different 
oligomeric states of a 6 kDa monomer are estimated using mean values from equations given in 
Ref. [181] (Table 4.3). Oligomeric states are approximated by increasing molecular weights of 
12 kDa (dimer), 18 kDa (trimer) and 24 kDa (tetramer). As can be seen from these calculations, 
the differences in RS values of various oligomers in a folded spherical conformation are larger 
relative to the variation observed in the data for the Par-4 LZ peptides (Table 4.4). Differences in 
RS values of potential coiled coil dimers, trimers or tetramers may be even smaller than for 
spherical proteins [249]. A folded coiled coil itself is a rod-like structure (Fig. 4.1C). Due to their 
rod-like structures, different types of oligomers (up to tetramers as suggested by simulations) are 
most likely of similar length but different width. It  is likely  that  the length of the molecule as the 
longest axis is more critical for the observed RS value than the width of the molecule. This seems 
likely as the 66-residue coiled coil domain of rinderpest virus Phosphoprotein P forms a 
homotetramer and was shown to have an RS of approximately  28 Å [250]. A value that is close to 
the values observed for rrPar-4LZD305K and rrPar-4LZE310K (Table 4.4). Even though the 
exact oligomeric state cannot be determined by DLS, a dimeric conformation, as indicated by 
sequence analysis (Chapter 4.1.2.), is consistent with the current data. Interestingly, there is a 
slight difference in the RS values between rrPar-4LZ at various pH values and the LZ point 
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mutants rrPar-4LZD305K and rrPar-4LZE310K at pH 7.0 and increasing concentrations of urea 
(Table 4.4). This difference is also observed by  SEC (Fig. 4.4A), however, the cause for this 
difference has not been determined yet.
5 ºC 25 ºC
Construct pH Urea MW RS MW RS
rrPar-4 LZ peptides N/A N/A 6.0 14.0 6.0 14.0
rrPar-4LZ 7.0 0 M 12.4 18.1 12.4 18.1
6.5 0 M N/A N/A 12.4 18.1
6.0 0 M 18.7 20.9 12.4 18.1
4 0 M 12.4 18.1 8.2 15.6
rrPar-4LZD305K 7.0 0 M 28.0 24.2 28.0 24.2
7.0 1 M N/A N/A 42.6 28.1
7.0 6 M N/A N/A 28.0 24.2
rrPar-4LZE310K 7.0 0 M 28.0 24.2 42.6 28.1
7.0 1 M N/A N/A 28.0 24.2
7.0 6 M N/A N/A 42.6 28.1
 Table 4.4 − DLS-determined hydrodynamic properties of Par-4 LZ peptides. MW (kDa) and RS (Å) 
values were calculated using the equation log(RS) = 0.357*log(MW) − 0.204 in reference to a spherical 
conformation [181]. The mode RS values of each measurement are shown. For comparison, theoretical 
values of a spherical conformation calculated from the amino acid sequence of rrPar-4LZ are also 
provided. Sample conditions are given in Table 4.2.
 The volume distributions for the Par-4 LZ peptides are shown in Figure 4.5. Relative narrow 
volume distributions are observed for Par-4 LZ peptides in a mostly  coiled coil conformation 
(e.g. rrPar-4LZ at pH 4, rrPar-4LZD305K at pH 7.0) consistent with a predominantly  single 
conformation (Fig. 4.5C). Compared to these relative narrow distributions, samples with partial 
α-helical character (e.g. rrPar-4LZ at pH 6.0 and 5 ºC, rrPar-4LZD305K at pH 7.0 + 1 M urea, 
rrPar-4LZE310K at pH 7.0 and 25 ºC) display significantly broader distributions (Figs. 4.5A, B 
and D). As was proposed for the SEC results, this observation is consistent with interconverting 
conformations. The volume distributions observed under 6 M urea concentrations are narrower 
relative to distributions under 1 M  urea concentrations (Figs. 4.5E and H), suggesting that 
exchange between folded and unfolded conformations is reduced as the peptides are mostly 
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unfolded. For rrPar-4LZD305K, the volume distribution under 6 M  urea is further slightly 
broader than in the absence of urea (Fig. 4.5F) consistent with an increased flexibility in the urea 
denatured state relative to the POD conformation.
 Figure 4.5 − DLS of Par-4 LZ peptides. Volume distribution representation of DLS results showing the 
apparent hydrodynamic radius (RS). (A) RS of rrPar-4LZ at pH 6.0 for temperatures of 5 and 25 ºC. (B) 
RS of rrPar-4LZD305K and rrPar-4LZE310K at 25 ºC and pH 7.0. (C) RS at 25 ºC of rrPar-4LZ at pH 4 
and rrPar-4LZD305K at pH 7.0. Volume distributions of rrPar-4LZD305K (D-F) and rrPar-4LZE310K 
(G-I) at pH 7.0 and 25 ºC under increasing concentrations of urea. Panels D and G compare results 
without urea with 1 M urea, panels E and H compare 1 M urea with 6 M urea, and panels F and I 
compare results without urea with 6 M urea. Results are summarised in Table 4.4. The abbreviations WT, 
D305K and E310K denote rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, respectively.
 Even though an accurate control of the concentration of the Par-4 proteins during SEC was 
not possible due to dilution effects upon loading the samples on the SEC column, the SEC results 
are consistent with DLS measurements. It  should be noted that the salt concentration is 2.5 fold 
increased for SEC relative to DLS to prevent non-specific interactions with the gel matrix. This 
suggests that SEC and DLS results do not change significantly within the analysed peptide and 
salt concentration range. It is possible that these results may hold true at higher protein and salt 
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concentrations, which have yet to be tested. To summarise this subsection, DLS results are 
consistent with disordered or coiled coil states of the Par-LZ peptides, and further with structural 
interconversion. Both of these observations are consistent with SEC results. Importantly, no 
significantly aggregated species were detected by DLS for the Par-4 LZ peptides.
d) Par-4 LZ Crosslinking
 The crosslinker EDC is used to initiate the formation of amide bonds between free carboxylic 
and amino groups (Fig. 4.6). Assuming a parallel dimer as suggested by the amino acid 
sequence, the interhelical salt  bridge between Glu 312 and Lys 317’ (the prime indicating the 
second helical molecule) could be involved in amide bond formation, resulting in the covalent 
connection of two monomers. For the mutants rrPar-4LZD305K and rrPar-4LZE310K the 
interhelical salt bridges between Lys 305 and Glu 310’ and between Asp 305 and Lys 312’, 
respectively, may also be involved in crosslinking reactions.
 Figure 4.6  − Crosslinking mechanism of EDC. EDC reacts with a carboxylic acid (Step I) to form an 
O-acylisourea intermediate (Step II). An amide bond is formed through the reaction of a primary amine 
with this O-acylisourea intermediate (Step III). For simplicity the leaving group of the former EDC is 
omitted in Step III.
 The results of Par-4 LZ crosslinking studies are shown in Figure 4.7. For each of the Par-4 LZ 
peptides, two predominant bands are seen. Molecular weight markers identify the most intense 
band as monomers (6 kDa), and the secondary band as a dimers (12 kDa). The appearance of the 
secondary  band is consistent with the formation of a parallel dimeric conformation. Similar 
results are obtained for rrPar-4LZ at pH 4 and rrPar-4LZE310K at pH 7.0 (data not shown). It 
should be noted that other possibilities such as amide bond formation between the free amino 
and carboxylic groups at the N- and C-termini, respectively, cannot be excluded. However, 
control experiments with the spherical protein aprotinin (6.5 kDa) show that such crosslinking 
reactions do not occur efficiently  (data not shown). For rrPar-4LZ at pH 6.0, faint additional 
bands above 21 kDa were detected, but are hardly visible in Figure 4.7B, that may result from 
non-specific crosslinking. Their relevance is currently unclear, but could be an indication of 
transient higher oligomer formation. Higher oligomer formation may be possible, as rrPar-4LZ 
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was shown to precipitate at pH values below 6.0. However, such transient complexes may not be 
detectable by DLS or SEC. Note however, that no stable high molecular weight complexes could 
be identified by crosslinking reactions.
Figure 4.7 − Crosslinking of Par-4 
LZ peptides. The Par-4 LZ 
peptides (A) rrPar-4LZ at pH 7.0, 
(B) rrPar-4LZ at pH 6.0 and (C) 
rrPar-4LZD305K at pH 7.0 were 
incubated for 1 h on ice with either 
water as negative control (lanes 1, 
3 and 5) or with 40 mM EDC 
(lanes 2, 4 and 6). Crosslinking 
reactions were analysed by 10% 
Tricine-PAGE. The control lanes 
identify the intense bands as 
monomers. The secondary bands in the EDC treated samples correspond to dimers as indicated by the 
molecular weight markers. Sample conditions prior to addition of EDC were 75 µM rrPar-4LZ in 20 mM 
NaCl, 10 mM Tris, pH 7.0, 40 µM rrPar-4LZ in 20 mM NaCl, 10 mM Mes, pH 6.0 and 75 µM 
rrPar-4LZD305K in 20 mM NaCl. The abbreviations WT and D305K denote rrPar-4LZ and 
rrPar-4LZD305K, respectively.
 Interestingly, also for rrPar-4LZ at pH 7.0 the appearance of dimers is observed. This seems 
to be in contradiction with CD (Fig. 4.2A) and SEC-MALLS (Fig. 4.4C) results indicating that 
rrPar-4LZ is mostly disordered at pH 7.0. This suggests that there is some interaction between 
rrPar-4LZ monomers at pH 7.0. It is possible that  this interaction is localised to the proposed 
trigger site of rrPar-4LZ (Chapter 4.3.2.), but that this interaction does not result in full coiled 
coil formation due to electrostatic repulsion. Note that the proposed trigger site comprises 
Glu 312 and Lys 317. It is interesting to note here that the downward slope of MW towards 
shorter elution times observed for rrPar-4LZ at pH 7.0 by  SEC-MALLS is unusual. It is not clear 
if this increase in MW from 5.4 kDa (leading edge) to 6.2 kDa (trailing edge) is significant 
(Fig. 4.4C). However, it may be indicative of transient association of a small proportion of the 
rrPar-4LZ ensemble resulting in a more compact conformation and thus later elution time and 
thus in a slightly  increased MW. It is also possible that the observed crosslinking of rrPar-4LZ at 
pH 7.0 is an artefact of the crosslinking reaction itself. The crosslinking reaction is initiated by 
the formation of an O-acylisourea intermediate between EDC and a free carboxylic group 
M
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(Fig. 4.6). Such a reaction may mask the electrostatic repulsion between Asp 305 and Glu 310 
residues and thus result in coiled coil formation with subsequent crosslinking. Taken together, 
crosslinking experiments suggest that the Par-4 LZ peptides form primarily  monomers and 
dimers and that the observed NMR line broadening (Chapter 4.3.2.) is not due to aggregation.
e) Future directions
 As was already mentioned above, the concentration dependency of the elution times of the 
Par-4 LZ peptides should be established by  SEC. This will allow a better understanding of the 
involved exchange processes and confirm a dimeric state for the Par-4 LZ mutants at pH 7.0. The 
analysis of rrPar-4LZ at  pH 6.0 by  SEC-MALLS should also be helpful for the analysis of the 
equilibrium of DOM  and POD conformations, as this peptide shows an elution time intermediate 
to DOMs and PODs. To further asses the exchange rate between DOMs and PODs additional 
analytical methods were started, such as AU (analytical ultracentrifugation). As conclusive 
results are pending possible advantages and limitations of AU will be discussed here. This 
system has the advantage that it is compatible with a variety of buffer conditions and also allows 
a temperature control. Therefore, various Par-4 peptides may be studied under different buffer 
(pH) conditions. However, as the Par-4 LZ peptides lack aromatic residues, the detection of the 
peptides by AU is limited to the A214 absorbance. The AU set-up  further requires a maximum 
absorbance of one. Detection at 214 nm limits the useful concentration range for the Par-4 LZ 
peptides to below 15 µM. Therefore comparison of the AU results with other results at higher 
peptide concentration presented in this document has to be done with caution.
 To summarise DLS, SEC and crosslinking results, a differentiation between coiled coil and 
unfolded states of the Par-4 LZ peptides by  DLS was not possible due small differences in the 
measured RS values. SEC results of coiled coil and disordered states were also found to be 
similar. However, both DLS and SEC results are consistent with elongated conformations as 
expected for either disordered or coiled coil states. SEC-MALLS results suggest dimeric states 
for the coiled coil peptides, as is suggested by the amino acid sequence, and monomeric states 
for the disordered peptides. A dimeric state of the coiled coil Par-4 LZ peptides is further 
confirmed by crosslinking results. Importantly, none of the here presented methods showed 
indications for large aggregates under the analysed conditions.
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4.3. Coiled coil formation of the Par-4 LZ domain analysed by NMR 
spectroscopy
4.3.1. Materials and Methods
a) Chemical shift assignment and CSI calculation
 The wild-type Par-4 LZ chemical shifts were assigned by Dr. Kaushik Dutta (New York 
Structural Biology Center, New York, USA) using 1H,15N-HSQC, HNCO, HNCACB, 
CBCA(CO)NH (backbone) and H(CC)(CO)NH-TOCSY, (H)CC(CO)NH-TOCSY, HC(CO)NH, 
C(CO)NH, and HBHA(CO)NH (side chain) experiments. Typical number of complex points per 
dimension were 1024 x 128 x 64 (1H x 13C x 15N). Data were processed with NMRPipe [251] 
and analysed with NMRView [252]. Spectra were acquired at  5 ºC on a Varian Inova 600 MHz 
spectrometer with an ambient temperature probe on a 13C,15N-labelled 51-residue peptide in 
20 mM NaCl, 12 mM Na2HPO4/NaH2PO4, pH 6.5. This 51-residue peptide was expressed and 
purified as described previously  [187]. It was used for sequential assignments and CSI 
calculations presented in this chapter. The rrPar-4LZ peptide (52 residues), used for all other 
experiments described in this chapter, differs from this 51-residue peptide by an additional N-
terminal leucine residue present in the vestigial protease cleavage site of rrPar-4LZ. Chemical 
shift dispersion of the 51-residue peptide is virtually identical to the rrPar-4LZ construct, except 
for one extra peak stemming from the leucine in the N-terminal vestigial protease cleavage site 
(data not shown). Assignments of the 51-residue peptide were therefore adopted for rrPar-4LZ 
for residues that have identical chemical shifts. Chemical Shift  Indexing (CSI) [253] was 
performed using the Cα, Cβ and C’ chemical shift values from Par-4 LZ at pH 6.5 and 5 ºC 
(Appendix H). C’ chemical shifts were corrected as described in Ref. [254].
b) 1H,15N-SOFAST-HMQC spectra of Par-4LZ peptides
 All NMR experiments are recorded on a Bruker Avance 700 MHz spectrometer as described 
in Chapter 3.4.1.b. 1H,15N-SOFAST-HMQC spectra were acquired on 300 µl samples in D2O 
matched Shigemi NMR tubes. Sample conditions are given in Table 4.2. All spectra were 
recorded at 5 ºC and 25 ºC with the following settings: 24 transients, 800 x 128 points (1H x 15N) 
and spectral widths of 10 and 30 ppm for 1H and 15N, respectively. Soft proton pulses with a 
bandwith of 3 ppm were centred at  7.8 ppm. The carrier was set to the frequency of the water 
resonance in the 1H and to 119 ppm in the 15N dimension. For rrPar-4LZ at pH 6.0, an additional 
spectrum with 512 transients, but otherwise identical conditions, was recorded. Acquisition 
parameters are given in Appendix G.
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c) 15N-relaxation measurements of rrPar-4LZ at pH 6.0
 15N-relaxation studies [255] and 3JHNHα coupling constant measurements were performed at 
5 ºC on a 300 µl sample in a D2O matched Shigemi NMR tube. The sample contained 100 µM 
rrPar-4LZ in 20 mM NaCl, 10 mM Mes, pH 6.0 and 5% D2O (v/v). T1 spectra were recorded with 
τ delays of 30.92, 90.35, 179.51, 298.38, 417.25, 595.56, 773.87 and 892.74 ms, while the T2 
measurements used values of 16.32, 32.64, 48.96, 81.6, 114.24, 146.88, 179.52, 212.16 and 
244.8 ms. The recycle delay was set to two seconds. {1H}15N steady state NOEs were obtained 
by recording spectra with and without 1H presaturation at a duration of three seconds. The 
recycle delay  was set to six seconds. T1, T2 and {1H}15N-NOE experiments were acquired with 
the following settings: 24 transients, 2048 x 256 points (1H x 15N) and spectral widths of 10 and 
25 ppm for 1H and 15N, respectively. A 3D-HNHA [256] experiment for the measurement of 
3JHNHα coupling constants was acquired with 24 transients, 2048 x 76 x 48 points (1H x 1H x 15N) 
and spectral widths of 10 and 25 ppm for 1H and 15N, respectively. The carrier frequency was set 
to the frequency of the water resonance in the 1H and to 119 ppm in the 15N dimension, 
respectively.
 Cross-correlated relaxation rates (ηxy) were acquired at  5 ºC as described in Ref. [257] on a 
300 µl sample in a D2O matched Shigemi NMR tube. The sample contained 60 µM  rrPar-4LZ in 
20 mM NaCl, 10 mM Mes, pH 6.0 and 5% D2O (v/v). The following settings were used: 48 
transients, 1024 x 256 points (1H x 15N) and spectral widths of 10 and 25 ppm for 1H and 15N, 
respectively. The carrier frequency was set to the frequency of the water resonance in the 1H and 
to 119 ppm in the 15N dimension, respectively. The recycle delay was set to 2.5 s.
d) NMR spectroscopy of REDPRO rrPar-4LZE310K
 1H,15N-TROSY-HSQC and {1H}15N steady  state NOE experiments of REDPRO 
rrPar-4LZE310K were acquired on a 300 µl sample in a D2O matched Shigemi NMR tube, and 
contained 0.3 mM peptide in 20 mM NaCl, 10 mM  Tris, pH 7.0 and 5% D2O (v/v). 1H,15N-
TROSY-HSQC and 1H,15N-HSQC spectra were recorded at 5 ºC with the following settings: 48 
transients, 2048 x 256 points (1H x 15N) and spectral widths of 10 and 30 ppm for 1H and 15N. 
The carrier was set to the frequency of the water resonance in the 1H and to 119 ppm in the 15N 
dimension. {1H}15N steady-state NOEs were obtained by recording spectra with and without 1H 
presaturation at a duration of six seconds. The recycle delay was set to six seconds. Spectra were 
recorded with the following settings: 72 transients, 2048 x 256 points (1H x 15N) and spectral 
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widths of 10 and 30 ppm for 1H and 15N, respectively. The carrier was set  to the frequency of the 
water resonance in the 1H and to 119 ppm in the 15N dimensions.
e) NMR spectra processing and analysis
 All data sets were linear predicted (32 prediction coefficients), apodised and zero-filled once 
in the indirect dimensions before Fourier transformation and final processing. Unless stated 
otherwise a shifted (π/2) squared sinusoidal bell function was used for apodisation. TopSpin 2.1 
(Bruker BioSpin GmbH, Rheinstetten, Germany) was used for spectral processing and lineshape 
analysis. The 1H and 15N chemical shifts were referenced to the water signal [216]. Cross peak 
intensities, 3JHNHα coupling constants, T1 and T2 rates were calculated using the program Analysis 
2.0 [258].
4.3.2. Results and Discussion
 CD spectropolarimetry shows that rrPar-4LZ at pH 6.5 and 5 ºC is mostly  disordered, but also 
displays weak α-helicity (Fig. 4.2B). Consistent  with this result, a weak, but significant, α-helical 
character is evident by CSI for the Par-4 LZ domain under similar conditions (Fig. 4.8), with the 
Glu 312-Lys 321 sequence displaying the highest degree of α-helicity. CSI calculations were 
performed with the Cα, Cβ and C’ chemical shift values obtained from the assignment process of 
Par-4(286-332)WT at pH 6.5 and 5 ºC. A fully formed α-helix, typically produces CSI values 
near +10 [253]. The modest CSI magnitudes observed for Par-4 indicate fluctuating torsion 
angles sampling regions typical for α-helical conformations [176] that may or may not be 
accompanied by intermittent formation of short or long helical stretches.
 It is possible that the Glu 312-Lys 321 region may represent a trigger site for the LZ domain. 
Trigger sites were proposed as autonomous helical folding units, which are necessary for coiled 
coil formation and are stabilised by inter- and intrahelical salt bridges [259,260]. Residues 
Glu 312-Lys 321 comprise the fourth heptad of the Par-4 LZ domain and contain a potential 
intrahelical i to i+3 salt  bridge between Glu 314 and Lys 317 and a potential interhelical i to i’+5 
salt bridge between Glu 312 and Lys 317’ that could help to stabilise this motif [261] (Figs. 4.1B 
and E). The occurrence of two asparagine residues (Asn 313, Asn 320) at position a within this 
region (Fig. 4.1B) appears to be in contradiction with the trigger site proposal, as these residues 
are usually detrimental for coiled coil stability [243]. However, monomer helix stability is a 
more critical factor for a trigger site [261] and additionally asparagines were shown not to be 
involved in the association step of coiled coil formation [242].
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 Figure 4.8  − CSI for the Par-4 LZ domain. The Par-4 LZ sequence (black bars) begins at residue 
Gln 286. Residues N-terminal to Gln 286 (white bars) stem from the vestigial protease cleavage site. A 
moderate preference for α-helix is evident for the Glu 312-Lys 321 sequence.
 After confirming in the previous chapter that CD spectropolarimetry  results of rrPar-4LZ at 
different pH values are comparable to previous results [184], rrPar-4LZ was subjected to NMR 
spectroscopy. The NMR spectra at temperatures of 5 and 25 ºC for rrPar-4LZ at pH 7.0, 6.0 and 
4 are shown in Figure 4.9. The virtually complete resonance assignment of the LZ domain 
obtained by Dr. Dutta is shown in Figure 4.9A and plotted onto the pH 7.0 1H,15N-SOFAST-
HMQC spectrum. Sequential assignment was achieved at pH 6.5 and 5 ºC, however, the NMR 
spectra at 5 ºC of rrPar-4LZ at pH 7.0 and 6.5 are virtually identical (data not  shown), allowing 
the transfer of the assignments to the pH 7.0 spectrum. These NMR results are not surprising as 
CD spectropolarimetry indicates mostly  unfolded conformations under both conditions 
(Figs. 4.2A and B).
 A significant difference in the CD spectra of rrPar-4LZ is observed between pH 7.0 and 6.0. 
In contrast to the mostly disordered conformation (~18% of combined regular and distorted α-
helicity) observed at pH 7.0, the pH 6.0 spectrum at 5 ºC displays α-helical (~56% α-helicity) yet 
not coiled coil character (Figs. 4.2A and C). Despite this clear increase in α-helicity at pH 6.0, 
the 5 ºC NMR spectra of rrPar-4LZ at pH 7.0 and 6.0 are virtually  identical and no obvious signs 
of structure are observed under the experimental conditions used (Fig. 4.9A). Apart from 
relatively minor changes mostly confined to charged residues (e.g. Glu 297, Asp 305, Glu 308, 
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Glu 310, or Glu 312), only  the appearance of additional peaks for Leu -3, Gly -2, Ser -1 and 
Gln 286 (marked by asterisks) is observed at pH 6.0. Note that residues with negative numbers 
stem from the vestigial protease cleavage at the N-terminus. A possible explanation for the 
occurrence of these peaks will be discussed below. A similar global conformational change is 
observed by  CD spectropolarimetry for rrPar-4LZ at pH 6.0 between 5 and 25 ºC (Fig. 4.2C). 
However, neglecting temperature induced shifts, the NMR spectra at  5 and 25 ºC (pH 6.0) are 
similar and show no obvious signs of structure. Note that the additional peaks (marked by 
asterisks) at pH 6.0 are more prominent at 5 ºC than at 25 ºC (Fig. 4.9B).
 Figure 4.9 − Influence of pH on the 1H,15N-SOFAST-HMQC spectra of rrPar-4LZ. (A) Pairwise 
comparison of the NMR spectra at 5 ºC of rrPar-LZ at pH 7.0 (black contours) and pH 6.0 (blue 
contours). Assignments of the Par-4 LZ domain at 5 ºC are shown, starting with Gln 286. Negative 
residue numbers indicate amino acids originating from the protease cleavage site. X and Y denote 
overlapped peaks consisting of Asp 287, Lys 288, Glu 290, Asp 314 (X) and Glu 289, Glu 298, Asp 311 
(Y). Additional peaks that arise at pH 6.0 (see text) are labelled in blue and marked by asterisks. (B) 
Overlay of the HMQC spectra at pH 6.0 for rrPar-4LZ at 5 ºC (blue contours) and 25 ºC (dark blue 
contours). Labelled peaks are as described in the legend to part (A). (C) Comparison of the NMR spectra 
at 25 ºC of rrPar-4LZ at pH 7.0 (black contours) and rrPar-4LZ at pH 4 (green contours). Selected peaks 
with an increased chemical shift dispersion are marked by black boxes. The black arrow indicates 
representative peaks that do not significantly change their position in response to decreasing pH. Sample 
conditions were 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0; 40 µM rrPar-4LZ in 20 mM 
NaCl, 10 mM Mes, pH 6.0; and 50 µM rrPar-4LZ in MQ-H2O pH 4. All samples were uniformly 15N-
labelled and contained 5% D2O (v/v) in the sample buffer. All spectra were recorded with 24 transients, 
further acquisition parameters are listed in Appendix G. The spectrum of rrPar-4LZ at pH 4 was 
apodised using a shifted (π/5) sinusoidal function in F2 and a shifted (π/2) squared sinusoidal bell 
function in F1.
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 Common to all rrPar-4LZ NMR spectra at pH values greater or equal to pH 6.0 is therefore 
the display  of sharp peaks and of narrow 1H chemical shift dispersions, which as discussed in 
Chapter 1.6.4. are characteristics of protein disorder. These features were observed for all 
rrPar-4LZ spectra at 5 and 25 ºC, and did not significantly  change between pH 7.0 and 6.0. 
Conversely, rrPar-4LZ at pH 4 displays a distinct NMR spectrum at 25 ºC with a slightly 
increased 1H chemical shift dispersion. For clarity, representative peaks with an increased 
dispersion are marked by black boxes in Figure 4.9C. As mentioned earlier, CD 
spectropolarimetry  shows that rrPar-4LZ at pH 4 adopts a coiled coil conformation (Fig. 4.2D) 
and is more thermo-stable (Fig. 4.3A) than other rrPar-4LZ samples at higher pH. However, the 
NMR spectrum is complicated by  a reduced signal intensity  and severe line broadening with an 
average 1H line width and standard deviation of 38.5 ± 43.9 Hz. Loss of signal intensity  and line 
broadening is further enhanced at 5 ºC resulting in a sharp reduction in signal intensity (data not 
shown). The importance of these facts will be discussed further below.
 The absence of NMR observable secondary structure for rrPar-4LZ at pH 6.0 and 5 ºC is 
further corroborated by 15N-relaxation studies (Fig. 4.10). The central residues Met 291-Val 327 
show R1 rates of 2.78 ± 0.14 s-1 and R2 rates of 7.03 ± 1.08 s-1 (Fig. 4.10A). In contrast, R2 rates 
of approximately  14 s-1 were observed for the dimeric state of the 46-residue rJunLZ [262]. This 
suggests that under these conditions, the rrPar-4LZ peaks correspond to a flexible non-folded 
state. The rrPar-4LZ N- and C-termini show greater flexibility than the central residues, marked 
by lower R2 relaxation rates without significant lowering of R1 rates (Fig. 4.10A). The termini 
also have negative or weakly  positive {1H}15N-NOE (Fig. 4.10B). To determine the contribution 
of chemical exchange processes to the apparent R2 rates, the exchange rate (Rex) was calculated 
from ηxy [183]. Rex contributions are suggested for residues Gly 293-Leu 301 (Fig. 4.10C).
 Values of 0.8 ± 0.1 for {1H}15N steady-state NOEs are usually observed for residues in 
regular secondary structure (e.g. α-helices and β-sheets), whereas negative values are observed 
for residues in highly flexible regions like the N- or C-terminal ends of proteins [263]. For the 
central residues Met 291-Val 327 of rrPar-4LZ, {1H}15N-NOE values of 0.41 ± 0.09 (Fig. 4.10B) 
were obtained, which is typically interpreted as an intermediate state between rigid secondary 
structure and high flexibility [146,263]. Similar {1H}15N-NOE values, R1, and R2 rates were 
obtained for rrPar-4LZ at pH 7.0 and 5 ºC consistent with an unfolded conformation (data not 
shown). Additional evidence for the absence of stable secondary structures at  5 ºC and pH 6.0 
comes from 3JHNHα coupling constant measurements. The calculated values of approximately 
6.4 ± 0.8 Hz are characteristic of a mostly disordered conformation (Fig. 4.10D). For 
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comparison, coupling constants for the α-helical rJunLZ dimer were approximately  4-5 Hz 
[246]. Note that NOESY spectra also show no indications of secondary structure within 
rrPar-4LZ at pH 6.0 (data not shown). As only  rrPar-4LZ samples at pH values greater or equal 
to pH 6.0 were amenable to NMR relaxation studies, no 15N-relaxation data was acquired for the 
coiled coil rrPar-4LZ at pH 4 (Fig. 4.2A) due to insufficient signal intensity  and severe line 
broadening.
 Figure 4.10 − 15N-relaxation and J-coupling of rrPar-4LZ at pH 6.0 and 5 ºC. (A) R1 (black bars) and 
R2 (grey bars) rates, (B) {1H}15N-NOE and (C) Rex rates [183,257] of not significantly overlapped peaks. 
Black bars in part (C) indicate Rex contributions > 1.5 s-1. (D) 3JHNHα coupling constants for the same 
residues. Coupling constants for glycine residues are not shown. 15N-relaxation rates, {1H}15N-NOE and 
3JHNHα coupling constants were acquired with a 100 µM sample in 20 mM NaCl, 10 mM Mes, pH 6.0 at 
5 ºC and Rex rates with a 60 µM sample.
 Only minor differences are observed at the first  glance in the NMR spectra of rrPar-4LZ at 
5 ºC and pH values of 7.0 and 6.0 (Fig. 4.9A), however, significant differences between these 
NMR spectra are observed for the HMQC cross peak intensities. After correcting for 
concentration differences, a decrease in signal intensity for the majority  of peaks of 45-65% is 
evident at pH 6.0 relative to pH 7.0, with intermediate intensities at pH 6.5 (Fig. 4.11A). At pH 4 
the decrease is even more pronounced than at pH 6.0 (Fig. 4.11B). However, due to line 
broadening only a few resonances could be identified that overlay  with peaks of the mostly 
unfolded rrPar-4LZ at pH 7.0 (a representative peak is marked by  a black arrow in Figure 4.9C). 
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The cross peak intensities of rrPar-4LZ at pH 4 and 5 ºC were not analysed due to insufficient 
signal intensity.
 Figure 4.11 − NMR peak intensity of Par-4 LZ peptides. (A) 1H,15N-SOFAST-HMQC peak intensity of 
rrPar-4LZ at 5 ºC as a function of pH. Displayed are the normalised peak heights at pH 7.0, pH 6.5 and 
pH 6.0. Intensities at pH 6.0 were acquired with a 60 µM rrPar-4LZ sample and were adjusted by a 
factor of 1.25 for comparison with the intensities at pH 7.0 and pH 6.5 acquired with 75 µM samples. (B) 
1H,15N-SOFAST-HMQC peak intensities at 25 ºC for rrPar-4LZ at pH 7.0 and 4, rrPar-4LZE310K at 
pH 7.0 and rrPar-4LZD305K at pH 7.0. Intensities of rrPar-4LZ at pH 4 were acquired with a 50 µM 
sample and were adjusted by a factor of 1.5 for comparison with the intensities of the other peptides 
acquired with 75 µM samples. Only resonances not significantly overlapped in each spectrum were 
analysed. Gaps for rrPar-4LZ at pH 4 indicate residues that could not be identified in the corresponding 
spectrum. Intensities were measured as peak heights. No significantly different results are obtained using 
peak volumes. Intensities in both panels were normalised to the highest peak intensity for comparison. 
The abbreviations WT, D305K and E310K denote rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, 
respectively.
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 As mentioned in the previous chapter, a drop  in pH is associated with an increase in α-helicity 
(Fig. 4.2). Based on SEC and MALLS results, a structural interconversion between DOM and 
POD fractions of the Par-4 LZ peptides was proposed in the previous chapter. The observed 
decrease in cross peak signal intensity of 45-65% for rrPar-4LZ at pH 6.0 (Fig. 4.11A) correlates 
well with the observed α-helicity  of 56% (Fig. 4.2C). This signal intensity  decrease and the 
chemical shift  similarities of the analysed peaks suggest  that the observable NMR cross peaks 
represent the DOM  fraction. The reduced cross peak intensities are consistent  with CD 
spectropolarimetry  results suggesting that the DOM fraction is the minor population under acidic 
conditions (Figs. 4.2C and D). The assignment of these peaks to the DOM fractions is further 
consistent with the 15N-relaxation data (Fig. 4.10) and other indications for protein disorder, such 
as sharp peaks, a narrow 1H chemical shift dispersion and chemical shift values close to random 
coil shifts (Fig. 4.9A).
 The results shown in Figures 4.9 and 4.11 also suggest that peaks of the POD fraction are not 
accessible by  NMR at the used NMR parameters with 24 transients per increments. A possible 
explanation is that peaks of the POD fraction are line broadened resulting in a signal intensity 
decrease beyond detection limits. Line broadening has been repeatedly observed for coiled coils 
and representative examples are given below. Relative to residues of the flexible and disordered 
C-Terminus of HSBP1 (heat shock binding protein 1), residues that  were part of the helical 
domain, which forms a coiled coil, were broad and of low intensity [247]. It was proposed by  the 
authors that line broadening is due to oligomerisation and/or non-globular shapes affecting the 
tumbling rate of the molecule. The contribution from non-globular shapes to the observed line 
broadening for the Par-4 LZ peptides is questionable, as NMR spectra with reasonably  sharp 
lines have been obtained for coiled coils of similar length (e.g. rJun leucine zipper [246], FIP2 
[264], or the N-terminus of the nucleocapsid protein of the Andes Hantavirus[265]). 
Additionally, line broadening may be due to chemical exchange processes as described for the 
coiled coil domain of FIP2 [264]. In complex with Rab11 a stable coiled coil is observed for 
FIP2. However, when unbound to Rab11 internal motions within FIP2 result in a fraying of the 
helices at the C-terminal end of the FIP2 coiled coil [264]. The observed line broadening for 
rrPar-4LZ at pH 4 indicates that similar mechanisms exist for the Par-4 LZ peptides resulting in 
the inaccessibility of the POD fraction. However, DLS results (Chapter 4.2.2.c) argue against 
aggregation.
 As the DOM peaks are observed as a separate set of peaks this suggests that chemical 
exchange between DOM and POD fractions is slow on the NMR time scale. A slow chemical 
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exchange process is likely  as exchange rates for model leucine zippers were found to be in the 
order of 10 s-1 [138]. This value is relatively small compared to the chemical shift difference 
observed for folded and unfolded leucine zippers [266]. Further indications for a slow exchange 
come from four additional peaks (marked by asterisks in Fig. 4.9A) observed for rrPar-4LZ at 
pH 6.0 and 5 ºC. Sequential assignment of these peaks is difficult, as they only become suitably 
intense under low pH conditions where solubility becomes limited. However, based on the 
chemical shifts, two of these peaks must  arise from a glycine and either a serine or a threonine. 
The only sequential Gly-Ser or Gly-Thr pair within the rrPar-4LZ sequence is Gly -2 and Ser -1 
(negative numbers indicate residues from the protease cleavage site). Additionally, the previously 
assigned Gly -2 and Ser -1 peaks show nearly identical nitrogen chemical shifts as these two 
additional peaks (Fig. 4.9A). Therefore, these two peaks were denoted Gly -2* and Ser -1*. The 
other two additional peaks were denoted Leu -3* and Gln 286* due to their proximity to the N-
terminal residues Leu -3 and Gln 286. The asterisks denote a second conformation arising as pH 
is decreased, which is likely the POD conformation.
 As the 11 N-terminal residues are not likely to form a coiled coil (Chapter 4.1.2.), they are 
probably  mostly  disordered independent of pH. This is consistent with a maximum of 70-85% α-
helicity for the Par-4 LZ peptides [184,185]. The intensity of these four additional peaks at 
pH 6.0 is significantly  greater at  5 ºC than at 25 ºC (Fig. 4.9B), corroborating that these peaks 
stem from the N-terminus of the POD fraction, which is more populated at  5 ºC than at 25 ºC 
(Fig. 4.2C). Relative to Gly -2 and Ser -1 of the DOM fraction, Gly -2* and Ser -1* have similar 
R1 rates of approximately 2 s-1, but four to six times higher R2 rates (Fig. 4.10A). The increased 
R2 rates are partly due to an increase in Rex (Fig. 4.10C). Furthermore, the {1H}15N-NOE are 
slightly larger than for the peaks of the DOM  fraction (Fig. 4.10B). Taken together, these data 
suggest that Gly -2* and Ser -1* are relatively  unstructured regions of the POD fraction. Relative 
to the ordered section of the POD fraction, these four additional peaks are more flexible and thus 
have sharper and more intense lines. Other peaks arising from residues of the POD fraction are 
either exchange broadened as described above, and/or are of to low intensity for detection under 
the conditions used. Otherwise peaks could be overlapped by the more intense peaks stemming 
from the DOM fraction.
 A similar dynamic exchange between a dimeric coiled coil state and a monomeric less 
structured state was recently described for the GCN4 leucine zipper [266]. In contrast to the 
present study, the monomeric form predominated at low pH. The monomeric state of GCN4 is in 
many ways consistent with the disordered rrPar-4LZ fraction. Both peptides display  similar 
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chemical shift dispersions and each provides indications of residual α-helical structure (see 
above). In both cases, central residues displayed {1H}15N-NOE near 0.4, and in the case of 
GCN4, this was explained by the proposal of a structural core. Conversely, the {1H}15N-NOE for 
urea unfolded GCN4 were mostly  negative. It  was suggested that this monomeric form of GCN4 
represents a stable folding intermediate that facilitates dimerisation; a proposal that is not 
inconsistent with the data for the Par-4 LZ domain. A further analysis of the coiled coil state of 
rrPar-4LZ was difficult due to its poor NMR spectroscopic properties. At pH 6.0 the solubility of 
rrPar-4LZ is limited and at pH 4 the NMR spectra are affected by severe line broadening. 
Therefore, NMR spectroscopy was focussed on the LZ point mutants rrPar-4LZD305K and 
rrPar-4LZE310K, which form a coiled coil independent of pH [185], but also display a better 
solubility than rrPar-4LZ at pH 6.0.
 The NMR spectra of the LZ point mutants rrPar-4LZD305K and rrPar-4LZE310K at 25 ºC 
and pH 7.0 are very similar to the spectrum of rrPar-4LZ at pH 4 (Figs. 4.12A and B), with all 
spectra displaying a similar 1H chemical shift  dispersion. Additionally, broad lines are evident for 
rrPar-4LZD305K and some less pronounced line broadening also occurs for rrPar-4LZE310K. 
The average 1H line widths for various Par-4 LZ peptides at 25 ºC are 17.5 ± 2.8 Hz (rrPar-4LZ, 
pH 7.0), 32.5 ± 11.1 Hz (rrPar-4LZE310K, pH 7.0) 43.7 ± 27.8 Hz (rrPar-4LZD305K, pH 7.0) 
and 38.5 ± 43.9 Hz (rrPar-4LZ, pH 4). The large standard deviation of rrPar-4LZD305K and 
rrPar-4LZ (pH 4) line widths is a result from the broadest line widths. The observed line 
broadening for the latter three peptides is even more pronounced at 5 ºC (data not shown). 
Interestingly, this increase in 1H line widths for the Par-4 LZ peptides appears to be correlated 
with an increase in thermal stability and coiled coil formation (Figs. 4.3A and B). Line 
broadening is probably  not due to high molecular weight complex formation, as aggregation is 
not suggested by  DLS or SEC for these NMR samples (Chapters 4.2.2.b and c). Consistent with 
the NMR signal intensity decrease observed for rrPar-4LZ with decreasing pH, rrPar-4LZD305K 
and rrPar-4LZE310K at pH 7.0 and 25 ºC display  a pronounced loss in HMQC cross peak 
intensity (Fig. 4.11B). The more stable rrPar-4LZD305K displays a lower signal intensity  at 
pH 7.0 than rrPar-4LZE310K. Analysis of the cross peak intensity at 5 ºC of both these peptides 
was not done due to insufficient  signal intensity. As was proposed for rrPar-4LZ, these results 
suggest that the analysed peaks, which overlay with peaks of rrPar-4LZ at pH 7.0 (marked by 
black arrows in Figs. 4.12A and B), represent the DOM  fraction. As the DOM fraction is the 
minor population for both LZ point mutants at 25 ºC (Figs. 4.2E and F) a significantly  reduced 
intensity for these peaks is expected relative to the disordered rrPar-4LZ at pH 7.0.
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 Figure 4.12 − 1H,15N-SOFAST-HMQC spectra of the Par-4 LZ point mutants. Overlay of the NMR 
spectra of rrPar-4LZ at pH 4 (green contours) and (A) rrPar-4LZE310K at pH 7.0 (red contours) or (B) 
rrPar-4LZD305K at pH 7.0 (orange contours). The influence of increasing concentrations of the 
denaturant urea on the 1H,15N-SOFAST-HMQC spectra of rrPar-4LZD305K at pH 7.0 is shown in 
Figures (C) and (D). Compared are the spectra in the absence of urea (orange contours) with the spectra 
in the presence of (C) 1 M urea (brown contours) and (D) 6 M urea (brown contours). Selected peaks 
associated with the POD conformation are marked by black boxes. The black arrow indicates 
representative peaks that are associated with the DOM conformation. All samples were uniformly 15N-
labelled and contained 5% D2O (v/v) in the sample buffer. Sample conditions were 50 µM rrPar-4LZ in 
MQ-H2O, pH 4; 75 µM rrPar-4LZE310K in 20 mM NaCl, 10 mM Tris, pH 7.0; and 75 µM 
rrPar-4LZD305K in 20 mM NaCl, 10 mM Tris, pH 7.0, with 0 M, 1 M and 6 M urea, respectively. All 
spectra were acquired at 25 ºC with 24 transients, further acquisition parameters are given in 
Appendix G. All spectra except for rrPar-4LZD305K in 6 M urea were apodised using a shifted (π/5) 
sinusoidal function in F2 and a shifted (π/2) squared sinusoidal bell function in F1. The abbreviations 
WT, D305K and E310K denote rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, respectively.
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 A similar degree of line broadening at 25 ºC is observed for rrPar-4LZD305K at pH 7.0 in the 
presence of 1 M urea relative to the spectrum without urea (Fig. 4.12C). Both spectra are very 
similar apart from minor shift  differences for some of the peaks. The shift differences may be 
due to the loss of secondary structure as observed by CD spectropolarimetry (Fig. 4.3C). As 
aggregation is disfavoured in the presence of 1 M urea and no aggregated species could be 
detected by DLS (Fig. 4.5D), this suggests that the observed line broadening is due to dynamic 
exchange processes within the POD fraction of rrPar-4LZD305K. Significantly sharper lines are 
observed for rrPar-4LZD305K at 25 ºC and pH 7.0 in the presence of 6 M urea (Fig. 4.12D). 
Additionally, a significant reduction in the 1H chemical shift  dispersion is evident. This is 
consistent with a urea unfolded state as indicated by  CD spectropolarimetry  (Fig. 4.3C). Note 
that similar results were obtained for rrPar-4LZE310K in 6 M urea (data not shown).
 These results indicate that the observed line broadening in the NMR spectra of the Par-4 LZ 
peptides (Figs. 4.9C and 4.12) reflects the coiled coil formation observed by CD spectro-
polarimetry. A slow exchange mechanism between POD and DOM states was proposed above 
for rrPar-4LZ, with the equilibrium between PODs and DOMs depending on the pH. A similar 
exchange process is likely  for the LZ point mutants, and peaks affected by line broadening are 
probably  associated with the POD fraction. 1H,15N-HSQC spectra of both LZ point mutants 
further suggest the existence of two separate sets of peaks (data not shown). However, analysis 
of the 1H,15N-HSQC spectra of rrPar-4LZD305K was still difficult due to line broadening. With 
the aim of reducing line broadening contributions from oligomerisation, a partially deuterated 
REDPRO sample of rrPar-4LZE310K was prepared (Chapter 2.11.8.). This peptide was chosen 
due to its ability  to form a coiled coil (Fig. 4.2F) with only minor line broadening at relatively 
high concentration (Fig. 4.12A). In particular the broad peaks (marked by  black boxes in 
Fig. 4.13A) of REDPRO rrPar-4LZE310K at pH 7.0 and 5 ºC displayed an improvement in line 
shape and peak intensity using a 1H,15N-TROSY-HSQC sequence. These results allowed a 
characterisation of some of the POD-associated peaks by 15N-relaxation measurements (see 
below).
 The 1H,15N-TROSY-HSQC spectrum of REDPRO rrPar-4LZE310K at pH 7.0 and 5 ºC 
clearly  shows the existence of two separate sets of peaks (Fig. 4.13A). A conservative peak count 
results in approximately 26 peaks with sharp lines and approximately  38 peaks with broad lines. 
The average 1H line widths of these peaks were 6.4 ± 2.1 Hz for the sharp  peaks, and 
26.1 ± 2.1 Hz for the broad peaks. Only the 1H line widths of well resolved peaks were analysed 
(Fig. 4.13A). Analysis of well resolved peaks further indicates a volume ratio of 1:3 between 
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sharp and broad peaks. Furthermore, {1H}15N NOE values of the broad peaks are slightly 
increased (0.60 ± 0.07) relative to the {1H}15N NOE values of the sharp peaks (0.34 ± 0.25). The 
large standard deviation for the sharp peaks arises due to negative values from residues probably 
located at the C-terminus of rrPar-4LZE310K. The majority of the sharp  peaks overlay with 
peaks of rrPar-4LZ at pH 7.0 and 5 ºC (a representative peak is marked by a black arrow in 
Fig. 4.13A). This suggests a similar chemical environment for these residues in both peptides 
and thus indicates that these residues are associated with the DOM fraction. In contrast, the three 
times increased volume of the broad peaks of REDPRO rrPar-4LZE310K suggest that the broad 
peaks represent the major population, which under these conditions is the POD fraction as 
indicated by CD spectropolarimetry (Fig. 4.2F). In addition, this set of broad peaks displays a 
wider chemical shift dispersion relative to the set of sharp peaks. For clarity, representative 
POD-associated peaks are marked by black boxes in Figure 4.13A. Furthermore, the {1H}15N 
steady  state NOE values of ~0.6 for the broad peaks of rrPar-4LZE310K confirm their 
assignment to the POD fraction, and indicates that residues of the POD fraction are in a slightly 
more rigid conformation than residues of the DOM  fraction with {1H}15N NOEs of ~0.34. 
However, a {1H}15N NOE value of 0.6 is still not indicative of rigid secondary structure [263] as 
expected for a coiled coil, and hence only suggests a predominantly ordered state. This suggests 
that internal factors within the Par-4 LZ sequence contribute to a less rigid conformation than is 
expected for stable leucine zippers, such as GCN4 or rJun [262].
 Similarly, two sets of peaks appear to exist for rrPar-4LZD305K at pH 7.0 (Fig. 4.12B) and 
rrPar-4LZ at pH 4 (Fig. 4.9C). However, artificially broad lines due to short acquisition times in 
the SOFAST-HMQC sequence make the difference in line widths less apparent. As the broader 
peaks have shorter proton T2 relaxation times, it is expected that a significant amount of NMR 
signal intensity is lost for these peaks during the evolution periods of the 1H,15N-correlation 
experiment relative to the signal intensity of the sharp  peaks. The DOM and POD fractions are 
approximately equally  populated for rrPar-4LZ at pH 6.0 and 5 ºC, as is indicated by  an α-
helicity of 56% (Fig. 4.2C). A more accurate description of the population state between PODs 
and DOMs is not possible. The observed CD signal is an averaged signal and contains protein 
disorder contributions from the dynamic interconversion between DOMs and PODs, and from 
disordered segments at the N-terminus of rrPar-4LZ (see above). Considering the potential loss 
in NMR signal intensity  during the evolution periods of the NMR experiment and assuming 
equal populations of DOMs and PODs for rrPar-4LZ at pH 6.0 and 5 ºC, it  is expected that the 
(broad) peaks associated with the ordered region of the POD conformation are significantly less 
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intense than the peaks associated with the DOM fraction. The acquisition of a 1H,15N-SOFAST-
HMQC spectrum of rrPar-4LZ at pH 6.0 and 5 ºC with 512 transients shows the existence of a 
second set of peaks with greatly reduced signal intensity  (Fig. 4.13B). These peaks display 
similar chemical shifts than the second set  of peaks observed for REDPRO rrPar-4LZ 
(Fig. 4.13B), rrPar-4LZD305K (Fig. 4.12B) or rrPar-4LZ at pH 4 (Fig. 4.9C). For clarity, these 
peaks are marked by  black boxes in the corresponding spectra. These observations are consistent 
with the above proposed slow chemical exchange between DOM and POD conformations.
 Figure 4.13 − A second set of peaks exist in the NMR spectra of the Par-4 LZ peptides. (A) Pairwise 
overlay of the 1H,15N-SOFAST-HMQC spectrum of rrPar-4LZ at pH 7.0 (black contours) and the 1H,15N-
TROSY-HSQC spectrum of rrPar-4LZE310K at pH 7.0 (red contours) (B) Comparison of the 1H,15N-
TROSY-HSQC spectrum  of rrPar-4LZE310K at pH 7.0 (red contours) and the 1H,15N-SOFAST-HMQC 
spectrum of rrPar-4LZ at pH 6.0 acquired with 512 transients (blue contours). Selected peaks associated 
with the POD conformation are marked by black boxes. The black arrow indicates representative peaks 
associated with the DOM conformation. All samples were uniformly 15N-labelled and contained 5% 
D2O (v/v) in the sample buffer. Sample conditions were 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, 
pH 7.0; 40 µM rrPar-4LZ in 20 mM NaCl, 10 mM Mes, pH 6.0; and 300 µM rrPar-4LZE310K in 20 mM 
NaCl, 10 mM Tris, pH 7.0. All spectra were acquired at 5 ºC, further acquisition parameters are given in 
Appendix G. The spectrum  of REDPRO rrPar-4LZE310K at pH 7.0 was apodised using a shifted (π/5) 
sinusoidal function in F2 and a shifted (π/2) squared sinusoidal bell function in F1. The abbreviations 
WT, D305K and E310K denote rrPar-4LZ, rrPar-4LZD305K and rrPar-4LZE310K, respectively.
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 The total peak number for REDPRO rrPar-4LZE310K was estimated with 64 peaks (see 
above). Since rrPar-4LZE310K contains only 51 residues, this suggests that only some residues 
are in slow exchange with a second conformation. However, an isodichroic point is observed for 
this peptide by CD spectropolarimetry (Fig. 4.2F), indicating that interconversion is only 
between two states without significantly  populated intermediates. This implies that separate sets 
of peaks arise from the DOM and POD fractions. However, spectral overlap  may  masks some 
peaks from both fractions. The N-terminus of the Par-4 LZ peptides is predicted to be disordered 
and may  thus possess distinct  NMR properties relative to the C-terminal residues involved in 
coiled coil formation. It is therefore possible that some of the observed peaks are not in a slow 
exchange between DOM and POD conformations, but in an intermediate to fast exchange. This 
may result in missing peaks due to line broadening or in averaged NMR signals. It may therefore 
be necessary to assign the additional peaks and also obtain additional 15N-relaxation experiments 
for a better characterisation of the involved exchange processes. However, chemical shift 
assignment of these additional peaks appears to be a challenging task, due to the narrow 
chemical shift dispersion of the Par-4 LZ peptides, resulting in peak overlap. The low signal 
intensity of the POD-associated peaks (rrPar-4LZ at pH 6.0 and 5 ºC) and a low resolution due to 
severe line broadening (e.g. rrPar-4LZ at pH 4.4, rrPar-4LZD305K at pH 7.0) are further factors 
limiting an assignment approach. Furthermore, it may be necessary to obtain kinetic data for the 
strand exchange rates of the Par-4 LZ coiled coils. This kinetic data should then be analysed for 
consistency with the proposed slow exchange process between DOMs and PODs.
 The {1H,15N}-NOEs of ~0.6 obtained for the broad peaks of the POD fraction of REDPRO 
rrPar-4LZE310K indicate that the backbone of the respective residues is of moderate rigidity. 
For stable secondary structure, and usually for coiled coils, {1H}15N-NOEs of approximately 0.8 
are observed [262,263]. These results are in contrast to CD spectropolarimetry results indicating 
a stable coiled coil conformation (Fig. 4.2F). Consistent with a less rigid coiled coil, peaks of the 
coiled coil POD fraction are affected by line broadening (Fig. 4.13A). It  is not known what 
causes the line broadening, but together with the {1H}15N-NOE values these results suggest that 
the coiled coil dimer experiences some kind of destabilisation. This destabilisation may be a 
result of internal motions within the coiled coil fraction. Various residues within the Par-4 LZ 
sequence have been described in Chapter 4.1.2. to be detrimental for coiled coil stability. The 
decrease in stability conferred by these residues may allow for internal motions and may thus 
cause the peaks of the POD fraction to broaden. As such important residues two asparagine 
residues (Asn 313 and Asn 320, Fig. 4.1) were identified. The influence of Asn 313 on coiled 
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coil stability  will be described in Chapter 4.5.2. However, other acidic residues, such as the 
aspartate patch (Fig. 4.1E), may also be critical for the coiled coil destabilisation, as the LZ point 
mutants show a slight increase in stability  with decreasing pH [185]. One may propose that the 
coiled coil conformation of the Par-4 LZ peptides displays properties of a molten-globule. Like a 
molten-globule, coiled coil Par-4 LZ peptides contain secondary structure, but also possess a 
significant degree of flexibility. However, the current data is not sufficient to call the coiled coil 
state of rrPar-4LZE310K a molten-globule, and hence this conformation is described in this 
document as a predominantly ordered dimer (POD).
 In summary, while coiled coil formation of the Par-4 LZ domain is observed by CD 
spectropolarimetry, NMR spectroscopy and other techniques suggest that the formed coiled coils 
are, at least under certain conditions, transient in nature and in equilibrium with disordered 
monomers. However, the coiled coil dimers are less stable relative to well-characterised leucine 
zipper model peptides, and are therefore more appropriately described as predominantly  ordered. 
Destabilisation of the Par-4 LZ coiled coil is probably related to sequence peculiarities within the 
Par-4 LZ sequence. The data further suggest that chemical exchange between DOMs and PODs 
is slow on the NMR time scale.
4.4. The effect of TFE on coiled coil formation of rrPar-4LZ
4.4.1. Materials and Methods
a) Sample preparation
 Samples of rrPar-4LZ were prepared at neutral pH with increasing concentrations of d3-TFE 
from 10-30% (v/v) (Table 4.5). As described in Chapter 4.2.1.a, the H2O-dissolved rrPar-4LZ was 
diluted in appropriate buffer to give a final peptide concentration of 75 µM. Addition of d3-TFE 
to 20 mM NaCl, 10 mM Tris, pH 7.0 resulted in a pH decrease to approximately 5. Therefore 
buffer and TFE were mixed in advance, neutralised and than used to dilute the rrPar-4LZ aliquot. 
For sterility reasons, pH values were measured with suitable pH paper strips. The same samples 
were used for CD and NMR spectroscopy.
b) Circular Dichroism
 CD spectra were recorded in 1 nm steps from 260 to 190 nm as described in Chapter 3.4.1.a. 
Acquisition parameters are given in Appendix F. Spectral deconvolution was performed with the 
algorithms Selcon3 [267] and CONTIN-LL [213] through the DICHROWEB interface.
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rrPar-4LZ peptide concentration Buffer composition
a) 75 µM 20 mM NaCl, 10 mM Tris, pH 7 + 10% d3-TFE (v/v)
b) 75 µM 20 mM NaCl, 10 mM Tris, pH 7 + 20% d3-TFE (v/v)
c) 75 µM 20 mM NaCl, 10 mM Tris, pH 7 + 30% d3-TFE (v/v)
d) 75 µM 20 mM NaCl, 10 mM Tris, pH 5 + 30% d3-TFE (v/v)
 Table 4.5 − Sample conditions of rrPar-4LZ with increasing concentrations of TFE.
c) NMR spectroscopy
 NMR experiments were performed on a Bruker Avance 700 MHz spectrometer as described 
in Chapter 3.4.1.b. 1H,15N-correlation spectra are acquired on 300 µl samples in D2O matched 
Shigemi NMR tubes. All samples were uniformly 15N-labelled and contained 5% D2O (v/v) in the 
sample buffer. All spectra were recorded at 5 ºC and 25 ºC. The carrier frequency was set to the 
frequency of the water resonance in the 1H dimension. Further acquisition parameters are given 
in Appendix G. Spectra were processed and referenced as described in Chapter 3.4.1.b. using a 
shifted (π/2) squared sinusoidal bell function for apodisation.
4.4.2. Results and Discussion
 Due to the problems associated with conformational exchange in the NMR spectra of the Par 
LZ peptides (see previous chapter), alternative methods were sought to stabilise the coiled coil 
conformation. The additive TFE has been described to stabilise secondary structures such as α-
helices [140]. Under certain conditions TFE was able to induce dimerisation and trimerisation of 
amphipathic α-helical peptides [268]. It was therefore thought that TFE might stabilise the α-
helical coiled coil fraction, and also reduce exchange with the disordered fraction. However, it 
was demonstrated previously  that TFE is able to disrupt tertiary and quaternary structures. 
Dependent on the concentration, TFE can dissociate coiled coils into monomeric forms 
[142,269]. The rationale was therefore to test if TFE can induce a transition from the disordered 
to an α-helical state of rrPar-4LZ. It  was further interesting to analyse if TFE would allow for 
self-association of rrPar-4LZ, or conversely  would disrupt the coiled coils. As TFE has also been 
described to affect conformational exchange equilibria and shift these to time scales that may 
allow structural characterisation by NMR [140,223], a potential improvement of the NMR 
spectra was another rationale for using TFE.
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 Figure 4.14  − CD spectropolarimetry of rrPar-4LZ under various TFE concentrations. Temperature 
dependence of the CD spectra of rrPar-4LZ at pH 7 with (A, B) 10% d3-TFE (v/v), (C, D) 20% d3-TFE 
(v/v), and (E, F) 30% d3-TFE (v/v). The influence of pH on the CD spectrum at 30% d3-TFE (v/v) at pH 5 is 
shown in panels (G) and (H). All spectra were acquired in 5 ºC intervals over a temperature range of 
5-75 ºC and traces for each temperature are shown in panels A, C, E and G. For clarity panels B, D, F 
and H show traces of five evenly spaced temperatures. (I) Thermal stability of rrPar-4LZ under various 
TFE concentrations showing the %[θ]222 values as a function of temperature. The %[θ]222 values were 
obtained by normalising the [θ]222 values at each temperature to the corresponding [θ]222 value at 5 ºC. 
Acquisition parameters are given in Appendix F. Sample concentrations are listed in Table 4.5.
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 CD spectra of rrPar-4LZ in TFE are shown in Figure 4.14. Significant α-helical character is 
obvious at 5 ºC under all TFE concentrations. However, at 25 ºC α-helicity is only observed for 
30% TFE, pH 5 (Fig. 4.14G). The spectrum at 10% TFE, pH 7 and 25 ºC suggests a mostly 
disordered state (Fig. 4.14A), with moderate α-helicities at 20% and 30% TFE at pH 7 
(Figs. 4.14C-F). This indicates that TFE stabilises an α-helical conformation of rrPar-4LZ at 
neutral pH as opposed to similar conditions without TFE (Fig. 4.2A). Spectral deconvolution 
further demonstrates an increase in α-helicity with increasing TFE concentrations and decreasing 
temperatures (Table 4.6). The Selcon3 algorithm suggests an increase in α-helicity  at 5 ºC from 
58% (10% TFE, pH 7) to 82% (30% TFE, pH 5). Similarly at 25 ºC, the α-helical content 
increases from 23% (10% TFE, pH 7) to 69% (30% TFE, pH 5). It  is further evident from these 
results that under identical TFE concentrations an acidic pH contributes to increased stability 
over neutral pH values. This is consistent with the previous notion that acidic residues within the 
Par-4 LZ domain are critical for coiled coil stability. It  should be noted that for the Selcon3 
algorithm the fits between calculated and experimental data are not optimal. NRMSD values 
above 0.25 are usually regarded as to constitute an error in the analysis procedure and values less 
than 0.1 should be aimed for [182]. Better NRMSD values are obtained using the CONTIN-LL 
algorithm (Table 4.6). Apart from slight differences at 25 ºC and for 10% TFE, pH 7 the 
deconvolution results from the CONTIN-LL algorithm are similar to the results from the Selcon3 
algorithm. Note that the overall increase in α-helicity with increasing TFE concentrations is not 
as well reflected in the deconvolution results from the CONTIN-LL algorithm.
 Despite this clear increase in α-helicity with increasing TFE concentration, the gain in thermal 
stability  is only small (Fig. 4.14I). At neutral pH the Tm value increases from 20 ºC (10% TFE) to 
25 ºC (20% TFE) (Table 4.7). Interestingly, at pH 7 rrPar-4LZ is more stable in 20% TFE than in 
30% TFE. A further increase is observed at 30% TFE, pH 5 with a Tm value of 35 ºC (Table 4.7). 
However, these values are significantly  lower than the thermal stabilities observed for rrPar-4LZ 
at pH 4 (Tm ≈ 50 ºC) and rrPar-4LZD305K at pH 7.0 (Tm ≈ 45 ºC) (Fig. 4.3B). This indicates that 
the latter two conditions are more stable and probably better suited for structural analysis than 
rrPar-4LZ in TFE. This is corroborated by  the supercoiling status. The [θ]222/[θ]208 ratios of 
rrPar-4LZ in TFE are shown in Table 4.7. No stable supercoiling is indicated for all tested TFE 
concentrations. In particular at 25 ºC, the [θ]222/[θ]208 ratios suggest mainly  monomeric states. 
Again this indicates that addition of TFE does not result in a greater stability  of the coiled coil 
relative to rrPar-4LZ at pH 4 or rrPar-4LZD305K at pH 7.0 (Figs. 4.2D and E). As mentioned 
earlier, [θ]222/[θ]208 ratios above one indicate supercoiling whereas values below 0.9 are usually 
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interpreted as non-interacting helices (see Ref. [142] and references therein). Therefore, the 
observed [θ]222/[θ]208 ratios at 5 ºC, which are close to 1, suggest a more dynamic equilibrium 
between α-helical and disordered states relative to rrPar-4LZ at pH 4 and rrPar-4LZD305K. Note 
that rrPar-4LZ in 30% TFE has a similar helical content to rrPar-4LZ at  pH 4 or 
rrPar-4LZD305K at pH 7.0 (compare Figs. 4.2D and E with Figs. 4.14E and G). However, the 
[θ]222/[θ]208 ratios between 1.0 and 0.9 suggest a more dynamic interconversion between 
disordered and α-helical states for rrPar-4LZ in 30% TFE. Additionally, in the presence of TFE 
the transition between α-helical and unfolded states appears to be of complex nature, as no well-
defined isodichroic points are observed (Figs. 4.14E and G).
α-helix (NRMSD)
Selcon3 CONTIN-LL
Buffer composition 5 ºC 25 ºC 5 ºC 25 ºC
0% TFE, pH 7.0 18% (0.172) 13% (2.103) 18% (0.058) 9% (0.63)
0% TFE, pH 6.0 53% (0.219) 22% (0.258) 74% (0.082) 22% (0.058)
10% TFE, pH 7.0 58% (0.157) 23% (0.373) 71% (0.077) 24% (0.084)
20% TFE, pH 7.0 68% (0.121) 46% (0.256) 69% (0.030) 56% (0.084)
30% TFE, pH 7.0 79% (0.120) 49% (0.280) 83% (0.023) 60% (0.097)
30% TFE, pH 5.0 82% (0.096) 69% (0.121) 81% (0.014) 74% (0.023)
 Table 4.6 − Influence of increasing TFE concentrations on the α-helicity of rrPar-4LZ. Spectral 
deconvolution was performed using the algorithms Selcon3 [267] and CONTIN-LL [213]. For simplicity, 
only the combined percentage of regular and distorted α-helix is shown. The NRMSD value is given in 
brackets as a quality parameter for each deconvolution. The corresponding CD spectra are shown in 
Fig. 4.14 and sample concentrations are given in Table 4.5. The results of rrPar-4LZ at pH 7.0 and 6.0 
without TFE are used for comparison. The corresponding CD spectra are shown in Figs. 4.2A and C. 
Sample concentrations for these two peptides were 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0 
and 40 µM rrPar-4LZ in 20 mM NaCl, 10 mM Mes, pH 6.0.
 TFE can dissociate coiled coils into monomers, and CD data suggests that TFE concentrations 
of 30% start to disrupt the coiled coil state of rrPar-4LZ at pH 7. Thermal stabilities and [θ]222/
[θ]208 ratios are reduced in the presence of 30% TFE relative to 20% TFE (Table 4.7). DLS 
measurements to determine the hydrodynamic properties of rrPar-4LZ in TFE were performed; 
however, measurements were unstable and the results of poor quality. This also indicates a very 
dynamic behaviour of rrPar-4LZ in TFE. Due to the poor quality  and great uncertainties in the 
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data, no DLS results are shown here. However, using TFE had another potentially positive 
outcome. Previous attempts to study rrPar-4LZ at pH 5 resulted in protein precipitation. Due to 
the well known ability  of TFE in solubilising proteins and peptides [140], no precipitation was 
observed allowing the analysis of rrPar-4LZ at pH 5 by CD and NMR spectroscopy. This ability 
of TFE may prove useful for other possibly  coiled coil Par-4 constructs that are prone to 
precipitate. However, suitable TFE concentrations need to be tested that do not completely 
disrupt the oligomeric state.
[θ]222/[θ]208 ratio
Buffer composition Tm 5 ºC 25 ºC
no TFE, pH 7.0 N/A 0.45 0.40
no TFE, pH 6.0 18 ºC 0.91 0.59
10% TFE, pH 7 20 ºC 0.99 0.72
20% TFE, pH 7 25 ºC 1.00 0.83
30% TFE, pH 7 22 ºC 0.97 0.78
30% TFE, pH 5 35 ºC 0.98 0.90
 Table 4.7 − Thermal stability and supercoiling of rrPar-4LZ under various TFE concentrations. 
Influence of increasing TFE concentrations on the Tm value and the [θ]222/[θ]208 ratio of rrPar-4LZ. 
Ratios above 1.0 are indicative of supercoiling. Tm values and [θ]222/[θ]208 ratios were calculated from the 
CD spectra shown in Figure 4.14. Protein concentrations and buffer conditions are given in the legend to 
Table 4.5. The results of rrPar-4LZ at pH 7.0 and 6.0 without TFE are used for comparison. The 
corresponding CD spectra are shown in Fig. 4.2A and C. Sample concentrations for these two peptides 
were 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0 and 40 µM rrPar-4LZ in 20 mM NaCl, 
10 mM Mes, pH 6.0.
 Despite the increase in α-helicity  with TFE, an improvement of the NMR spectra could not be 
achieved. The deconvolution algorithms predict a similar α-helical content for rrPar-4LZ in 10% 
TFE, pH 7 and for rrPar-4LZ at pH 6.0 without TFE (Table 4.6). Apart from slight shift 
differences, which are probably  due to TFE, almost identical NMR spectra are obtained under 
both conditions at 5 ºC (Fig. 4.15A) and 25 ºC (data not shown). As was discussed for rrPar-4LZ 
at pH 6.0 in the previous chapter, the NMR spectrum of rrPar-4LZ in 10% TFE, pH 7 displays no 
obvious signs of secondary structure. Interestingly, the additional peaks Gly -2* and Ser -1* 
(Fig. 4.9A) are also visible in the 10% TFE, pH 7 spectrum at 5 ºC. These peaks have been 
discussed above as belonging to the N-terminus of the POD conformation. As observed for 
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rrPar-4LZ at pH 6.0, the intensity  of these two peaks is temperature dependent and thus 
significantly decreased at  25 ºC (data not shown). These results suggests that the majority of the 
peaks observed for rrPar-4LZ in 10% TFE, pH 7 represent the DOM  fraction, and most peaks of 
the POD conformation are of low intensity, and therefore hidden in the noise.
 Figure 4.15 − 1H,15N-SOFAST-HMQC spectra of rrPar-4LZ at various TFE concentrations. (A) 
Pairwise overlay of the NMR spectra at 5 ºC of rrPar-4LZ at pH 6.0 (black contours) and rrPar-4LZ at 
pH 7 + 10% TFE (v/v) (red contours). Assignments are shown for rrPar-4LZ at pH 6.0. (B) Comparison of 
the NMR spectra at 5 ºC of rrPar-4LZ at pH 7 + 10% TFE (v/v) (black contours) with rrPar-4LZ at pH 7 
+ 20% TFE (v/v) (red contours) (C) Comparison of the same peptides as in panel (B) but at 25 ºC. (D) 
Overlay of the NMR spectra at 25 ºC of rrPar-4LZ + 30% TFE (v/v) at pH 7 (black contours) and pH 5 
(red contours). All samples were uniformly 15N-labelled and contained 5% D2O (v/v) in the sample buffer. 
Sample conditions were 40 µM rrPar-4LZ in 20 mM NaCl, 10 mM Mes, pH 6.0; conditions for the other 
peptides are given in Table 4.5. Acquisition parameters are given in Appendix G.
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 As higher TFE concentrations of 20% and 30% were shown to increase the α-helical content 
of rrPar-4LZ (Fig. 4.14), better quality  NMR spectra were expected. However, as higher TFE 
concentrations do not confer increased stability, these NMR spectra are severely affected by line 
broadening and decreased signal intensity. At  5 ºC, where CD spectropolarimetry indicates 
significant α-helical character, very  little signal is detected by  NMR (Fig. 4.15B). Not 
surprisingly, the most intense peaks probably  belong to the N- and C-terminal residues Leu -3, 
Gly -2, Ser -1 and Arg 322, which are probably  more flexible than other residues of rrPar-4LZ. 
Interestingly, Gly -2* and Ser -1* appear to be more intense than Gly -2 and Ser -1 (Fig. 4.15B, 
for assignments see panel A). The increase in signal intensity  at 25 ºC is probably due to a 
population increase of the DOM fraction (Fig. 4.15C). The peaks are further severely  line 
broadened, but the cause for this line broadening cannot be fully  explained at this time. It is 
possible that line broadening is related to the viscosity increase at higher TFE concentrations 
[270] affecting the tumbling rate of the molecule. Interestingly, no significant differences are 
observed in the NMR spectra for rrPar-4LZ in 30% TFE at pH 7 and 5 (Fig. 4.15D). The 
increased thermal stability observed at pH 5 (Fig. 4.14I) therefore does not result in an improved 
spectrum. Even though some peaks display an increased chemical shift dispersion and may thus 
be associated with the ordered fraction, the overall spectral quality is not suitable for further 
analysis.
 In summary, an α-helical fold, as judged by CD spectropolarimetry, is induced by  TFE at 
neutral pH. The α-helical content is dependent on the TFE concentration, but a higher α-helical 
content does not result in an increased stability of the ordered state. The results further suggest a 
very dynamic behaviour between disordered and ordered conformations in the presence of TFE. 
Overall no significant improvement in the NMR spectra was obtained that allowed a structure 
determination of the Par-4 LZ domain.
4.5. Asparagine residue contributions to Par-4 LZ stability
4.5.1. Materials and Methods
a) Sample preparation
 The rrPar-4LZN313I peptide was expressed and purified as described in Chapter 2.11.9. 
Samples at various pH values were prepared by diluting H2O-dissolved rrPar-4LZN313I with 
appropriate buffers (Table 4.8). For samples with pH values below or equal to pH 6.0 the 
solubility of rrPar-4LZN313I was reduced and precipitation occurred. The precipitate was 
removed by  centrifugation in a tabletop centrifuge and the protein concentration was 
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remeasured. The same samples were used for CD, DLS and NMR spectroscopy. Sample d 
(Table 4.8) was only used for NMR spectroscopy.
rrPar-4LZN313I peptide concentration Buffer composition
a) 50 µM 20 mM NaCl, 10 mM Tris, pH 7.0
b) 7 µM 20 mM NaCl, 10 mM Mes, pH 6.0
c) 40 µM H2O, pH 4
d) 2.5 mM H2O, pH 4
 Table 4.8 − Sample conditions of rrPar-4LZN313I at various pH values.
b) Circular Dichroism
 CD spectra were recorded in 1 nm steps from 260 to 190 nm as described in Chapter 3.4.1.a. 
Acquisition parameters are given in Appendix F. Spectral deconvolution was performed using 
the algorithms Selcon3 and CONTIN-LL through the DICHROWEB interface.
c) Dynamic Light Scattering
 DLS measurements were performed as described in Chapter 3.2.1.a.
d) NMR spectroscopy
 NMR experiments were performed on a Bruker Avance 700 MHz spectrometer as described 
in Chapter 3.4.1.b. 1H,15N-correlation spectra were acquired on 300 µl samples in D2O matched 
Shigemi NMR tubes. All samples were uniformly 15N-labelled and contained 5% D2O (v/v) in the 
sample buffer. All spectra were recorded at 5 ºC and 25 ºC. The carrier frequency was set to the 
frequency of the water resonance in the 1H dimension. Further acquisition parameters are given 
in Appendix G. The spectra were processed and referenced as described in Chapter 3.4.1.b. using 
a shifted (π/2) squared sinusoidal bell function for apodisation.
4.5.2. Results and Discussion
 Despite clear indications of coiled coil formation by CD spectropolarimetry, the poor quality 
of the NMR spectra of the Par-4 LZ did not allow a structure determination of the coiled coil 
conformation. In Chapter 4.2.2.b an interconversion between DOM  and POD conformations was 
proposed, and the equilibrium between DOM  and POD conformations was shown to be pH 
dependent. The DOM conformation dominates at neutral pH and the POD conformation at  pH 4 
4. Order-disorder Equilibria in the Coiled Coil region of Par-4
164
(Chapter 4.3.2.). However, NMR spectra at pH 4 showed severe line broadening for the majority 
of the POD-associated peaks, which prevented a more detailed analysis by NMR. It was 
suggested that line broadening is due to internal motions within the POD fraction 
(Chapter 4.3.2.). Stabilisation of the POD conformation, and thus a reduction in line broadening, 
was investigated as an approach that would allow structure determination. However, a 
stabilisation of the POD conformation could not be achieved by simple means such as addition 
of TFE. Therefore, other measures became necessary  to stabilise the coiled coil fraction of the 
Par-4 LZ peptides.
 Unlike most other LZ-families (except for the Oasis family) [117] the Par-4 LZ domain 
contains two asparagine residues at position a within its heptad repeats (Figs. 4.1B and C). These 
residues are proposed to contribute to conformational exchange. Previously, it was demonstrated 
that asparagine residues contribute to coiled coil stability, not by  affecting the association step, 
but mainly by  controlling the dissociation rate of the oligomer [242]. Furthermore, the influence 
of asparagine residues on coiled coil stability depends on their position in the coiled coil, with 
asparagine residues at the N-terminus having a greater destabilising effect than asparagine 
residues at the C-Terminus [243]. Also increasing numbers of asparagines result in decreased 
coiled coil stability [243]. To test whether the internal asparagine residues contribute to Par-4 LZ 
stability, the more N-terminal asparagine at position 313 (Fig. 4.1C) was mutated to an 
isoleucine residue. To preserve the proposed dimeric state (Chapter 4.1.2.) only one of the 
asparagine residues was mutated at a time. The remaining asparagine would further maintain the 
specificity of coiled coil formation and prevent the formation of coiled coils in different 
registers. Isoleucine was preferred over other hydrophobic residues as it strongly promotes a 
dimeric coiled coil conformation [129]. Unlike valine, which also promotes dimeric 
conformations, isoleucine contributes to an increased thermal stability  due to additional van der 
Waals interactions between methylene groups of residues at position a and d [109,129]. The 
rationale of this mutation approach was to create a Par-4 LZ peptide with a stable coiled coil 
conformation that would allow structure determination. A stable coiled coil conformation would 
further serve as a reference state for additional biophysical methods. Analysis of the Par-4 LZ 
peptides by  various techniques, such as SEC or DLS, has been complicated by the 
conformational exchange between dimeric and monomeric conformations (Chapter 4.2.2.).
 As was observed for the Par-4 LZ wild-type rrPar-4LZ, rrPar-4LZN313I is mostly insoluble at  
pH values below or equal to pH 6.0, but solubility improves around pH 4.0 or below. Not 
surprisingly, DLS indicates high molecular weight species at pH 6.0 suggesting aggregation 
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under these conditions (Table 4.9). Aggregation may occur as the pH approaches the pI value of 
rrPar-4LZN313I. Interestingly, even at pH 7.0 high molecular weight species were detected with 
approximate RS values between 32.5-121.8 Å. The species with smaller RS values predominate at 
5 ºC (~80%), whereas at 25 ºC this proportion decreases to ~40%, indicating that at 25 ºC the 
aggregated species predominate (Table 4.9). In contrast, DLS results obtained at  pH 4 are of 
similar magnitude as observed for rrPar-4LZ (Table 4.4) and indicate low molecular weight 
species. As mentioned for rrPar-4LZ (Chapter 4.2.2.c), the oligomeric state of the 
rrPar-4LZN313I coiled coil could not be assessed by DLS. The high RS values observed at 
neutral pH may be an artefact of the substitution of the polar asparagine for the hydrophobic 
isoleucine. Thus, the increased hydrophobic surface might result in non-specific hydrophobic 
interactions of rrPar-4LZN313I molecules that are not accompanied by  coiled coil formation 
(Fig. 4.16). This indicates that asparagine residues may also be important regulators of 
aggregation in non-coiled coil conformations preventing the formation of insoluble aggregates in 
vivo [131]. This is consistent with previous notions that substitution of asparagine residues can 
result in the formation of higher order oligomers [109].
5 ºC 25 C
Sample condition MW RS MW RS
rrPar-4LZN313I peptide 6.0 20.9 6.0 20.9
rrPar-4LZN313I at pH 7.0 64.0/2590 32.5/121.8 97.0/1720 37.7/105.2
rrPar-4LZN313I at pH 6.0 N/A 4125 N/A 13350
rrPar-4LZN313I at pH 4 8.2 15.6 N/A N/A
 Table 4.9 − DLS-determined hydrodynamic properties of rrPar-4LZN313I. MW (kDa) and RS (Å) 
values were calculated using the equation log(RS) = 0.357*log(MW) − 0.204 in reference to a spherical 
conformation [181]. The mode RS values of each measurement are shown. For comparison, theoretical 
values for a urea unfolded state of rrPar-4LZN313I calculated from  the amino acid sequence are also 
provided. Sample conditions are given in Table 4.8. Note that calculated MWs for rrPar-4LZN313I at 
pH 6.0 are in the GDa range and therefore omitted.
 Coiled coil formation of rrPar-4LZN313I is strongly suggested by CD spectropolarimetry 
(Fig. 4.16). As was observed for rrPar-4LZ, coiled coil formation occurred predominantly  at 
acidic pH and low temperature. Consistent with these results, only weak α-helical character of 
approximately 40% (average of both deconvolution algorithms) is observed at neutral pH and 
4. Order-disorder Equilibria in the Coiled Coil region of Par-4
166
5 ºC for rrPar-4LZN313I (Fig. 4.16A). This character is significantly  stronger than observed for 
the wild-type rrPar-4LZ (Fig. 4.2A) suggesting that Asn 313 significantly  affects coiled coil 
formation. In contrast to rrPar-4LZ where no Tm value could be estimated, a Tm value of ~15 ºC 
is determined for rrPar-4LZN313I at neutral pH (Fig. 4.16G). Consistent with the increased α-
helicity of rrPar-4LZN313I at pH 7.0, a significantly increased α-helical content and thermal 
stability  is observed at pH 6.0 (Fig. 4.16C) relative to rrPar-4LZ (Fig. 4.2C). However, DLS 
indicates large soluble aggregates under these conditions suggesting that the increased stability 
may be related to aggregation.
 Strong α-helical character and a greatly  increased thermal stability are also observed at pH 4 
(Fig. 4.16E). The α-helical content under these conditions is estimated at approximately 90%. A 
Tm value could not be determined as it is outside the probed temperature range of 5-75 ºC 
(Fig. 4.16G). Note that DLS indicates that this increased thermal stability is not due to 
aggregation. The CD spectrum further suggests coiled coil formation with [θ]222/[θ]208 ratios 
above one until 25 ºC. This is somewhat surprising as it is similar to the behaviour observed for 
rrPar-4LZ at pH 4 (Fig. 4.2D) despite a greatly increased thermal stability. However, for 
rrPar-4LZN313I this ratio remains above 0.9 until 65 ºC thus suggesting an equilibrium between 
disordered and ordered conformations under these conditions, with the ordered fraction 
representing the major population. The well-defined isodichroic point at  203 nm further suggests 
a two-state transition (Fig. 4.16E).
 CD spectropolarimetry  shows that at 5 ºC and pH 7.0 both rrPar-4LZ (Fig. 4.2A) and 
rrPar-4LZN313I (Fig. 4.16A) are mostly  disordered. As expected, the corresponding NMR 
spectra are almost  identical (Fig. 4.17A). Shift differences for residues neighbouring Asn 313 
(e.g. Glu 312, Gln 315 or Leu 316) probably  arise due to substitution of the polar asparagine 
residue by the hydrophobic isoleucine residue. Due to aggregation (see above) and resulting 
sensitivity limitations spectra of rrPar-4LZN313I at  pH 6.0 are not shown. Despite the clear 
increase in thermal stability of rrPar-4LZN313I at pH 4 relative to rrPar-4LZ, the corresponding 
NMR spectrum at 25 ºC is still affected by severe line broadening and low sensitivity. Relative to 
the wild-type rrPar-4LZ at pH 4 the 1H chemical shift  dispersion is only marginally increased, 
however, the intensity for the majority of peaks is further deceased. Interestingly, two sets of 
peaks seem to exist for Gly -2, Ser -1 and Arg 322 (Fig. 4.17B, for assignments compare with 
panel A) suggesting that at least two different conformations exist under these conditions. These 
two separate sets may be due to exchange of ordered and disordered conformations on a slow 
NMR time scale or alternatively due to the formation of a non-symmetric dimer/oligomer. 
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However, a more definitive analysis would require a chemical shift assignment, which was not 
possible due to the poor quality of the NMR spectra.
 Figure 4.16 − CD spectropolarimetry of rrPar-4LZN313I. Temperature dependence of the CD spectra 
of rrPar-4LZN313I at (A, B) pH 7.0, (C, D) pH 6.0, and (E, F) pH 4. The complete temperature series is 
shown in panels A, C, and E. For clarity, four evenly spaced temperature series are shown in panels B, D, 
and F. (G) Thermal stability of rrPar-4LZ at various pH values showing the %[θ]222 values as a function 
of temperature. The %[θ]222 values were obtained by normalising the [θ]222 values at each temperature to 
the corresponding [θ]222 value at 5 ºC. Sample conditions are given in Table 4.8. Acquisition parameters 
are given in Appendix F.
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 To circumvent the sensitivity problem, an additional sample of rrPar-4LZN313I at pH 4 with 
a concentration of 2.5 mM was prepared. The corresponding spectrum shows an improved 
sensitivity (Fig. 4.17C), but is otherwise still of poor quality. At 25 ºC, a significant peak overlap 
is observed and a conservative peak counts estimates at least 120 peaks. The situation is further 
worsened by line broadening. Eventual NMR experiments such as chemical shift  assignment or 
relaxation measurements would be extremely challenging under such conditions. Note that  no 
DLS data is available for this sample and some of the observed problems may  be attributed to 
aggregation, which cannot be excluded at  the high Par-4 LZ concentration, in particular for 
rrPar-4LZN313I which is prone to aggregate. However, it is possible that spectra of higher 
quality are obtained at an intermediate concentration and that NMR spectra of rrPar-4LZN313I 
benefit from deuteration.
 Figure 4.17 − NMR spectroscopy of rrPar-4LZN313I. Pairwise overlay of the 1H,15N-SOFAST-HMQC 
spectra of rrPar-4LZ (black contours) and rrPar-4LZN313I (red contours) at (A) 5 ºC and pH 7.0, and 
(B) 25 ºC and pH 4. (C) Concentration dependence of the 1H,15N-correlation spectra of rrPar-4LZN313I 
at 25 ºC and pH 4. Displayed are the 1H,15N-HSQC spectrum acquired at a concentration of 2.5 mM 
(black contours) and the 1H,15N-SOFAST-HMQC spectrum acquired at a concentration 40 µM (red 
contours). All samples were uniformly 15N-labelled and contained 5% D2O (v/v) in the sample buffer. 
Sample conditions were 75 µM rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0 and 50 µM rrPar-4LZ in 
MQ-H2O, pH 4. For rrPar-4LZN313I conditions see Table 4.8. Acquisition parameters are given in 
Appendix G.
 Data presented here suggest that the asparagine residue at position a within rrPar-4LZ affects 
coiled coil stability, resulting in decreased thermal stability relative to hydrophobic residues such 
as isoleucine. For rrPar-4LZ at  pH 4, a Tm value of approximately 50 ºC (Fig. 4.3A) is obtained 
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that is significantly lower than the Tm value (> 75 ºC) for rrPar-4LZN313I (Fig.4.16G). Despite 
this clear difference in thermal stability, the corresponding NMR spectra of both peptides are 
very similar and of poor quality. It  is currently not known what causes the poor NMR 
spectroscopic properties of the Par-4 LZ peptides, as NMR solution structures of coiled coils of 
similar length have been described in the literature (e.g. rJun leucine zipper [246], FIP2 [264], or 
the N-terminus of the nucleocapsid protein of the Andes Hantavirus [265]). These peptides 
produce sharper and better dispersed 1H,15N-correlation spectra relative to the Par-4 LZ peptides. 
However, the lack of chemical shift dispersion for Par-4 may be related to the absence of 
aromatic residues that could induce a greater dispersion due to ring current effects. Interestingly, 
for the rJun leucine zipper a similar Tm value of 52 ºC relative to rrPar-4LZ at pH 4 was 
determined. Note that this Tm value was measured on a four to five times less concentrated 
sample (pH 3.6, 15 µM  rJun concentration). It is possible that rJun produces better NMR spectra 
than rrPar-4LZ, as the rJun dimer was stabilised through an intermolecular disulfide bond at the 
N-terminus [246]. This covalent linkage of the rJun dimer may reduce the conformational 
exchange between disordered monomers and ordered dimers. Such a conformational exchange 
was proposed above for rrPar-4LZ and rrPar-4LZN313I. Mutation of asparagine residues at 
position a of the heptad to hydrophobic residues has been demonstrated to decrease 
conformational exchange [138], and an improvement of the NMR spectra was therefore 
expected. However, the observed line broadening for rrPar-4LZN313I indicates that 
conformational exchange continues. Also the low pH conditions should have resulted in a 
decrease in conformational exchange, as pH 4 was shown to be more stabilising than mutation of 
either Asp 305 or Glu 310 to lysine residues in mitigating the repulsive electrostatic interactions 
(Fig. 4.3B). An alternative explanation for the observed line broadening may be that due the 
propensity  of rrPar-4LZN313I to aggregate it is in exchange between different oligomeric coiled 
coil states (e.g. between dimer and tetramers).
 Taken together, more than three and a half years were spent on trying to optimise the NMR 
conditions for the Par-4(286-332) peptide with little success. Even the latest N313I mutant, 
which showed favourable stability  by CD spectropolarimetry, was not amenable to NMR. It is 
questionable if further improvements can be achieved by  mutation such as an N313I, D305K 
double mutant. Such constructs may profit  from additional van der Waals interactions[185], but 
should still be analysed at acidic pH to mitigate destabilising interactions from an aspartate patch 
in the Par-4 LZ domain (Chapter 4.1.2.). These aspartate residues are therefore also prime 
candidates for mutation. Substitution of aspartates such as Asp 307 or Asp 311 by arginine could 
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increase the stability  of the Par-4 LZ domain by introducing new intrahelical salt bridges and 
mitigating some of the intrahelical electrostatic repulsion. Also the helix-forming propensity of 
arginine is higher than for aspartate [241]. It  is further possible to remove the Met 309 residue by 
mutation and replace it  by  a leucine to increase coiled coil stability. Methionine is occasionally 
found at position d [117], but might interfere with packing of the side chains in the hydrophobic 
interface. However, any mutation will lead further away from the wild-type sequence. It  was 
demonstrated in Chapter 1.2.1 that the Par-4 LZ domain is highly conserved in vertebrates 
(Fig. 1.1). This suggests that  most residues are essential for the Par-4 function, even though some 
of them may be detrimental to coiled coil formation. The D305K, E310K and N313I mutants 
were created to stabilise the coiled coil fraction and allow structure determination of the Par-4 
LZ domain. To the knowledge of the author these mutants have no physiological relevance, nor 
have Par-4 mutants with these mutations tested for their pro-apoptotic potential in vivo. 
Similarly, additional mutations described above would also only serve to stabilise the coiled coil 
fraction, but have no biological relevance.
 A different approach to reduce conformational exchange between disordered monomers and 
ordered dimers could be the introduction of cysteine residues a suitable positions within the 
heptad. Disulfide bond formation between opposing cysteine residues may stabilise the dimeric 
conformation. This may  allow the determination of the NMR solution structure as seems to be 
suggested by  the results of the rJun leucine zipper [246]. An alternative way  to continue from 
here is to change the construct length. The Par-4(286-332) constructs were created to comprise 
the Par-4 LZ domain. Only Par-4 constructs with residues Gln 286-Arg 332 were, to a certain 
extent, soluble upon heterologous expression in E. coli. However, as the LZ domain is predicted 
to start with Ile 292, these constructs contain eleven residues (Gln 286-Met 291 + five residues 
from the protease cleavage site Gly -5 - Ser -1) that are not likely  to be involved in coiled coil 
formation. A disordered conformation for these 11 residues is corroborated by deconvolution 
results, usually  predicting 20-30% of the Par-4 LZ peptide sequence not to be in an α-helical 
conformation (i.d. β-sheet, β-turn or disordered). These deconvolution results are taken from the 
Par-4 LZ peptides in their most stable condition at 5 ºC, e.g rrPar-4LZ at pH 4, rrPar-4LZD305K 
at pH 7.0 or rrPar-4LZE310K at pH 7.0 (Figs. 4.2D-F). This suggests that 20-30% of the 
residues of the Par-4 LZ peptides are freely accessible for other interactions, which could involve 
transient associations with other Par-4 LZ molecules. It is possible that such transient 
associations may also negatively  affect the NMR spectra. It should be noted here that for the 
majority  of the Par-4 LZ peptides in a mostly coiled coil state only  Leu -3, Gly -2 and Ser -1 
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(and sometimes Arg 332) are observed by NMR as sharp and intense peaks, whereas all other 
resonances appear to be broad (e.g. Fig. 4.17B). Hence, it is likely that some of the N-terminal 
residues (e.g. Gln 286-Met 291), which are not  predicted to be part of a coiled coil, may be 
involved in other interactions. It should therefore be considered to create new Par-4 LZ 
constructs with shorter N-terminii. The Gln 286-Met 291 stretch was supposedly  necessary for 
the solubility of the Par-4 LZ peptides, however, with the here described denaturing protocol it 
should be possible to purify  even N-terminally  truncated Par-4 LZ peptides with lower solubility. 
To further reduce the length of this unfolded stretch at the N-terminus it  is possible to switch to 
the pCFE-GST-TEV/2 expression vectors that allow for a shorter protease cleavage site 
(Chapter 2.3.2, Appendix B). Finally, another way could involve increasing the length of the 
Par-4 construct. Introducing additional heptad repeats could thus increase the coiled coil stability 
[136,224]. This approach is corroborated by initial results from the analysis of the Par-4 CC 
domain, which will be presented in the following chapter.
4.6. Structural characterisation of the Par-4 Coiled Coil domain
4.6.1. Materials and Methods
a) Sample preparation
 rrPar-4CC was expressed and purified as described in Chapter 2.10. Samples with increasing 
concentrations of urea were prepared by diluting H2O-dissolved rrPar-4CC with appropriate 
buffers (Table 4.10). For samples at neutral pH and with urea concentrations below or equal to 
1 M, the solubility  of rrPar-4CC was reduced and precipitation occurred. The precipitate was 
removed by  centrifugation in a tabletop centrifuge and the protein concentration was 
remeasured. The same samples were used for CD and DLS spectroscopy.
rrPar-4LZN313I peptide concentration Buffer composition
a) 7 µM 20 mM NaCl, 10 mM Tris, pH 7.0 + 1M urea
b) 25 µM 20 mM NaCl, 10 mM Tris, pH 7.0 + 6 M urea
c) 25 µM H2O, pH 4
 Table 4.10 − Sample conditions of rrPar-4CC used for DLS and CD spectropolarimetry.
4. Order-disorder Equilibria in the Coiled Coil region of Par-4
172
b) Circular Dichroism
 CD spectra were recorded as described in Chapter 3.4.1.a. Acquisition parameters are given in 
Appendix F. Due to buffer absorption the spectral width of the CD spectra was reduced from 
190-260 nm (native buffer) to 205-260 nm (native buffer + 1 M urea) and 210-260 nm (native 
buffer + 6 M urea). Spectral deconvolution was performed using the algorithms Selcon3 and 
CONTIN-LL through the DICHROWEB interface.
c) Dynamic Light Scattering
 DLS measurements were performed as described in Chapter 3.2.1.a. RS values obtained from 
measurements in urea were corrected using the Dispersion Technology Software 5.1 to account 
for the increased solvent viscosity and the increased refractive index.
d) Crystallisation trials
 Crystal screenings were performed using the HR2-110 Crystal Screen and the HR2-112 
Crystal Screen 2 (Hampton Research). The concentration of H2O-dissolved rrPar-4CC used for 
crystal screening was approximately 12 mg/ml (~1 mM). Sitting drops were set up as a 1:1 
dilution of 0.5 µl rrPar-4CC and 0.5 µl of mother liquor. Crystal Screens were incubated at 
temperatures of 4 ºC and 21 ºC.
4.6.2. Results and Discussion
 Spectral deconvolution suggests that approximately 30% of the residues of rrPar-4FL adopt an 
α-helical conformation (Chapter 3.4.2.). It was further proposed that the majority of this α-helical 
character can be attributed to the coiled coil formation observed for rrPar-4FL (Chapter 3.6.) due 
to the presence of the LZ domain. As the Par-4 LZ domain only comprises 40 residues (Fig. 1.1) 
this indicates that other residues are involved in self-association. The most  likely candidates are 
the residues of the Par-4 CC domain (residues 254-332, Fig. 1.1). This domain has been 
discussed above as an N-terminal extension of the Par-4 LZ domain (Chapter 4.1.2.). It was 
proposed that this extension might increase the stability of the Par-4 coiled coil due to formation 
of additional heptad repeats. However, it was also noted that this domain contains characteristics 
that would be in contrast with a stable coiled coil. But  as CD spectropolarimetry  suggests, the 
additional heptad repeats in rrPar-4FL have overcome these destabilising factors. Similarly, it 
was previously shown that increasing the chain length of C-terminal Par-4 peptides resulted in a 
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more pronounced self-association [54]. Note that this assumption does not exclude that other 
regions of Par-4 may contribute to the α-helical signal and/or are involved in self-association.
 To analyse the coiled coil forming propensity of the Par-4 CC domain the Par-4(240-332)WT 
construct (rrPar-4CC) was used, which contains the full Par-4 CC domain. This construct is of 
particular interest as this protein was shown to act in a dominant-negative manner, blocking the 
pro-apoptotic activity of full-length Par-4 in PC-3 cell cultures [55]. Assuming that the Par-4 CC 
domain forms a coiled coil, it was proposed that this construct inhibits Par-4 through direct 
association via the CC domain with full-length Par-4 itself, or through direct binding to Par-4 
effector proteins. As described in Chapter 2.6, self-association of full-length Par-4 (rrPar-4FL) 
results in decreased solubility and hence a denaturing purification protocol became necessary. 
Therefore, a denaturing purification protocol was applied for rrPar-4CC, and it was noticed 
during purification that this protein behaves very similar to rrPar-4FL.
 Unlike rrPar-4FL, rrPar-4CC is not stable in native buffer (20 mM NaCl, 10 mM Tris, 
pH 7.0). The majority of rrPar-4CC precipitated reducing the concentration from 25 µM to 
~1 µM. The concentration was estimated from A205 absorbance readings acquired parallel with 
the CD spectrum. The solubility  of rrPar-4CC is also reduced in native buffer + 1 M  urea and the 
concentration was estimated at ~8 µM. Not surprisingly, no solubility  limitations are observed in 
native buffer + 6 M  urea. As noticed for other Par-4 peptides (Chapter 4.2.2.a), the most stable 
tested condition for rrPar-4CC, with no apparent solubility  limitations in the absence of urea, 
was detected in MQ-H2O at an acidic pH of approximately 4. For sterility reason the pH was 
only assessed with suitable pH paper strips. Like rrPar-4LZ, the stock solutions can be easily 
diluted with MQ-H2O for the final CD samples and both rrPar-4CC and rrPar-4LZ are stable 
under these conditions.
 The CD spectrum of rrPar-4CC in MQ-H2O at pH 4 (Fig. 4.18A) is characteristic of a well 
defined and thermo-stable coiled coil. The α-helical content at 5 and 25 ºC is predicted with 
~89% (average of both deconvolution algorithms). The Tm value is estimated at ~70 ºC 
(Fig. 4.19A), which is significantly  greater relative to rrPar-4LZ (Tm ≈ 50 ºC) under similar 
conditions at pH 4 (Fig. 4.19B). This suggests that the increased chain length in rrPar-4CC 
confers an increased stability  of the coiled coil. Accordingly, the θ222/θ208 ratio remains above 1.0 
till 35 ºC in contrast to rrPar-4LZ with only  25 ºC (Chapter 4.2.2.a). Due to the low 
concentration of rrPar-4CC in native buffer at  pH 7.0 the resulting CD spectrum is very noisy 
(Fig. 4.18C). However, even at that low concentration the spectrum would suggest that 
rrPar-4CC forms a coiled coil at pH 7.0. Coiled coil formation of rrPar-4CC at pH 7.0 and 5 ºC is 
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also indicated in the presence of 1 M urea (Fig. 4.18E). The α-helical conformation under these 
conditions is relatively  stable with a Tm value of approximately 40 ºC (Fig. 4.19A). In native 
buffer + 6 M  urea some α-helicity is evident at temperatures below 15 ºC (Fig. 4.18G), however, 
above 15 ºC rrPar-4CC is mostly disordered. The observation of coiled coil conformations at 
neutral pH is consistent with the earlier proposed coiled coil state of rrPar-4FL (Chapter 3.6.). 
This strongly  suggests that the increased chain length of rrPar-4CC, relative to rrPar-4LZ, is 
sufficient for self-association at pH 7.0. rrPar-4LZ is probably too short to overcome the 
repulsive electrostatic interaction between Asp 305 and Glu 310 residues that has been identified 
as the main destabilising factor for rrPar-4LZ at  neutral pH [185]. The observed pH dependence 
for rrPar-4LZ therefore appears to be an experimental artefact as coiled coil formation is 
observed for the whole CC domain. Decreasing pH may stabilise the coiled coil through 
protonation of acidic residues that were shown to decrease Par-4 coiled coil stability 
(Chapter 4.2.2.a). However, most of the characterised Par-4 interactions take place in the 
cytoplasm or nucleoplasm at physiological pH. The commonly observed decrease in pH during 
apoptosis is probably not low enough to significantly alter the self-association properties of Par-4 
as, in most cases, this drop does not fall below pH 6.5 [11].
 It was already mentioned that the properties of rrPar-4CC are very  similar to rrPar-4FL. Not 
surprisingly, a polymeric state of rrPar-4CC at pH 4 (RS ~1500 Å at 25 ºC) is detected by DLS 
(Table 4.11). It is possible that  the increased thermal stability relative to rrPar-LZ can, in part, be 
attributed to aggregation. This is consistent with the absence of an isodichroic point, thus 
suggesting a more complex folding behaviour than a simple two-state transition. Note that the 
traces in Figures 4.18A and B do not  converge in one single point. The RS values of rrPar-4CC in 
the presence of urea are greatly reduced and no significant difference (RS ~32.5 Å at 25 ºC) is 
observed between 1 and 6 M  urea (Table 4.11). It is not clear if the slight difference of 5 Å at  5 
and 25 ºC is significant (Table 4.11). These results therefore suggest a disruption of the 
polymeric complex under denaturing conditions. Interestingly, in 1 M  urea coiled coil formation 
is still observed (Fig. 4.18E). Using the equation given in Ref. [181] an RS value of 
approximately 29.1 Å is calculated for rrPar-4CC in a urea denatured coil-like conformation. 
This theoretical value is similar to the experimentally determined RS value of 32.5 Å in 6 M urea 
at 25 ºC (Table 4.11) and suggests that the RS values obtained in 1 and 6 M  urea are associated 
with low molecular weight species. As mentioned earlier, the high apparent MWs obtained for 
rrPar-4CC in 1 or 6 M urea (Table 4.11) are consistent with proteins in coil-like or coiled coil 
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conformations. Note that MWs calculated for rrPar-4CC at pH 4 according to the equation given 
in Ref. [181] are in the GDa range and are therefore omitted in Table 4.11.
 Figure 4.18 − CD spectropolarimetry of rrPar-4CC. CD spectra of rrPar-4CC as a function of 
temperature are shown for various conditions: (A, B) at pH 4, (C, D) at pH 7.0, (E, F) at pH 7.0 + 1 M 
urea, and (G, H) at pH 7.0 + 6 M urea. The complete temperature series are shown in panels A, C, E and 
G. For clarity, five evenly spaced temperature series are shown in panels B, D, F and H. Sample 
conditions are listed in Table 4.10. The concentration of rrPar-4CC in 20 mM NaCl, 10 mM Tris, pH 7.0 
(panel C and D) was estimated at ~1 µM. Acquisition parameters are given in Appendix F.
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 Polymerisation of α-helical proteins such as rrPar-4CC is not uncommon. It was for instance 
shown recently  that the tau protein can, under certain conditions, form α-helical fibrillar 
aggregates, which have spectroscopic features of α-helical coiled coils [271]. Similar polymeric 
states were usually not observed for rrPar-4LZ, except under special conditions. Particularly 
rrPar-4LZ is predominantly  in a low oligomeric state in MQ-H2O at pH 4 (Fig. 4.5C). This 
suggests that the additional N-terminal residues in rrPar-4CC create a surface that allows for 
polymerisation. It is also possible that rrPar-4LZ is not stable enough to allow for polymerisation 
as lower oligomeric complexes may dissociate at a much faster rate. In contrast, rrPar-4CC 
displays an increased thermal stability (Fig. 4.19B) and low order oligomeric complexes may be 
stable enough to polymerise. Note that the thermally more stable rrPar-4LZN313I also displayed 
a propensity for polymerisation (Table 4.9). The interactions involved in polymerisation appear 
to be of weak nature as polymerisation is to a certain extent suppressed in 1 M urea (Table 4.11).
5 ºC 25 C
Sample condition MW RS MW RS
rrPar-4CC peptide 11.4 29.1 11.4 29.1
rrPar-4CC at pH 4, 0 M urea N/A 1275/3076 N/A 1477
rrPar-4CC at pH 7.0, 1 M urea 97.0 37.7 64.0 32.5
rrPar-4CC at pH 7.0, 6 M urea 97.0 37.7 64.0 32.5
 Table 4.11  − DLS-determined hydrodynamic properties of rrPar-4CC. MW (kDa) and RS (Å) values 
were calculated using the equation log(RS) = 0.357*log(MW) − 0.204 in reference to a spherical 
conformation [181]. This equation was used to display that the degree of extended structure is very high 
for the rrPar-4CC proteins in urea. The mode RS values of each measurement are shown. For 
comparison, theoretical values for a urea unfolded state of rrPar-4CC calculated from the amino acid 
sequence are also provided. Calculated MWs for rrPar-4CC at pH 4 are in the GDa range and therefore 
omitted. Sample conditions are given in Table 4.10.
 For full-length rrPar-4FL polymerisation is also observed, but to a significantly lesser extent 
(RS ~189 Å, Table 3.1). This indicates that Par-4 segments N-terminal to the CC domain may 
prevent higher order polymerisation of the CC domain in the context of full-length Par-4. This 
would further indicate that polymerisation is an artefact of the experimental conditions and may 
not represent the biologically  active state. Post-translational modifications in mammalian cells 
may also regulate the oligomeric state of the CC domain and may thus prevent polymerisation in 
vivo. For instance, phosphorylation of laminins during mitosis results in their depolymerisation 
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triggering the disassembly of the nuclear lamina[272]. It should be noted that the first 19 N-
terminal residues of rrPar-4CC (Gly 240-Asn 253 + five residues of the protease cleavage site) 
are not predicted to be part of a coiled coil (Fig. 4.1A) and may therefore contribute to 
polymerisation in an unknown way. These residues may be removed for future studies of the CC 
domain. Due to the propensity of the CC domain to polymerise it may be helpful to include 
additives that prevent oligomerisation, but still allow for coiled coil formation. Urea did not give 
the best results, as rrPar-4CC was still fairly  insoluble in 1 M  urea. Thus acetonitrile or TFE may 
be alternative candidates. In particular TFE was shown to have a favourable solubilising property 
at pH 5 for rrPar-4LZ (Chapter 4.4.2.). However, for both additives optimal concentrations need 
to be determined that allow further structural characterisations of the coiled coil state.
 Figure 4.19 − Thermal stability of various Par-4 constructs. Temperature dependence of the molar 
ellipticity measured at 222 nm for (A) rrPar-4CC under denaturing and non-denaturing conditions, (B) 
various Par-4 constructs under non-denaturing conditions, (C) various Par-4 constructs in native buffer 
(20 mM NaCl, 10 mM Tris, pH 7.0) + 1 M urea and (D) two Par-4 constructs in native buffer + 6 M urea. 
Displayed are the %[θ]222 value of (A) 25 µM rrPar-4CC in MQ-H2O, pH 4 (open circles); 8 µM 
rrPar-4CC in native buffer + 1 M urea (open triangles); and 25 µM rrPar-4CC in native buffer + 6 M 
urea (open diamonds); in (B) 8 µM rrPar-4FL in native buffer (open squares); 25 µM rrPar-4CC in MQ-
H2O, pH 4 (open circles); and 75 µM rrPar-4LZ in MQ-H2O, pH 4 (open triangles); in (C) 8 µM 
rrPar-4FL (open squares); 8 µM rrPar-4CC (open circles); 75 µM rrPar-4LZD305K (open triangles); 
and 75 µM rrPar-4LZD305K (open diamonds) all four in native buffer + 1 M urea; and in (D) 8 µM 
rrPar-4FL (open squares); and 25 µM rrPar-4CC (open circles) both in native buffer + 6 M urea. The 
%[θ]222 values were obtained by normalising the [θ]222 values at each temperature to the corresponding 
[θ]222 value at 5 ºC.
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 As rrPar-4CC was not 15N-labelled and due to its low concentration, NMR spectroscopy  was 
not a suitable method for further structural characterisation. However, the concentration of the 
rrPar-4CC stock solution (~12 mg/ml) was sufficient for crystallisation trials. After 
approximately 6 weeks crystals were obtained at 21 ºC (Fig. 4.20). Based on the mother liquor, 
which contained 0.2 mM sodium citrate, 0.1 mM HEPES, pH 7.5 and 20% isopropanol (v/v), 
additional screenings were prepared as hanging drops. For these screenings the drop volume was 
increased, and the rrPar-4CC and precipitant concentration was varied in a sensible manner. 
These additional screenings were further seeded with crystals from the first screening plate and 
left at  21 ºC for crystal growth. So far no crystals at a suitable size for X-ray diffraction have 
been obtained. However, given the morphology and three-dimensional nature of these crystals, 
crystallisation of rrPar-4CC remains a promising lead.
 Figure 4.20 − Crystallisation trials of rrPar-4CC. Crystals of rrPar-4CC obtained with A) the 
original screening in 0.2 mM sodium citrate, 0.1 mM HEPES, pH 7.5 and 20% isopropanol (v/v). Crystals 
obtained after optimisation with decreasing concentration of isopropanol are shown in B) with 15% 
isopropanol (v/v) and C) with 10% isopropanol (v/v).
 A comparison of thermal stabilities of various Par-4 constructs under denaturing and non-
denaturing conditions is shown in Figures 4.19B-D. As noted above rrPar-4CC displays an 
increased stability over rrPar-4LZ (Fig. 4.19B). Interestingly, even in their most stable state at 
pH 4 both rrPar-4LZ and rrPar-4CC are not as stable as rrPar-4FL under non-denaturing 
conditions (Fig. 4.19B). Similar trends are observed in native buffer + 1 M urea and in native 
buffer + 6 M urea (Figs. 4.19C and D). In each case rrPar-4FL displays a greater thermal stability 
over rrPar-4CC and the Par-4 LZ peptides. Under non-denaturing conditions the high thermal 
stabilities of rrPar-4FL and rrPar-4CC (Fig. 4.19B) can be partly  attributed to polymerisation 
(see above). However, disruption of the polymeric state by urea results in a similar order of 
200 µm 100 µm 100 µm
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stabilities (Figs. 4.19C and D). Note that rrPar-4LZD305K and rrPar-4LZE310K are displayed in 
Figure 4.19C for comparative purposes, as the wild-type rrPar-4LZ does not  adopt a coiled 
conformation at neutral pH (Fig. 4.2A). However, they  are omitted from Figure 4.19D as they 
are mostly unfolded in native buffer + 6 M urea.
 It is interesting to note that rrPar-4FL and rrPar-4CC display distinct stabilities under 
denaturing and non-denaturing conditions. As both proteins contain the whole CC domain, this 
suggests that other factors contribute to the stability difference. An increased thermal stability 
due to an increased concentration of rrPar-4FL is unlikely, as rrPar-4FL (8 µM) was used in a 
lower concentration than rrPar-4CC (25 µM) (Figs. 4.19B and D), except for conditions in native 
buffer + 1 M urea where both proteins are at  a concentration of 8 µM  (Fig. 4.19C). In addition, 
polymerisation of both proteins under non-denaturing conditions may interfere with thermal 
stabilities, but to what extent is currently unknown. It is therefore likely that other segments of 
Par-4 N-terminal to the CC domain, and thus absent in rrPar-4CC, contribute to coiled coil 
stability. As mentioned earlier (Chapter 1.2.1.), the N-terminal region of Par-4 was shown to 
interact with the CC domain, however, this interaction was proposed to prevent coiled coil 
formation rather than enhance it [54]. Thus other regions of Par-4 between the N-Terminus and 
the CC domain are potentially involved in the stabilisation.
 rrPar-4CC displays a relatively high thermal stability at pH 4 with an Tm value of ~70 ºC 
(Fig. 4.19A). The θ222/θ208 ratio that  is close to one further suggests a stable coiled coil at the 
physiological temperature of 35 ºC (Fig. 4.18A). Based on the presented data it is reasonable to 
assume that at physiological pH the stability  of the coiled coil is reduced. Furthermore, 
polymerisation may artificially increase coiled coil stability. Hence, it is possible that under 
physiological conditions (pH 7.0 and 37 ºC) a similar interconversion between coiled coil and 
disordered conformations exists, as is observed for the Par-4 LZ peptides (Chapter 4.3.2.). This 
is not surprising as the Par-4 CC domain contains various highly  conserved residues that are 
detrimental to coiled coil stability  (Fig. 1.1). These conserved residues include Asp 305 and 
Glu 310, and the repulsive electrostatic interaction between them, the aspartate patch within the 
LZ domain, three asparagine residues at position a and two charged residues at position d of the 
heptad (Fig. 4.1B-E). Even though, these residues may not prevent coiled coil formation in the 
context of the whole CC domain under physiological conditions, they may destabilise it resulting 
in transient coiled coil formation or allowing for strand exchange. It is interesting to note, in this 
context, that for the trimeric Heat Shock Factor-binding Protein 1 (HSBP1) motional processes 
on the millisecond time scale were detected by NMR. Other NMR data indicated an otherwise 
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stable coiled coil conformation with a rigid peptide backbone. CD spectropolarimetry further 
indicated a moderate melting temperature of 48 ºC [247]. It is possible that similar motions on 
the millisecond time scale are possible for the Par-4 CC domain under physiological conditions.
 In summary, additional heptad repeats present in rrPar-4CC are sufficient to overcome 
destabilising factors that prevent coiled coil formation of the Par-4 LZ domain at neutral pH. 
This provides evidence that the pH dependent  coiled coil formation of rrPar-4LZ may not be 
physiologically relevant as the peptide is probably too short to stabilise a coiled coil 
conformation. The full Par-4 CC domain may therefore represent the physiologically relevant 
domain for self-association. However, evolutionary  conserved residues, which confer to a 
decreased stability of the Par-4 coiled coil, suggest that in vivo self-association through the 
coiled coil domain may be transient.
4.7. The advantage of transient coiled coil formation in Par-4
 The highly conserved sequence of the Par-4 CC domain displays features that are commonly 
considered to be detrimental to coiled coil stability (Chapter 4.1.2.). Based on these observations 
and the observed order-disorder equilibrium for rrPar-4LZ (Chapter 4.3.2.) it is proposed here 
that also full-length Par-4 may display a dynamic equilibrium between ordered oligomers and 
disordered monomers. However, great caution should be taken when transferring in vitro results 
obtained from an isolated domain (Par-4 LZ domain) to the full-length protein (Par-4). Such 
results may not necessarily have a physiological relevance for the full-length protein and the 
observed disorder-order equilibria may only apply for the Par-4 LZ constructs. Possible models 
how such a dynamic exchange behaviour could be advantageous for the function of Par-4 are 
shown in Figure 4.21. These models are based on the current literature and the results presented 
in this document, however, they  are speculative and experimentally  unproven. They may be 
useful for the design of future experiments to determine which models are appropriate. A coiled 
coil with high thermal stability and hardly any strand exchange may not be desirable from a 
regulatory point of view. Buried asparagine residues have long been considered to weaken coiled 
coil stability [129] and to tune strand exchange rates in coiled coils [138]. It has therefore been 
suggested that reduced coiled coil stability conferred by the presence of asparagine residues at 
position a and/or other factors can facilitate readily  reversible homo- and heterodimerisation 
[107]. For leucine zipper-containing transcription factors [117,118], this would allow formation 
of different arrays of homo- and heterodimers, thereby  modulating DNA affinity  and hence the 
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range of affected genes [273,274]. A similar mechanism for sampling of effector molecules 
might be possible for Par-4.
 Figure 4.21 − Potential order-disorder equilibria may be necessary for the function of Par-4. The 
displayed models are hypothetical and not confirmed by experiments. Par-4 was shown to self-associate 
through the CC domain. It is likely that in vivo Par-4 exists in an equilibrium between disordered 
monomers and self-associated ordered oligomers. Based on the analysis of the amino acid sequence, self-
associated Par-4 is displayed as dimers. (A) Due to inherent destabilising factors self-association of 
Par-4 is of transient nature and the dimer rapidly dissociates. Binding of an effector protein to the 
dimerised Par-4 CC domain results in stabilisation of the dimer. This newly formed complex is then able 
to induce apoptosis. (B) A disordered Par-4 monomer is bound by a coiled coil or leucine zipper domain 
containing effector protein (e.g. AATF (Chapter 1.3.4.m)) possibly forming a heterodimeric coiled coil. 
(C) The binding domain of an effector protein, which is not a coiled coil or leucine zipper domain (e.g. 
the zinc-finger domain of aPKCζ (Chapter 1.3.4.a)), can provide a surface that better accommodates 
potentially destabilising residues in a homodimeric Par-4 coiled coil. As for model (B), the newly formed 
heterodimer is stable enough to induce apoptosis. Potential modes for CC domain containing Par-4 
deletion mutants (e.g. rrPar-4CC) acting in a dominant-negative manner are shown in panels (D) and 
(E). These mutants may titrate Par-4 effector proteins (D) or titrate full-length Par-4 trough 
heterodimerisation via the CC domain (E).
 In one possible model Par-4 may bind its effector molecules through the CC domain as a 
monomer (Figs. 4.21B and C). Potential dynamic exchange properties of Par-4 may allow 
reversible homo- and heterodimerisation (or oligomerisation) as proposed above for leucine 
zipper-containing transcription factors (Fig. 4.21B). For instance, it has been demonstrated that 
the Par-4 CC domain is essential for the interaction with the leucine zipper domain of AATF and 
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probably  of Dlk (Chapter 1.3.4.) suggesting the formation of a hetero-oligomeric coiled coil. 
Dynamic exchange would therefore offer a simple regulatory  mechanism controlling the 
function, cellular localisation and turnover of Par-4. Binding partners of Par-4 may further 
provide a binding surface that can better accommodate residues that would be destabilising in the 
homo-oligomeric coiled coil conformation. This may result in an increased stability of the 
heterodimer, relative to the Par-4 homodimer (Fig. 4.21C). A dynamic exchange behaviour may 
further be necessary for the regulation of Par-4. As mentioned above, ectopic overexpression of 
rrPar-4CC was shown to abolish the pro-apoptotic function of Par-4, indicating that this 
construct can act in a dominant negative manner. It was shown above that  rrPar-4CC is less 
stable than full-length Par-4 suggesting that self-association of rrPar-4CC may be disfavoured 
relative to rrPar-4FL. Opportunities for heterodimerisation with full-length Par-4 may thus be 
enhanced (Fig. 4.21E), making rrPar-4CC an effective inhibitor of Par-4. The potentially  more 
dynamic exchange behaviour of rrPar-4CC may also interfere with the binding of full-length 
Par-4 to its effector proteins (Fig. 4.21D). The same considerations can be applied to a 
physiologically more relevant splice isoform of Par-4. This naturally  occurring 33 kDa splice 
variant of Par-4 lacks exon 3, which contains amino acids necessary for nuclear translocation of 
Par-4, and shows no nuclear localisation [47]. It was therefore proposed that this variant may 
associate with full-length Par-4 via the CC domain, which is still present in this splice variant, 
and prevent nuclear translocation of full-length Par-4. In this way, it  may inhibit Par-4’s pro-
apoptotic function and thus act as a naturally  occurring dominant negative splice variant [47]. 
Possible order-disorder equilibria in the context of the full-length Par-4 protein may  therefore 
allow reversible association with this splice variant.
 Self-association of Par-4 through the CC domain may be a prerequisite for binding to its 
effector molecule (Fig. 4.21A). Several cases have been described where a coiled coil domain 
provides the binding surface for interaction with other proteins (e.g the binding of Rab11 to the 
FIP2 coiled coil [264], the binding of ARF6 to the JIP4 coiled coil [275] or association of the 
coiled coil domain of NEMO with ubiquitin [276]). Such a binding mode for Par-4 is 
corroborated by recent findings demonstrating that substitution of three leucine residues at 
position d within the Par-4 LZ domain to alanines abrogates binding to Amida [53]. The 
proposed dynamic exchange of Par-4 between disordered monomers and ordered dimers may 
therefore represent another regulatory switch for the pro-apoptotic function of Par-4. 
Homodimerisation of Par-4 may occur in vivo, but is of transient nature preventing a 
sensitisation of cells to apoptosis. However, binding of Par-4 effector molecules to the coiled coil 
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CC domain strengthens the self-association of Par-4, resulting in a stable hetero-oligomer 
consisting of a Par-4 dimer and the effector protein(s) (Fig. 4.21A). This stable hetero-complex 
is then able to promote apoptosis. It has also been shown in a previous work that association with 
effector proteins can result in structural rearrangement of a coiled coil. Binding of DNA-ligase 
IV to Xrcc4 was shown to induce a local unwinding of the coiled coil of Xrcc4 and thereby 
flattening the binding surface [277]. Reduced coiled coil stability in Par-4 could therefore 
potentially facilitate local structural rearrangements upon association with effector molecules. It 
is also possible that a combination of the above described mechanisms apply  for Par-4 depending 
on the Par-4 association partner.
 It was suggested that the full-length Par-4 forms a very thermo-stable coiled coil under 
physiological conditions (Figs. 3.11A and 4.19B). This high stability may not allow for a readily 
reversible and dynamic association behaviour as described above. As CD spectropolarimetry 
only measures the average of all conformations in solution, a rapid exchange between monomers 
and oligomers may  not be detected under the current conditions. The strong coiled coil character 
obtained for rrPar-4FL is probably overemphasised by the subtraction of the CD spectrum of 
rrPar-4ΔLZ (Fig. 3.11). As mentioned earlier, rrPar-4ΔLZ lacks the complete LZ domain 
(residues 291-332) and shows no significant α-helical character (Fig. 3.7B). In contrast, full-
length Par-4 displays α-helicity that can be attributed to the LZ domain and to regions N-
terminal to it, such as the remainder of the CC domain (Fig. 3.7A and Chapter 3.6.). These N-
terminal regions adopt an α-helical fold only  in conjunction with the LZ domain as observed for 
rrPar-4FL, but not in the absence of the LZ domain as in rrPar-4ΔLZ. Thus, the subtraction 
shown in Figure 3.11A is likely to be skewed to more negative θ222 values relative to θ208 values 
due to α-helical regions in rrPar-4FL not formed in rrPar-4ΔLZ. This suggests that the coiled coil 
proposed for rrPar-4FL may not be as stable as Figure 3.11A implies.
 NMR spectra of full-length Par-4 show that approximately  50% of the expected peaks are 
missing (Fig. 3.8), which may be considered as another indication for the existence of exchange 
processes. Whether the missing peaks are due to an exchange process between disordered and 
ordered states was not determined. Note that the earlier proposal in Chapter 3.4.2, that peaks of 
the CC domain are broadened beyond detection due to formation of a higher molecular weight 
complex of non-globular shape, is also consistent with the data. However, as these results were 
obtained in vitro with heterologously expressed Par-4, the properties of Par-4 may be different  in 
vivo. Post-translational modifications such as phosphorylation were shown to interfere with 
coiled coil formation, either abrogating or in some cases promoting self-association [278,279]. A 
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few phosphorylation sites in the Par-4 C-terminus have been predicted most  notably  a casein 
kinase II site within the CC domain at Ser 258, which is highly conserved among mammals [27] 
(Fig. 1.1). Additionally, recent in vivo NMR studies suggest that proteins may not be as rigid as 
the results of in vitro NMR studies suggest [280]. Thus, in vivo self-association of Par-4 may  be 
more dynamic than results presented here indicate.
 The highly conserved polar residues that may be detrimental for coiled coil stability may  not 
only facilitate order-disorder equilibria, but could also be important  regulators of protein 
solubility. In Chapter 4.5.2. the contribution of a buried asparagine residue to the stability  of the 
Par-4 LZ domain was demonstrated. Substitution of this residue by an isoleucine was not 
sufficient to induce self-association at neutral pH, probably as electrostatic repulsion between 
Asp 305 and Glu 310‘ was the dominating factor for coiled coil stability under these conditions. 
However, under acidic pH conditions a significant increase in thermal stability was observed. 
Interestingly, an increased propensity to aggregate was observed for this peptide. This may be 
just an artefact of the in vitro studies; however, it may also be important  for the in vivo function 
of Par-4. It is possible that more canonical stabilising residues within the Par-4 CC domain 
would result in higher order complex formation and aggregation [131], rendering Par-4 
biologically inactive. Accumulation of (Par-4) protein aggregates within the cell could trigger 
stress responses that may lead to cellular damage (Chapter 1.3.1.).
 The high conservation of polar residues at positions a and d within the Par-4 CC domain 
suggests that these residues are essential for the biological function of Par-4, even though they 
are commonly considered to destabilise a coiled coil. It  was proposed above that  these conserved 
residues are necessary to prevent in vivo aggregation of Par-4 resulting in the loss of Par-4 
activity. It was also proposed that conserved polar residues facilitate a dynamic exchange 
behaviour between Par-4 monomers and oligomers that may be essential for Par-4 to function as 
an effective regulator of apoptosis.
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5.1. Conclusions
 (i) The first conclusion to be drawn from the presented data is that Par-4 can be classified as 
an IDP (Chapters 3.2.2. and 3.4.2.). Apart from the C-terminus that self-associates possibly via 
coiled coil formation (Chapter 3.6.), the majority of the Par-4 sequence adopts an elongated coil-
like conformation in solution. The α-helical character observed for full-length Par-4 by CD 
spectropolarimetry  was mostly  attributed to coiled coil formation of the C-terminus, but may 
also involve other regions of Par-4 (Chapters 3.4.2.). It was further shown that the isolated Par-4 
SAC domain, despite being primarily  disordered, displays indications for residual structure. 
Interestingly, the isolated SAC domain possess distinct  NMR spectroscopic properties compared 
to the SAC domain in the context of full-length Par-4 (Chapter 3.4.2.).
 (ii) Deletion studies suggest that the entire Par-4 CC domain (residues 254-332) is necessary 
for coiled coil formation under physiological conditions (Chapter 4.6.2.). Neither the isolated LZ 
domain as in rrPar-4LZ (residues 292-332) (Chapter 4.2.2.) nor the five N-terminal heptads of 
the CC domain as in rrPar-4ΔLZ (residues 254-290) (Chapter 3.4.2.) are sufficient, in isolation, 
to adopt a coiled coil conformation at  neutral pH. However, both sub-domains together as part of 
the entire CC domain, as in rrPar-4FL or rrPar-4CC, are sufficient for coiled coil formation 
(Chapters 3.6. and 4.6.2.). Despite the presence of the first five heptad repeats of the CC domain, 
rrPar-4ΔLZ displays no α-helical character and shows no indications for self-association. In 
contrast to this, rrPar-4FL that contains the whole CC domain, including the LZ domain, self-
associates (Chapter 3.6.).
 (iii) Consistent  with the previous conclusion, the five additional heptad repeats of the Par-4 
CC domain relative to the LZ domain are sufficient for coiled coil formation at physiological pH 
(Chapter 4.6.2.), despite inherent factors that are commonly considered to be detrimental to 
coiled coil stability. The interhelical charge-charge repulsion between residues Asp 305 and 
Glu 310‘ was identified as the main destabilising factor that prevents coiled coil formation of the 
Par-4 LZ domain at neutral pH [184]. The destabilising effect of this interaction is probably 
outweighed by the gain in stability through additional heptad repeats. It should be noted that 
other factors that potentially interfere with coiled coil stability, such as asparagine residues at 
position a, charged residues at position d and the aspartate patch within the LZ domain, appear 
also to be compensated for by the increased chain length. Especially the charged residues at 
position d within the hydrophobic interface, make this coiled coil structure an interesting target 
for structural characterisation.
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 (iv) The fourth conclusion arises from the previous conclusions. The pH dependence of coiled 
coil formation for rrPar-4LZ (Chapter 4.2.2.) is probably not physiologically relevant. The chain 
length of rrPar-4LZ is probably too short to overcome coiled coil destabilising factors. In 
contrast, the increased chain length of rrPar-4CC with additional heptad repeats is sufficient for 
coiled coil formation at neutral pH. This highlights an interesting point about the danger of 
studying protein domains in vitro and in isolation. Therefore, caution should be taken when 
transferring results obtained from isolated domains to the full-length protein. Nonetheless, the 
peculiar NMR spectroscopic properties of the coiled coil Par-4 LZ peptides make these peptides 
interesting academic targets.
 To summarise the conclusions, Par-4 is a highly  conserved protein indicating that  the majority 
of residues are essential for the biological function. While the N-terminus of Par-4 displays a 
high degree of ID, the C-terminus of Par-4 was shown to self-associate through coiled coil 
formation at  neutral pH. However, a pH dependency of coiled coil formation for Par-4 as 
observed for the isolated Par-4 LZ domain is questionable.
5.2. Contributions to the current knowledge
 Despite great problems with the purification of the Par-4 proteins, some interesting results 
could be obtained that help to better understand the properties of Par-4. Intrinsic disorder in 
Par-4 and coiled coil formation of the Par-4 C-terminus could be predicted from the amino acid 
sequence and verified by various biophysical methods. The advantages of IDPs for regulatory 
processes have been discussed in (Chapter 1.5.) and clarify how Par-4 may act as an effective 
regulator of apoptosis, in particular as a hub protein integrating pro- and anti-apoptotic signals. 
The problems observed during purification and biophysical characterisation of Par-4 described in 
this study, and by other research groups, can be attributed to a great extent to the ID nature and 
self-association of Par-4.
 The results further suggest that Par-4 self-associates at neutral pH through coiled coil 
formation, which is localised to the Par-4 C-terminus. Despite being essential for self-
association, the LZ domain is not the biologically relevant domain. Self-association depends on 
an intact CC domain including the LZ domains. This indicates that previous results 
demonstrating a pH dependence of coiled formation are an experimental artefact of the LZ 
construct itself. Even though this pH dependence may be of academic interest, the biological 
relevance is questionable especially  in context of the biological function of Par-4. This 
information may, however, be of great importance for the design of inhibitory  peptides that 
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specifically associate with full-length Par-4 and block its function. Peptides may be designed in 
such a way that homodimerisation is disfavoured, but heterodimerisation with full-length Par-4 
occurs with high affinity.
 Substitution of a polar asparagine within the oligomeric interface by a hydrophobic isoleucine 
resulted in an increased thermal stability  of the coiled coil, however, also resulted in an increased 
propensity  to aggregate (Chapter 4.5.2.). This suggests that  polar residues within the oligomeric 
interface, even though they are detrimental for coiled coil stability, are important regulators of 
protein solubility, and thus important for the biologic activity [131].
5.3. Future work
 Like many PhDs, this thesis produces more new question than it answers. Probably  one of the 
most interesting questions that arose from this thesis is what  residues are visible in the NMR 
spectra of rrPar-4FL and rrPar-4ΔLZ. Therefore chemical shift assignment of both proteins 
should be one of the major next steps. Especially for rrPar-4FL it would be interesting to know if 
peaks from the CC domain can be observed. In addition to the assignments, 15N-relaxation 
measurements may be recorded, which would further allow conclusions about the dynamics of 
the involved residues to be drawn. It may be beneficial to perform these NMR measurements on 
(partially) deuterated proteins, as rrPar-4FL is likely  to contain non-globular shaped domains that 
may not be detected in non-deuterated samples. Similar NMR experiments could be performed 
for rrPar-4SAC. This domain shows some indication of residual secondary or tertiary structure 
and further displays distinct NMR properties than the SAC domain in the context of full-length 
Par-4. Additional NMR experiments may  therefore be useful to clarify  some of the observed 
differences.
 As isolation of rat full-length Par-4 and its analysis by  NMR proved to be a challenging task, 
expression of Par-4 orthologues from different species, such as human or zebrafish, may produce 
proteins that  are more amenable to NMR studies. Furthermore, bioassays should be developed to 
confirm that the heterologously expressed Par-4 proteins are biologically  functional. A simple 
test could demonstrate that the isolated Par-4 proteins still bind their effector proteins.
 The Par-4 LZ peptides displayed peculiar NMR spectroscopic properties that were difficult to 
analyse. However, their physiological relevance is questionable as the whole CC domain is likely 
to be the biologically functional unit. Analysing their folding behaviour may be of academic 
interest, however, results cannot  be easily transferred to the CC domain, as it  probably shows 
different structural properties. It is therefore in my  opinion not worth continuing with Par-4 LZ 
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peptides in their current form and work should rather focus on the entire CC domain. This may 
involve new constructs with greater solubility, and the optimisation of experimental conditions. 
The CC domain offers the advantage to study coiled coil formation under almost physiological 
conditions and removes pH as a critical factor for oligomerisation. As a highly non-globular 
shape can be expected, CC constructs may benefit from deuterium labelling.
 Par-4 CC constructs may further be necessary for the analysis of association with Par-4 
interaction partners. Previous results (Chapter 1.3.4.) suggest that a functional Par-4 CC domain 
is necessary for binding to its effector proteins. LZ peptides may show only weak binding 
relative to CC constructs. This is corroborated by initial interaction studies showing that the 
wild-type Par-4 LZ domain only  interacts with the zinc-finger domain of aPKCζ at  pH 6.0 
(personal communication with Dr. K. Dutta). Analysis of Par-4 in complex with other proteins is 
therefore another important aim for future studies. So far, work was mainly concentrated on the 
aPKCζ zinc-finger domain, however, this domain is highly  insoluble and could not be isolated in 
a stable soluble form (personal communication with H. Prasad). Therefore other Par-4 interaction 
partners need to be screened.
 To assess the oligomeric state of the Par-4 constructs, methods other than NMR may be 
necessary. It was already mentioned that characterisation of Par-4 LZ peptides by MALLS and 
AU have begun. Similar experiments may be performed with full-length Par-4 and constructs 
comprising the CC domain. A different method that may be approached is SAXS, which could 
also provide information about the oligomeric state of Par-4. Also FT-IR spectroscopy(Fourier 
transform - infrared spectroscopy) is a possible method to study the oligomeric state of coiled 
coils. Vibrational bands obtained for coiled coils depend on the pitch value of the supercoil and 
therefore may allow differentiation between dimers, trimers or tetramers [281].
 It is further necessary to analyse the strand exchange rates in the Par-4 constructs to better 
understand the existing dynamics. Possible methods to measure strand exchange rates have been 
described in Ref. [138] and involve fluorescence labelling techniques. The easiest experiment 
probably  involves the labelling of peptides with two different fluorescence labels. Labels should 
be chosen so that close proximity of the two different labels results in quenching of the 
fluorescence. Mixing of these two differently labelled peptide species and measuring the 
fluorescence decay over time should allow the determination of the strand exchange rates within 
the coiled coils. These experiments could be performed with full-length Par-4 and Par-4 CC 
constructs. Similar types of fluorescence experiments should be performed in (cancer) cells 
mainly to study the oligomeric state of Par-4 in its native environment. These experiments are 
5. Conclusions and Future work
191
further necessary  to clarify if Par-4 homodimerisation (-oligomerisation) is physiologically 
relevant.
 NMR results of the Par-4 LZ peptides indicate a dynamic equilibrium between disordered 
monomers and coiled coil dimers (Chapter 4.3.2.). Due to the sequence peculiarities of the Par-4 
CC domain similar equilibria may exist for full-length Par-4 or isolated Par-4 CC constructs. It 
was proposed in Chapter 4.7. that such equilibria may be necessary  for the biologic function of 
Par-4 facilitating hetero-oligomerisation with Par-4 effector proteins. Identification of such 
equilibria and analysis of the underlying factors causing the equilibrium is therefore another 
potential aim. This should help to understand if coiled coil stabilising and destabilising factors 
are balanced in such a way in Par-4 that self-association occurs, but still allow hetero-
oligomerisation.
 Crystallisation trials showed that it  is possible to obtain crystals for the Par-4 CC domain. 
Therefore crystallisation trials may be intensified to obtain crystals that would allow structure 
determination. As rrPar-4CC contained a stretch of disordered residues at the N-terminus, a 
further optimisation of the Par-4 construct and the crystallisation conditions may be necessary.
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Appendix A: List of Suppliers
15N-ammonium chloride (99%) Cambridge Isotope Lab., Andover, USA
Amylose resin High Flow New England Biolabs, Ipswich, USA
Restriction Endonuclease BamH I New England Biolabs, Ipswich, USA
BL21(DE3) CodonPlus E. coli strain  Stratagene, La Jolla, USA
BSA  Sigma-Aldrich, St. Louis, USA
Chelating Sepharose Fast Flow GE Healthcare, Uppsala, Sweden
CM-sephadex Sigma Chemical Co., St. Louis, USA
Crystal Screen, HR2-110 Hampton Research, Aliso Viejo, USA
Crystal Screen 2, HR2-112 Hampton Research, Aliso Viejo, USA
Cuvette, plastic, 1 cm path-length Sarstedt, Nürnbrecht, Germany
Cuvette, quartz, 0.1 cm path-length Hellma, Müllheim, Germany
Delta Pak 15u C18-300Å, 300 x 3.9 mm column Waters Corporation, Milford, USA
Deuterium oxide (99.9%) Cambridge Isotope Lab., Andover, USA
DH5α E. coli strain Invitrogen, Carlsbad, USA
EDC  Sigma-Aldrich, St. Louis, USA
Restriction Endonuclease EcoR I Roche Applied Science, Penzberg, Germany
Gel Filtration Calibration Kit (6.5-75 kDa) GE Healthcare, Uppsala, Sweden
U13C6–D-glucose (99%) Cambridge Isotope Lab., Andover, USA
Glutaraldehyde (25%) Ajax Finechem, Taren Point, Australia
Glutathione Sepharose 4 Fast Flow GE Healthcare, Uppsala, Sweden
Restriction Endonuclease Hind III Roche Applied Science, Penzberg, Germany
HiTrap Q FF, 1 ml column  GE Healthcare, Uppsala, Sweden
HiTrap SP FF, 1 ml column  GE Healthcare, Uppsala, Sweden
Isopropyl-β-D-thiogalactopyranoside Probiogen Biochemicals, Milton, Australia
Jupiter 5u C18 300Å, 250 x 10 mm column Phenomenex Inc., Torrance, USA
KOD Hot Start DNA Polymerase Merck Biosciences, Darmstadt, Germany
Maltoheptaose agarose Sigma-Aldrich, St. Louis, USA
Molecular Weight Marker Kit (12-200 kDa) Sigma-Aldrich, St. Louis, USA
Restriction Endonuclease Nde I Roche Applied Science, Penzberg, Germany
pET23a/pET32a Merck Biosciences, Darmstadt, Germany
pH paper strips, pH-Fix 0-14 Macherey-Nagel, Düren, Germany
pH paper strips, Special indicator (5.2-7.2) Merck KGaA, Darmstadt, Germany
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pGex-4T-3/pGex-6P-3 GE Healthcare, Uppsala, Sweden
pProEX-HTb Invitrogen, Carlsbad, USA
Protease inhibitor cocktail set III Merck Biosciences, Darmstadt, Germany
Restriction Endonuclease Pst I Roche Applied Science, Penzberg, Germany
Pwo DNA Polymerase Roche Applied Science, Penzberg, Germany
QAE-sephadex Sigma-Aldrich, St. Louis, USA
Rosetta(DE3) E. coli strain Merck Biosciences, Darmstadt, Germany
Restriction Endonuclease Sal I Roche Applied Science, Penzberg, Germany
Superdex 75 10/300 GL column GE Healthcare, Uppsala, Sweden
Superdex 200 10/300 GL column GE Healthcare, Uppsala, Sweden
Syringe filter, 0.2 µm pore size, sterile  Advantec Toyo Kaisha, Tokyo, Japan
Syringe filter, 0.8 µm pore size, non-sterile Sartorius AG, Göttingen, Germany
T4 DNA Ligase Roche Applied Science, Penzberg, Germany
TALON cobalt affinity resin BD Biosciences, Palo Alto, USA
Thrombin Sigma-Aldrich, St. Louis, USA
TOP10 E.coli strain  Invitrogen, Carlsbad, USA
2,2,2-Trifluoroethanol-d3 (99,5%) Sigma-Aldrich, St. Louis, USA
Trypsin Sigma-Aldrich, St. Louis, USA
Ultrafree-MC Centrifugal Filter (0.22 µm) Millipore Corporation Billerica, USA
Vivaspin 20 Vivascience AG, Hannover, Germany
Restriction Endonuclease Xba I Roche Applied Science, Penzberg, Germany
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Appendix B: Plasmid maps of cell free expression vectors
p
AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGTCC...642bp...CCAAAATCGGATCTGGAAGTTCTGTTCCAGGGGCCCCTGGGATCCGAATTCGAGCTC
   MetSer...214aa...ProLysSerAspLeuGluValLeuPheGlnGlyProLeuGlySerGluPheGluLeu
Nde I
Xba IT7-Promoter rbs
GST-tag
Bgl II
CGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
ArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
3C protease cleavage site
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AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGTCC...642bp...CCAAAATCGGATGAAAACCTGTATTTTCAGGGATCCGAATTCGAGCTC
   MetSer...214aa...ProLysSerAspGluAsnLeuTyrPheGlnGlySerGluPheGluLeu
Nde I
Xba IT7-Promoter rbs
GST-tag
Bgl II
CGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
ArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
rTEV cleavage site
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AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGTCC...642bp...CCAAAATCGGATGATTACGATATCCCAACGACCGAAAACCTGTATTTTCAGGGATCCGAATTCGAGCTC
   MetSer...214aa...ProLysSerAspAspTyrAspIleProThrThrGluAsnLeuTyrPheGlnGlySerGluPheGluLeu
Nde I
Xba IT7-Promoter rbs
GST-tag
Bgl II
CGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
ArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
rTEV cleavage site
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AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGCATCACCATCACCATCACATGAAA..1089bp...CAGACTAATTCGAGCTCGAACAACAACAACAATAACAATAACAACAACCTCGGG
   MetHisHisHisHisHisHisMetLys...363aa...GlnThrAsnSerSerSerAsnAsnAsnAsnAsnAsnAsnAsnAsnAsnLeuGly
Nde I
Xba IT7-Promoter rbsBgl II
HMBP-tag
GAAAACCTGTATTTTCAGGGCGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
GluAsnLeuTyrPheGlnGlyGlySerGluPheGluLeuArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
rTEV cleavage site
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AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGTCGTACTACCATCACCATCACCATCACGATTACGATATCCCAACGACCGAAAACCTGTATTTTCAGTCC
   MetSerTyrTyrHisHisHisHisHisHisAspTyrAspIleProThrThrGluAsnLeuTyrPheGlnGly
Nde I
Xba IT7-Promoter rbsBgl II
His-tag
GGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
GlySerGluPheGluLeuArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
rTEV cleavage site
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AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA
CATATGAGC...315bp...CTGGCCGGTTCTGGTTCTGGCCATATGCATCACCATCACCATCACGATTACGATATCCCAACGACC
   MetSer...105aa...LeuAlaGlySerGlySerGlyHisMetHisHisHisHisHisHisAspTyrAspIleProThrThr
Nde I
Xba IT7-Promoter rbs
Trx-tag
Bgl II
Nde IMsc I His-tag
GAAAACCTGTATTTTCAGGGCGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA
GluAsnLeuTyrPheGlnGlyGlySerGluPheGluLeuArgArgGlnAlaCysGlyArgThrArgAlaProProProProProLeuArgSerGlyCysEnd
BamH I EcoR I Sac I
Hinc II
Sal I Hind III
Eag I
Not I Xho I
CAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7-terminator
rTEV cleavage site
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Appendix C: Initial NMR spectroscopic characterisation of
Par-4(286-332)WT
 As discussed in Chapter 2.12.2, Par-4(286-332) constructs purified according to the original 
protocol described in Chapter 2.11.1. were unstable and displayed a poor spectral quality. In 
comparison to the more stable RP-HPLC purified rrPar-4LZ, Par-4(286-332)WT purified with 
original protocol displays a multitude of additional peaks at neutral pH (Fig. A.1A). As the Par-4 
LZ domain is disordered under these conditions only 49 peaks are expected (51 residues - 1 N-
terminal residue - 1 prolyl residue). With decreasing pH the number of additional peaks increases 
(Fig. A.1B and C). It was therefore assumed that this increase in peak number is associated with 
an increase in secondary structural content, as is suggested by CD spectroscopy  for a decreasing 
pH [184].
 Interestingly, a Par-4(286-332)WT sample that went through the whole pH titration process 
from pH 7.5 immediately  down to 3.4 and then stepwise back to 7.5 (Fig. A.1C and D) shows a 
significant difference in peak numbers between the start and end point of the titration process 
(Fig. A.1D). To obtain spectra at intermediate pH values around pH 5 it was necessary to drop 
the pH first below 4 and then steadily  increase it back to 7.5. Otherwise, if the pH is decreased 
stepwise from neutral pH precipitation occurred below pH 6.0. Note that the spectra in Figure 
A.1D are from two different  NMR samples but  from the same stock solution. A spectrum at 
neutral pH was not acquired prior to the pH titration as this was done with the previous sample 
shown in black contours in Figure A.1D. The observed difference between both spectra suggests 
that the increase in additional peak numbers is a time dependent process probably  due to 
degradation. It should be noted that between individual measurements at each pH value several 
days passed allowing for degradation (Fig. A.1). Similar spectra were obtained for Par-4
(286-332)D305K and Par-4(286-332)E310K also suggesting degradation. Both LZ point mutants 
were purified with the same original protocol as Par-4(286-332)WT.
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 Figure A.1 − 1H,15N-TROSY-HSQC spectra of Par-4(286-332)WT. (A) Pairwise comparison of the 1H,
15N-TROSY-HSQC spectrum of Par-4(286-332)WT at pH 7.5 (black contours) with the 1H,15N-SOFAST-
HMQC spectrum  of rrPar-4LZ at pH 7.0 (red contours). (B) Overlay of the 1H,15N-TROSY-HSQC spectra 
of Par-4(286-332)WT at pH 7.5 (black contours) and pH 5.8 (red contours); (C) at pH 5.5 (black 
contours) and pH 3.4 (red contours); and (D) at pH 7.5. Spectra in D were acquired with two NMR 
samples at different dates before and after the pH titration. All spectra were acquired at 5 ºC. Further 
acquisition parameters are given in Appendix G. Par-4(286-332)WT was uniformly 2H,15N-labelled; 
rrPar-4LZ was uniformly 15N-labelled. Sample conditions were 200 µM Par-4(286-332)WT in 20 mM 
Na2HPO4/NaH2PO4, pH 7.5, 6.0, 5.5 or 3.4, respectively, and 5% D2O (v/v); 75 µM rrPar-4LZ in 20 mM 
NaCl, 10 mM Tris, pH 7.0 and 5% D2O (v/v). The rationale for using a deuterated Par-4(286-332)WT 
sample was to reduce line broadening contributions arising due to aggregation.
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Appendix D: NMR spectroscopy of the Par-4 LZ domain as GST fusion 
protein
a) Materials and Methods
 The GST-Par-4(286-332)WT fusion protein (GST-LZ) was purified as described in 
Chapter 2.11.4. After adding D2O to 5% (v/v) the sample was used for NMR spectroscopy. The 
GST-LZ concentration was 30 µM. After acquisition of an 1H,15N-HSQC reference spectrum, 
half of the NMR sample was dialysed overnight at  4 ºC to 500 ml 50 mM  NaCl, 1 mM DTT and 
20 mM Na2HPO4/NaH2PO4, pH 5.5. The final NMR sample had a concentration of ~15 µM 
GST-LZ and contained 5% D2O (v/v). 1H,15N-HSQC spectra were recorded and processed as 
described in Chapter 3.4.1.b. Acquisition parameters are given in Appendix G.
b) Results and Discussion
 Due to the stability problems of the Par-4 LZ peptides mentioned in Chapter 2.12.2, 
alternative methods to analyse the Par-4 LZ domain were sought. As mentioned in Chapter 3.6, 
for small GST-fusion proteins signals in 1H,15N-HSQC spectra almost exclusively  arise from the 
target protein [230]. It was proposed that  signals of the GST-tag are probably broadened beyond 
observable limits due to dimerisation of GST. As the target protein is attached to GST through a 
linker sequence, it retains a certain degree of flexibility allowing rapid reorientation that results 
in observable peaks. Since the Par-4(286-332)WT construct is 5.9 kDa in size it  seemed likely 
that it can be studied in this way. It  was further thought that the GST tag might also increase the 
stability  of the LZ construct and prevent proteolytic degradation to a certain extent. Furthermore, 
non-specific aggregation may be minimised in the presence of the bulky  GST-tag. As mentioned 
in Chapter 2.12.2, these two factors are likely to be related to the poor quality  of the initial NMR 
spectra. Even though these considerations made the study of GST-LZ an interesting target, other 
factors limiting this approach were considered as well. The presence of the bulky GST tag may 
interfere or prevent oligomerisation of the attached LZ domain. Also oligomerisation of the LZ 
domain may  affect the tumbling rate and hence lead to line broadening of the peaks associated 
with the LZ domain.
 For comparative purposes 1H,15N-HSQC spectra of GST-LZ were acquired at pH 7.0 and 
25 ºC as a reference for a disordered conformation. As mentioned earlier, coiled coil formation of 
the Par-4 LZ domain is pH and temperature dependent [184]. An NMR buffer at pH 5.5 was 
therefore used to study  GST-LZ under conditions where the LZ tag is supposed to be mostly 
folded. Comparison of the NMR spectrum of GST-LZ at pH 7.0 and 25 ºC with rrPar-4LZ at 
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pH 7.0 and 25 ºC shows that both spectra are similar (Fig. A.2A). The spectrum of rrPar-4LZ at 
pH 7.0 and 25 ºC serves as an example for a mostly  disordered conformation of the isolated 
(non-GST-tagged) Par-4 LZ domain (Chapter 4.3.2.). As expected, the narrow 1H chemical shift 
dispersion and the sharp peaks observed for the GST-LZ spectrum are consistent with an 
unfolded conformation for the LZ tag under these conditions. Approximately  56 peaks are 
counted for GST-LZ consistent with the assumption that next to the resonances from the LZ tag 
(52 residues) also signals from the linker sequence are visible. An exact peak count is difficult 
due to significant signal overlap in the centre of the spectrum. Note that no assignments were 
made for this spectrum.
 Figure A.2 − NMR spectroscopy of the Par-4 LZ domain as a GST-fusion protein. (A) Pairwise 
comparison of the 1H,15N-SOFAST-HMQC spectrum of rrPar-4LZ at pH 7.0 (black contours) with the 1H,
15N-HSQC spectrum of GST-LZ at pH 7.0 (red contours). Both spectra were acquired at 25 ºC. (B) 
Overlay of the 1H,15N-HSQC spectra at 25 ºC of GST-LZ at pH 7.0 (red contours) and pH 5.5 (black 
contours). (C) Temperature dependance of the 1H,15N-HSQC spectra of GST-LZ at pH 5.5. Displayed are 
the spectra recorded at 5ºC (red contours) and 25 ºC (black contours). Sample concentration were 75 µM 
rrPar-4LZ in 20 mM NaCl, 10 mM Tris, pH 7.0 and 5% D2O (v/v); 30 µM GST-LZ in 50 mM NaCl, 1 mM 
DTT and 20 mM Na2HPO4/NaH2PO4, pH 7.0 and 5% D2O (v/v), and 15 µM GST-LZ in 50 mM NaCl, 
1 mM DTT and 20 mM Na2HPO4/NaH2PO4, pH 5.5 and 5% D2O (v/v). Acquisition parameters are given 
in Appendix G.
 A drop in pH to 5.5 results only in minor changes for GST-LZ at 25 ºC (Fig. A.2B). Some 
shifted resonances are visible at pH 5.5 relative to pH 7.0, however, the overall spectrum is still 
indicative of a disordered conformation. The peak number seems to be unchanged with 51 easily 
identified peaks. Again spectral overlap prevents an exact peak count. Note that the pH decrease 
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to 5.5 did not resulted in protein precipitation as was observed for the isolated rrPar-4LZ 
constructs indicating that GST improved the solubility at pH 5.5. A decrease in temperature to 
further stabilise the coiled coil conformation at pH 5.5 does not  result in significant changes of 
the NMR spectrum (Fig. A.2C). A notable difference between the two spectra at pH 5.5 is the 
intensity decrease for some of the resonances at 5 ºC relative to 25 ºC. This seems to be related 
to the slightly decreased peak number of approximately 46 peaks. A similar cross peak intensity 
decrease that accompanied a drop in pH was observed for rrPar-4LZ (Chapter 4.3.2.). Coiled coil 
formation of GST-LZ could not be verified as a CD spectrometer was not available at this time. 
It is therefore possible that the presence of a GST tag prevented coiled coil formation. However, 
SEC indicated a self-association of the GST-LZ beyond the expected dimeric state of GST (data 
not shown).
 Taken together, an improvement in the NMR spectra that would allow a structural 
characterisation of the Par-4(286-332)WT construct at various pH values could not be achieved 
using a GST fusion protein of Par-4(286-332)WT. Since the results of RP-HPLC purified 
rrPar-4LZ showed no stability  problems or signs of excessive aggregation, analysis of the GST-
LZ fusion protein was not pursued further. This approach, however, may prove useful for the 
study of binding partners of the LZ domain. Various conditions for protein-protein interactions 
such as pH or protein concentration can be easily screened in this way [230].
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Appendix E: Calibration curves for size exclusion chromatography
 Calibration curves were established with Superdex 75 and 200 columns connected to the 
BioLogic DuoFlow System and using isocratic flow of 0.4 ml/min at  4 ºC. The Kav value is 
defined as Kav = (Ve-V0)/(Vc-V0), where Vc is the geometric column volume, V0 is the column 
void volume and Ve is the elution volume of the molecular weight marker. Trend line equations 
and R2 values are given for each column.
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Appendix F: CD spectropolarimetry acquisition parameters
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Appendix G: NMR spectroscopy acquisition parameters
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Appendix H: Chemical Shifts for Par-4(286-332)WT
Residue Hα (ppm) Cα (ppm) Cβ (ppm) C’ (ppm)
Gly -4 4.01 43.25 N/A N/A
Pro -3 4.50 63.52 32.31 177.63
Gly -2 4.03 45.25 N/A 174.47
Ser -1 4.45 58.61 63.76 174.93
Gln 286 4.37 55.99 29.34 175.86
Asp 287 4.57 54.74 41.13 176.45
Lys 288 N/A 56.85 33.01 176.83
Glu 289 4.26 56.95 30.31 176.89
Glu 290 4.25 56.84 30.34 176.78
Met 291 N/A 55.71 32.65 176.55
Ile 292 N/A 61.88 38.50 177.78
Gly 293 3.94 45.45 N/A 174.24
Lys 294 4.32 56.39 33.31 176.91
Leu 295 4.35 55.43 42.30 177.72
Lys 296 N/A 57.04 32.97 176.78
Glu 297 4.25 56.64 30.41 176.59
Glu 298 4.28 56.88 30.29 176.96
Ile 299 4.08 61.77 38.93 176.32
Asp 300 4.26 54.66 41.00 176.55
Leu 301 4.24 55.86 42.21 174.93
Leu 302 N/A 55.65 42.07 176.55
Asn 303 N/A 53.35 38.80 175.26
Arg 304 N/A 56.38 30.97 176.16
Asp 305 4.58 54.73 40.98 176.55
Leu 306 4.30 55.49 42.23 177.60
Asp 307 N/A 54.75 41.13 176.19
Asp 308 4.59 54.49 41.00 176.42
Met 309 4.48 55.64 32.83 176.62
Glu 310 4.24 56.87 30.27 176.96
Asp 311 4.58 54.55 41.38 176.90
Glu 312 4.21 57.58 29.99 176.98
Asn 313 4.67 54.15 38.88 176.33
Glu 314 4.14 58.04 29.77 177.68
Gln 315 4.18 57.39 28.77 177.33
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Residue Hα (ppm) Cα (ppm) Cβ (ppm) C’ (ppm)
Leu 316 4.18 56.16 41.98 178.20
Lys 317 4.22 57.37 32.81 177.63
Gln 318 4.26 56.42 29.21 176.83
Glu 319 4.21 57.35 30.16 176.82
Asn 320 4.70 53.68 38.57 175.88
Lys 321 4.31 57.13 32.88 177.34
Thr 322 N/A 62.94 69.52 174.70
Leu 323 4.34 55.40 42.24 177.29
Leu 324 4.32 55.22 42.25 177.26
Lys 325 4.32 56.28 33.07 176.45
Val 326 4.11 62.33 32.91 176.40
Val 327 4.09 62.87 32.77 176.84
Gly 328 3.96 45.21 N/A 173.93
Gln 329 4.33 55.77 29.78 176.08
Leu 330 4.44 55.29 42.45 177.62
Thr 331 4.36 61.84 70.08 173.64
Arg 332 N/A 57.483 31.471 N/A
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